{
  "experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600
  },
  "results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "The number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) is **37,028 thousand**, as disclosed in its 2022 10-K filing (Chunk 1 and Chunk 2), while Procter & Gamble (PG) has **2 million securities** remaining available for future issuance under its equity compensation plans, specifically for stock options, restricted stock units, and performance stock units (Chunk 3). This comparison directly addresses the question by contrasting CL’s 37,028 thousand available securities with PG’s 2,000,000 securities, leveraging the KG triplet connection that links CL’s equity plans to PG through the \"Securities Remaining Available\" entity.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> Equity Compensation Plans Approved by Security Holders (FIN_INST)",
        "Equity Compensation Plans Approved by Security Holders (FIN_INST) -> Securities Remaining Available (FIN_INST)",
        "Securities Remaining Available (FIN_INST) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6948,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2468,
        "completion_tokens": 181,
        "total_tokens": 2650
      }
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google's foreign exchange forward contracts exhibit sensitivity to a 10% U.S. dollar weakening of approximately $946 million (2023) and $660 million (2024) in cumulative translation adjustment (CTA), reflecting risk mitigation through hedging of forecasted foreign currency transactions linked to Disney (DIS) via the KG pattern ORG -[Invests_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Hedges]- ORG. Disney's hedge coverage demonstrates significantly larger notional exposure at $9.9 billion (as of September 2024) for forecasted foreign currency transactions, with net deferred gains of $99 million in AOCI for contracts maturing within 12 months, enabling targeted risk mitigation over a multi-year horizon (generally up to four years) to offset earnings volatility from foreign exchange movements.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Hedges]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Foreign Exchange Forward Contracts (FIN_INST)",
        "Foreign Exchange Forward Contracts (FIN_INST) -> Forecasted Transactions (FIN_INST)",
        "Forecasted Transactions (FIN_INST) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8095,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2719,
        "completion_tokens": 199,
        "total_tokens": 2919
      }
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble (PG) has 2,814,005 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive (CL) has 37,028 securities remaining available under the same category, as shown in their respective disclosures. This comparison is derived from the KG triplet relationship where both companies disclose \"Securities Remaining Available\" under \"Equity Compensation Plans Approved by Security Holders,\" with PG reporting 2,814,005 (from the total of 133,185,995 minus 130,371,990 in columns a and b) and CL reporting 37,028 (from column c), both explicitly tied to their approved plans through the disclosed financial instruments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> Securities Remaining Available (FIN_INST)",
        "Securities Remaining Available (FIN_INST) -> Equity Compensation Plans Approved by Security Holders (FIN_INST)",
        "Equity Compensation Plans Approved by Security Holders (FIN_INST) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6948,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2455,
        "completion_tokens": 175,
        "total_tokens": 2630
      }
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie's patent litigation against Sandoz Inc. over upadacitinib (Rinvoq) involves filing a Delaware antitrust lawsuit in November 2023 to enforce its patents against Sandoz's proposed generic version, seeking declaratory and injunctive relief to block commercial manufacture and sales until patent expiration. This legal strategy directly parallels Amgen's approach in its denosumab biosimilar patent dispute with Sandoz, where Amgen similarly filed a New Jersey District Court lawsuit in June 2023 to enforce its asserted patents (11,434,514 among others) against Sandoz's biosimilar candidate, seeking permanent injunctions and monetary remedies for alleged infringement, while also responding to Sandoz's counterclaims challenging patent validity. Both cases exemplify how major biopharma companies leverage patent litigation to block biosimilar competition, with AbbVie's upadacitinib enforcement against Sandoz and Amgen's denosumab defense against Sandoz's counterclaims reflecting a coordinated industry tactic of using patent enforcement to delay generic/biosimilar market entry through injunctive relief and counterclaims over patent validity.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP -[Discloses]-> LITIGATION <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Sandoz, Inc. (COMP)",
        "Sandoz, Inc. (COMP) -> Counterclaims (LITIGATION)",
        "Counterclaims (LITIGATION) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_156",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_156",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15777,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4614,
        "completion_tokens": 288,
        "total_tokens": 4902
      }
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "The voting power dilution mechanism in CMCSA's Class B to Class A conversion differs significantly from GOOGL's structure: CMCSA's Class B shares carry 15 votes per share and maintain a fixed 33.3% non-dilutable voting block that converts share-for-share into Class A stock with identical voting rights, while GOOGL's Class B shares convert to Class A shares with identical voting rights (1 vote per share) but its $62.2 billion 2023 repurchase of Class A and Class C shares directly reduces the total outstanding shares that carry voting rights, potentially amplifying relative voting power of remaining shares. This repurchase activity, authorized by GOOGL's Board for up to $70 billion of Class A and Class C shares (with $36.3 billion remaining as of December 2023), creates a structural contrast where GOOGL actively reduces its voting-equity base through buybacks, whereas CMCSA's conversion mechanism preserves a fixed voting percentage through contractual non-dilution clauses.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Converts_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3791,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1638,
        "completion_tokens": 246,
        "total_tokens": 1884
      }
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Based on the provided 10-K filings and knowledge graph relationships, the number of shares reserved for future issuance under Nike's Equity Compensation Plan is **97,567,370 shares** (as disclosed in NKE's 2023 filing, Chunk 1, Item 12, and quantified in Chunk 2's \"Number of securities remaining available for future issuance\" column), while Tesla's outstanding warrants represent **11 shares** (as shown in TSLA's 2023 diluted share calculation in Chunk 3, where \"Warrants\" are explicitly listed as 11 weighted average shares for 2023). This comparison highlights that Nike has reserved approximately 8.9 million times more shares for future issuance under its plan than the total warrants outstanding at Tesla, reflecting vastly different capital allocation strategies between the two companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Equity Compensation Plan (ACCOUNTING_POLICY)",
        "Equity Compensation Plan (ACCOUNTING_POLICY) -> Warrants (FIN_INST)",
        "Warrants (FIN_INST) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8670,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2849,
        "completion_tokens": 199,
        "total_tokens": 3049
      }
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Based on the disclosures in all three chunks, Tesla's 2023 10-K (Chunk 1) reveals that the weighted average shares used in computing diluted net income per share were 3,485 million, which includes 11 million shares issuable upon exercise of outstanding warrants. This is confirmed by the KG triplet relationship showing Warrants (FIN_INST) -> Equity Compensation Plan (ACCOUNTING_POLICY) -> NKE (ORG), linking Tesla's warrants to Nike's equity compensation framework. Nike's 2023 10-K (Chunk 2) explicitly states that 97,567,370 shares remain available for future issuance under its equity compensation plans, while Chunk 3 (NKE_10k_2023.pdf) confirms this information is part of Nike's \"Executive Compensation - Equity Compensation Plan Information\" disclosure required by SEC regulations. Therefore, the number of shares issuable upon exercise of Tesla's outstanding warrants (11 million) is significantly smaller than the shares remaining available for future issuance under Nike's equity compensation plans (97.6 million).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Warrants (FIN_INST)",
        "Warrants (FIN_INST) -> Equity Compensation Plan (ACCOUNTING_POLICY)",
        "Equity Compensation Plan (ACCOUNTING_POLICY) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8670,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2859,
        "completion_tokens": 256,
        "total_tokens": 3116
      }
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "The differential voting power in GOOGL's Class B common stock—granting 10 votes per share versus one vote per share for Class A and no voting rights for Class C—creates a concentrated control structure where insiders and long-term investors holding Class B shares can dominate board elections and strategic decisions, fundamentally shaping Alphabet's governance by prioritizing management continuity over broad shareholder participation; this contrasts sharply with Netflix's uniform voting model where each share carries exactly one vote, ensuring a more equitable one-share-one-vote system that aligns shareholder and management interests through standard democratic governance practices observed across most public companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4679,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1851,
        "completion_tokens": 182,
        "total_tokens": 2033
      }
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Based on the KG pattern and all provided chunks, Chevron (CVX) holds a 30.0% stake in Qatargas Operating Company Limited (QG3), which directly produces crude oil. Chunk 2 and 3 confirm that QG3's average daily net crude oil production in 2021 was 13 MBD, and Chevron's interest in this project is explicitly stated as 30.0% in the \"Interest\" column. Therefore, 30.0% of Chevron's average daily net crude oil production from QG3 through its stake in Qatargas Operating Company Limited came from this specific project.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Produces]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Crude Oil (RAW_MATERIAL)",
        "Crude Oil (RAW_MATERIAL) -> Qatargas Op Co Ltd (COMP)",
        "Qatargas Op Co Ltd (COMP) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 1550,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1046,
        "completion_tokens": 129,
        "total_tokens": 1175
      }
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "The adoption of ASU 2022-04 requires both 3M and Honeywell to disclose roll-forward information for supplier finance program obligations, enhancing transparency of these liabilities. 3M began roll-forward disclosures in 2024 (effective January 1, 2024), reporting approximately $0.3 billion in outstanding confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during 2024, while Honeywell adopted the same guidance effective January 1, 2024, though its specific roll-forward amounts are not detailed in the provided materials. Both companies now provide annual disclosures of key program terms, balance sheet presentation details, and rollforward activity, with Honeywell explicitly citing the ASU’s requirement for \"annual disclosure of the key terms of the program, a description of where in the financial statements amounts outstanding under the program are presented, a rollforward of such amounts, and interim disclosure of amounts outstanding as of the end of each period\" to improve transparency of supplier finance obligations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Agrees]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Supplier Finance Programs (ACCOUNTING_POLICY)",
        "Supplier Finance Programs (ACCOUNTING_POLICY) -> ASU 2022-04 (ACCOUNTING_POLICY)",
        "ASU 2022-04 (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15549,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4576,
        "completion_tokens": 268,
        "total_tokens": 4845
      }
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "LMT's revenue recognition approach for U.S. Government contracts, governed by FAR, treats contracts as single performance obligations with transaction prices typically equal to the contract-stated price due to regulatory constraints, and recognizes revenue over time as control transfers continuously to the government customer 【Chunk 1】.  \nRTX faces significant financial exposure to U.S. Government contract risks under fixed-price structures—including firm fixed-price (FFP) and fixed-price incentive (FPI) contracts—where it bears full cost overruns beyond negotiated ceilings, and these contracts are subject to termination for convenience or default, partial funding, and potential cost disallowances that can materially affect profitability 【Chunk 3】.  \nBoth companies operate under the FAR framework, with LMT’s contracts subject to FAR and CAS cost audits, while RTX highlights that fixed-price contracts under FAR expose it to the risk of unrecoverable cost increases and require careful cost control to avoid adverse financial impacts 【Chunk 2】 and 【Chunk 3】.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> FAR (REGULATORY_REQUIREMENT)",
        "FAR (REGULATORY_REQUIREMENT) -> U.S. Government Contracts (REGULATORY_REQUIREMENT)",
        "U.S. Government Contracts (REGULATORY_REQUIREMENT) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16721,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4876,
        "completion_tokens": 267,
        "total_tokens": 5144
      }
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "The expiration timeline of BMY's Eliquis patent rights in Europe involves ongoing litigation across multiple countries, with final negative decisions in the UK (allowing generic entry), positive decisions in Norway, Sweden, and Switzerland, and appeals pending in key markets like Spain (where a composition-of-matter patent was initially invalidated but later overturned on appeal) and Finland (where generics have entered despite pending proceedings). This complex European landscape directly impacts BMY's market exclusivity strategy by forcing reliance on appeals and injunctions to delay generic competition, while the KG pattern shows Market Exclusivity (REGULATORY_REQUIREMENT) is negatively impacted by Patent Rights (RISK_FACTOR) and tied to BMY's legal enforcement efforts. In contrast, MRK's Januvia family patent in the U.S. expired in January 2023, but due to favorable court rulings on later expiring salt-form patents and regulatory exclusivity extensions, market exclusivity is maintained until May 2026 (for Januvia) and July 2026 (for Janumet XR), with the KG triplet revealing that Market Exclusivity (REGULATORY_REQUIREMENT) is positively linked to MRK (ORG) through patent strategy and regulatory compliance. Consequently, BMY's European patent battles require active litigation to sustain exclusivity, whereas MRK leverages patent term extensions and regulatory mechanisms to delay U.S. generic entry, creating divergent market exclusivity strategies where BMY faces fragmented European enforcement risks and MRK utilizes structured patent term management to prolong U.S. exclusivity.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR -[Provides]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Patent Rights (RISK_FACTOR)",
        "Patent Rights (RISK_FACTOR) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13454,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4054,
        "completion_tokens": 401,
        "total_tokens": 4455
      }
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "The total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal is $35 million, as disclosed in the litigation‑related deposits and payments note (Chunk 2). Since October 2004, PM USA has paid judgments and settlements (including related costs and fees) of approximately $1 billion plus about $241 million of interest, a cumulative total that is disclosed in the litigation overview (Chunk 3). Thus, the appeal‑bond amount ($35 million) represents a small fraction of the roughly $1.24 billion in payments made for adverse tobacco‑related verdicts and settlements over the same period.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> COMP -[Posts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PM (ORG) -> PM USA (COMP)",
        "PM USA (COMP) -> Appeal Bonds (FIN_INST)",
        "Appeal Bonds (FIN_INST) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 26164,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 7209,
        "completion_tokens": 152,
        "total_tokens": 7362
      }
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple's 2022 Greater China net sales were $74,200 million, which includes Taiwan within its geographic segment. NVIDIA reported direct revenue from Taiwan of $8,544 million for the same fiscal year. This shows Taiwan contributed approximately 11.5% of Apple's Greater China revenue ($8,544 ÷ $74,200), while representing a significant standalone revenue stream for NVIDIA. The KG triplet Taiwan → NVDA confirms NVIDIA's direct operational presence in Taiwan, distinct from Apple's regional segment reporting.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Greater China (GPE)",
        "Greater China (GPE) -> Taiwan (GPE)",
        "Taiwan (GPE) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3164,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 127,
        "total_tokens": 1568
      }
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "NVDA's revenue growth from Taiwan was 182% from $3,025M in fiscal 2020 to $8,544M in fiscal 2022, while AAPL's revenue from Greater China (which includes Taiwan) grew 84% from $40,308M in fiscal 2020 to $74,200M in fiscal 2022, reflecting significantly faster growth in NVDA's Taiwan-specific revenue compared to AAPL's broader Greater China region growth.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3164,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 89,
        "total_tokens": 1533
      }
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft's effective tax rate of 18% in fiscal 2024 reflects a lower rate than the U.S. statutory rate, driven by foreign earnings taxed at reduced rates in jurisdictions like Ireland, where it maintains regional operations centers. This structure positions Microsoft to be impacted by the OECD's Pillar Two Global Minimum Tax rules, which establish a 15% minimum corporate tax rate for multinational enterprises beginning in fiscal 2025, potentially increasing its global tax liability as countries implement related legislation.\n\nBroadcom (AVGO), subject to global minimum tax rules in jurisdictions like Singapore (effective for fiscal 2026), faces materially increased effective tax rates and cash tax costs due to its broader international footprint and operational mix, as noted in its disclosure of volatility from tax reforms and anti-base erosion legislation. While Microsoft anticipates no material impact from Pillar Two implementation due to its lack of operations in low-tax jurisdictions, Broadcom explicitly identifies substantial risks from global minimum tax adoption, including potential material increases to its tax provisions and cash flows. Both companies are subject to tax audits across jurisdictions, but Microsoft's exposure to the OECD rules is framed as monitor-only with no current material estimate, whereas Broadcom's disclosures highlight concrete, material adverse consequences from similar regulatory shifts.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Pillar Two Model Rules (REGULATORY_REQUIREMENT)",
        "Pillar Two Model Rules (REGULATORY_REQUIREMENT) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11480,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3569,
        "completion_tokens": 360,
        "total_tokens": 3929
      }
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "The voting rights structure fundamentally shapes shareholder influence, as NFLX common stock carries only one vote per share, while GOOGL Class B common stock carries 10 votes per share, creating a significant disparity in voting power that directly impacts corporate governance and decision-making authority among shareholders. This structural difference is explicitly defined in the accounting policies of both companies, where voting rights are tied to specific stock classes (NFLX's common stock and GOOGL's Class B common stock), and is reinforced by the organizational relationships captured in the knowledge graph triplets linking these entities to their respective accounting policies and financial instruments. Consequently, GOOGL Class B shareholders wield substantially greater influence over corporate matters compared to NFLX shareholders, who have equal voting rights per share, thereby concentrating control in the hands of Class B shareholders despite the company's overall equity structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Has]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3632,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 251,
        "total_tokens": 1849
      }
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD generated $2,091 million in revenue from Taiwan in 2021 (per Chunk 1), while Apple's Greater China segment—which includes Taiwan—reported $74,200 million in net sales for 2022 (per Chunk 3). This comparison highlights that Apple's total revenue from the broader Greater China region (encompassing mainland China, Hong Kong, and Taiwan) in 2022 was approximately 35 times larger than AMD's standalone 2021 revenue from Taiwan alone. The KG relationship confirms Taiwan is included within Greater China (Chunk 1 triplet: Taiwan → Greater China), establishing the geographic linkage required for this cross-entity comparison.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3505,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 156,
        "total_tokens": 1675
      }
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, specifically enabling incentive stock option grants to employees under its compensation strategy. Starbucks, by contrast, reported 99.7 million shares available for future equity-based compensation awards and 10.8 million shares reserved for its ESPP as of October 2, 2022, reflecting its broader equity grant capacity that includes incentive stock options as part of its incentive structure. Both companies utilize incentive stock options within their respective plans, but Tesla's reserved shares under the 2019 Plan represent a defined reserve for future grants, while Starbucks' available shares encompass both general equity awards and its employee stock purchase plan.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Grants]-> FIN_INST -[Includes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Incentive Stock Options (FIN_INST)",
        "Incentive Stock Options (FIN_INST) -> 2019 Plan (ACCOUNTING_POLICY)",
        "2019 Plan (ACCOUNTING_POLICY) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3066,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 198,
        "total_tokens": 1655
      }
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "GD employs valuation models that incorporate broker/dealer quotes as key observable inputs for Level 2 assets, specifically for fixed-income securities and commingled funds where underlying investments are valued using market-based inputs like quoted prices for similar assets and unit prices derived from observable market data, resulting in fair value measurements dependent on third-party broker/dealer quotes. In contrast, BA's approach for available-for-sale debt investments uses broker/dealer quotes as part of a market approach but explicitly emphasizes industry-standard valuation models (including income and market-based methods) where all significant inputs—such as broker/dever quotes on same/similar securities, credit spreads, and benchmark rates—are observable, directly integrating these quotes into fair value estimation without hierarchical distinctions between Level 1 and Level 2 inputs as seen in GD's plan assets. Both companies utilize broker/dealer quotes in their fair value frameworks, but GD applies them within a defined Level 2 hierarchy for pension plan assets, while BA incorporates them more broadly across available-for-sale securities and derivatives using observable market inputs as standard practice.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GD (ORG) -> Valuation Models (ACCOUNTING_POLICY)",
        "Valuation Models (ACCOUNTING_POLICY) -> Broker/Dealer Quotes (FIN_INST)",
        "Broker/Dealer Quotes (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4631,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1834,
        "completion_tokens": 309,
        "total_tokens": 2144
      }
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "The current zero percent Countercyclical Capital Buffer (CCyB) reduces the overall capital buffer requirement for both Morgan Stanley and American Express under Basel III, as the CCyB is a component of the total buffer calculated in both the standardized and advanced approaches. Morgan Stanley incorporates the Stress Capital Buffer (SCB) into its Advanced Approach calculation, while American Express is explicitly subject to the SCB, meaning its buffer requirement includes this additional layer despite the CCyB being set at zero. Consequently, the total regulatory capital buffer for each firm is determined by summing the capital conservation buffer, G-SIB surcharge, CCyB (currently 0%), and the Stress Capital Buffer, with the latter being mandatory for American Express through regulatory subjectivity.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MS (ORG) -> Capital Conservation Buffer (REGULATORY_REQUIREMENT)",
        "Capital Conservation Buffer (REGULATORY_REQUIREMENT) -> Stress Capital Buffer (REGULATORY_REQUIREMENT)",
        "Stress Capital Buffer (REGULATORY_REQUIREMENT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3785,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1687,
        "completion_tokens": 202,
        "total_tokens": 1890
      }
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "The $4.0 billion increase in the AMT 2021 Credit Facility’s commitment (bringing total commitments to $4.0 billion) was explicitly used to help fund the CoreSite acquisition and to repay existing indebtedness, reflecting AMT’s strategy of expanding its revolving‑credit capacity to finance acquisitions and corporate growth.  In contrast, SPG’s financing approach as of December 31, 2021 relied on real‑estate joint ventures—using joint‑venture structures and construction‑loan financing to fund property development and to diversify risk—rather than increasing a corporate credit facility to support acquisitions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Supplies]-> FIN_INST <-[Supplies]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Credit Facility (FIN_INST)",
        "2021 Credit Facility (FIN_INST) -> Financing (FIN_INST)",
        "Financing (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8202,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2729,
        "completion_tokens": 153,
        "total_tokens": 2883
      }
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks' Taiwan stores grew from 523 to 544 locations between 2021 and 2022 (a 21-store increase), representing part of its 1,169-store global net expansion during that period. Nike's Greater China region, which includes Taiwan, contributed $7,547 million in revenue in 2022 according to Nike's financial reporting, where Taiwan is explicitly included within the Greater China geographic segment. This revenue figure reflects Nike's operations across mainland China, Hong Kong, and Taiwan as a single reporting unit.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8160,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2698,
        "completion_tokens": 129,
        "total_tokens": 2828
      }
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing's OPB plan assets are indirectly invested in equities through the balanced index fund, which comprises approximately 60% equities, confirming that equities represent a defined portion of the fund's composition. However, the provided text does not specify the exact percentage of OPB plan assets indirectly invested in equities via this fund, only stating the fund's internal allocation (60% equities, 40% debt). Meanwhile, 3M's (MMM) pension plan held $785 million in equities at fair value as of December 31, 2023, as reported in its 10-K, but this figure represents the total fair value of equities held directly by MMM's plan, not a comparative percentage of Boeing's OPB assets. Thus, while the KG pattern links BA → Balanced Index Fund → Equities ← Discloses MMM, the data provided only allows stating that Boeing's OPB fund includes equities (60% of the fund), and MMM's plan had $785M in equities, without enabling a direct percentage comparison between Boeing's indirect equity exposure and MMM's total equity holdings.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BA (ORG) -> Balanced Index Fund (FIN_INST)",
        "Balanced Index Fund (FIN_INST) -> Equities (FIN_INST)",
        "Equities (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8433,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2786,
        "completion_tokens": 258,
        "total_tokens": 3044
      }
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "AMT accessed $1.0 billion of 2021 USD Delayed Draw Term Loans, which are classified as financing instruments that directly support its liquidity and capital resources, and the same financing category is linked to SPG through the KG pattern ORG → FIN_INST ← ORG, indicating that SPG also utilizes comparable financing structures for its real‑estate joint ventures. While AMT’s delayed‑draw facility amounts to roughly $1 billion, SPG’s joint‑venture financing is disclosed as construction loans and other advances totaling $88.4 million, reflecting a markedly smaller dollar scale but a similar reliance on debt‑based funding to fund property development and acquisitions. Both companies therefore employ delayed‑draw term‑loan or construction‑loan mechanisms, yet AMT’s financing is orders of magnitude larger and is tied to its senior unsecured term loan and credit facilities, whereas SPG’s financing is embedded in joint‑venture construction loans used to fund specific real‑estate projects.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Supplies]-> FIN_INST <-[Supplies]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 USD Delayed Draw Term Loans (FIN_INST)",
        "2021 USD Delayed Draw Term Loans (FIN_INST) -> Financing (FIN_INST)",
        "Financing (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5179,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1975,
        "completion_tokens": 248,
        "total_tokens": 2223
      }
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "XOM relies on crude oil as its primary raw material, which is transported via the Caspian Pipeline Consortium (CPC) from Chevron-operated Kazakhstan fields like Tengiz and Karachaganak—fields producing 1.2 million barrels per day and 0.2 million barrels per day respectively, all exported through CPC. Chevron holds a 15 % stake in CPC, meaning its equity investment directly links to the pipeline’s operation, while CVX’s 15 % ownership in CPC creates a financial tie that underscores how XOM’s crude demand intersects with CVX’s pipeline equity. This synergy is reinforced by the $4,500 million loan Chevron provided to TCO for the Future Growth Project, which will boost crude output by 260,000 bbl/d, further increasing volumes flowing through CPC and thereby amplifying the strategic overlap between XOM’s raw‑material dependence and CVX’s pipeline investment.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Transports]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Crude Oil (RAW_MATERIAL)",
        "Crude Oil (RAW_MATERIAL) -> CPC (COMP)",
        "CPC (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7646,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2580,
        "completion_tokens": 216,
        "total_tokens": 2796
      }
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "The decommissioning funding shortfall risk at NEE's nuclear facilities is directly tied to market volatility affecting trust fund assets, mirroring Duke Energy's exposure to nuclear decommissioning trust fund volatility through shared environmental and financial risks. Both companies face the core risk that market fluctuations could deplete decommissioning trust funds, potentially requiring significant additional funding to cover decommissioning costs—NEE's risk is explicitly linked to environmental risks impacting its nuclear plants, while Duke Energy's SEC filing highlights how market performance directly affects its NDTF investments and could trigger funding shortfalls if asset values decline.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR -[Subject_To]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Environmental Risks (RISK_FACTOR)",
        "Environmental Risks (RISK_FACTOR) -> Nuclear Power Plants (PRODUCT)",
        "Nuclear Power Plants (PRODUCT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19306,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5521,
        "completion_tokens": 176,
        "total_tokens": 5697
      }
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "LOW applies Level 3 valuation techniques using pricing models that rely on unobservable inputs such as total equity value, volatility, and expected term for contingent consideration, while GM classifies its Level 3 instruments as using significant unobservable inputs per its accounting policy. Both companies subject valuations to the observability of inputs, with LOW's contingent consideration measured using an income approach requiring significant assumptions, and GM's Level 3 hierarchy explicitly defining Level 3 as techniques using unobservable inputs, though GM's disclosures focus on marketable securities rather than contingent consideration. The accounting policy requirement that valuations depend on input observability directly links LOW's pricing model usage and GM's Level 3 classification to their respective reliance on unobservable inputs in fair value measurements.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Applies]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> Level 3 Valuation (ACCOUNTING_POLICY)",
        "Level 3 Valuation (ACCOUNTING_POLICY) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_212",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9049,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2961,
        "completion_tokens": 221,
        "total_tokens": 3183
      }
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "The $10.5 billion of committed financing under AMT’s 2021 Multicurrency Credit Facility was used to fund the CoreSite acquisition and to replace the $10.5 billion JPMorgan bridge commitment that had been arranged for the same purpose, illustrating a deliberate capital‑deployment strategy that leverages large, multi‑currency facilities to replace bridge financing and thereby diversify funding risk across multiple lenders and instruments.  This approach contrasts with Simon Property Group’s (SPG) joint‑venture financing, which relies on smaller, property‑level construction loans and equity stakes in unconsolidated entities, deploying capital on a project‑by‑project basis and spreading risk through multiple joint‑venture partners rather than through a single, broad‑based credit facility.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Supplies]-> FIN_INST <-[Supplies]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> Financing (FIN_INST)",
        "Financing (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8202,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2735,
        "completion_tokens": 198,
        "total_tokens": 2934
      }
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD generated $1,841 million in sales to Taiwan in 2023, representing a meaningful portion of its $22,680 million total revenue, while QCOM relies on foundry partners in Taiwan for consistent chipset supply—critical infrastructure highlighted by its explicit risk disclosure that \"a significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan, which would have a material adverse impact on our business.\" This operational dependency creates parallel exposure to geopolitical instability, as both companies face severe disruption risks from Taiwan-related conflicts despite AMD's direct revenue presence and QCOM's indirect supply chain reliance, with both operating in the same high-stakes semiconductor ecosystem where Taiwan serves as a critical node for revenue generation (AMD) and manufacturing (QCOM).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Supplies]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Foundry Partners (COMP)",
        "Foundry Partners (COMP) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12567,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3797,
        "completion_tokens": 229,
        "total_tokens": 4026
      }
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "The expected impact of the 15% global minimum tax under OECD Pillar 2 on SBUX’s consolidated financial statements is assessed as not material, and SBUX expects it to become effective only for fiscal 2025, whereas MCD similarly notes that the enactment of Pillar 2 will not have a material impact on its consolidated financial statements, although both companies will continue to monitor further guidance and implementation timelines across jurisdictions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> Pillar 2 (REGULATORY_REQUIREMENT)",
        "Pillar 2 (REGULATORY_REQUIREMENT) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10150,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3232,
        "completion_tokens": 113,
        "total_tokens": 3345
      }
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorganChase's risk governance framework mandates firmwide ownership of risk assessment, requiring all lines of business to identify, assess, and manage risks within established parameters, with the Chief Risk Officer leading independent oversight through the Board Risk Committee; this structure directly informs its stress testing methodology, which is integrated into capital adequacy evaluations as part of the firmwide risk governance process, ensuring stress test results are used to assess capital planning and regulatory compliance. In contrast, Goldman Sachs explicitly ties stress testing to capital adequacy by using firmwide stress tests to quantify vulnerabilities and assess capital planning, while also applying risk limits and thresholds approved by its Risk Appetite Committee to manage exposures, but its approach is characterized by a second-line risk function reporting to the CRO that focuses on assessing and monitoring risks like interest rate risk (EaR/EVE), with stress testing techniques applied to portfolios and scenarios to model potential losses, and its capital adequacy assessment is directly linked to these stress test outcomes as part of its risk management process.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Requires]-> ACCOUNTING_POLICY -[Used_For]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Risk Assessment (ACCOUNTING_POLICY)",
        "Risk Assessment (ACCOUNTING_POLICY) -> Stress Testing (ACCOUNTING_POLICY)",
        "Stress Testing (ACCOUNTING_POLICY) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13971,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4190,
        "completion_tokens": 300,
        "total_tokens": 4490
      }
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "XOM's asset exposure in Kazakhstan is $8,463 million in long‑lived assets (as disclosed in its 2021 10‑K), whereas Chevron (CVX) holds a 50 % equity stake in the Tengizchevroil joint venture, reflecting both an ownership interest and a $4.5 billion loan to fund the FGP/WPMP development, highlighting a deeper financial involvement beyond mere asset presence.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Kazakhstan (GPE)",
        "Kazakhstan (GPE) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5634,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2064,
        "completion_tokens": 89,
        "total_tokens": 2154
      }
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Geopolitical tensions involving Taiwan could severely limit QCOM's chipset supply from its foundry partners in Taiwan, directly disrupting its ability to deliver products to customers and potentially causing material adverse impacts on its business and the broader semiconductor industry. This supply disruption would also threaten NVDA's supply continuity, as its operations depend on similar foundry partners in Taiwan for critical components, with geopolitical tensions posing a material adverse risk to its ability to maintain consistent supply and meet customer demand.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP -[Operates_In]-> GPE <-[Impacts]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Foundry Partners (COMP)",
        "Foundry Partners (COMP) -> Taiwan (GPE)",
        "Taiwan (GPE) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18331,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5237,
        "completion_tokens": 143,
        "total_tokens": 5380
      }
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company's environmental compliance costs driven by regulatory requirements could reduce electricity demand from industrial customers, as stated in both SO chunks where \"compliance costs...could contribute to reduced demand for electricity and natural gas\" and \"many commercial and industrial customers may also be affected by existing and future environmental requirements, which may have the potential to reduce their demand for electricity or natural gas.\" This regulatory-driven demand shift contrasts with Duke Energy's exposure, which explicitly identifies industrial demand volatility as a core risk in its \"Operational Risks\" section (Chunk 3), noting that \"declines in demand for electricity or natural gas as a result of economic downturns...will reduce overall sales and lessen cash flows, especially as industrial customers reduce production.\" While Southern Company's compliance costs may indirectly suppress industrial demand through rate increases, Duke Energy's risk framework directly ties market and economic conditions to industrial demand fluctuations, making its exposure more immediate and explicitly tied to customer behavior rather than compliance cost pass-through mechanisms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_on]-> REGULATORY_REQUIREMENT -[Impacted_By]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "SO (ORG) -> Environmental Requirements (REGULATORY_REQUIREMENT)",
        "Environmental Requirements (REGULATORY_REQUIREMENT) -> Industrial Customers (COMP)",
        "Industrial Customers (COMP) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16062,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4727,
        "completion_tokens": 302,
        "total_tokens": 5029
      }
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "NKE's $9.9 billion notional amount of foreign exchange cash flow hedges, disclosed in its 10-K as protecting forecasted product costs and non-functional currency sales, directly offsets its significant foreign currency transaction exposures described in Note 12, particularly through its NT C sourcing hub and factory input cost adjustments that create natural currency offsets. This hedge program manages cross-border risk by fixing costs in USD terms for its global supply chain, contrasting with MCD's approach of hedging only its diversified foreign currency net asset exposures—defined as foreign currency assets less liabilities—which totaled a specific basket-level exposure (though the exact notional figure for MCD's hedges is not provided in the MCD 10-K excerpt). While NKE quantifies its hedge notional at $9.9 billion to neutralize transactional risks from product purchases and external sales, MCD's disclosed foreign currency net asset exposures represent a different risk profile focused on balance sheet items, with no comparable notional amount given for its hedging activities.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Impacts]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> Foreign Currency Assets (FIN_INST)",
        "Foreign Currency Assets (FIN_INST) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7749,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2609,
        "completion_tokens": 274,
        "total_tokens": 2883
      }
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "The Coca-Cola Company's exposure to Ukraine is indirect and mediated through its bottling partner Coca-Cola HBC AG, which operates in Ukraine as part of its broader bottling network spanning 28 countries; this relationship is captured by the KG triplet **Coca-Cola HBC (COMP) → Ukraine (GPE) ← Depends_On KO (ORG)**, indicating that KO's operational footprint includes Ukraine via its bottler, but this represents only bottling and distribution exposure—not direct manufacturing or supply chain reliance. In stark contrast, Procter & Gamble's direct reliance on Ukraine is explicitly quantified as negligible (<1% of net assets and <2% of consolidated net sales), with its Ukrainian operations facing significant disruption risks including potential facility damage, supply chain breakdowns, and sanctions-related impacts that could materially affect its manufacturing and supply chain stability; however, the KG triplet **Ukraine (GPE) → PG (ORG)** confirms this direct operational link, while the text emphasizes that PG's exposure is minimal in scale but carries high uncertainty due to the war's escalation risks. Consequently, while Coca-Cola's exposure to Ukraine is limited to bottling partner operations (indirect and non-core to its concentrate supply chain), Procter & Gamble's direct manufacturing and supply chain dependence on Ukraine—though currently small in magnitude—exposes it to acute operational vulnerabilities that could disrupt its entire production ecosystem, making PG's reliance far more operationally critical despite its smaller absolute footprint.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola HBC (COMP)",
        "Coca-Cola HBC (COMP) -> Ukraine (GPE)",
        "Ukraine (GPE) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18116,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5188,
        "completion_tokens": 394,
        "total_tokens": 5582
      }
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "The combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS) is $4,551 million (MET) plus $7,268 million (BAC), totaling $11,819 million. MET’s fair value of CMBS at December 31 2023 is $4,551 million, which exceeds BAC’s amortized cost of $1,720 million for the same category.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Structured Securities (FIN_INST)",
        "Structured Securities (FIN_INST) -> CMBS (FIN_INST)",
        "CMBS (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_274",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 37533,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 10053,
        "completion_tokens": 75,
        "total_tokens": 10129
      }
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "The cyber intrusion risks at nuclear power plants create material financial obligations and strategic imperatives for both Duke Energy (DUK) and Southern Company (SO) through their nuclear operations and decommissioning exposures. Duke Energy’s subsidiaries operate nuclear facilities requiring funded decommissioning trusts whose value depends on market performance, with cyber threats potentially triggering increased security costs and regulatory penalties that could strain cash flows needed to meet these obligations, while Southern Company’s nuclear units at Alabama Power and Georgia Power face similar risks where cyber intrusions could lead to NRC enforcement actions, fines, or forced shutdowns that might cause decommissioning costs to exceed trust assets, thereby compelling additional capital expenditures and influencing operational strategies to mitigate such threats across both companies’ nuclear portfolios.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Nuclear Power Plants (PRODUCT)",
        "Nuclear Power Plants (PRODUCT) -> Cyber Intrusions (RISK_FACTOR)",
        "Cyber Intrusions (RISK_FACTOR) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19170,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5479,
        "completion_tokens": 231,
        "total_tokens": 5710
      }
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "HD's treatment of dividend equivalents on unvested restricted stock units requires settling these equivalents in **additional shares of stock** upon vesting, directly increasing the total shares issued without cash cost. This mechanism creates a direct link to additional share issuance, as evidenced by the KG pattern where \"Dividend Equivalents\" leads to \"Additional Shares\" and connects to LOW via the relationship \"Additional Shares\" → \"LOW\". In contrast, LOW's ASR agreements in fiscal 2021 delivered **additional shares** through contractual share repurchase arrangements, where the company purchased shares from third parties and delivered them to participants, resulting in tangible share issuance (e.g., 0.2–1.6 million additional shares per quarter in 2021). While HD's dividend equivalents generate shares internally upon vesting, LOW's ASR-driven additional shares were part of externally sourced repurchase agreements, making HD's approach an internal equity incentive mechanism and LOW's a market-based share acquisition strategy, both ultimately increasing the total shares outstanding but through fundamentally different operational pathways.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Pays]-> FIN_INST -[Increases]-> FIN_INST <-[Delivers]- ORG",
      "triplets_used": [
        "HD (ORG) -> Dividend Equivalents (FIN_INST)",
        "Dividend Equivalents (FIN_INST) -> Additional Shares (FIN_INST)",
        "Additional Shares (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6223,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2237,
        "completion_tokens": 289,
        "total_tokens": 2527
      }
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "AT&T employs sensitivity analyses to assess its $67,854 million goodwill balance, testing discount‑rate assumptions and other key inputs within its annual impairment review, and the same external auditor also performs similar sensitivity analyses on Netflix’s content amortization assumptions, using historical and forecasted viewing patterns to evaluate how changes in those estimates would affect amortization expense.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "triplets_used": [
        "T (ORG) -> Sensitivity Analyses (ACCOUNTING_POLICY)",
        "Sensitivity Analyses (ACCOUNTING_POLICY) -> Auditor (ACCOUNTING_POLICY)",
        "Auditor (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15857,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4657,
        "completion_tokens": 105,
        "total_tokens": 4762
      }
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard views fintech-developed payment platforms as a direct threat of disintermediation driven by regulations like PSD2, which could route transactions away from its network and commoditize transaction data, potentially diminishing demand for its integrated products if customers bypass its ecosystem. In contrast, Visa adopts a strategic partnership approach with fintechs, integrating them into its network while managing data-sharing risks, but this exposes Visa to competitive advantages for partners and relies on collaborative innovation to maintain its position in the digital payments ecosystem amid regulatory pressures. Both companies face competitive threats from alternative payment providers and regulatory shifts, but Mastercard emphasizes defensive concerns over disintermediation, whereas Visa leverages partnerships to expand volume and services within the same regulatory landscape.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT -[Develops]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "MA (ORG) -> Competitive Products (PRODUCT)",
        "Competitive Products (PRODUCT) -> Fintechs (COMP)",
        "Fintechs (COMP) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16983,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4923,
        "completion_tokens": 226,
        "total_tokens": 5150
      }
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "The expected impact of the 15% global minimum tax under Pillar 2 differs between MCD and SBUX in that both companies anticipate **no material effect on their consolidated financial statements** and note that the tax will not become effective for them until fiscal 2025, but the **earliest effective dates for implementation** are tied to the OECD framework: MCD references the OECD’s Pillar 2 framework and indicates that numerous countries have enacted it with the earliest effective date for taxable years beginning after December 31, 2023, while SBUX specifically states that certain countries where it operates have enacted legislation to adopt Pillar 2 effective for fiscal years beginning on or after December 31, 2023, with implementation expected in fiscal 2025; thus, although the regulatory relationship (ORG → Pillar 2 → Global Minimum Tax → SBUX) links the same tax regime to both firms, MCD’s disclosure emphasizes that the enactment will not materially affect its financial statements and that it will continue to evaluate the impact, whereas SBUX similarly expects no material impact but highlights that the tax will not be effective until fiscal 2025 and that it will continue to monitor developments, reflecting a parallel but distinct timing and assessment of the Pillar 2 obligations across the two entities.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Pillar 2 (REGULATORY_REQUIREMENT)",
        "Pillar 2 (REGULATORY_REQUIREMENT) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10150,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3225,
        "completion_tokens": 331,
        "total_tokens": 3556
      }
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "Based on the provided information, BlackRock Institutional Trust Company (BTC) demonstrated a satisfactory capital adequacy position as of December 31, 2024, having exceeded all applicable regulatory capital requirements including Common Equity Tier 1, Tier 1 leverage, and total risk-based capital ratios, as explicitly confirmed in its calculations within the regulatory capital requirements section of its filings. While the knowledge graph establishes BTC's subject-to-regulatory-capital-requirements relationship with AXP through the shared regulatory framework, the specific comparative capital ratios for AXP are detailed in its own regulatory capital ratios table (Table 22.1) in AXP_10k_2024.pdf, which confirms it maintained capital ratios in excess of those required to qualify as well capitalized, thereby meeting all regulatory standards applicable to its banking subsidiary AENB under Federal Reserve and OCC supervision.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BLK (ORG) -> BTC (COMP)",
        "BTC (COMP) -> Regulatory Capital Requirements (REGULATORY_REQUIREMENT)",
        "Regulatory Capital Requirements (REGULATORY_REQUIREMENT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_158",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7003,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2443,
        "completion_tokens": 233,
        "total_tokens": 2677
      }
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "SPG provided $88.4 million of interest‑bearing construction loans to its real‑estate joint‑venture partners (as disclosed in its 2021 10‑K), whereas AMT financed its growth primarily through the 2021 Multicurrency Credit Facility—borrowing roughly $7.8 billion under that facility to fund acquisitions such as Telxius and CoreSite, with the facility’s commitments later expanded to $6 billion for revolving loans and $4 billion for term loans. This contrast shows SPG’s strategy of using targeted, partnership‑level construction financing to fund specific development projects, while AMT relies on large, multi‑currency revolving and term loan facilities to fund acquisitions and repay existing debt, reflecting a more capital‑market‑driven approach to scaling its tower portfolio.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> FIN_INST -[Supplies]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Financing (FIN_INST)",
        "Financing (FIN_INST) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8202,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2740,
        "completion_tokens": 195,
        "total_tokens": 2935
      }
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "Cisco's $0.5 billion interest‑rate swap hedges the fixed‑rate senior notes it issued in February 2024, converting their fixed rate to a SOFR‑plus‑basis‑points floating rate and thereby offsetting the notes' sensitivity to market‑rate changes; in contrast, Broadcom holds $56.3 billion of fixed‑rate senior notes, and a hypothetical 50‑basis‑point shift in rates would alter their fair value by roughly $1.7 billion, exposing the company to a far larger interest‑rate‑driven valuation swing. Both firms use swaps to manage this risk, but Cisco’s hedge targets only a $0.5 billion tranche, whereas Broadcom’s exposure spans $56.3 billion of senior debt.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST -[Hedges_Fixed_Rate_Senior_Notes]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Interest Rate Swap (FIN_INST)",
        "Interest Rate Swap (FIN_INST) -> Fixed Rate Senior Notes (FIN_INST)",
        "Fixed Rate Senior Notes (FIN_INST) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6828,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2394,
        "completion_tokens": 162,
        "total_tokens": 2556
      }
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "NKE employs option contracts as part of its cash flow hedging program to manage foreign currency exposure from product purchases and non-functional currency sales, with gains/losses on these instruments deferred in AOCI and recognized upon settlement, directly offsetting exchange rate impacts on inventory costs and revenue—mirroring TSLA's approach of using similar derivatives to hedge forecasted foreign currency transactions, though TSLA discloses significantly larger notional amounts ($9.9B vs. NKE's implied smaller-scale usage) and explicitly recognizes deferred gains/losses in AOCI that mature within twelve months ($99M), while TSLA's foreign currency exposure primarily stems from unhedged intercompany balances causing volatile \"Other income (expense), net\" fluctuations due to lack of systematic hedging.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Impacts]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> Foreign Currency Assets (FIN_INST)",
        "Foreign Currency Assets (FIN_INST) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8552,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2823,
        "completion_tokens": 204,
        "total_tokens": 3027
      }
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing's Five-Year Credit Agreement uses Citibank, N.A. as administrative agent with amendment activity finalized on August 25 2022, whereas Caterpillar's comparable 5‑Year Facility also appoints Citibank, N.A. as agent but structures it within a broader 3‑Year and 5‑Year facility framework that includes additional local‑currency addenda and amendments dated August 31 2023; both agreements position Citibank as the primary administrative and agent bank, but Boeing’s amendment was limited to its five‑year term (effective 2019) while Caterpillar’s facility includes separate 3‑Year and 5‑Year tranches each amended in 2023, reflecting distinct timeline and scope of Citibank’s role across the two companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Regulates]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "BA (ORG) -> Five Year Credit Agreement (FIN_INST)",
        "Five Year Credit Agreement (FIN_INST) -> Citibank, N.A. (COMP)",
        "Citibank, N.A. (COMP) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 25289,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 7004,
        "completion_tokens": 177,
        "total_tokens": 7181
      }
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "The voting rights structure differs significantly between the two companies: Netflix grants one vote per share of common stock to all holders, while Meta’s Class B common stock carries 10 votes per share, creating a substantially higher voting power per share for Meta’s Class B holders compared to Netflix’s uniform one‑vote‑per‑share structure. This contrast is highlighted by the KG relationship where Netflix’s “Voting Rights” accounting policy applies to its common stock, whereas Meta’s “Class B Common Stock” (a financial instrument) is linked to Meta’s organization, underscoring that Meta’s Class B shares provide ten times the voting influence per share relative to Netflix’s standard common shares.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7955,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2674,
        "completion_tokens": 177,
        "total_tokens": 2851
      }
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMY's 2023 10-K reveals that Cardinal Health, Inc. supplied 23% of its distribution network, while Cardinal Health holds a 50% ownership stake in Red Oak Sourcing, LLC—the generic pharmaceutical sourcing entity jointly controlled by BMY and CVS. This creates a direct financial intersection where CVS consolidates Red Oak Sourcing in its Pharmacy & Consumer Wellness segment (as disclosed in CVS's 10-K), and BMY's significant reliance on Cardinal Health for distribution (23% in 2023) is intertwined with CVS's consolidation of the same entity through its 50% stake. The $183 million quarterly payments from Cardinal to CVS for Red Oak's services further link BMY's distribution dependency to CVS's consolidated financials, as these payments reduce CVS's inventory carrying value and are recognized in cost of products sold when inventory is sold.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Has_Stake_In]-> COMP <-[Consolidates]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Cardinal Health, Inc. (COMP)",
        "Cardinal Health, Inc. (COMP) -> Red Oak Sourcing,LLC (COMP)",
        "Red Oak Sourcing,LLC (COMP) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9871,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3149,
        "completion_tokens": 212,
        "total_tokens": 3361
      }
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife's Retirement and Income Solutions segment faces negative impacts on its Life Insurance products from declining interest rate scenarios, where minimum crediting rate guarantees and disability reserve accounting cause gross margin compression that is partially mitigated through interest rate derivatives, while rising rates allow reinvestment in higher-yielding assets to offset compression. This exposure is structurally connected to AIG's experience through the KG relationship where Life Insurance (product) is negatively impacted by AIG (organization), as evidenced by AIG's 2021 Life Insurance reserve update showing a net favorable $106 million impact from actuarial assumption changes that reduced reserves due to refined modeling of universal life policies with secondary guarantees, a dynamic that contrasts with MetLife's scenario-driven margin pressures in its RIS segment.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT -[Includes]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MET (ORG) -> Retirement and Income Solutions (PRODUCT)",
        "Retirement and Income Solutions (PRODUCT) -> Life Insurance (PRODUCT)",
        "Life Insurance (PRODUCT) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_184",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10446,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3306,
        "completion_tokens": 222,
        "total_tokens": 3528
      }
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla and Panasonic have multiple battery supply agreements, including the 2011 Supply Agreement (Exhibit 10.25†), its 2013 amendment (10.26†), 2014 General Terms (10.28†), and subsequent pricing agreements like the 2019 and 2020 Pricing Agreements (10.35††, 10.36††), establishing a deep, long-term partnership for 2170 battery cells at Gigafactory Texas. While General Motors also depends on Panasonic for batteries (as shown in the KG triplet GM -> Batteries -> Panasonic Corporation), GM's sourcing relationship is less vertically integrated and lacks the same scale of dedicated factory partnerships and pricing agreements tied to specific gigafactories that Tesla has with Panasonic.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "GM (ORG) -> Batteries (PRODUCT)",
        "Batteries (PRODUCT) -> Panasonic Corporation (COMP)",
        "Panasonic Corporation (COMP) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8521,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2795,
        "completion_tokens": 172,
        "total_tokens": 2967
      }
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "MDLZ manages commodity price risk through exchange-traded commodity futures and options, which are classified as Level 1 financial assets requiring quoted market prices for fair value measurement, and explicitly uses these instruments for hedging raw material costs like wheat, sugar, and cocoa without speculative intent. In contrast, COST discloses holding no Level 1 financial assets whatsoever, reflecting its simpler investment approach focused solely on cash equivalents and short-term investments with no derivatives or market-linked instruments in its risk management strategy. Both companies employ derivative instruments for hedging—MDLZ for commodity and currency exposure, COST for none—but MDLZ’s Level 1 classification and active use of exchange-traded futures directly tie to its disclosed risk management framework, while COST’s complete absence of Level 1 assets underscores a fundamentally different, lower-complexity financial instrument posture.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Commodity Futures (FIN_INST)",
        "Commodity Futures (FIN_INST) -> Level 1 Financial Assets (FIN_INST)",
        "Level 1 Financial Assets (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10477,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3310,
        "completion_tokens": 241,
        "total_tokens": 3551
      }
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Both Apple and Broadcom adopted Rule 10b5‑1(c) trading plans to provide an affirmative‑defense shield for insider‑trading disclosures, but the scope and timing of the potential sales differ. Apple’s executives—Deirdre O’Brien and Jeff Williams—entered plans that cover up to 100,000 shares each, with sales scheduled between April 1, 2025 and October 1, 2026 (O’Brien’s plan expires Dec 31, 2026; Williams’s expires Dec 15, 2025), whereas Broadcom’s sole insider‑trading arrangement, adopted by board member Diane M. Bryant, permits the sale of up to only 15,000 shares and is set to expire on September 12, 2025. Thus, while Apple’s plans involve a substantially larger share volume and a longer sales window extending into 2026, Broadcom’s plan is limited to a much smaller quantity of shares and concludes earlier, reflecting a more constrained trading schedule.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> ACCOUNTING_POLICY <-[Affects_Stock]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Rule 10b5-1(c) (REGULATORY_REQUIREMENT)",
        "Rule 10b5-1(c) (REGULATORY_REQUIREMENT) -> Trading Plan (ACCOUNTING_POLICY)",
        "Trading Plan (ACCOUNTING_POLICY) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10637,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3340,
        "completion_tokens": 216,
        "total_tokens": 3556
      }
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "The involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M’s May 11 2023 Five‑Year Credit Agreement and Honeywell’s March 20 2023 Amended and Restated Five‑Year Credit Agreement demonstrates a shared banking relationship that links the two credit facilities through a common financial institution, reinforcing a coordinated syndication structure across the companies’ capital‑raising arrangements. This common role underscores a strategic alignment in their financing arrangements, as evidenced by the KG pattern where the same COMP (JPMorgan Chase Bank, N.A.) participates in agreements with both ORG entities (MMM and HON).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Amends]-> FIN_INST -[Regulates]-> COMP <-[Enters_Agreement]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Five Year Credit Agreement (FIN_INST)",
        "Five Year Credit Agreement (FIN_INST) -> JPMorgan Chase Bank, N.A. (COMP)",
        "JPMorgan Chase Bank, N.A. (COMP) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_125",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 26647,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 7361,
        "completion_tokens": 160,
        "total_tokens": 7522
      }
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus could restrict Coca-Cola HBC’s operations in the country by limiting its ability to source materials, distribute products, or engage in tobacco-related activities, potentially disrupting its bottling and distribution of Coca-Cola beverages if any ancillary tobacco-linked supply chains or partnerships are affected. Given Coca-Cola HBC’s significant role as a bottler for The Coca-Cola Company in Belarus and its inclusion in the list of Coca-Cola’s five largest independent bottling partners (representing 41% of global unit case volume), any operational disruption in Belarus could reduce Coca-Cola HBC’s contribution to global unit case volume. This, in turn, might impact The Coca-Cola Company’s overall unit case volume, particularly in non-U.S. markets where Coca-Cola HBC accounts for a notable share of its bottling operations, though the exact magnitude would depend on the extent of sanctions’ impact on Coca-Cola HBC’s business.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola HBC (COMP)",
        "Coca-Cola HBC (COMP) -> Belarus (GPE)",
        "Belarus (GPE) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14587,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4323,
        "completion_tokens": 251,
        "total_tokens": 4575
      }
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps would directly pressure Capital One’s interchange fee income by lowering fee levels on debit transactions processed through Mastercard’s four-party network, as indicated by the Federal Reserve’s proposed rulemaking that could automatically update caps every two years (Chunk 2). This regulatory shift aligns with ongoing legal challenges involving interchange fees that Visa and Mastercard face, including antitrust lawsuits and settlements related to fee-fixing allegations (Chunk 3), which could further constrain fee income through potential litigation costs or negotiated reductions. Additionally, merchants’ ability to negotiate lower interchange fees or develop alternative payment systems—exacerbated by regulatory pressures like Regulation II and proposed routing mandates—could compound the impact on Capital One’s revenue, as noted in its 10-K disclosures about heightened focus on interchange fees and the material adverse effects of income loss (Chunk 1).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Faces]- ORG",
      "triplets_used": [
        "COF (ORG) -> Interchange Fee Regulation (REGULATORY_REQUIREMENT)",
        "Interchange Fee Regulation (REGULATORY_REQUIREMENT) -> Mastercard (COMP)",
        "Mastercard (COMP) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15799,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4645,
        "completion_tokens": 258,
        "total_tokens": 4903
      }
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy's exposure to LIBOR-indexed financial contracts necessitates a detailed assessment of ASU 2020-04's optional expedients for managing interest rate swap modifications and alternative rate transitions, directly tying to its regulatory relationship with the Reference Rate Reform (RRR) requirement under the KG pattern ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY. While Chunk 1 confirms Duke Energy actively evaluates RRR impacts on its LIBOR-indexed debt and swaps, Chunk 2 explicitly identifies ASU 2020-04 as the accounting policy mechanism for this transition, and Chunk 3 shows Southern Company similarly evaluates ASU 2020-04 but does not specify a timeline—highlighting that both companies face comparable regulatory accounting pressures from RRR, though Duke Energy's operational exposure to LIBOR derivatives creates a distinct, active evaluation context within its segment reporting structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Reference Rate Reform (REGULATORY_REQUIREMENT)",
        "Reference Rate Reform (REGULATORY_REQUIREMENT) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_195",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10117,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3227,
        "completion_tokens": 238,
        "total_tokens": 3466
      }
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "The Black-Scholes-Merton model applied by KO for stock option valuation relies on weighted-average assumptions (e.g., volatility, risk-free rate) as inputs, directly linking to the same category of assumptions used in CL's pension plan cost calculations, though CL explicitly details a broader range of actuarial inputs like discount rates and long-term return on assets. While KO's model focuses on option-specific metrics for equity compensation expense recognition, CL's weighted-average assumptions underpin pension liability and cost computations, creating a shared accounting policy framework where both entities utilize standardized assumption sets for distinct financial reporting purposes, with KO's approach tied to equity awards and CL's to pension obligations, as evidenced by the KG pattern connecting ORG → ACCOUNTING_POLICY ←[Discloses]- ORG.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Black-Scholes-Merton Model (ACCOUNTING_POLICY)",
        "Black-Scholes-Merton Model (ACCOUNTING_POLICY) -> Weighted-Average Assumptions (ACCOUNTING_POLICY)",
        "Weighted-Average Assumptions (ACCOUNTING_POLICY) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8674,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2881,
        "completion_tokens": 214,
        "total_tokens": 3095
      }
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "American Tower (AMT) uses its subsidiary's equity interests as collateral for the $525 million Series 2015‑2 Notes, securing the debt with the equity held in GTP Acquisition Partners and related entities. In contrast, Simon Property Group (SPG) monetizes equity interests through outright disposals, generating a $18.8 million gain from such transactions, which is recorded as a non‑cash gain on the sale of equity interests. Both strategies involve leveraging equity stakes, but AMT does so via debt‑backed collateral while SPG realizes cash gains by selling the interests.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST -[Depends_On]-> FIN_INST <-[Disposes]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Series 2015-2 Notes (FIN_INST)",
        "Series 2015-2 Notes (FIN_INST) -> Equity Interests (FIN_INST)",
        "Equity Interests (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17021,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4943,
        "completion_tokens": 143,
        "total_tokens": 5086
      }
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips' operational exposure in Nigeria is characterized by production-sharing contracts (PSCs) that grant 30-year terms with a 10-year exploration period under Oil Prospecting Licenses (OPLs), convertible to Oil Mining Leases (OMLs) upon commercial discovery, and subject to partial relinquishment at the end of exploration; this structure directly ties reserve reporting to the contractual term and regulatory framework of the PSCs, where reserve definitions require economic producibility prior to contract expiration unless renewal is reasonably certain, and the PSCs' terms are governed by the Petroleum Industry Act (PIA) of 2021, which mandates specific relinquishment provisions and production periods. In contrast, ExxonMobil's reliance on production-sharing contracts across Africa (including Nigeria, Angola, and Mozambique) involves contractual terms that vary by country but generally feature fixed exploration periods (e.g., 3–4 years with extensions) and production periods of 20–30 years, with reserves reported based on the economic interest defined by fiscal terms in each agreement, and crucially, ExxonMobil's reserve reporting explicitly incorporates production-sharing contract arrangements as a distinct category where reserves are calculated on an oil-equivalent basis and are subject to inverse volume-price relationships due to negotiated fiscal terms, as evidenced by the 12% of total proved reserves (2021) tied to such contracts. The KG triplet relationship Nigeria → Production-Sharing Contracts → XOM confirms ExxonMobil's structural exposure to these contracts, while ConocoPhillips' Nigeria operations (COP → Nigeria) operate under similar PSC frameworks but with distinct term structures (e.g., 30-year PSCs with 10-year exploration phases) that directly impact reserve reporting timelines and regulatory compliance, as both companies must align reserve estimations with contract expiration risks and regulatory requirements under frameworks like the PIA and SEC Rule 4-10.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Nigeria (GPE)",
        "Nigeria (GPE) -> Production-Sharing Contracts (REGULATORY_REQUIREMENT)",
        "Production-Sharing Contracts (REGULATORY_REQUIREMENT) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10510,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3304,
        "completion_tokens": 503,
        "total_tokens": 3807
      }
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM's strategy centers on commercializing generative AI through hybrid cloud integration to enhance enterprise productivity and differentiation, leveraging its R&D investments and developer ecosystem to embed AI into cloud-based solutions, while Qualcomm is advancing edge-based generative AI and cloud computing to enable on-device, low-power AI processing for mobile, automotive, and IoT devices, as evidenced by its focus on high-performance, low-power computing technologies for edge applications and its vision of ubiquitous generative AI in smartphones and edge devices.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> CONCEPT -[Complements]-> CONCEPT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "IBM (ORG) -> Generative AI (CONCEPT)",
        "Generative AI (CONCEPT) -> Cloud Computing (CONCEPT)",
        "Cloud Computing (CONCEPT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11841,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3648,
        "completion_tokens": 144,
        "total_tokens": 3792
      }
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy's exposure to nuclear decommissioning funding risks is heightened by its reliance on market‑driven trust assets that can fall short of projected returns, potentially forcing substantial cash contributions to meet decommissioning obligations and straining the holding company’s cash flows, especially given its dependence on subsidiary dividends. In contrast, NextEra Energy manages similar nuclear‑related financial risks through diversified derivative‑instrument strategies and dedicated decommissioning funds, yet it remains vulnerable to market volatility and regulatory‑driven cost overruns that could affect its liquidity and results of operations. Both utilities face the risk that insufficient market performance or unexpected expenses could jeopardize their ability to fund decommissioning, but Duke Energy’s risk is amplified by its corporate structure and limited internal cash generation, while NextEra mitigates exposure through more robust hedging and investment practices.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Nuclear Power Plants (PRODUCT)",
        "Nuclear Power Plants (PRODUCT) -> Financial Risks (RISK_FACTOR)",
        "Financial Risks (RISK_FACTOR) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19306,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5512,
        "completion_tokens": 249,
        "total_tokens": 5761
      }
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "CAT and UPS both adopted ASU 2020-04, which governs hedge accounting relief for reference rate reform, but they differ in their transition approaches and derivative contract management strategies.  \n\n- **CAT** formally documents hedge relationships and assesses effectiveness at inception and ongoing, designating specific foreign currency forwards/options as cash flow hedges with maturities up to 60 months, and uses fixed-to-floating interest rate contracts as fair value hedges.  \n- **UPS** transitioned affected debt to SOFR in 2023 but did not elect the practical expedients under Topic 848, instead focusing on broader reference rate reform disclosures without altering its hedge accounting framework.  \n\nBoth companies adopted ASU 2020-04 in 2020, but CAT’s strategy emphasizes active hedge designation and effectiveness testing, while UPS’s approach centers on reference rate transition compliance without material changes to its derivative management.  \n\nThis divergence reflects CAT’s detailed documentation of risk-management objectives (e.g., hedging foreign currency exposure up to five years) versus UPS’s focus on SOFR migration as part of broader regulatory adaptation, with neither company’s adoption materially impacting financial statements per their disclosures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Hedging Relationships (ACCOUNTING_POLICY)",
        "Hedging Relationships (ACCOUNTING_POLICY) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15582,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4590,
        "completion_tokens": 320,
        "total_tokens": 4911
      }
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast lacks voting rights in its investment in Atairos, resulting in no control over the VIE's key decision-making, whereas Alphabet maintains dual-class control through its Class B shares with 10 votes per share, enabling significant influence despite repurchasing Class A and C shares. Alphabet's $62 billion in Class A/C share repurchases in 2024 and the $70 billion authorized buyback program underscore its active capital management, contrasting with Comcast's non-voting stake in Atairos where distributions are treated as advances and the investment is accounted for via the equity method, highlighting divergent control implications between the two structures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8903,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2912,
        "completion_tokens": 167,
        "total_tokens": 3079
      }
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The extension of reference rate reform accounting relief under ASU 2022‑06 adds a one‑year deferral of the sunset date for Topic 848, allowing entities to continue applying the temporary expedients through December 31 2024.  UPS had already completed its transition of affected debt to SOFR by December 31 2023, whereas FedEx is still monitoring its contracts and will keep assessing potential application of the ASU through May 31 2024, reflecting the broader two‑year relief window now provided by ASU 2022‑06.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Defers]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "UPS (ORG) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> ASU 2022-06 (ACCOUNTING_POLICY)",
        "ASU 2022-06 (ACCOUNTING_POLICY) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_168",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13114,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3982,
        "completion_tokens": 128,
        "total_tokens": 4110
      }
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (AMESA) is 29% of its total beverage revenue, as shown in the 2023 financial breakdown where AMESA accounts for 29% of beverage sales and 71% of convenient foods sales. This regional exposure is explicitly tied to PepsiCo through the KG relationship Africa,Middle East,and South Asia (GPE) → PEP (ORG), confirming PepsiCo's operational presence in these markets. In contrast, Target's merchandise segments describe operations exclusively within the U.S., with no geographic revenue breakdown provided for beverages or other categories, indicating Target's beverage sales lack meaningful international geographic exposure comparable to PepsiCo's AMESA focus.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Beverages (PRODUCT)",
        "Beverages (PRODUCT) -> Africa,Middle East,and South Asia (GPE)",
        "Africa,Middle East,and South Asia (GPE) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4754,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1873,
        "completion_tokens": 184,
        "total_tokens": 2057
      }
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "The absence of the Countercyclical Capital Buffer eliminates a regulatory layer that would otherwise increase SCHW's minimum capital requirements, as indicated by the KG relationship SCHW → Countercyclical Capital Buffer → TLAC to RWAs Requirement. While SCHW's filings confirm it maintains zero countercyclical buffers (Chunk 1), GS's disclosures specify that its TLAC to RWAs requirement incorporates the countercyclical buffer (set at 0% by the FRB) alongside other buffers like the 2.5% capital conservation buffer and 18% minimum (Chunks 2 and 3). This structural difference means SCHW's minimum capital threshold is comparatively lower than GS's, which explicitly layers the countercyclical buffer into its TLAC to RWAs calculation despite its current 0% value. Consequently, SCHW operates under a less stringent regulatory capital framework than GS for TLAC compliance, even though both entities are subject to multi-layered buffers.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Discloses]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Countercyclical Capital Buffer (REGULATORY_REQUIREMENT)",
        "Countercyclical Capital Buffer (REGULATORY_REQUIREMENT) -> TLAC to RWAs Requirement (REGULATORY_REQUIREMENT)",
        "TLAC to RWAs Requirement (REGULATORY_REQUIREMENT) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2471,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 235,
        "total_tokens": 1559
      }
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction illustrates its ownership stake in self‑generated facilities, as the joint‑ownership agreements require Georgia Power to reimburse a portion of each co‑owner’s costs incurred in building the plant. This contrasts with NextEra Energy Resources’ model, which relies on long‑term contracts that cover roughly 94 % of its generating capacity, securing revenue through fixed‑price agreements rather than direct cost‑sharing with co‑owners. Consequently, Dalton’s revenue stream is tied to its share of plant output and cost‑recovery mechanisms, while NEE’s revenue is primarily generated from contracted sales of that output.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Pays]-> COMP -[Has_Stake_In]-> PRODUCT <-[Generates_Revenue_From]- ORG",
      "triplets_used": [
        "SO (ORG) -> Dalton (COMP)",
        "Dalton (COMP) -> Generation Facilities (PRODUCT)",
        "Generation Facilities (PRODUCT) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_189",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9993,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3190,
        "completion_tokens": 176,
        "total_tokens": 3366
      }
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX manages customer financing through its $7.0 billion revolving credit facilities, which provide short‑term liquidity for general corporate purposes and are backed by a $5 billion agreement maturing in 2025; this financing is accounted for under lease‑option policies that link RTX to BA as the lessee, whereas BA’s customer financing consists of long‑term aircraft lease structures (typically 1‑12 year terms with purchase options) recorded as operating or finance leases and reflected in its Property, Plant and Equipment schedule, highlighting a key contrast in how each company handles financing obligations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Contains]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Customer Financing (FIN_INST)",
        "Customer Financing (FIN_INST) -> Lease Options (ACCOUNTING_POLICY)",
        "Lease Options (ACCOUNTING_POLICY) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9261,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2990,
        "completion_tokens": 153,
        "total_tokens": 3144
      }
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca-Cola (KO) and Philip Morris International (PM) both disclose weighted-average assumptions within their Black-Scholes-Merton option-pricing models for equity-based compensation, as shown by the KG triplet **Weighted-Average Assumptions → PM** and **Black-Scholes-Merton Model → Weighted-Average Assumptions** linking both entities to the same accounting policy. However, while KO’s weighted-average assumptions are explicitly detailed in its 10-K for stock option awards (Chunk 1 and 2), including vesting periods and grant-date pricing methodology, PM’s weighted-average assumptions are referenced only in the context of pension and postretirement costs (Chunk 3), indicating a divergence in application—KO uses them for equity compensation expensing, whereas PM applies them to actuarial calculations for retirement obligations. This reflects fundamentally different uses of weighted-average assumptions within their respective financial reporting frameworks, despite shared underlying accounting standards.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Black-Scholes-Merton Model (ACCOUNTING_POLICY)",
        "Black-Scholes-Merton Model (ACCOUNTING_POLICY) -> Weighted-Average Assumptions (ACCOUNTING_POLICY)",
        "Weighted-Average Assumptions (ACCOUNTING_POLICY) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 1641,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1090,
        "completion_tokens": 253,
        "total_tokens": 1343
      }
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "The expiration timeline of regulatory exclusivity for Merck's Januvia family products is set for May 2026 for Januvia and Janumet and July 2026 for Janumet XR, whereas Gilead’s U.S. regulatory exclusivity under its composition‑of‑matter patent extends to 2032. This prolonged exclusivity for Gilead will delay generic entry in the United States, preserving its market share and pricing power, while Merck’s earlier loss of exclusivity in 2026 will expose its products to generic competition sooner, likely accelerating sales declines and pressuring its market position. Consequently, Merck faces a more rapid erosion of revenue from these diabetes drugs compared with Gilead, whose longer exclusivity window provides a competitive advantage in maintaining higher prices and market dominance.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> Regulatory Exclusivity (REGULATORY_REQUIREMENT)",
        "Regulatory Exclusivity (REGULATORY_REQUIREMENT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8628,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2880,
        "completion_tokens": 197,
        "total_tokens": 3078
      }
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel's amortization expense for developed technology used in cybersecurity, disclosed as $1,283 million in 2021 (Chunk 1), is directly linked to its developed technology product (INTC → Developed Technology → Cloud Security), which Cisco (CSCO) also leverages for its cloud security offerings (Cloud Security → CSCO). Cisco recognizes revenue for its cloud security products ratably over the contract term due to a single distinct performance obligation (Chunk 3), contrasting with Intel's amortization approach of capitalizing and expensing the technology cost over a 9-year useful life (Chunk 1), while Cisco's revenue recognition timing reflects a service-based model rather than amortization of developed technology costs.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Developed Technology (PRODUCT)",
        "Developed Technology (PRODUCT) -> Cloud Security (PRODUCT)",
        "Cloud Security (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4969,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1905,
        "completion_tokens": 181,
        "total_tokens": 2087
      }
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "ASU 2022‑02 eliminated the old TDR concession test and replaced it with a “financial‑difficulty‑modification” (FDM) model that requires only a short‑term or non‑insignificant payment delay, term extension, interest‑rate reduction, or principal forgiveness to qualify; consequently MET now reports such modifications as FDMs rather than TDRs, while JPM continues to classify the same types of residential‑real‑estate concessions under the legacy TDR guidance. The new standard also expands disclosures (e.g., gross write‑offs by origination year) and, as MET notes, has not materially affected the financial statements beyond the added Note 11 disclosures, whereas JPM’s 2023 disclosures quantify the financial impact of its FDMs—$136 million of modifications with term extensions and interest‑rate cuts that lengthen loan lives by ~20 years and lower weighted‑average rates from 7.21 % to 4.44 %—and separately tracks $69 million of trial modifications and $9 million of Chapter 7 loans, illustrating a clear divergence in the type and measured financial effect of modifications between the two banks under the respective accounting frameworks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY -[Replaces]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> ASU 2022-02 (ACCOUNTING_POLICY)",
        "ASU 2022-02 (ACCOUNTING_POLICY) -> TDR Guidance (ACCOUNTING_POLICY)",
        "TDR Guidance (ACCOUNTING_POLICY) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_245",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13899,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4170,
        "completion_tokens": 286,
        "total_tokens": 4456
      }
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "CVX's upstream natural gas reserves in South America represent a significant portion of its total reserves, with 4,250 billion cubic feet reported at year-end 2020 and 5,885 billion cubic feet at year-end 2021, reflecting growth in South American reserves that are part of the broader Americas region. This upstream strength contrasts with XOM's downstream operations, which span the entire Americas region including both North and South America as a key geographic segment for its integrated refining, marketing, and logistics business. While CVX's reserves data (Chunk 1) demonstrates its upstream dominance in South American natural gas, XOM's downstream footprint across the Americas (referenced in Chunk 3's description of its \"large manufacturing footprint\" and operations in \"the Americas\" as a reportable segment) highlights its extensive downstream presence that complements its upstream activities, though XOM's specific downstream volume metrics are not detailed in the provided materials. The KG triplets confirm this regional connection through \"South America → Americas → XOM,\" establishing the geographical linkage between CVX's South American reserves and XOM's downstream operations across the broader Americas.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> South America (GPE)",
        "South America (GPE) -> Americas (GPE)",
        "Americas (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14286,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4217,
        "completion_tokens": 307,
        "total_tokens": 4524
      }
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio's $25 million commercial paper exposure represents a significantly smaller short-term liquidity position compared to Tesla's $470 million commercial paper holdings, reflecting divergent capital management strategies where Ohio's utility-focused financing contrasts with Tesla's broader investment portfolio allocation. This disparity is contextualized by their respective KG relationships: HD operates in Ohio (HD->Ohio), Ohio discloses commercial paper (Ohio->Commercial paper), and Commercial paper discloses TSLA (Commercial paper->TSLA), establishing the entities' financial instrument connections across all provided data sources.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "HD (ORG) -> Ohio (GPE)",
        "Ohio (GPE) -> Commercial paper (FIN_INST)",
        "Commercial paper (FIN_INST) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_165",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5232,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1965,
        "completion_tokens": 163,
        "total_tokens": 2128
      }
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "META's Class A common stock carries voting rights that are effectively dominated by Class B shares, which control roughly 66 ⅓ % of the combined voting power despite representing a minority of outstanding shares; this structure lets Mr. Zuckerberg dictate board composition, merger approvals and other key decisions even when his share ownership is far below a majority. In contrast, Alphabet’s Class B common stock grants each share 10 votes—significantly more than the single vote per Class A share—so holders of Class B (currently owned entirely by Brian Roberts) command the same 66 ⅓ % voting influence, giving them outsized control over corporate actions. Consequently, while META’s dual‑class setup concentrates power in Class B shares that can override the interests of Class A investors, GOOGL’s Class B shares provide an even higher per‑share voting weight (10 vs 1) that similarly enables a single insider to control outcomes despite a smaller equity stake.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7059,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2446,
        "completion_tokens": 242,
        "total_tokens": 2688
      }
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard's B Class Shares explicitly grant non-voting dividend rights while maintaining identical dividend rights across voting and non-voting equity holders, as evidenced by the $0.0001 par value and \"Non-voting Dividend rights\" designation in the company's capital structure disclosure. This structure ensures dividend alignment between voting and non-voting shareholders, though the KG triplet connection to Charles Schwab (SCHW) through \"Dividend Rights (ACCOUNTING_POLICY) -> SCHW (ORG)\" indicates a cross-entity relationship where Schwab's identical dividend rights across voting/nonvoting classes (as stated in its 10-K) create a parallel framework demonstrating industry-standard equity compensation practices that reinforce shareholder return consistency.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "MA (ORG) -> B Class Shares (FIN_INST)",
        "B Class Shares (FIN_INST) -> Dividend Rights (ACCOUNTING_POLICY)",
        "Dividend Rights (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3120,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 191,
        "total_tokens": 1691
      }
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft expects no material impact from OECD Pillar Two rules despite their 15% global minimum tax, as indicated by its effective tax rate remaining below the U.S. statutory rate due to foreign earnings taxed at lower rates in jurisdictions like Ireland, and its foreign income ($44.9B in 2024) significantly exceeding U.S. income ($62.9B in 2024), while Oracle warns that Pillar Two could materially increase its international tax costs due to potential adverse effects on its provision for income taxes and effective tax rate from changes in international tax laws.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Pillar Two Model Rules (REGULATORY_REQUIREMENT)",
        "Pillar Two Model Rules (REGULATORY_REQUIREMENT) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11179,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3510,
        "completion_tokens": 142,
        "total_tokens": 3652
      }
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "GM applies Level 3 valuation techniques to its marketable debt securities and commercial finance receivables, where significant inputs are unobservable and involve internally developed pricing models or DCF methodologies that rely on management judgment and economic forecasts rather than quoted market prices. LOW, in contrast, applies Level 3 valuation primarily to contingent consideration from its fiscal 2022 Canadian retail business sale, using an income approach with option pricing models that require unobservable inputs like total equity value, volatility, and expected term, and requires ongoing adjustments based on operating performance and risk-adjusted discount rates. Both companies avoid Level 3 transfers between hierarchy levels, but GM’s Level 3 inputs focus on credit and market risk for financial assets, while LOW’s Level 3 inputs center on contingent consideration valuation tied to specific transaction performance.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Applies]- ORG",
      "triplets_used": [
        "GM (ORG) -> Level 3 Valuation (ACCOUNTING_POLICY)",
        "Level 3 Valuation (ACCOUNTING_POLICY) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_212",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9049,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2945,
        "completion_tokens": 235,
        "total_tokens": 3180
      }
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "The voting power dynamics tied to Comcast's Class B common stock—holding 33.3% of voting rights with 15 votes per share and non-dilutive aggregate power—directly influence Alphabet's Class A share conversion mechanics, as Class B shares of Comcast are convertible share-for-share into Class A common stock under specific restrictions, while Alphabet's aggressive Class A and C repurchase strategy ($62.2B in 2023, with $36.3B remaining authorization) could pressure conversion rates by altering the relative supply/demand for Class A shares, especially given that Class B conversions to Class A are automatic upon sale/transfer and may be strategically leveraged amid repurchase activity.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10240,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3249,
        "completion_tokens": 172,
        "total_tokens": 3421
      }
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "Based on the 2022 10-K disclosures analyzed across all provided chunks and their KG relationships, the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL is calculated as follows:  \n\n- MDLZ discloses **48,932,017** remaining securities available for future issuance (Chunk 1, Table column (c)).  \n- CL discloses **37,028** (in thousands) remaining securities available for future issuance (Chunk 2 and 3, Table column (c)), which equates to **37,028,000** securities.  \n- The difference is **48,932,017 - 37,028,000 = 11,904,017** remaining securities, reflecting MDLZ's significantly larger reserve for future equity compensation compared to CL.  \n\nThis calculation integrates MDLZ's standalone disclosure (Chunk 1) and CL's detailed breakdown (Chunks 2 and 3), with the KG triplet relationship confirming both entities' disclosures of \"Equity Compensation Plans Approved by Security Holders\" (FIN_INST) linking to their respective \"Securities Remaining Available for Future Issuance\" (FIN_INST) metrics.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Securities Remaining Available (FIN_INST)",
        "Securities Remaining Available (FIN_INST) -> Equity Compensation Plans Approved by Security Holders (FIN_INST)",
        "Equity Compensation Plans Approved by Security Holders (FIN_INST) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_140",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6133,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2223,
        "completion_tokens": 267,
        "total_tokens": 2491
      }
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "The impact of Illinois' Clean Energy Law on ComEd's transmission rate structure—specifically its requirement to accelerate amortization of unprotected excess deferred income taxes and to file a multi-year rate plan by January 2023—creates a regulatory risk that directly affects ComEd’s revenue outlook, a risk that is mirrored in Tesla’s exposure to state‑level regulatory challenges where direct‑sales restrictions could limit its market access and profitability. Both entities face heightened uncertainty from state‑driven rules: ComEd must navigate new Illinois mandates that could alter its rate base and cost recovery, while Tesla must contend with potential bans or limitations on its direct‑to‑consumer sales model in states that restrict such practices.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Faces]-> RISK_FACTOR <-[Faces]- ORG",
      "triplets_used": [
        "HD (ORG) -> Illinois (GPE)",
        "Illinois (GPE) -> Regulatory Challenges (RISK_FACTOR)",
        "Regulatory Challenges (RISK_FACTOR) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EXC_10k_2022.pdf",
          "page_id": "page_218",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11409,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3518,
        "completion_tokens": 190,
        "total_tokens": 3708
      }
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA's Medicare Part D redesign imposes manufacturer discounts and price caps beginning in 2025, which will force both AMGN and BMY to adjust their gross‑to‑net rebate accruals. For AMGN, the redesign directly ties its ENBREL product to the regulatory requirement (IRA) and therefore will increase the GTN accrual for that drug as Medicare price‑setting and inflation penalties take effect. For BMY, the redesign similarly drives higher GTN adjustments for its Medicare Part D‑dependent products, with the magnitude of the impact depending on each product’s payer‑channel mix and the specific contract prices applied under the new discount and cap regime. Both companies must therefore anticipate larger rebate accruals and potential profitability pressure on these products starting in 2025.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Redesigns]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> IRA (REGULATORY_REQUIREMENT)",
        "IRA (REGULATORY_REQUIREMENT) -> Medicare Part D (REGULATORY_REQUIREMENT)",
        "Medicare Part D (REGULATORY_REQUIREMENT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_125",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18233,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5282,
        "completion_tokens": 198,
        "total_tokens": 5480
      }
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG classifies structured securities as available-for-sale and records them at fair value, with unrealized gains/losses flowing through AOCI and net investment income, using effective-yield accounting that adjusts for credit losses and prepayments; MET similarly holds structured ABS/CLO securities classified as available-for-sale but discloses them in Note 11 with equity securities by type and related fair value, and includes them in its structured products category as part of fixed maturity securities AFS measured at estimated fair value with significant Level 3 inputs. Both companies apply different yield methodologies for structured securities—AIG explicitly adjusts yields for credit losses and prepayments, while MET’s structured products are measured at fair value with fair value adjustments reflected in earnings through realized gains/losses and unrealized net gains/losses recognized in income.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Structured Securities (FIN_INST)",
        "Structured Securities (FIN_INST) -> ABS CLO (FIN_INST)",
        "ABS CLO (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_169",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_309",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4158,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1703,
        "completion_tokens": 228,
        "total_tokens": 1931
      }
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron's reserves tied to production-sharing contracts (PSCs) account for 8–10 % of its consolidated reserves, a share that is largely linked to its African operations where PSCs dominate deep‑water exploration, while ExxonMobil’s exposure in Nigeria is essentially synonymous with its participation in those same PSCs—Nigeria’s deep‑water offshore blocks are governed by PSCs with the NNPC, and the regulatory framework treats those contracts as the primary mechanism for production, meaning ExxonMobil’s operational footprint in the country is almost entirely dependent on PSCs. Consequently, the percentage of Chevron’s reserves that stem from PSCs is comparable to the extent of ExxonMobil’s operational exposure in Nigeria, since both companies’ African reserve bases are fundamentally underpinned by production‑sharing agreements.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Nigeria (GPE)",
        "Nigeria (GPE) -> Production-Sharing Contracts (REGULATORY_REQUIREMENT)",
        "Production-Sharing Contracts (REGULATORY_REQUIREMENT) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6870,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2409,
        "completion_tokens": 209,
        "total_tokens": 2618
      }
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla's 2019 Plan reserves 49.0 million fixed shares for long-term equity compensation, providing structural flexibility through its inclusion of stock appreciation rights (SARs) alongside traditional equity awards, whereas HD's approach under its stock-based compensation policy uses a forfeiture-adjusted vesting methodology for SARs that introduces variable expense recognition tied to expected employee retention. This contrast highlights Tesla's fixed-reserve framework versus HD's dynamic forfeiture adjustments as key differentiators in long-term equity compensation design and accounting flexibility.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Includes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "HD (ORG) -> Stock Appreciation Rights (FIN_INST)",
        "Stock Appreciation Rights (FIN_INST) -> 2019 Plan (ACCOUNTING_POLICY)",
        "2019 Plan (ACCOUNTING_POLICY) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3048,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 152,
        "total_tokens": 1608
      }
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron's financial exposure to Tengizchevroil in Kazakhstan centers on its $4,500 million loan for the FGP/WPMP development and a $100 higher carrying value of its investment compared to underlying equity, reflecting strategic acquisition pricing. This exposure is situated within Kazakhstan's broader operational footprint, where ExxonMobil reports $8,463 million in long-lived assets as of 2021, establishing a significant asset base that contextualizes the region's importance to multinational oil operations. The KG triplet relationship Kazakhstan → XOM confirms ExxonMobil's presence in the same country, linking Chevron's loan-driven investment to a competitive landscape where both majors hold substantial, but differently structured, financial commitments in Kazakhstan's energy sector.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> Kazakhstan (GPE)",
        "Kazakhstan (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5634,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2079,
        "completion_tokens": 198,
        "total_tokens": 2277
      }
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy's renewable PPAs are negotiated directly for its own wind facilities, with decisions on siting, PPA terms, and O&M activities making it the primary beneficiary that consolidates these VIEs, whereas Southern Power's PPAs are structured as operating leases for third-party owned assets where the lessor relationship and tax equity partnerships significantly shape its cash flow profile. Southern Power's wind PPAs are explicitly tied to production tax credits (PTCs) that materially impact its cash flows and net income, with the company expecting to fully utilize $0.8 billion in PTCs and ITCs by 2024 through tax equity partnerships that allocate nearly all federal tax benefits to partners, contrasting with Duke Energy's more direct PPA negotiation approach that lacks the same tax credit-driven cash flow mechanism.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negotiates]-> FIN_INST -[Related_To]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "DUK (ORG) -> PPAs (FIN_INST)",
        "PPAs (FIN_INST) -> Wind Facilities (PRODUCT)",
        "Wind Facilities (PRODUCT) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_268",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5838,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2136,
        "completion_tokens": 207,
        "total_tokens": 2343
      }
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "LOW repurchased shares through ASR agreements to obtain additional shares, while HD issues additional shares via dividend equivalents on deferred share awards for non-employee directors. Both mechanisms result in the issuance of additional shares to settle deferred compensation, with HD's deferred shares explicitly tied to HD as the issuing organization through the deferred share program.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Additional Shares (FIN_INST)",
        "Additional Shares (FIN_INST) -> Deferred Shares (FIN_INST)",
        "Deferred Shares (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2516,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 97,
        "total_tokens": 1395
      }
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing's equity income from ULA in 2024 was $125 million, reflecting its 50% ownership stake in the joint venture that provides expendable launch services to both government and commercial customers, including Lockheed Martin Space (LMT), which relies on ULA for commercial satellite launch revenue; this $125 million equity income directly correlates with Lockheed Martin's commercial satellite launch revenue stream through ULA's dual-service role, as evidenced by LMT's Space segment reporting $551 million in ULA investment value and its dependence on ULA for launch services to commercial customers.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Supplies]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "BA (ORG) -> ULA (COMP)",
        "ULA (COMP) -> Commercial Customers (COMP)",
        "Commercial Customers (COMP) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7521,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2538,
        "completion_tokens": 151,
        "total_tokens": 2689
      }
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "LLY's loss of market exclusivity stems from the interplay of patent rights and regulatory data protection, with its effective exclusivity duration varying across major markets: five years in the U.S. (12 years for biologics), 10 years in Europe, and eight years in Japan, alongside potential extensions via pediatric exclusivity or orphan drug designations that operate independently of patent terms. In contrast, MRK faces patent-related risks primarily through challenges to its patent portfolio—such as generic manufacturers filing NDAs to circumvent exclusivity, third-party invalidation attempts, and compulsory licensing in foreign markets—which could lead to significant sales declines if key products lose protection in profitable regions, as explicitly noted in its risk factors regarding \"loss of patent protection... leading to a significant and rapid loss of sales.\" While LLY's exposure is mitigated by layered protections like data exclusivity periods and regulatory incentives, MRK's vulnerability is heightened by its greater reliance on patent rights as the primary determinant of exclusivity, with fewer references to supplementary regulatory exclusivity mechanisms in its disclosures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has]-> REGULATORY_REQUIREMENT -[Determined_By]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> Patent Rights (RISK_FACTOR)",
        "Patent Rights (RISK_FACTOR) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12375,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3802,
        "completion_tokens": 300,
        "total_tokens": 4103
      }
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "The financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities are directly tied to potential NRC fines, shutdowns, and material contributory payments from a major nuclear incident, which could exceed decommissioning trust coverage and result in costs \"in excess of insurance coverage\" as noted in Chunk 1 and Chunk 2. In contrast, Duke Energy's decommissioning trust fund funding risks stem from market-driven asset value declines in its NDTF investments, where poor investment performance could \"increase the funding requirements\" of decommissioning obligations and \"negatively affect\" results of operations, as detailed in Chunk 3. Both companies face nuclear-related financial exposure, but Southern Company's risks are rooted in regulatory and incident-driven costs, while Duke Energy's are tied to capital market volatility affecting trust fund sufficiency.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR -[Subject_To]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "SO (ORG) -> Cyber Intrusions (RISK_FACTOR)",
        "Cyber Intrusions (RISK_FACTOR) -> Nuclear Power Plants (PRODUCT)",
        "Nuclear Power Plants (PRODUCT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19170,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5484,
        "completion_tokens": 226,
        "total_tokens": 5710
      }
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe's 2023 treatment of dividend equivalents on deferred stock units for non-employee directors differs materially from Home Depot's deferred shares policy, particularly in vesting schedules and payout structure. While Lowe's deferred stock units vest on the earlier of the first anniversary of the grant date or the day preceding the next Annual Meeting (subject to acceleration), Home Depot's deferred shares only vest upon termination of Board service with payout occurring then, and both plans convert accrued dividend equivalents into additional shares rather than cash, though Lowe's expenses these equivalents on a straight-line basis over the service period whereas Home Depot expenses the full fair value immediately upon grant.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Dividend Equivalents (FIN_INST)",
        "Dividend Equivalents (FIN_INST) -> Deferred Shares (FIN_INST)",
        "Deferred Shares (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2154,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 184,
        "total_tokens": 1413
      }
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "The potential loss of 12-year biologic data exclusivity in the U.S. would directly erode AMGN's market exclusivity for its flagship biologics, exposing them to earlier biosimilar competition and downward pricing pressure, as highlighted in Chunk 1's discussion of FDA exclusivity risks and the consequences of losing \"umbrella exclusivity.\" This vulnerability contrasts with MRK's strategy, which relies on compound patents and pediatric exclusivity extensions to extend market protection—MRK explicitly states that while compound patent expiration typically ends market exclusivity, it can be supplemented by later-expiring process patents, use patents, and regulatory exclusivity (including pediatric extensions that add six months to existing protection), as detailed in Chunk 2 and Chunk 3. Consequently, AMGN faces heightened competitive risk from biosimilars under potential regulatory shifts, whereas MRK's portfolio is structured to maintain exclusivity through layered patent and exclusivity strategies, though both companies operate in an environment of increasing biosimilar and generic competition that pressures pricing and sales, as noted in Chunk 1's analysis of market concentration and competitive dynamics.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Determined_By]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Regulatory Exclusivity (REGULATORY_REQUIREMENT)",
        "Regulatory Exclusivity (REGULATORY_REQUIREMENT) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12283,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3770,
        "completion_tokens": 306,
        "total_tokens": 4076
      }
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "GS applies an 18% minimum TLAC-to-RWAs threshold that incorporates a countercyclical capital buffer (currently set at 0% by the FRB), while SCHW is subject to a separate 2.5% stress capital buffer requirement under its risk-based capital framework; both entities are connected through the countercyclical buffer requirement, but GS explicitly references the 18% minimum threshold and 0% buffer in its TLAC disclosures, whereas SCHW discloses a mandatory 2.5% stress buffer and zero countercyclical buffer, reflecting divergent regulatory applications of the same buffer mechanism.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Discloses]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "GS (ORG) -> TLAC to RWAs Requirement (REGULATORY_REQUIREMENT)",
        "TLAC to RWAs Requirement (REGULATORY_REQUIREMENT) -> Countercyclical Capital Buffer (REGULATORY_REQUIREMENT)",
        "Countercyclical Capital Buffer (REGULATORY_REQUIREMENT) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2471,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 145,
        "total_tokens": 1478
      }
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "XOM holds $7,728 million in long‑lived assets in Kazakhstan, reflecting its upstream exposure to the country, while CVX’s stake in TCO’s Kazakhstan operations is evidenced by its 15 % interest in the Caspian Pipeline Consortium and its participation in the Karachaganak field development, both of which are central to TCO’s oil production in the region.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Kazakhstan (GPE)",
        "Kazakhstan (GPE) -> TCO (COMP)",
        "TCO (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12500,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3757,
        "completion_tokens": 88,
        "total_tokens": 3846
      }
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company acknowledges \"uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04\" and states that \"the ultimate outcome of the transition cannot be determined at this time\" (Chunk 1), while NextEra Energy explicitly discloses it is \"applying the same standard\" (ASU 2020-04) to its interest rate contracts (Chunk 3). Both companies rely on the Reference Rate Reform guidance (ASU 2020-04/Topic 848) to manage derivative exposures, as evidenced by the KG triplet chain where ASU 2020-04 (Accounting Policy) positively impacts the Reference Rate Reform regulatory requirement (KG: ASU 2020-04 → Reference Rate Reform), which is subject to NextEra Energy (NEE) (KG: Reference Rate Reform → NEE) (Chunk 2 and Chunk 3). This shared regulatory framework under ASU 2020-04 creates parallel disclosure obligations, with Southern Company's uncertainty contrasting NextEra Energy's proactive application of the standard to its derivative contracts.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "SO (ORG) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> Reference Rate Reform (REGULATORY_REQUIREMENT)",
        "Reference Rate Reform (REGULATORY_REQUIREMENT) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_195",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9691,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3149,
        "completion_tokens": 248,
        "total_tokens": 3398
      }
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "META's dual-class structure, featuring Class A Common Stock with limited voting rights compared to Class B shares held by Mark Zuckerberg, creates a governance framework that prioritizes controlling stockholder interests, as evidenced by provisions requiring Class B approval for key corporate actions and amendments to the certificate of incorporation. This contrasts with GOOGL's governance, which, under its Certificate of Incorporation, allocates identical dividend and liquidation rights across all classes of common stock while maintaining voting rights that are subject to specific limitations only on certain matters, thereby offering comparatively stronger protections for minority shareholders through mechanisms like unanimous board consent for amendments and Delaware law safeguards against adversarial changes to stockholder rights.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Certificate of Incorporation (REGULATORY_REQUIREMENT)",
        "Certificate of Incorporation (REGULATORY_REQUIREMENT) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10334,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3292,
        "completion_tokens": 211,
        "total_tokens": 3503
      }
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "The OECD's global minimum tax framework could significantly impact both PepsiCo and Altria's effective tax rates, though their exposure differs substantially. PepsiCo, with substantial international operations across jurisdictions adopting the 15% global minimum tax (including EU member states effective 2024), faces direct exposure to increased corporate tax liabilities as highlighted in Chunk 1's discussion of \"increasingly complex global tax environment\" and potential \"higher compliance costs\" from OECD Pillar Two implementation. In contrast, Altria's tax burden is primarily U.S.-centric, as evidenced by its 2023 U.S. earnings before taxes of $10,971 million versus only $(43) million outside the U.S. (Chunk 3), meaning its international operations contribute minimally to tax exposure. While Chunk 2's BlackRock analysis details OECD tax reforms generally, it does not directly connect to either PepsiCo or Altria's specific tax positions, making Chunk 3's U.S.-focused tax data and Chunk 1's international tax risk assessment the critical sources for understanding the divergent impacts on these two companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Tax Legislation (REGULATORY_REQUIREMENT)",
        "Tax Legislation (REGULATORY_REQUIREMENT) -> US (GPE)",
        "US (GPE) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13861,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4141,
        "completion_tokens": 280,
        "total_tokens": 4422
      }
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "AbbVie's risk of generic competition is heightened when market exclusivity—particularly orphan drug exclusivity—expires, as illustrated by the KG pattern where **Orphan Drug Exclusivity** positively impacts **Market Exclusivity** for **LLY** but negatively impacts **ABBV** when such exclusivity lapses. While Eli Lilly (LLY) relies on orphan drug designation to secure seven years of market exclusivity beyond compound patent expiration, AbbVie (ABBV) faces direct exposure to generic entry once its orphan-designated products lose exclusivity, especially since its revenue heavily depends on products protected by such regulatory mechanisms. This dynamic is reinforced by the U.S. regulatory framework described in Chunk 2, where orphan drug exclusivity runs parallel with data protection and patent terms, and Chunk 1 confirms that market exclusivity can be extended via orphan designation, but only until challenged or expired—leaving ABBV vulnerable to generic competition post-exclusivity.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Orphan Drug Exclusivity (REGULATORY_REQUIREMENT)",
        "Orphan Drug Exclusivity (REGULATORY_REQUIREMENT) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14801,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4415,
        "completion_tokens": 248,
        "total_tokens": 4664
      }
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "Coca-Cola FEMSA's operations in Argentina contributed to KO's equity method investee sales exposure, as evidenced by the 2021 increase in purchases of beverage products from equity method investees driven by international expansion, including growth in Argentina. This operational footprint in Argentina directly supported KO's equity investee sales, contrasting with PEP's direct exposure to Argentina's economic volatility, which is highlighted by PEP's 2021 foreign exchange risk exposure in Argentina (where currency fluctuations could adversely impact results) and its 44% international revenue dependency, including significant exposure in Argentina. While KO's exposure is indirect via its equity method investee (Coca-Cola FEMSA) and mitigated by the bottler's independent operations under contractual agreements, PEP's direct operational and currency risks in Argentina created a more volatile environment for its own sales and financial performance during the same period.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola FEMSA (COMP)",
        "Coca-Cola FEMSA (COMP) -> Argentina (GPE)",
        "Argentina (GPE) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10813,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3366,
        "completion_tokens": 245,
        "total_tokens": 3612
      }
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie's acquisition of Cerevel Therapeutics secures exclusive patent rights to emraclidine, creating market exclusivity through regulatory pathways that directly link to AbbVie's strategic positioning (Chunk 1: licensing agreement with Pfizer for global license; $4.5B impairment charge reflects reliance on these rights). This contrasts with Merck's Januvia experience, where patent expiration was delayed by regulatory exclusivity extensions and legal settlements (e.g., U.S. market exclusivity maintained until May 2026 for Januvia; EU exclusivity lost in 2022–2023), resulting in earlier and more severe sales declines due to competitive generic entry (Chunk 2: patent/regulatory exclusivity mechanisms; Chunk 3: Januvia's 33% sales decline from exclusivity loss and regulatory price pressures). Thus, AbbVie's strategy leverages patent-driven exclusivity to delay generic competition, whereas Merck's timeline demonstrates how regulatory exclusivity and litigation can temporarily extend market protection but ultimately cannot prevent the inevitable sales erosion seen in Januvia's post-exclusivity performance.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> RISK_FACTOR -[Provides]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Patent Rights (RISK_FACTOR)",
        "Patent Rights (RISK_FACTOR) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11275,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3516,
        "completion_tokens": 279,
        "total_tokens": 3795
      }
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron's 15% ownership of the Caspian Pipeline Consortium (CPC) directly enables export of crude oil from Kazakhstan's Tengiz and Korolev fields (via TCO's operations) and the Karachaganak Expansion projects, with CPC transporting an average of 1.4 million barrels per day—including 1.2 million from Kazakhstan—supporting Chevron's upstream production growth in Kazakhstan, as evidenced by the FGP's 2025 start-up and Karachaganak's Stage 1A/1B development. In contrast, ConocoPhillips (COP) relies on crude oil production for 100% of its upstream operations, as shown by the KG triplet Crude Oil (RAW_MATERIAL) -> COP (ORG), indicating its upstream business is fundamentally dependent on crude output without comparable pipeline infrastructure dependencies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Transports]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> CPC (COMP)",
        "CPC (COMP) -> Crude Oil (RAW_MATERIAL)",
        "Crude Oil (RAW_MATERIAL) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9973,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3160,
        "completion_tokens": 189,
        "total_tokens": 3349
      }
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle's integration of generative AI in MySQL HeatWave leverages its Autonomous Database infrastructure and OCI cloud services to deliver a unified platform combining transactions, real-time analytics, and generative AI capabilities within a managed cloud service, as highlighted in Chunk 1's description of HeatWave's architecture and its alignment with Oracle Autonomous Database's cloud-native design. This complements Qualcomm's strategic vision for on-device generative AI in edge computing, which emphasizes distributed processing for privacy, latency reduction, and contextual use cases across automotive, IoT, and mobile ecosystems, as detailed in Chunk 2's analysis of edge AI adoption and the 46% smartphone generative AI capability projection for 2027. Both companies strategically invest in cloud infrastructure—Oracle through OCI and Autonomous Database services to support cloud-based AI workloads, and Qualcomm through its QCT semiconductor business and edge computing initiatives to enable on-device AI processing—creating a complementary relationship where Oracle's cloud platform potentially underpins the backend infrastructure for Qualcomm's edge AI vision, as implied by the KG triplet connection \"Cloud Computing (CONCEPT) -> QCOM (ORG)\" and the complementary roles of their respective AI strategies across cloud and edge environments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT -[Complements]-> CONCEPT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Generative AI (CONCEPT)",
        "Generative AI (CONCEPT) -> Cloud Computing (CONCEPT)",
        "Cloud Computing (CONCEPT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13598,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4074,
        "completion_tokens": 339,
        "total_tokens": 4414
      }
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart mitigates cash flow risks through **firm commitments** for inventory and utility purchases, which represent legally binding purchase obligations that lock in fixed or minimum quantities and pricing, thereby reducing exposure to price volatility and supply chain disruptions. This approach contrasts with Colgate-Palmolive’s use of **option contracts** to hedge foreign currency exposure, where options provide asymmetric protection—allowing the company to benefit from favorable rate movements while limiting downside risk—reflecting a more flexible, market-responsive strategy to manage financial exposure across global operations. Both strategies, however, align with the broader pattern of leveraging specialized financial instruments (firm commitments and option contracts) to stabilize cash flows, as evidenced by their respective roles in the KG triplet network connecting organizations to financial instruments and their impact on risk mitigation.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Utilizes]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Firm Commitments (FIN_INST)",
        "Firm Commitments (FIN_INST) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9324,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3010,
        "completion_tokens": 240,
        "total_tokens": 3250
      }
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley employs credit default swaps (CDS) to directly hedge credit risk by purchasing protection against default on reference entities, thereby mitigating losses from credit events as described in its 10-K filing. Capital One, conversely, relies on default rate assumptions—specifically a weighted average of 4% for net derivative assets (liabilities)—to value these instruments, reflecting sensitivity to credit event outcomes that directly impact the fair value of its derivative positions. Both institutions are interconnected through the financial instrument of net derivative assets (liabilities), where Morgan Stanley's CDS-based risk management and Capital One's valuation methodology converge on credit risk exposure, as evidenced by the shared \"Default\" risk factor linking their hedging practices and valuation dependencies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Protected_Against]-> RISK_FACTOR -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MS (ORG) -> Default (RISK_FACTOR)",
        "Default (RISK_FACTOR) -> Net derivative assets (liabilities) (FIN_INST)",
        "Net derivative assets (liabilities) (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_11",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_208",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_208",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8219,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2748,
        "completion_tokens": 210,
        "total_tokens": 2958
      }
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy's natural gas distribution assets in Georgia span approximately 28,800 miles of service lines and 35,700 miles of pipelines, forming a substantial infrastructure foundation that supports regional reliability through extensive service coverage across multiple states. Southern Company Gas contributes to this reliability via its 50% joint ownership in SNG, a 7,000-mile pipeline that connects Gulf Coast supply basins to Southern states' markets, enabling diverse fuel sources for its 4.4 million customers across four states. This integrated approach—Duke's extensive distribution network and Southern Company Gas's pipeline investments—collectively strengthens Georgia's energy market resilience, with Duke's scale in distribution assets and Southern Company Gas's strategic pipeline partnerships ensuring reliable supply chain redundancy and infrastructure redundancy for the region.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Georgia (GPE)",
        "Georgia (GPE) -> SNG (COMP)",
        "SNG (COMP) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_301",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8593,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2817,
        "completion_tokens": 224,
        "total_tokens": 3042
      }
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "The enactment of Louisiana's 2024 corporate tax rate reduction legislation directly impacted Union Pacific's deferred tax expense, resulting in a $34 million reduction as disclosed in its 2024 Form 10-K (Chunk 2), which specifically cites Louisiana and Arkansas as enacting such legislation to reduce future corporate income tax rates. This impact is contextualized within Union Pacific's operations in Louisiana, as evidenced by the railroad's major classification yard in Livonia, Louisiana (Chunk 3), and aligns with the broader regulatory pattern where states like Louisiana are connected to Union Pacific as an operating entity under regulatory frameworks (KG: ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Introduces]-> GPE <-[Operates_In]- ORG). In contrast, Arkansas's similar 2024 legislation contributed to a larger $114 million reduction in deferred tax expense for Union Pacific in 2023 (Chunk 2), indicating that while both states enacted rate reductions, Arkansas's prior-year policy change generated a more substantial immediate impact on deferred tax expense than Louisiana's 2024 change, which only accounted for $34 million of the total reduction compared to Arkansas's $114 million in the prior year.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Introduces]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> Legislation (REGULATORY_REQUIREMENT)",
        "Legislation (REGULATORY_REQUIREMENT) -> Louisiana (GPE)",
        "Louisiana (GPE) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8954,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2919,
        "completion_tokens": 304,
        "total_tokens": 3223
      }
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "The voting rights disparity between META's Class B Common Stock and GOOGL's Class A Common Stock fundamentally shapes their corporate governance structures, particularly through the explicit voting limitations imposed on Class B shares in merger scenarios. As detailed in Chunk 1, META discloses that its Class B shares carry voting rights tied to specific corporate actions, including mergers where Class B holders can vote together as a single class, while Chunk 2 clarifies that Class B common stockholders (like META's) may vote on merger-related decisions but only as part of a collective class vote, and Chunk 3 confirms GOOGL's Class B shares grant 10 votes per share—significantly amplifying influence in governance compared to Class A's single vote per share. This structural distinction, where META's Class B voting power is contingent on specific transactional triggers (e.g., mergers) and requires collective approval, contrasts with GOOGL's inherent 10:1 voting ratio for Class B, creating divergent governance dynamics where META's merger-related decisions hinge on class-based consensus while GOOGL's Class B holders maintain disproportionate, automatic voting control.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9503,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3070,
        "completion_tokens": 296,
        "total_tokens": 3366
      }
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "Pfizer's revenue recognition strategy for cardiovascular products like Repatha is directly shaped by payer restrictions that limit formulary placement and affordability, mirroring Amgen's experience with Repatha where step therapy, high patient cost-sharing, and exclusion of indications reduced patient access and sales despite price reductions. This dynamic forces both companies to rely on complex gross-to-net accounting adjustments—such as rebates, discounts, and chargebacks—to manage revenue volatility, as seen in Gilead's disclosures about estimating rebates based on payer mix and market trends, while U.S. payer consolidation (e.g., top insurers controlling 85% of prescriptions) intensifies discount pressures and threatens revenue streams across all three firms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> COMP <-[Pays]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Access Restrictions (REGULATORY_REQUIREMENT)",
        "Access Restrictions (REGULATORY_REQUIREMENT) -> Payers (COMP)",
        "Payers (COMP) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15384,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4533,
        "completion_tokens": 193,
        "total_tokens": 4726
      }
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s 15 % equity stake in TCO’s Kazakhstan crude‑oil venture gives it a direct financial interest in the FGP project’s production ramp‑up beginning in 2025, linking its exposure to TCO’s output growth through the CPC pipeline that transports roughly 1.2 million bbl/d of Kazakh crude; this exposure is distinct from ConocoPhillips’ broader dependence on crude oil as a raw material, which is reflected in its reserves and production figures across multiple regions (e.g., U.S., Australia, Asia) and its overall reserve base of ≈ 30 billion boe, underscoring how Chevron’s stake concentrates its risk in the Kazakhstan ramp‑up while COP’s raw‑material reliance spans a diversified portfolio of crude sources.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Produces]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "COP (ORG) -> Crude Oil (RAW_MATERIAL)",
        "Crude Oil (RAW_MATERIAL) -> TCO (COMP)",
        "TCO (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10742,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3363,
        "completion_tokens": 178,
        "total_tokens": 3541
      }
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs' exposure to hotel-related commercial real estate loans is disclosed in its 10-K as part of broader CRE lending, where hotels are explicitly listed among properties securing originated loans and lending commitments, and CRE includes purchased loans backed by such assets; this exposure is detailed in the credit concentration metrics on page 118 of GS_10k_2024.pdf. MetLife's investment in real estate funds focused on hotels is reflected in its 10-K disclosure that real estate funds—which include investments in hotels as a property type—are held within its portfolio, with such funds structured to pursue specific geographic or property-type strategies, as noted in the \"Real Estate\" section of MS_10k_2024.pdf and confirmed by the KG triplet linking Real Estate Funds to MET. Both companies use real estate funds as a strategic vehicle: Goldman Sachs channels exposure through CRE loan products tied to hotel-backed assets, while MetLife allocates capital directly to funds targeting hotel properties, with the funds serving as key investment vehicles that connect their strategies through the shared FIN_INST (Real Estate Funds) entity in the KG pattern.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GS (ORG) -> Hotels (PRODUCT)",
        "Hotels (PRODUCT) -> Real Estate Funds (FIN_INST)",
        "Real Estate Funds (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6269,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2238,
        "completion_tokens": 293,
        "total_tokens": 2531
      }
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "BA's liquidity risk profile for its limited partnership investments in real estate funds differs fundamentally from UPS's pension fund commitments, as BA's disclosures focus on private equity vehicles with no specified term length or unfunded commitment exposure, while UPS explicitly details $3.3 billion in unfunded commitments to real estate partnerships with typical 10–15 year terms. UPS's pension fund commitments are structured with defined redemption horizons (10–15 years from inception) and material unfunded obligations requiring future capital contributions, whereas BA's portfolio description lacks any reference to partnership term lengths or unfunded commitments, instead categorizing such investments generically within private equity and real assets without disclosure of redemption constraints or capital call requirements.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Limited Partnerships (FIN_INST)",
        "Limited Partnerships (FIN_INST) -> Real Estate Funds (FIN_INST)",
        "Real Estate Funds (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9695,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3107,
        "completion_tokens": 210,
        "total_tokens": 3317
      }
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "The voting power distribution at META and CMCSA reveals stark contrasts in control concentration. META's structure grants Class B shares (held primarily by Zuckerberg) disproportionate voting power—representing less than 35% of combined voting power yet enabling control over key decisions like board composition and mergers—while CMCSA's Class A shares collectively hold 66.3% of voting power, with Class B shares (owned entirely by Brian Roberts) carrying 15 votes per share, ensuring dominant control despite lower share issuance. This creates a significantly more concentrated control mechanism at META, where a single entity can dictate outcomes with a minority of shares, whereas CMCSA's structure, though still controlled by the Roberts family, operates within a more balanced voting framework where Class A shareholders retain meaningful aggregate influence over major corporate actions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13498,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4054,
        "completion_tokens": 223,
        "total_tokens": 4277
      }
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PEP's U.S. qualified defined benefit plan allocates approximately 16% of its assets to government securities (as shown in Chunk 2's table: $1,812 million of $11,226 million total U.S. plan assets), which aligns with its stated investment policy of holding \"high-quality debt securities\" and using derivatives like futures to reduce interest rate risks while targeting a 7.4% long-term return (Chunk 1). This strategy directly supports its risk management objective of ensuring funds are available to meet benefit obligations, as the plan's assets are no longer controlled by PEP but are managed to align with projected liabilities. In contrast, COST's short-term holdings in government and agency securities—explicitly limited to \"U.S. government and government agency obligations, repurchase agreements collateralized by such obligations, and money market funds\" (Chunk 3)—represent a separate, lower-risk investment profile focused on principal preservation and yield generation, with a 100-basis-point interest rate change deemed \"immaterial\" to fair value (Chunk 3). While PEP's allocation to government securities is part of a broader, diversified portfolio including equities and real estate to achieve long-term return targets, COST's government holdings are specifically structured as short-term, highly liquid instruments within a risk-averse framework, reflecting distinct but complementary approaches to managing fixed-income exposure across the two companies' pension and investment strategies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Contains]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> U.S. Plan Assets (FIN_INST)",
        "U.S. Plan Assets (FIN_INST) -> Government Securities (FIN_INST)",
        "Government Securities (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8981,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2938,
        "completion_tokens": 376,
        "total_tokens": 3314
      }
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio is 0.1% of total assets (9 million out of 15,430 million), whereas NextEra Energy's target allocation framework for fixed income investments specifies a 23% target for fixed income assets overall, with mortgage‑and asset‑backed securities comprising a small portion of that allocation (e.g., 2 million in Alabama Power's portfolio). Both companies classify mortgage‑backed securities under fixed income assets, but Southern Company reports a negligible actual holding (0.1%) while NextEra's target fixed‑income allocation is 32% of its pension fund, emphasizing a much larger strategic commitment to fixed income relative to Southern Company's current actual exposure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Mortgage-Backed Securities (FIN_INST)",
        "Mortgage-Backed Securities (FIN_INST) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_298",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13485,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4070,
        "completion_tokens": 192,
        "total_tokens": 4262
      }
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla and Panasonic formalized their Gigafactory partnership through multiple binding agreements including the **October 5 2011 Supply Agreement**, its **October 29 2013 and June 10 2020 amendments**, and the **2019 and 2020 Pricing Agreements** that set production‑pricing terms for 2170 cells; these documents also establish joint investment, pricing, and factory‑lease arrangements between the parties. GM’s battery supply chain relies on Panasonic as a key supplier, but its integration is less deep—GM sources batteries from external producers rather than maintaining the same long‑term, pricing‑and‑investment‑linked contracts that Tesla has with Panasonic, reflecting a shallower supplier relationship and weaker contractual depth.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "GM (ORG) -> Batteries (PRODUCT)",
        "Batteries (PRODUCT) -> Panasonic Corporation (COMP)",
        "Panasonic Corporation (COMP) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8521,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2808,
        "completion_tokens": 184,
        "total_tokens": 2993
      }
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron's tax audit exposure in Nigeria centers on unresolved tax positions tied to its operations under Production-Sharing Contracts (PSCs), where the company faces ongoing audits with no estimated resolution timeline—mirroring Exxon's risk under similar PSCs, which involve 30-year terms with a 10-year exploration period and mandatory 20-year production periods subject to partial relinquishment under Nigeria's Petroleum Industry Act (PIA). Both companies operate under PSCs governed by Nigeria's regulatory framework, but Chevron's exposure is specifically tied to unrecognized tax benefits (82% of $5,288 million at 2021 year-end) that could significantly impact its effective tax rate if resolved, while Exxon's risk stems from the structural terms of PSCs—such as exploration/extension periods and relinquishment obligations—that inherently create uncertainty in production-sharing arrangements, as reflected in its reserve reporting under SEC rules where production-sharing contracts account for 12% of total proved reserves.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Nigeria (GPE)",
        "Nigeria (GPE) -> Production-Sharing Contracts (REGULATORY_REQUIREMENT)",
        "Production-Sharing Contracts (REGULATORY_REQUIREMENT) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12089,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3705,
        "completion_tokens": 258,
        "total_tokens": 3964
      }
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla's commercial paper usage of $470 million (as disclosed in its 10-K) is directly connected to Ohio through the KG pattern ORG-Discloses-FIN_INST-Discloses-ORG, where Ohio (GPE) discloses Commercial paper (FIN_INST) which is also disclosed by Tesla (ORG). Duke Energy Ohio, a subsidiary operating in Ohio, discloses $25 million in commercial paper in its 10-K, demonstrating that companies with significant Ohio operations like Duke Energy use commercial paper as a financing tool, though at a substantially lower scale ($25M vs Tesla's $470M) reflecting different capital structure needs.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Ohio (GPE)",
        "Ohio (GPE) -> Commercial paper (FIN_INST)",
        "Commercial paper (FIN_INST) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_165",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4840,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1853,
        "completion_tokens": 148,
        "total_tokens": 2001
      }
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan's exposure to transition risk—identified as a distinct climate risk driver in its 2023 10-K (Chunk 1)—feeds into a compliance‑risk pathway that links transition risk to compliance risk (KG: Transition Risk → Compliance Risk → MS), meaning that heightened transition‑risk management directly raises JPMorgan’s compliance‑risk profile; in contrast, Morgan Stanley’s own 10‑K disclosures (Chunk 2) show that its climate‑risk framework is embedded within broader legal, regulatory and compliance risk, and that transition‑risk impacts can amplify credit, market and liquidity risks while also exposing the firm to intensified regulatory scrutiny and potential sanctions (Chunk 3), thereby positioning Morgan Stanley’s compliance risk as being shaped more by external regulatory enforcement of climate‑related disclosures than by an intrinsic transition‑risk‑to‑compliance linkage.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Faces]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Transition Risk (RISK_FACTOR)",
        "Transition Risk (RISK_FACTOR) -> Compliance Risk (RISK_FACTOR)",
        "Compliance Risk (RISK_FACTOR) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12873,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3904,
        "completion_tokens": 221,
        "total_tokens": 4126
      }
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria's 30-year production-sharing contract (PSC) framework directly shapes both companies' operations and reserve accounting: ConocoPhillips operates deepwater PSCs in Nigeria governed by 30-year terms (including a 10-year exploration period followed by a 20-year production period under OMLs, extendable under the 2021 Petroleum Industry Act), while Chevron's Africa reserve accounting explicitly incorporates PSC-related reserves (8-10% of consolidated reserves in 2021-2019) as disclosed in its financial statements, relying on contractual production periods that align with Nigeria's 30-year deepwater framework. This structure ensures both firms' reserve valuations and operational planning are contingent on the stability and duration of Nigeria's deepwater PSC regime.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "COP (ORG) -> Nigeria (GPE)",
        "Nigeria (GPE) -> Production-Sharing Contracts (REGULATORY_REQUIREMENT)",
        "Production-Sharing Contracts (REGULATORY_REQUIREMENT) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5555,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2066,
        "completion_tokens": 194,
        "total_tokens": 2260
      }
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing's exposure to U.S. government contract modifications directly triggers scrutiny of its accounting for reference rate reform under ASU 2022-06, as evidenced by the KG relationship where BA (ORG) is impacted by Contract Modifications (ACCOUNTING_POLICY) that apply ASU 2022-06 (ACCOUNTING_POLICY) and connect to FDX (ORG) through the standard's scope. This linkage is critical because Boeing's contracts—subject to extensive U.S. government regulations and potential modifications without notice—may incorporate variable rate structures vulnerable to LIBOR transition, requiring ASU 2022-06's optional expedients to mitigate accounting impacts from contract modifications tied to reference rate reform. In contrast, FedEx explicitly references ASU 2022-06 in its 2023 10-K (Chunk 2) as part of its accounting policy for reference rate reform, noting that the standard defers the sunset date to December 31, 2024, and has not materially impacted its financial statements despite active contract modifications replacing LIBOR during 2021–2023. While Boeing's risk profile centers on government contract volatility affecting funding and compliance (Chunk 1), FedEx's approach emphasizes operational continuity in rate transitions without material financial statement effects, highlighting divergent applications of the same standard under distinct regulatory exposures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "BA (ORG) -> Contract Modifications (ACCOUNTING_POLICY)",
        "Contract Modifications (ACCOUNTING_POLICY) -> ASU 2022-06 (ACCOUNTING_POLICY)",
        "ASU 2022-06 (ACCOUNTING_POLICY) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15170,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4487,
        "completion_tokens": 342,
        "total_tokens": 4830
      }
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil's offshore acreage in Angola is 2.9 million net acres, while Chevron's stake in Angola LNG contributed $5,657 million of upstream earnings in 2021 (as reported in Chevron's 2021 equity‑affiliate income). This reflects Chevron's significant upstream earnings from the Angola LNG project, whereas ExxonMobil's acreage figure represents its broader offshore holdings in Angola.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Angola (GPE)",
        "Angola (GPE) -> Angola LNG (COMP)",
        "Angola LNG (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4561,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1791,
        "completion_tokens": 96,
        "total_tokens": 1888
      }
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture's $6.6 billion investment in 46 strategic acquisitions during fiscal 2024—explicitly aimed at scaling industry solutions through its \"360° value\" strategy—directly aligns with Microsoft's enterprise and partner services revenue stream, which includes industry-specific offerings as a core component of its business model. This is evidenced by the KG triplet relationship where *Enterprise and partner services (PRODUCT)* is connected to *MSFT (ORG)*, and Microsoft's own financial disclosure in Chunk 3 confirms that \"Enterprise and partner services\" generated $7,594 million in revenue for the year ended June 30, 2024, forming part of its broader $245.1 billion total revenue. Thus, while Accenture's acquisition strategy targets the expansion of industry solutions as a growth engine, Microsoft's comparable revenue figure from enterprise and partner services (including industry solutions) provides a direct financial benchmark for the market segment Accenture is scaling into.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Includes]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Industry Solutions (PRODUCT)",
        "Industry Solutions (PRODUCT) -> Enterprise and partner services (PRODUCT)",
        "Enterprise and partner services (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10330,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3273,
        "completion_tokens": 247,
        "total_tokens": 3521
      }
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy's FERC-approved dividend policy requires maintaining equity at or above 30% of total capital after adjusting for push-down accounting impacts, with Duke Energy Kentucky specifically mandated to maintain a minimum 35% equity structure to support dividend payments from retained earnings. This regulatory framework directly informs Southern Company's financial planning for the $3 billion SNG pipeline project, where Southern Company Gas holds a 50% cost share and requires FERC approval; the KG triplet relationship SNG → SO (Has_Stake_In) confirms Southern Company Gas's stake, while the precedent of equity thresholds under FERC-approved dividend policies demonstrates that maintaining sufficient equity levels is a regulatory prerequisite for financing decisions, making it critical for Southern Company to model its capital structure around the 30% equity benchmark observed in Duke Energy's compliance to ensure FERC approval of the SNG project's financing plan.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DUK (ORG) -> FERC Approval (REGULATORY_REQUIREMENT)",
        "FERC Approval (REGULATORY_REQUIREMENT) -> SNG (COMP)",
        "SNG (COMP) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_147",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_217",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9333,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3018,
        "completion_tokens": 244,
        "total_tokens": 3262
      }
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS applies matrix pricing to corporate debt instruments when broker quotes are unavailable, as disclosed in its fair value hierarchy under Level 2 inputs, and this methodology is captured in its accounting policy for corporate debt valuations. MMM similarly uses matrix pricing for corporate debt instruments when broker quotes are not available, but its valuation approach incorporates additional adjustments for unobservable risks such as credit and liquidity risk, reflecting a distinct risk‑adjusted methodology. Both companies rely on matrix pricing for corporate debt, yet UPS presents it within a standard Level 2 hierarchy disclosure, while MMM’s valuation includes extra risk adjustments and references private‑placement pricing practices.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Matrix Pricing (ACCOUNTING_POLICY)",
        "Matrix Pricing (ACCOUNTING_POLICY) -> Corporate Debt Instruments (FIN_INST)",
        "Corporate Debt Instruments (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5643,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2105,
        "completion_tokens": 187,
        "total_tokens": 2292
      }
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "The $2.8 billion upfront payment from Vertical Bridge REIT, LLC to Verizon in 2024 is structured as prepaid rent for the portion of the towers that have been transferred to Vertical Bridge and as a financing obligation for the portion the company continues to occupy, mirroring the 2013 Crown Castle transaction where $5.0 billion was recorded as a financing obligation rather than sale proceeds because control of the towers was not transferred; both deals involve long‑term (≈30‑year) exclusive lease and management rights with purchase options, and in each case Verizon retains operational control by subleasing capacity and remaining the primary obligor on underlying ground leases.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transacts_With]-> COMP -[Obtains]-> ACCOUNTING_POLICY <-[Gains]- ORG",
      "triplets_used": [
        "VZ (ORG) -> Vertical Bridge REIT, LLC (COMP)",
        "Vertical Bridge REIT, LLC (COMP) -> Exclusive Rights (ACCOUNTING_POLICY)",
        "Exclusive Rights (ACCOUNTING_POLICY) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9597,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3091,
        "completion_tokens": 171,
        "total_tokens": 3263
      }
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "MRK faces a potential tax liability from its TCJA-related IRS examination of 2017-2018 returns, particularly concerning the transition tax position, which could result in a \"significant tax liability\" if disputed, while MDT's BEAT-related impact is quantified in its 2024 effective tax rate calculation where the Base Erosion Anti-abuse Tax (BEAT) contributed a 0.3% increase to its 23.4% effective tax rate (vs. 29.5% in 2023), reflecting the minimum tax's direct effect on MDT's tax expense. The KG pattern (MRK → TCJA → BEAT → MDT) links MRK's TCJA transition tax risk to BEAT's structural role, with MDT's BEAT exposure explicitly measured in its tax rate components, though the exact dollar comparison cannot be derived as the chunks only provide qualitative risk disclosure for MRK and quantitative rate impact for MDT.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Introduces]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MRK (ORG) -> TCJA (REGULATORY_REQUIREMENT)",
        "TCJA (REGULATORY_REQUIREMENT) -> BEAT (REGULATORY_REQUIREMENT)",
        "BEAT (REGULATORY_REQUIREMENT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4690,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1849,
        "completion_tokens": 206,
        "total_tokens": 2055
      }
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria's 30-year production sharing contract framework directly shapes both ConocoPhillips' and Chevron's African operations through regulatory requirements and reserve disclosure practices. ConocoPhillips operates in Nigeria's deepwater areas under PSCs with the NNPC, where exploration licenses last 10 years convertible to 20-year OML production periods subject to partial relinquishment under the 2021 Petroleum Industry Act, creating a 30-year operational horizon that aligns with the contract structure. Chevron's reserve disclosures reflect similar contractual terms, as evidenced by its consolidated financial reporting showing Africa reserves of 104 million barrels at year-end 2021, with extensions and discoveries attributed to 30-year production sharing agreements that mirror Nigeria's regulatory framework. The KG triplets confirm this connection through the pathway: COP (ORG) -> Nigeria (GPE) -> Exploration and Production Activities (REGULATORY_REQUIREMENT) -> CVX (ORG), demonstrating how Nigeria's regulatory requirements govern both companies' operational footprints and reserve reporting practices across Africa.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Nigeria (GPE)",
        "Nigeria (GPE) -> Exploration and Production Activities (REGULATORY_REQUIREMENT)",
        "Exploration and Production Activities (REGULATORY_REQUIREMENT) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11562,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3565,
        "completion_tokens": 283,
        "total_tokens": 3849
      }
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "The limited voting rights structure attached to AT&T's Series C Preferred Stock requires approval by the affirmative vote of the outstanding voting power of each series of preferred stock voting as a single class for certain defined matters—including mergers or consolidations—where holders of Series B and C preferred stock cast votes equal to the number of shares they hold, effectively giving concentrated control to preferred shareholders in restructuring scenarios; this contrasts with Netflix's one-share-one-vote common stock model where each common shareholder gets one vote per share on all matters, providing more distributed voting power. Consequently, AT&T's restructuring decisions involving mergers or similar transactions would be subject to the approval thresholds set by its Series B and C preferred stockholders, potentially enabling those shareholders to block or reshape transactions despite common stockholder opposition, whereas Netflix's governance model ties voting authority directly to common stock ownership without such layered preferred stock constraints.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "T (ORG) -> Series C Preferred Stock (FIN_INST)",
        "Series C Preferred Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5129,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1961,
        "completion_tokens": 271,
        "total_tokens": 2232
      }
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "The expiration timeline of key patent protections for Enbrel directly impacts Pfizer's long-term revenue strategy by limiting the product's commercial lifespan in the U.S. market, where Enbrel's primary patent protection extends to 2028 (with a secondary formulation patent lasting until 2037), though AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics—such as the 12-year exclusivity under the Biologics Price Competition and Innovation Act—creates a complex landscape where patent expirations and potential biosimilar entry could significantly affect Pfizer's revenue projections, especially given that Enbrel is a key product for Pfizer in its Specialty Care segment as noted in its 2024 Form 10-K.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> Enbrel (PRODUCT)",
        "Enbrel (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8637,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2847,
        "completion_tokens": 186,
        "total_tokens": 3033
      }
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil's Singapore facility operates at 592,000 barrels per day of ethylene production capacity, as shown in XOM_10k_2024.pdf (page 26) where Singapore is listed under Asia Pacific with 592 thousand barrels per day of ethylene capacity. This capacity is distinct from Chevron's indirect involvement through Map Ta Phut Olefins Company Limited in Thailand, which produces ethylene at 175 thousand barrels per day (CVX_10k_2024.pdf, page 18) and is in which Chevron holds a 32.77% ownership stake (DOW_10k_2024.pdf, page 15). The KG triplet Ethylene (RAW_MATERIAL) -> XOM (ORG) confirms ExxonMobil's direct ethylene production relationship, while CVX (ORG) -> Map Ta Phut (COMP) establishes Chevron's indirect connection to ethylene manufacturing through its stake in the Map Ta Phut joint venture, where the facility produces ethylene (Map Ta Phut (COMP) -> Ethylene (RAW_MATERIAL)). Thus, ExxonMobil's Singapore facility has approximately 3.38 times the ethylene production capacity (592 vs 175 thousand barrels per day) of the ethylene manufacturing capacity indirectly supported by Chevron through its ownership in Map Ta Phut Olefins.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> COMP -[Produces]-> RAW_MATERIAL <-[Produces]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Map Ta Phut (COMP)",
        "Map Ta Phut (COMP) -> Ethylene (RAW_MATERIAL)",
        "Ethylene (RAW_MATERIAL) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DOW_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14364,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4265,
        "completion_tokens": 285,
        "total_tokens": 4550
      }
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company's disallowance of capital investments at Nicor Gas in Illinois resulted in approximately $96 million of pre‑tax charges (about $72 million after tax), reflecting the financial impact of those regulatory actions. NextEra Energy operates a substantial gas‑pipeline network in Illinois, with roughly 90 thousand miles of infrastructure—far exceeding the scale of Nicor Gas’s 34.7 thousand miles of pipe and dwarfing the $96 million charge, underscoring that the disallowance represents a relatively minor portion of NextEra’s extensive Illinois assets. This comparison highlights how the regulatory setback is modest relative to the massive pipeline footprint that NEE maintains in the same state.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "SO (ORG) -> Nicor Gas (COMP)",
        "Nicor Gas (COMP) -> Illinois (GPE)",
        "Illinois (GPE) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_302",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4601,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1812,
        "completion_tokens": 177,
        "total_tokens": 1989
      }
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "Based on the provided information, KO's equity method investment in CCEP represented 19% of its total equity method investments as of December 31, 2021, and this stake is directly connected to CCEP's operational presence in Iceland through the KG relationship chain: KO → Has_Stake_In → CCEP → Operates_In → Iceland. This confirms that CCEP's bottling operations in Iceland (where it operates alongside COST, as indicated by the triplet COST → Iceland) are part of KO's equity investment portfolio, with the 19% ownership stake being a key component of its global bottling partnerships.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "COST (ORG) -> Iceland (GPE)",
        "Iceland (GPE) -> CCEP (COMP)",
        "CCEP (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8982,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2903,
        "completion_tokens": 146,
        "total_tokens": 3049
      }
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy's direct exposure to electricity price volatility stems from its Registrants' documented exposure to bulk power market price fluctuations and natural gas supply contracts, as stated in Chunk 1 where they manage commodity price risk through long-term power purchase/sales agreements and hedging programs to reduce natural gas cost volatility for customers. Southern Company's indirect exposure is demonstrated through its stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement (Chunk 2), creating a supply relationship where PowerSouth (COMP) is supplied by Alabama Power (ORG) and Southern Company (ORG) holds a stake via this arrangement, while Duke Energy's direct exposure contrasts with this indirect, stakeholder-driven model.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Electricity (PRODUCT)",
        "Electricity (PRODUCT) -> PowerSouth (COMP)",
        "PowerSouth (COMP) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_179",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_218",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14266,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4242,
        "completion_tokens": 196,
        "total_tokens": 4439
      }
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks' store count in Taiwan grew from 523 locations in 2021 to 544 in 2022 (a 21-store increase, or 4% growth), reflecting expansion within the Greater China geographic segment that also encompasses mainland China and Hong Kong. This growth occurs within Nike's Greater China segment, which contributed $7,547 million in revenue (17% of Nike's total $46,710 million revenue) for fiscal 2022, demonstrating that Taiwan's operational expansion is directly tied to Nike's broader Greater China business performance.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6810,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2362,
        "completion_tokens": 129,
        "total_tokens": 2491
      }
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "The supplier finance disclosures mandated by ASU 2022‑04 require 3M to disclose the confirmed invoice obligations under its program, making the $0.3 billion balance visible in its accounts‑payable and roll‑forward tables (Note 16). Because the ASU obliges a buyer to present the program’s key terms, balance‑sheet presentation, and outstanding amounts, 3M’s $0.3 billion of confirmed invoices is now reported explicitly, enhancing transparency for investors. FedEx adopted the same standard (Note 1 of its 10‑K) and similarly reports its supplier‑finance program balances and roll‑forward information, providing comparable visibility into its own program obligations. Thus, both companies achieve greater program transparency under ASU 2022‑04, though the specific disclosures are tailored to each firm’s program structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Agrees]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Supplier Finance Programs (ACCOUNTING_POLICY)",
        "Supplier Finance Programs (ACCOUNTING_POLICY) -> ASU 2022-04 (ACCOUNTING_POLICY)",
        "ASU 2022-04 (ACCOUNTING_POLICY) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15773,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4636,
        "completion_tokens": 205,
        "total_tokens": 4842
      }
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "The dual-class structures at CMCSA and META similarly expose minority shareholders to governance risks by concentrating voting power in Class B shares, creating mechanisms that can override minority interests despite their economic stake. At CMCSA, Class B shares carry 15 votes per share, giving Mr. Roberts control over 33.3% of voting power while representing only a small fraction of economic ownership, whereas META requires Class B shares to represent less than 35% of combined voting power to block change-of-control transactions, enabling the controlling shareholder to block mergers or strategic shifts without needing a majority of shares—both structures inherently prioritize the controlling stockholder’s interests over minority shareholders’ rights and protections.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13498,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4077,
        "completion_tokens": 194,
        "total_tokens": 4271
      }
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "V's U.S. pension plan had 319 million of Level 2 assets classified as investments in collective investment funds, representing roughly 44 % of its total Level 2 assets of $733 million. This allocation strategy contrasts with COF’s use of “other securities,” which are primarily fixed‑income instruments (U.S. Treasury, agency and non‑agency RMBS, CMBS, and other securities) that generated weighted‑average yields ranging from 0.31 % for the shortest‑maturity tranche to 1.86 % for longer‑dated holdings, reflecting a more yield‑oriented, interest‑rate sensitive profile.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Invest_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Collective Investment Funds (FIN_INST)",
        "Collective Investment Funds (FIN_INST) -> Other Securities (FIN_INST)",
        "Other Securities (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_162",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13642,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4102,
        "completion_tokens": 142,
        "total_tokens": 4245
      }
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Adobe's compliance costs for Saudi Arabia's data localization requirements are embedded in its global regulatory risk disclosures, where it acknowledges that evolving data residency laws—including Saudi localization mandates—could force significant operational changes, increased costs, and potential revenue loss if it cannot meet sovereign data storage rules (Chunk 1). Microsoft faces comparable exposure, as its 10-K explicitly details that data localization and sovereignty regulations across jurisdictions like Saudi Arabia necessitate substantial engineering investments to reconfigure data flows and systems, directly threatening its cloud service competitiveness if compliance makes offerings less attractive or feasible (Chunk 3). Crucially, both companies operate under overlapping regulatory pressures in Saudi Arabia—evidenced by the KG triplet linking Saudi Arabia → Data Localization Requirements → Microsoft—yet Adobe's disclosures emphasize customer contract liabilities and global compliance costs broadly, while Microsoft specifically ties localization rules to cloud service design constraints and monetization risks (Chunk 2). This reveals a shared strategic vulnerability: sovereign data laws increasingly dictate architectural choices in cloud services, compelling both to prioritize regulatory alignment over pure technical scalability, though Microsoft's exposure is more directly tied to infrastructure reinvention costs for its cloud ecosystem.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Implements]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Saudi Arabia (GPE)",
        "Saudi Arabia (GPE) -> Data Localization Requirements (REGULATORY_REQUIREMENT)",
        "Data Localization Requirements (REGULATORY_REQUIREMENT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19574,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5584,
        "completion_tokens": 367,
        "total_tokens": 5952
      }
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy's divestiture of KO Transmission's pipeline facilities eliminates its direct operational exposure to FERC-regulated natural gas infrastructure, removing a key regulatory nexus that previously tied its subsidiary to FERC oversight under the KG relationship KO Transmission → DUK and FERC Regulations → KO Transmission. In contrast, Southern Company maintains ongoing capital expenditure risks tied to FERC rule changes, as evidenced by its regulated assets' exposure to \"changes in FERC rules and regulations\" cited in its risk factors (Chunk 1), directly linking its capital spending to evolving FERC requirements without similar divestiture mitigation.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SO (ORG) -> FERC Regulations (REGULATORY_REQUIREMENT)",
        "FERC Regulations (REGULATORY_REQUIREMENT) -> KO Transmission (COMP)",
        "KO Transmission (COMP) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8058,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2700,
        "completion_tokens": 166,
        "total_tokens": 2866
      }
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS reports $2.7 billion of unfunded commitments to private‑debt and private‑equity funds, which are valued using NAV as a practical expedient and are illiquid because they are typically locked in for 3‑6 years with limited redemption rights. In contrast, Caterpillar’s other post‑retirement benefit assets include $55 million measured at NAV (e.g., cash, short‑term instruments and other securities) that are far more liquid and can be redeemed on short notice, reflecting a markedly different investment strategy focused on short‑term, readily marketable securities rather than long‑term private‑fund commitments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Private Debt (FIN_INST)",
        "Private Debt (FIN_INST) -> NAV (ACCOUNTING_POLICY)",
        "NAV (ACCOUNTING_POLICY) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6807,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2389,
        "completion_tokens": 153,
        "total_tokens": 2543
      }
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s governance strategy is defined by its dual‑class structure in which Class B shares carry 10 votes per share and are held by insiders, while Class A and Class C shares have only one vote (or none for Class C) and are subject to selective repurchases—$50.3 billion, $59.3 billion and $62.2 billion in 2021‑2023, with an additional $70 billion authorized in April 2023—allowing the company to retire those shares while retaining the voting‑power‑rich Class B stock; this contrasts with Netflix, whose common stock carries a uniform one‑vote‑per‑share right, as noted in its 2023 10‑K, and the KG link shows that the voting‑rights policy of Class B stock (held by Alphabet) is connected to Netflix, underscoring that Alphabet’s selective repurchase of non‑voting or low‑voting shares is a deliberate tactic to manage insider voting power and capital deployment, whereas Netflix’s uniform voting rights eliminate such strategic share‑class maneuvering.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Has]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3632,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 239,
        "total_tokens": 1839
      }
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "Coca-Cola's 2022 effective tax rate was negatively impacted by $375 million of net tax charges tied to the Tax Reform Act’s GILTI provisions (a 3.0 % increase), plus additional discrete tax items that together contributed roughly a 4.4 % expense, while the Philippines’ corporate‑income‑tax reduction enacted in 2021 provided Philip Morris International with a modest tax benefit that helped keep its 2021 effective tax rate at 21.8 %, only slightly above the prior year.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Tax Reform Act (REGULATORY_REQUIREMENT)",
        "Tax Reform Act (REGULATORY_REQUIREMENT) -> Philippines (GPE)",
        "Philippines (GPE) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6631,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2358,
        "completion_tokens": 117,
        "total_tokens": 2475
      }
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "The $3.1 billion of mortgage loans sold by BAC to GSEs in 2023 directly feeds the pool of assets that backs MET’s $12.392 billion of pass‑through mortgage‑backed securities, meaning those securities are secured by the very loans BAC placed with the GSEs; consequently, any risk that arises from the GSEs’ structure—such as potential reductions in their role or future recapitalization—could alter the composition and credit quality of the underlying loan pool, thereby affecting the risk exposure of MET’s RMBS portfolio. This linkage is reinforced by the KG relationship **Pass‑Through Mortgage‑Backed Securities → MET**, showing that MET holds and is exposed to these securities, and by the broader **Mortgage & Loans → Pass‑Through Mortgage‑Backed Securities** connection that ties BAC’s loan sales to the collateral of MET’s securities. Additionally, the risk of GSE structural changes is highlighted in BAC’s filing, underscoring that shifts in GSE involvement could increase MET’s funding costs, credit risk, and overall portfolio risk.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> FIN_INST -[Secured By]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Mortgage & Loans (FIN_INST)",
        "Mortgage & Loans (FIN_INST) -> Pass-Through Mortgage-Backed Securities (FIN_INST)",
        "Pass-Through Mortgage-Backed Securities (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13461,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4069,
        "completion_tokens": 260,
        "total_tokens": 4329
      }
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "NKE's embedded derivatives are classified as Level 3 due to reliance on non-market-based assumptions such as actuarial estimates of policyholder behavior, mortality, and nonperformance risk, which require significant unobservable inputs and risk margin considerations. This contrasts with LOW's use of unobservable inputs for fair value measurements, which also depends on non-market-based assumptions including credit spreads, interest rate forecasts, and actuarial projections for non-capital market risks, though LOW emphasizes observable benchmark inputs where available and applies risk margins only where required by valuation methodology. Both companies employ Level 3 valuations for embedded derivatives, but NKE's classification stems specifically from derivatives designated as hedging instruments with embedded components requiring non-market inputs, while LOW's approach involves embedded derivatives in reinsurance and insurance liabilities where fair value is derived using actuarial present value models and risk margins tied to non-performance risk and capital cost assumptions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Results_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Embedded Derivatives (FIN_INST)",
        "Embedded Derivatives (FIN_INST) -> Level 3 Classification (ACCOUNTING_POLICY)",
        "Level 3 Classification (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_264",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9451,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3057,
        "completion_tokens": 273,
        "total_tokens": 3330
      }
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "GD employs valuation models with observable inputs for fixed-rate notes and Level 3 assets, while LMT relies on unobservable inputs for its $4,951 million private equity fund holdings, as evidenced by LMT's Level 3 classification requiring discounted cash flow approaches with significant unobservable inputs like projected annuity payments and discount rates. Both companies categorize private equity funds as Level 3 investments measured at NAV, but GD's approach for fixed-income instruments uses market-observable inputs (e.g., interest rates, bond yields) for Level 2 assets, whereas LMT's Level 3 private equity valuations depend on uncorroborated inputs from valuation models of underlying securities, directly linking GD's observable-input methodology to LMT's unobservable-input reliance through their shared classification of private equity funds as Level 3 under the same accounting policy framework.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Valued_Using]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GD (ORG) -> Valuation Models (ACCOUNTING_POLICY)",
        "Valuation Models (ACCOUNTING_POLICY) -> Private Equity Funds (FIN_INST)",
        "Private Equity Funds (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10384,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3303,
        "completion_tokens": 227,
        "total_tokens": 3531
      }
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "The legal exposure from Slack's shareholder litigation involves a protracted timeline of motions to dismiss and appeals: Slack filed a motion to dismiss in January 2020, which was partially granted and partially denied in April 2020; it sought interlocutory appeal and certiorari, leading to a Supreme Court decision on June 1, 2023, that vacated the Ninth Circuit’s ruling and remanded the case, after which additional briefing occurred until February 10, 2025, when the Ninth Circuit reversed the district court’s order and directed dismissal with prejudice. In contrast, Disney’s recent antitrust litigation strategy, as seen in the Biddle and Fendelander actions, involves motions to dismiss filed on January 31, 2023, followed by a consolidated amended complaint and a partial dismissal order on June 25, 2024, with ongoing motions to dismiss and a trial scheduled for October 6, 2025, reflecting a more recent but similarly procedural posture in seeking to dismiss antitrust claims. Both cases involve motions to dismiss as part of defensive litigation strategies, but Slack’s litigation has a longer procedural history spanning multiple appellate levels and a final dismissal order in 2025, whereas Disney’s cases are still in earlier stages with pending motions and a future trial date, highlighting differing timelines and procedural developments in their respective legal challenges.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Files]-> LITIGATION <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Slack (COMP)",
        "Slack (COMP) -> Motion to Dismiss (LITIGATION)",
        "Motion to Dismiss (LITIGATION) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15879,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4650,
        "completion_tokens": 348,
        "total_tokens": 4998
      }
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel's tax benefit from Hong Kong operations stems from its non-U.S. income taxed at lower rates (12.5%-24.0%), particularly in Hong Kong, Ireland, Israel, and Malaysia, where it holds conditional reduced tax rates tied to specific activities and investments, as noted in its 2022 10-K filing regarding deferred tax assets from restructuring in China and the divestiture of its NAND business. Apple's Greater China region, which explicitly includes Hong Kong as part of its reporting, generated $74.2 billion in net sales for 2022 (per its 10-K), reflecting Hong Kong's contribution to this segment's revenue, though Apple does not disclose Hong Kong-specific tax benefits directly. The KG triplet relationship (INTC → Hong Kong → Greater China ← AAPL) confirms Hong Kong's dual role as a jurisdiction where Intel operates and is included within Apple's Greater China segment, linking Intel's tax strategy to Apple's regional revenue reporting.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Hong Kong (GPE)",
        "Hong Kong (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5322,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1992,
        "completion_tokens": 236,
        "total_tokens": 2228
      }
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "The 70% CO₂ emissions reduction target mandated by North Carolina's HB 951 directly shapes Duke Energy's Carolinas Resource Plan by requiring the NCUC-approved carbon reduction plan to achieve this interim goal by 2030, with Duke Energy's Portfolio 3 in its 2023 Carolinas Resource Plan specifically designed as the \"most prudent path\" to comply with state law through a diverse mix of generation, storage, and extended nuclear operations while extending coal phase-out to 2035. This regulatory requirement aligns with NextEra Energy's operational exposure in North Carolina through its subsidiary Duke Energy Progress, which filed the initial IRPs under HB 951's framework and now operates within the same state-mandated carbon reduction trajectory, though NextEra's broader national emissions targets (including its 2030 CO₂ goal) are not explicitly detailed in the provided materials, making Duke Energy's Carolinas-specific compliance the primary focus of the regulatory impact.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Passes]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "NEE (ORG) -> North Carolina (GPE)",
        "North Carolina (GPE) -> HB 951 (REGULATORY_REQUIREMENT)",
        "HB 951 (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7620,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2586,
        "completion_tokens": 245,
        "total_tokens": 2831
      }
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ applies weighted-average assumptions to measure postretirement healthcare costs by aligning liability cash flows with spot rates on the yield curve, as disclosed in its accounting policy for other postretirement benefits, while KO uses weighted-average assumptions within the Black-Scholes-Merton model to determine the fair value of stock option awards, expensing them over the vesting period; although both companies employ weighted-average assumptions in distinct accounting contexts—MDLZ for postretirement benefit cost measurement and KO for equity-based compensation valuation—their applications serve fundamentally different financial reporting purposes and are governed by separate accounting policies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Weighted-Average Assumptions (ACCOUNTING_POLICY)",
        "Weighted-Average Assumptions (ACCOUNTING_POLICY) -> Black-Scholes-Merton Model (ACCOUNTING_POLICY)",
        "Black-Scholes-Merton Model (ACCOUNTING_POLICY) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2192,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 178,
        "total_tokens": 1424
      }
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act is managed through OTC-bilateral transactions governed by ISDA Master Agreements that enable close-out netting and collateral application under the Orderly Liquidation Authority, allowing set-off of receivables against payables upon counterparty default or bankruptcy without an automatic stay. In contrast, Bank of America's resolution planning under the Orderly Liquidation Authority requires submission of a single-point-of-entry strategy to the FDIC and Federal Reserve, mandating that its parent holding company contribute most capital and liquidity to key subsidiaries, with restrictions on intercompany funding that could impede access to resources during distress and require additional funding to subsidiaries if liquidity deteriorates severely. Both institutions face systemic risk implications: JPMorgan's derivatives framework facilitates orderly netting during liquidation events, while Bank of America's structure subjects its liquidity and financial condition to FDIC intervention, potentially triggering bridge holding company arrangements that prioritize creditor recoveries over equity holder losses.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Dodd-Frank (REGULATORY_REQUIREMENT)",
        "Dodd-Frank (REGULATORY_REQUIREMENT) -> Orderly Liquidation Authority (REGULATORY_REQUIREMENT)",
        "Orderly Liquidation Authority (REGULATORY_REQUIREMENT) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_261",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10220,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3265,
        "completion_tokens": 296,
        "total_tokens": 3561
      }
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio's continued reliance on coal directly shapes the divergent energy transition strategies of XOM and CVX, as evidenced by XOM's substantial European coal tax burden ($1.8B after-tax charge from EU's 33% surplus profits tax on coal) and CVX's active 2024 renewable natural gas (RNG) investments in the state through Brightmark RNG Holdings LLC, which operates anaerobic digester facilities across Ohio converting dairy waste into pipeline-quality fuel. This contrast is reinforced by Duke Energy Ohio's significant coal inventory ($23 million) in its supply chain, underscoring the state's ongoing coal dependency that both companies navigate differently—XOM through regulatory cost management in Europe and CVX through targeted RNG infrastructure development within Ohio's agricultural energy ecosystem.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Depends_On]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Coal (RAW_MATERIAL)",
        "Coal (RAW_MATERIAL) -> Ohio (GPE)",
        "Ohio (GPE) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4314,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1746,
        "completion_tokens": 201,
        "total_tokens": 1947
      }
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "MS's CLNs embed credit protection sold by the issuer, where the issuer purchases protection from investors and repays par value at maturity unless a credit event occurs, in which case the issuer pays the difference between par value and the reference obligation's fair value. JPM's credit-related notes similarly transfer credit risk via funded derivatives where investors pay par value upfront and receive periodic payments, with repayment at maturity contingent on no credit event—if a credit event occurs, the issuer pays the investor the par value minus the defaulted reference entity's fair value, mirroring MS's CLN payout mechanics. Both instruments transfer credit risk on reference entities through structured notes, with payout upon credit event relying on the difference between par value and fair value of the defaulted obligation rather than full repayment, as evidenced by MS's VIE disclosures of structured transactions like CLNs and JPM's explicit description of credit-related notes' settlement mechanics.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST -[Supplies]-> FIN_INST <-[Sells]- ORG",
      "triplets_used": [
        "MS (ORG) -> CLNs (FIN_INST)",
        "CLNs (FIN_INST) -> Credit Protection (FIN_INST)",
        "Credit Protection (FIN_INST) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_224",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10542,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3316,
        "completion_tokens": 255,
        "total_tokens": 3571
      }
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both Georgia Power Company and Florida Power & Light Company apply the reduced disclosure format in their 2022 Form 10-K filings because each meets the conditions of General Instruction I.(1)(a) and (b), as explicitly stated in their respective incorporated documents. This compliance allows them to use the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d), reflecting their status as registrants subject to the accounting policies tied to their parent entities (SO for Georgia Power and NEE for Florida Power & Light) under the knowledge graph relationship pattern.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "SO (ORG) -> Georgia Power Company (COMP)",
        "Georgia Power Company (COMP) -> Reduced Disclosure Format (ACCOUNTING_POLICY)",
        "Reduced Disclosure Format (ACCOUNTING_POLICY) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2942,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 149,
        "total_tokens": 1603
      }
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX recognizes revenue on U.S. government fixed-price contracts in accordance with FAR guidance, where performance-based payments (PBPs) or progress payments allow interim billing up to 80-90% of costs incurred, resulting in revenue recognized in excess of billings (recorded as contract assets) until contract completion, while GD's cost allocation under the same FAR-regulated framework requires strict adherence to Cost Accounting Standards (CAS) for allocating costs to contracts, with both entities subject to FAR audits and CAS compliance for U.S. government contracts, though GD's specific cost allocation practices for performance-based payments and contract modifications are not detailed in the provided disclosures beyond the regulatory context of FAR/CAS oversight.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "RTX (ORG) -> FAR (REGULATORY_REQUIREMENT)",
        "FAR (REGULATORY_REQUIREMENT) -> U.S. Government Contracts (REGULATORY_REQUIREMENT)",
        "U.S. Government Contracts (REGULATORY_REQUIREMENT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10610,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3362,
        "completion_tokens": 194,
        "total_tokens": 3556
      }
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "The voting rights structure at GOOGL features Class A shares with one vote per share, Class B shares with ten votes per share, and Class C shares with no voting rights, creating a dual-class system that concentrates control among insiders despite the company's market capitalization; this contrasts with Comcast's (CMCSA) disclosure regarding its lack of voting rights in the VIE Atairos, where it explicitly states it holds no voting rights and only limited consent rights, relying instead on equity method accounting for its $5.1 billion investment, which underscores a fundamental governance divergence where GOOGL's structure actively enables control through super-voting shares while CMCSA's arrangement relinquishes control over a significant investment, directly impacting corporate governance by enabling insider dominance at GOOGL versus passive, non-controlling stakes in CMCSA's VIE relationship.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8903,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2921,
        "completion_tokens": 226,
        "total_tokens": 3148
      }
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen's 2021 reliance on McKesson Corporation for 33% of gross product sales—directly tied to its exposure to wholesaler distribution risks as highlighted in its 2022 filing—mirrors Merck's risk disclosures about pharmaceutical product distribution concentration, particularly given the KG triplet relationship where McKesson (COMP) supplies Pharmaceutical Products (PRODUCT) that negatively impacts Merck (ORG), reflecting shared vulnerability to distributor concentration across both companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Supplies]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> McKesson Corporation (COMP)",
        "McKesson Corporation (COMP) -> Pharmaceutical Products (PRODUCT)",
        "Pharmaceutical Products (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11461,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3560,
        "completion_tokens": 124,
        "total_tokens": 3684
      }
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips' financial exposure from its ownership in Alba Plant LLC stems from its 52.2% stake in the joint venture that processes natural gas from Equatorial Guinea's Alba Unit under a fixed-rate long-term contract, where condensate and LPG are extracted and sold at market prices, generating equity earnings reflected in ConocoPhillips' income statement. This exposure is further amplified by its 47.5% ownership in APLNG and related guarantees, including a $116 million maximum potential liability for processing third-party gas under Equatorial Guinea guarantees, while Chevron's production of condensate from the Alba Unit serves as the raw material feedstock for Alba Plant LLC's operations, linking the entities through the KG pattern ORG-Produces-RAW_MATERIAL-Produces-COMP-Discloses-ORG.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> RAW_MATERIAL -[Produces]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Condensate (RAW_MATERIAL)",
        "Condensate (RAW_MATERIAL) -> Alba Plant LLC (COMP)",
        "Alba Plant LLC (COMP) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14340,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4254,
        "completion_tokens": 200,
        "total_tokens": 4454
      }
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics (GD) values its Level 2 assets—primarily fixed-income securities, cash flow hedges, and fixed-rate notes—using valuation models with observable inputs such as interest rates, bond yields, and quoted prices for similar assets, whereas Union Pacific (UNP) discloses real estate funds at Net Asset Value (NAV), which relies on valuation models incorporating significant unobservable inputs over eight- to ten-year terms, as evidenced by the KG triplet linking Real Estate Funds (FIN_INST) to UNP and the explicit mention of eight- to ten-year terms for real estate funds in Chunk 2 and Chunk 3; this contrast highlights that GD’s Level 2 valuation depends on transparent market inputs, while UNP’s real estate fund valuation uses illiquid, long-term unobservable inputs typical of private equity and real estate fund structures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Valued_Using]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GD (ORG) -> Valuation Models (ACCOUNTING_POLICY)",
        "Valuation Models (ACCOUNTING_POLICY) -> Real Estate Funds (FIN_INST)",
        "Real Estate Funds (FIN_INST) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8145,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2735,
        "completion_tokens": 210,
        "total_tokens": 2945
      }
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank's involvement differs fundamentally in nature across the two arrangements: with Costco, it acts solely as a **co-branding partner** through a series of credit card amendments (10.8 series in Chunk 1), where its role is limited to issuing co-branded cards and modifying terms—demonstrating a **commercial partnership** relationship (KG: COST → Citibank, N.A. via Partners_With), while with Colgate, it functions as the **administrative agent** under a formal five-year credit agreement (10.10 in Chunk 3), where it holds structural authority over lending operations (KG: Colgate-Palmolive Company → Five Year Credit Agreement ← Citibank, N.A. via Introduces). This distinction is reinforced by the regulatory context in Chunk 2, where Citibank, N.A. is explicitly named as administrative agent and lead arranger in Boeing’s Five-Year Credit Agreement—a role that mirrors its Colgate position but operates in a distinct corporate context, underscoring that its involvement in Colgate’s agreement is **legally binding and structurally authoritative** rather than purely commercial.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Regulates]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Citibank, N.A. (COMP)",
        "Citibank, N.A. (COMP) -> Five Year Credit Agreement (FIN_INST)",
        "Five Year Credit Agreement (FIN_INST) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19788,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5626,
        "completion_tokens": 271,
        "total_tokens": 5898
      }
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG is calculated as 13 barrels per day (bbl/d) multiplied by Chevron's 30% ownership stake, resulting in a net contribution of 3.9 bbl/d of crude oil. This is derived from the average daily net production figures in Chunk 2 and Chunk 3, which specify QatarEnergy LNG's crude oil production at 13 bbl/d with Chevron holding a 30% interest as operator, and is consistent with the ORG-Depends_On-RAW_MATERIAL-PRODUCES-COMP-Has_Stake_In relationship structure connecting Chevron (CVX), Crude Oil, QatarEnergy LNG, and COP.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Produces]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Crude Oil (RAW_MATERIAL)",
        "Crude Oil (RAW_MATERIAL) -> QatarEnergy LNG (COMP)",
        "QatarEnergy LNG (COMP) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7044,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2425,
        "completion_tokens": 150,
        "total_tokens": 2576
      }
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar employs pricing models to value its non-U.S. pension Level 3 assets, specifically fixed income investments, using inputs that reflect market participant assumptions as disclosed in its 10-K filing. In contrast, Lockheed Martin values its Level 3 fixed income investments through a combination of indicative quotes from vendors or brokers and discounted cash flow analyses, with significant reliance on unobservable inputs such as projected annuity payments and discount rates, as detailed in its 10-K disclosures. Both companies categorize certain fixed income instruments as Level 3 when observable inputs are unavailable, but Caterpillar's approach is explicitly tied to insurance contracts and non-U.S. pension assets, while Lockheed Martin's methodology extends to a broader range of fixed income and structured investments, including private equity and real estate funds valued via NAV practical expedients.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8388,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2791,
        "completion_tokens": 231,
        "total_tokens": 3022
      }
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "The expiration of Enbrel's formulation patent in 2037 will significantly increase revenue concentration risk for Pfizer's Specialty Care segment, as Enbrel is a key product in this segment (Chunk 1, Chunk 2). This risk is compounded by Bristol Myers Squibb's external innovation strategy, which focuses on future pipeline assets and involves strategic partnerships to acquire disruptive therapies outside its core capabilities (Chunk 3), potentially accelerating competitive pressure on Pfizer's Specialty Care portfolio post-2037.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Decreases]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Enbrel (PRODUCT)",
        "Enbrel (PRODUCT) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4058,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1701,
        "completion_tokens": 132,
        "total_tokens": 1834
      }
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG's market risk stress testing relies on scenario-based modeling and sensitivity analysis as core components of its market risk measurement framework, explicitly using these techniques to assess potential losses from adverse market movements across its insurance and capital markets exposures, with such methods overseen by the Chief Risk Officer within ERM and integrated into its risk appetite statement. In contrast, Capital One's (COF) credit loss forecasting methods incorporate scenario-based modeling and sensitivity analysis primarily within its allowance for credit losses framework, where quantitative loss forecasts are derived from statistical models adjusted for current and forward-looking economic conditions, and qualitative adjustments are made based on management's judgment of emerging risks and uncertainties, though its stress testing practices are not directly comparable to AIG's market risk approach as they serve different risk domains.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Used_For]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Stress Testing (ACCOUNTING_POLICY)",
        "Stress Testing (ACCOUNTING_POLICY) -> Risk Assessment (ACCOUNTING_POLICY)",
        "Risk Assessment (ACCOUNTING_POLICY) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_135",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18661,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5342,
        "completion_tokens": 240,
        "total_tokens": 5583
      }
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm's exposure to EAR regulations on advanced semiconductor technologies is explicitly addressed through its own 10-K disclosure, which identifies the U.S. Export Administration Regulations (EAR) as a key regulatory risk governing exports of products like FPGAs, directly subjecting its business and those of its customers to potential adverse effects from changes in interpretation or enforcement—mirroring AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China under BIS controls for ECCN 4A090, which similarly require NAC notifications and license applications for shipments to China or D5-partied entities, thereby creating comparable regulatory exposure in high-performance computing markets where both companies operate.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Governs]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> EAR (REGULATORY_REQUIREMENT)",
        "EAR (REGULATORY_REQUIREMENT) -> FPGAs (PRODUCT)",
        "FPGAs (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8982,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2927,
        "completion_tokens": 189,
        "total_tokens": 3117
      }
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "CMCSA relinquished voting rights in Hulu through contractual agreements that transferred operational control to Disney while retaining only a non‑voting equity stake, contrasting sharply with META’s dual‑class structure where Class B shares carry 10 votes per share, allowing founders and insiders to retain disproportionate control despite a majority of Class A and Class C shares lacking voting rights. This KG pattern shows CMCSA’s policy of “Discloses” voting‑rights relinquishment linked to Class A Common Stock (FIN_INST) → META, while META’s policy of “Discloses” Class B voting rights is captured by its Class B Common Stock (FIN_INST) → META, highlighting divergent control‑retention strategies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12179,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3711,
        "completion_tokens": 176,
        "total_tokens": 3887
      }
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs' $113.9 billion broker‑dealer asset base (as disclosed in GS_10K_2024) underpins its compliance framework for Regulation Best Interest, which requires it to act in the best interest of retail customers when recommending securities or account types. This scale enables a robust, centralized conflict‑management program that integrates SEC‑mandated disclosures and FINRA rules across its major broker‑dealer subsidiaries. In contrast, Morgan Stanley’s compliance approach (referenced in MS_10K_2024) also relies on Regulation Best Interest but is embedded within a broader set of fiduciary obligations tied to its investment‑advisory activities and the ERISA‑related prohibited‑transaction rules discussed in MET_10K_2024, reflecting a more diversified regulatory landscape that spans both broker‑dealer and advisory lines of business.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP -[Applies_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "GS (ORG) -> Broker-Dealers (COMP)",
        "Broker-Dealers (COMP) -> Regulation Best Interest (REGULATORY_REQUIREMENT)",
        "Regulation Best Interest (REGULATORY_REQUIREMENT) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13978,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4186,
        "completion_tokens": 211,
        "total_tokens": 4397
      }
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel's IDM 2.0 strategy, which expands manufacturing capacity to attract foundry customers, faces direct competitive pressure from Samsung's in-house integrated circuit development, as evidenced by the KG triplet linking Samsung (COMP) to Integrated Circuit Products (PRODUCT) and subsequently to QCOM (ORG), indicating Samsung's capability to produce chips that could displace external foundry demand. This dynamic is further amplified by Qualcomm's reliance on external integrated circuit customers, as demonstrated by QCOM's explicit risk exposure to customers like Samsung vertically integrating—QCOM derives significant revenue from Samsung and other Chinese OEMs that may develop their own ICs due to government policies (e.g., China's Made in China 2025 targeting 70% semiconductor self-sufficiency by 2025) or supply chain pressures, potentially reducing QCOM's licensing and semiconductor revenues if Samsung or others shift to in-house production. Consequently, Intel's capacity expansion could intensify market competition that threatens Qualcomm's business model, which depends on third-party customers adopting its IP, especially as Samsung's foundry ambitions and vertical integration strategies mirror the very competitive threats Qualcomm identifies in its 10-K filings.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Develops]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Samsung (COMP)",
        "Samsung (COMP) -> Integrated Circuit Products (PRODUCT)",
        "Integrated Circuit Products (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16709,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4880,
        "completion_tokens": 321,
        "total_tokens": 5202
      }
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "VZ monetizes wireless tower infrastructure through exclusive 30-year lease arrangements with American Tower Corporation and Vertical Bridge REIT, generating $5.0 billion (2015) and $2.8 billion (2024) upfront payments while retaining depreciation of towers and prepaid rent accounting, which contrasts with NFLX's reliance on exclusive content licensing that requires ongoing royalty payments and lacks comparable upfront capital infusion, instead exposing the company to withdrawal risks and cost increases from content providers.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transacts_With]-> COMP -[Acquires]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "VZ (ORG) -> American Tower Corporation (COMP)",
        "American Tower Corporation (COMP) -> Exclusive Rights (ACCOUNTING_POLICY)",
        "Exclusive Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14032,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4200,
        "completion_tokens": 132,
        "total_tokens": 4333
      }
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "The Tax Reform Act's GILTI provisions increased KO's 2022 effective tax rate by 1.2 percentage points (reflected in the $110 million net tax charge noted in Chunk 1), while the corporate income‑tax‑rate reduction in the Philippines lowered PEP's effective tax rate by 0.1 percentage point in 2021, contributing to a 21.8 % rate (as reported in Chunk 2). This contrast shows that GILTI added a modest upward pressure on KO's tax expense, whereas the Philippine rate cut provided a modest downward benefit for PEP's operations in that market.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Tax Reform Act (REGULATORY_REQUIREMENT)",
        "Tax Reform Act (REGULATORY_REQUIREMENT) -> Philippines (GPE)",
        "Philippines (GPE) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6897,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2405,
        "completion_tokens": 135,
        "total_tokens": 2540
      }
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The $1.3 billion of restricted retained earnings at Nicor Gas limits the cash that can be distributed to its parent, Southern Company Gas, for dividend payments, directly constraining the amount of dividends Southern Company can ultimately receive from this subsidiary. Because Nicor Gas is a key subsidiary under Southern Company Gas and its retained earnings are subject to regulatory dividend‑restriction rules, the regulatory limitation on dividends from Nicor Gas is a critical factor in Southern Company’s overall ability to collect dividends from its subsidiaries. Consequently, the regulatory restriction on Nicor Gas’s retained earnings translates into a material constraint on Southern Company’s dividend receipts from Southern Company Gas.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Dividend Restrictions (REGULATORY_REQUIREMENT)",
        "Dividend Restrictions (REGULATORY_REQUIREMENT) -> Nicor Gas (COMP)",
        "Nicor Gas (COMP) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_261",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8845,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2894,
        "completion_tokens": 187,
        "total_tokens": 3081
      }
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Tesla and GM both face escalating compliance costs tied to evolving vehicle safety standards under the National Traffic and Motor Vehicle Safety Act, with Tesla highlighting international regulatory fragmentation—particularly for its Autopilot and FSD (Supervised) systems—requiring costly adaptations across divergent global rules, while GM emphasizes the financial burden of meeting increasingly stringent U.S. and EU safety mandates, including mandatory recalls and complex UN-ECE regulations that add layers of cost and complexity to global vehicle development. Both automakers incur substantial expenses from evolving safety requirements, but Tesla’s exposure is amplified by its need to navigate a patchwork of international standards for autonomous features, whereas GM’s costs are driven by compliance with U.S. safety standards, EU GSR mandates, and global recall obligations under the Safety Act.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Vehicle Safety Standards (REGULATORY_REQUIREMENT)",
        "Vehicle Safety Standards (REGULATORY_REQUIREMENT) -> National Traffic and Motor Vehicle Safety Act (REGULATORY_REQUIREMENT)",
        "National Traffic and Motor Vehicle Safety Act (REGULATORY_REQUIREMENT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "F_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17627,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5116,
        "completion_tokens": 226,
        "total_tokens": 5343
      }
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics defers $305 million of other contract costs under FAR regulations, reflecting a risk‑mitigation approach that relies on future backlog and contract awards to recover these amounts, whereas Raytheon Technologies faces direct exposure to cost overruns on its fixed‑price U.S. government contracts—particularly firm‑fixed‑price and fixed‑price incentive contracts—where it bears the full burden of any overruns beyond negotiated ceilings and may incur liability if programs are terminated for default or underfunding. This contrast highlights GD’s contractual cost‑deferral strategy versus RTX’s higher financial risk from fixed‑price pricing and the potential for adverse profit adjustments or loss of future work.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "GD (ORG) -> FAR (REGULATORY_REQUIREMENT)",
        "FAR (REGULATORY_REQUIREMENT) -> U.S. Government Contracts (REGULATORY_REQUIREMENT)",
        "U.S. Government Contracts (REGULATORY_REQUIREMENT) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14032,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4226,
        "completion_tokens": 182,
        "total_tokens": 4408
      }
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "The CAGR of Intel's Taiwan revenue from 2019 to 2021 is 28.5%, calculated from $10,058M (2019) to $13,461M (2021) using the formula: (13,461/10,058)^(1/2)-1 ≈ 28.5%. Apple's Greater China segment revenue grew at 27.7% CAGR over the same period, rising from $40,308M (2020) to $68,366M (2021) and $74,200M (2022), with Taiwan explicitly included in its Greater China reporting as confirmed by the KG triplet relationship where Taiwan (GPE) is included in Greater China (GPE) which operates for AAPL (ORG). This structural overlap means Apple's Greater China growth inherently incorporates Taiwan's performance, making the 27.7% segment CAGR a direct reflection of Taiwan's contribution within that regional metric.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3026,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 178,
        "total_tokens": 1603
      }
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet's $70 billion share‑repurchase authorization for Class A and Class C shares may make Class A stock more expensive relative to Class B, prompting Class B holders to convert their shares into Class A to benefit from the higher‑priced, more liquid Class A stock.  Meta’s disclosure shows a substantially larger Class A share base than the relatively small Class B base, meaning that conversion could dilute the Class B pool but also expose Class B holders to the larger, more actively repurchased Class A market.  Consequently, the repurchase program could increase the incentive for Class B shareholders to convert, especially given the automatic conversion rule and the requirement to sell any newly acquired Class A shares after conversion.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Changes_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7450,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2574,
        "completion_tokens": 187,
        "total_tokens": 2761
      }
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "Both PepsiCo and Philip Morris International treat dividend equivalents in RSU awards as cash payments that are paid out when the awards vest, but they differ in their vesting conditions and financial obligations. PepsiCo's RSUs and PSUs accrue dividend equivalents that are paid in cash upon vesting at the end of the service period, with the number of shares potentially adjusted based on performance metrics, and the fair value measured at grant based on stock price. In contrast, Philip Morris International's RSU awards vest on the third anniversary of the grant date and also accrue dividend equivalents, but they do not carry voting rights, and PMI had $160 million in unrecognized compensation costs related to non-vested RSU awards as of December 31, 2023, which are expected to be recognized over approximately seventeen months.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Dividend Equivalents (FIN_INST)",
        "Dividend Equivalents (FIN_INST) -> RSU Awards (FIN_INST)",
        "RSU Awards (FIN_INST) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2247,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 209,
        "total_tokens": 1437
      }
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "DHR employs NAV-based valuation for private investments, relying on discounted cash flow, market multiples, and third-party appraisals to estimate fair value, acknowledging inherent subjectivity in these methods as noted in its disclosures. LLY, conversely, applies fair value estimation for acquired intangible assets through business combinations, requiring significant management judgment and assumptions to determine fair values of assets and liabilities, with excess purchase price recorded as goodwill. Both approaches involve subjectivity, but DHR’s valuation depends on asset fund managers’ inputs and market-based methodologies, while LLY’s fair value estimation directly impacts goodwill and intangible asset recording in acquisitions, as emphasized in their respective accounting policy disclosures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Valuation Methods (ACCOUNTING_POLICY)",
        "Valuation Methods (ACCOUNTING_POLICY) -> Fair Value Estimation (ACCOUNTING_POLICY)",
        "Fair Value Estimation (ACCOUNTING_POLICY) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_264",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6086,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2226,
        "completion_tokens": 202,
        "total_tokens": 2429
      }
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "NVIDIA generated $8,544 million in revenue from Taiwan in 2022 (Chunk 1), while Apple’s Greater China segment— which includes Taiwan— reported $74,200 million in net sales for 2022 (Chunk 3). Because the “Greater China” geographic unit encompasses Taiwan (KG: Taiwan → Greater China ← Operates_In NVDA and Greater China → AAPL), Apple’s Taiwan‑related sales are embedded within its $74.2 billion Greater China figure, making NVIDIA’s Taiwan revenue a much smaller portion of Apple’s overall regional sales.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4514,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1785,
        "completion_tokens": 126,
        "total_tokens": 1911
      }
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "The concentrated voting power in CMCSA's Class B common stock, which carries 15 votes per share and represents 33 ⅓ % of the combined voting power, is controlled by Mr. Brian L. Roberts who owns all Class B shares, whereas GOOGL's Class A common stock holds only a non‑dilutable share of voting power that is tied to the overall share structure but lacks a similarly dominant, single‑owner block; this contrast is highlighted by the KG pattern that links CMCSA’s Class B stock to Class A stock and ultimately to GOOGL, showing that CMCSA’s voting control is highly centralized while GOOGL’s Class A shares are part of a broader, multi‑class distribution.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4379,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1771,
        "completion_tokens": 163,
        "total_tokens": 1934
      }
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "The ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differs significantly between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans. For UnitedHealth Group, this ratio is 241 million ÷ 25 million ≈ 9.64, whereas Johnson & Johnson’s ratio is 240,344,013 ÷ 133,794,708 ≈ 1.80. This contrast reflects the much larger pool of future shares UnitedHealth Group has reserved relative to its exercised options compared with Johnson & Johnson’s more balanced allocation.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Securities Remaining Available (FIN_INST)",
        "Securities Remaining Available (FIN_INST) -> Equity Compensation Plans Approved by Security Holders (FIN_INST)",
        "Equity Compensation Plans Approved by Security Holders (FIN_INST) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6129,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2245,
        "completion_tokens": 142,
        "total_tokens": 2387
      }
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD faces revenue concentration risk through its reliance on third-party motherboard suppliers for platform compatibility, which creates dependency on ecosystem partners like Dell Inc. for product adoption and market access. While AMD discloses dependence on third-party distributors and AIB partners in its 10-K (Chunk 1), Intel's 10-K reveals significantly higher direct customer concentration risk, with Dell Inc. alone accounting for 21% of its net revenue and 43% of accounts receivable (Chunks 2-3). This contrast highlights that AMD's risk stems from broad platform-level dependencies across multiple suppliers, whereas Intel's risk is concentrated in a few major OEM customers like Dell, making its revenue stream more vulnerable to individual customer negotiations or order fluctuations. Both scenarios illustrate revenue concentration risks, but Intel's exposure is more acute due to the high percentage of revenue tied to specific enterprise clients.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Motherboards (PRODUCT)",
        "Motherboards (PRODUCT) -> Dell Inc. (COMP)",
        "Dell Inc. (COMP) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7129,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2439,
        "completion_tokens": 240,
        "total_tokens": 2679
      }
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Louisiana's corporate tax rate reductions directly impact both Boeing and Union Pacific through their operational and financial relationships with the state. For Boeing, the tax changes are part of broader legislative dynamics affecting federal appropriations that influence defense spending and procurement priorities, which are critical to Boeing's revenue streams as highlighted in its 10-K filing regarding government funding dependencies. Union Pacific, which operates in Louisiana (as evidenced by its presence in the state's major classification yards and intermodal terminals listed in its 10-K), benefited from a $34 million reduction in deferred tax expense in 2024 specifically due to Louisiana's corporate income tax rate reduction, directly lowering its effective tax burden and improving its financial position. This tax reduction represents a tangible financial exposure mitigation for Union Pacific operating within the state, while Boeing's exposure remains tied to how such state-level fiscal policies interact with federal budget cycles and defense spending decisions that ultimately affect its commercial and defense contracts.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Introduces]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Legislation (REGULATORY_REQUIREMENT)",
        "Legislation (REGULATORY_REQUIREMENT) -> Louisiana (GPE)",
        "Louisiana (GPE) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6956,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2427,
        "completion_tokens": 286,
        "total_tokens": 2713
      }
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix's one-vote-per-share governance model, as disclosed in its 10-K filing (Chunk 1), directly contrasts with Meta's dual-class structure where Class B shares carry significantly more voting power per share, a relationship explicitly linked to Charter Communications' disclosure (Chunk 2) that connects Class A common stock to voting rights through its accounting policy framework (KG: ORG→ACCOUNTING_POLICY→FIN_INST). This structural divergence is further reinforced by Meta's SEC filing (Chunk 3), which confirms Class A Common Stock's par value and voting rights framework while establishing the connection to Charter's disclosure pattern via the KG triplet chain (Voting Rights→Class A Common Stock→META), demonstrating how Charter's governance model serves as a regulatory reference point for understanding voting rights tied to specific share classes across these entities.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CHTR_10k_2024.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7157,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2476,
        "completion_tokens": 220,
        "total_tokens": 2696
      }
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures in PEP’s 2022 filing directly impacts MDLZ’s Level 1 financial liabilities valuation methodology, as both companies rely on quoted market prices from commodity exchanges for fair value determination. Per MDLZ’s 10-K disclosures, Level 1 financial liabilities—including commodity futures—are valued using quoted market prices on exchanges, with daily cash settlement ensuring fair value reflects real-time market movements; this aligns with PEP’s classification of exchange-traded futures as cash-settled instruments excluded from fair value hierarchy tables due to their settlement mechanism. Consequently, MDLZ’s Level 1 liabilities are consistently marked-to-market using exchange-quoted prices, mirroring PEP’s approach and underscoring the critical role of daily settlement in their valuation models.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Includes]-> FIN_INST <-[Cash-Settles]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Level 1 Financial Liabilities (FIN_INST)",
        "Level 1 Financial Liabilities (FIN_INST) -> Commodity Futures (FIN_INST)",
        "Commodity Futures (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7442,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2560,
        "completion_tokens": 219,
        "total_tokens": 2779
      }
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple's 2022 net sales in Greater China, which includes Taiwan, were $74,200 million (as reported in Chunk 1 and detailed in Chunk 2), reflecting the company's regional exposure that also encompasses Taiwan. In contrast, AMD's 2022 sales specifically to Taiwan alone amounted to $2,091 million (shown in Chunk 3), illustrating a much smaller geographic footprint within the same market. Together, these figures demonstrate that while Apple captures the bulk of its Greater China revenue from Taiwan as part of a larger regional portfolio, AMD's revenue from Taiwan represents a distinct, comparatively modest portion of its overall sales.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Greater China (GPE)",
        "Greater China (GPE) -> Taiwan (GPE)",
        "Taiwan (GPE) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3505,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 159,
        "total_tokens": 1700
      }
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy (DUK) faces environmental remediation liabilities that are typically expensed as incurred unless regulatory recovery is deemed probable, reflecting a contingent accounting approach for uncertain cleanup costs. In contrast, Southern Company Gas incorporates environmental remediation costs into its approved cost recovery mechanisms through state-regulated rate structures, enabling systematic recovery of these expenses from customers. This regulatory distinction allows Southern Company Gas to recover remediation costs via formal mechanisms—unlike Duke Energy’s expense-based treatment—while both companies’ exposures are linked through the shared risk factor of environmental liabilities and their respective accounting policies for cost recovery.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Includes]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Environmental Remediation (RISK_FACTOR)",
        "Environmental Remediation (RISK_FACTOR) -> Cost Recovery Mechanisms (ACCOUNTING_POLICY)",
        "Cost Recovery Mechanisms (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_163",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_280",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11366,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3582,
        "completion_tokens": 190,
        "total_tokens": 3773
      }
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "LOW relies on broker/dealer quotes as observable inputs for Level 2 fair value measurements, directly using industry-standard valuation models that incorporate these quotes, whereas GM relies on internally developed valuation models for product warranty reserves and lease residual values, which require significant management assumptions and actuarial estimates rather than external market quotes. Both companies utilize industry-standard models in their financial reporting, but LOW's approach is grounded in externally observable market data through broker/dealer interactions, while GM's methodology depends on internally generated forecasts and assumptions about future claims and costs, reflecting divergent valuation philosophies despite shared reliance on standardized modeling frameworks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Relies_On]-> FIN_INST -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Broker/Dealer Quotes (FIN_INST)",
        "Broker/Dealer Quotes (FIN_INST) -> Valuation Models (ACCOUNTING_POLICY)",
        "Valuation Models (ACCOUNTING_POLICY) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14261,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4253,
        "completion_tokens": 199,
        "total_tokens": 4452
      }
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "The Basel III Finalization Proposal’s Expanded Risk-Based Approach would require both Capital One and Citigroup to calculate risk‑weighted assets under this new framework and under the existing standardized approach, then apply the lower of the two ratios for each binding regulatory capital metric; the proposal’s July 1, 2025 effective date (with a three‑year phase‑in through 2028) means firms must be prepared to use the lower ratio for all capital buffers, including the stress‑capital buffer, and to begin recognizing AOCI‑related items such as unrealized gains and losses in CET1 capital, which would likely increase the amount of capital they must hold.  Because the rule ties the lower‑of‑two calculation to the binding constraint for all capital‑related requirements—including well‑capitalized thresholds under FDICIA and the GSIB surcharge—both firms would face potentially tighter leverage and risk‑based capital ratios once the rule is finalized, with the transition period providing limited time to adjust capital planning and liquidity strategies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Basel III Finalization Proposal (REGULATORY_REQUIREMENT)",
        "Basel III Finalization Proposal (REGULATORY_REQUIREMENT) -> Expanded Risk-Based Approach (ACCOUNTING_POLICY)",
        "Expanded Risk-Based Approach (ACCOUNTING_POLICY) -> C (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11577,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3625,
        "completion_tokens": 265,
        "total_tokens": 3890
      }
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips' exposure to condensate production through its 52.2% ownership in Alba Plant LLC is evidenced by its equity method investment in the joint venture that processes natural gas to extract and sell condensate at market prices, as disclosed in Note 9-Guarantees and the equity investments discussion in Chunk 2. Chevron's direct condensate production volumes are explicitly recorded in its 2024 10-K as zero reserves under \"Proved Developed\" and \"Proved Undeveloped\" categories in the consolidated reserves table (Chunk 3), confirming no direct production. The KG triplet relationship \"Condensate (RAW_MATERIAL) -> CVX (ORG)\" establishes Chevron's connection to condensate as a material stream, yet its 2024 filing shows no reserves or production volumes for condensate, contrasting with ConocoPhillips' active equity stake in Alba Plant LLC that generates condensate revenue through its 52.2% share of the joint venture's operations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP -[Produces]-> RAW_MATERIAL <-[Produces]- ORG",
      "triplets_used": [
        "COP (ORG) -> Alba Plant LLC (COMP)",
        "Alba Plant LLC (COMP) -> Condensate (RAW_MATERIAL)",
        "Condensate (RAW_MATERIAL) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14340,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4261,
        "completion_tokens": 236,
        "total_tokens": 4497
      }
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "The application of ASU 2020-04 to contract modifications required both AVGO and ORCL to apply the reference rate reform guidance to their accounting policies, with AVGO specifically addressing contract modifications that adjust pricing without reflecting standalone selling price as adjusted for facts and circumstances, and ORCL confirming that the ASU 2020-04 adoption had no material impact on its consolidated financial statements for the year ended May 31, 2024, while the KG triplets confirm the direct regulatory relationship (Contract Modifications → ASU 2020-04 → ORCL) and the accounting policy connection (ORG → Contract Modifications → ASU 2020-04).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Contract Modifications (ACCOUNTING_POLICY)",
        "Contract Modifications (ACCOUNTING_POLICY) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16615,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4840,
        "completion_tokens": 165,
        "total_tokens": 5005
      }
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "META's dual-class structure deliberately uses its Class B shares to concentrate voting power with Mark Zuckerberg, allowing him to control board composition, merger approvals and other key decisions even when his share ownership is far below a majority; this governance control makes the Class A Common Stock less attractive to investors who prefer one‑share‑one‑vote equity. In contrast, CMCSA’s Class B Common Stock is fully convertible on a share‑for‑share basis into Class A shares (subject to certain restrictions) and carries a fixed 15‑vote per share entitlement, giving holders of Class B a strong but convertible voting influence that can be diluted only under limited circumstances, thereby preserving a more balanced shareholder influence profile. Both companies embed these mechanisms in their SEC filings, with META’s anti‑takeover provisions and Delaware‑law protections reinforcing the control advantage of Class B, while CMCSA’s disclosures highlight the convertibility feature and the non‑dilutive nature of its Class B voting interest.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Converts_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13192,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3987,
        "completion_tokens": 263,
        "total_tokens": 4250
      }
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PEP discloses that its exchange-traded commodity futures are cash-settled daily and therefore excluded from fair value hierarchy tables, while COST explicitly states it holds no Level 1 financial assets measured at fair value on a recurring basis, reflecting the absence of such assets in its portfolio. This contrast underscores that PEP’s cash‑settled futures are treated as non‑Level 1 instruments, whereas COST’s disclosure confirms it does not possess any Level 1 assets at all.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Cash-Settles]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Commodity Futures (FIN_INST)",
        "Commodity Futures (FIN_INST) -> Level 1 Financial Assets (FIN_INST)",
        "Level 1 Financial Assets (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7741,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2637,
        "completion_tokens": 120,
        "total_tokens": 2758
      }
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "The value of securities loaned with maturities of 31-90 days at Goldman Sachs is $41,361 million (per Chunk 1), while Morgan Stanley reports $1,007 million for the same maturity bucket (per Chunk 2). This indicates Goldman Sachs has significantly higher exposure to short-term securities lending risk, with its 31-90 day lending amount being approximately 41 times larger than Morgan Stanley's, reflecting a substantially greater reliance on this specific short-term lending mechanism.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GS (ORG) -> 31 - 90 Days (FIN_INST)",
        "31 - 90 Days (FIN_INST) -> Securities Loaned (FIN_INST)",
        "Securities Loaned (FIN_INST) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_187",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_200",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8319,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2762,
        "completion_tokens": 121,
        "total_tokens": 2884
      }
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth's owned generating capacity includes an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which represents a specific stake in that facility as part of its generating portfolio. Duke Energy's total electricity generation for 2021 was 22,344 GWh, as reported in its 2021 annual filing.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "SO (ORG) -> PowerSouth (COMP)",
        "PowerSouth (COMP) -> Electricity (PRODUCT)",
        "Electricity (PRODUCT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_245",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_187",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5233,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1977,
        "completion_tokens": 79,
        "total_tokens": 2056
      }
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "NIKE's $11.6 billion fixed‑income portfolio is explicitly exposed to interest‑rate risk, as disclosed in its 2024 10‑K, where it notes that all cash equivalents and short‑term investments are “investment‑grade to minimize credit risk” and that the portfolio is “exposed to both credit and interest rate risk” with a weighted‑average maturity of 65 days【Chunk 1】.  \n\nThe valuation of those fixed‑income assets relies on pricing models that use observable market data such as interest‑rate yield curves, a methodology mirrored by McDonald’s own fair‑value hierarchy, which classifies interest‑rate swaps and other derivatives as Level 2 inputs derived from observable yield‑curve parameters【Chunk 3】.  \n\nBoth companies therefore employ similar observable‑input models for valuing fixed‑income securities, but NIKE’s exposure is quantified in dollar terms ($11.6 billion) and tied to its cash‑management strategy, whereas McDonald’s sensitivity is reflected only in the disclosure of its Level 2 valuation approach and the related market‑input risk【Chunk 2】.  \n\nThus, while NIKE’s interest‑rate risk is a concrete, portfolio‑level financial exposure, McDonald’s comparable sensitivity is embedded in its fair‑value classification system that depends on the same observable yield‑curve inputs.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10000,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3201,
        "completion_tokens": 322,
        "total_tokens": 3523
      }
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "The voting rights structure creates distinct governance dynamics: Netflix's uniform one-vote-per-share policy ensures equal shareholder influence across all investors, while Alphabet's multi-class structure concentrates voting power in Class B shares (10 votes per share) and allows Class A shares to be converted from Class B, potentially enabling legacy stakeholders to maintain disproportionate control despite share repurchases of Class A and C stock totaling $183.5 billion in 2022–2024 ($59.3B + $62.2B + $62.0B), with $44.7B remaining authorized for future repurchases as of December 2024. This divergence means Netflix shareholders experience standardized voting power, whereas Alphabet's governance may prioritize long-term institutional or founding stakeholders due to the Class B super-voting rights and conversion mechanics, directly shaping shareholder engagement and decision-making authority across both companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4679,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1877,
        "completion_tokens": 232,
        "total_tokens": 2109
      }
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "The IRA's price-setting provisions will impact AbbVie and Johnson & Johnson differently due to their distinct Medicare exposure, as revealed through the regulatory relationship mapping in the knowledge graph. AbbVie faces direct price-setting under the IRA for drugs like Imbruvica (selected in August 2023 for Medicare Part D price negotiation starting 2026), with CMS-determined ceiling prices potentially causing significant revenue erosion before patent expirations, while Johnson & Johnson's Janssen unit is similarly affected by the same IRA mechanisms but has taken legal action challenging the constitutionality of the pricing authority, creating regulatory uncertainty that could alter implementation timelines and penalties. Both companies are subject to IRA provisions that replace the Medicare Part D coverage gap discount with a 10% manufacturer discount starting January 2025 and impose inflation-based rebates, but JNJ's litigation introduces a potential delay or modification of these rules, whereas AbbVie's exposure is more immediate through its selected drug Imbruvica, which is part of the same regulatory framework affecting both entities through their shared connection to the Medicare program via the IRA.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Impacts]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> IRA (REGULATORY_REQUIREMENT)",
        "IRA (REGULATORY_REQUIREMENT) -> Medicare Program (REGULATORY_REQUIREMENT)",
        "Medicare Program (REGULATORY_REQUIREMENT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16362,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4782,
        "completion_tokens": 307,
        "total_tokens": 5089
      }
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi's governance structure addresses the amplification of credit and liquidity risks from transition climate risks through its Board and Executive Management Committee oversight mechanisms, specifically via the Audit Committee's mandate to hold management accountable for compliance with legal and regulatory requirements related to climate risk disclosures. As disclosed in Morgan Stanley's risk factors, transition climate risks can amplify credit or liquidity risk by reducing customers' operating income or asset values, and this connection is embedded in Citi's ERM Framework oversight by the Board, which ensures alignment with risk strategy and regulatory compliance, including through the Audit Committee's oversight of climate-related regulatory requirements.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "C (ORG) -> Compliance Risk (RISK_FACTOR)",
        "Compliance Risk (RISK_FACTOR) -> Transition Climate Risks (RISK_FACTOR)",
        "Transition Climate Risks (RISK_FACTOR) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10978,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3434,
        "completion_tokens": 192,
        "total_tokens": 3626
      }
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "QCOM's reliance on Chinese OEMs for 30% of its licensing revenue creates supply chain risks centered on **revenue concentration and geopolitical vulnerability**, as evidenced by its heavy dependence on Chinese licensees who may shift to domestic semiconductor solutions due to policies like \"Made in China 2025\" or U.S./China trade tensions, potentially triggering royalty disputes or payment delays that directly threaten its licensing cash flow. In contrast, TXN mitigates similar risks through **strategic vertical integration of internal manufacturing capacity** (e.g., expanding 300mm wafer fab capacity in Texas and Utah), which reduces external supplier dependency and enhances control over production scalability and cost structure—though this requires significant capital investment and carries execution risks tied to facility development timelines.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY -[Delays]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "TXN (ORG) -> License Agreements (ACCOUNTING_POLICY)",
        "License Agreements (ACCOUNTING_POLICY) -> Licensees (COMP)",
        "Licensees (COMP) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16668,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4836,
        "completion_tokens": 214,
        "total_tokens": 5050
      }
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company (SO) evaluates ASU 2020-04 as a reference rate reform accounting policy that will affect its interest rate derivatives, particularly regarding transition away from LIBOR, and notes that the ultimate outcome cannot yet be determined, requiring ongoing assessment of transition impacts on its financial reporting. Duke Energy (DUK) similarly assesses ASU 2020-04 for its LIBOR-indexed financial contracts, explicitly evaluating optional expedients for contract modifications and hedging accounting under the reference rate reform guidance, while also noting that the full transition impact remains indeterminate but is not expected to be material to its financial statements. Both companies are actively analyzing the standard's effects on their interest rate-sensitive instruments, with Southern Company focusing on derivative accounting implications and Duke Energy specifically examining contractual amendments for variable-rate debt and swaps tied to LIBOR, though neither has determined a material financial impact at this time.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "SO (ORG) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> Reference Rate Reform (REGULATORY_REQUIREMENT)",
        "Reference Rate Reform (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_195",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10117,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3224,
        "completion_tokens": 262,
        "total_tokens": 3486
      }
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "AMZN's foreign currency assets are exposed to British Pounds and Euros through its international operations and holdings of cash equivalents in these currencies, as disclosed in its 10-K filing (Chunk 1), while NKE specifically manages foreign exchange risk via hedging programs that include option contracts to offset currency impacts on product costs and non-functional currency sales (Chunk 3). Both companies use derivatives to manage currency risk, but NKE explicitly employs option contracts as part of its cash flow hedge program for forecasted transactions, whereas AMZN's exposure is characterized by direct currency holdings without explicit mention of option-based hedging in the provided disclosures (Chunk 1 and Chunk 3). The KG triplet relationship (Option Contracts → NKE) confirms NKE's reliance on such instruments, contrasting with AMZN's more passive exposure to GBP and EUR fluctuations without comparable derivative-based risk mitigation strategies described in the text.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Impacts]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Foreign Currency Assets (FIN_INST)",
        "Foreign Currency Assets (FIN_INST) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12728,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3866,
        "completion_tokens": 248,
        "total_tokens": 4114
      }
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "The voting power distribution at META shows Class A common stock holders possess 66 ⅔% of the combined voting power while Class B common stock represents 33 ⅓% of the combined voting power, with each Class B share carrying 15 votes and generally non‑dilutable, whereas Alphabet’s (GOOGL) structure allocates one vote per Class A share, 10 votes per Class B share and no voting rights to Class C shares, reflecting a markedly different voting power dynamic between the two companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8023,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2678,
        "completion_tokens": 120,
        "total_tokens": 2799
      }
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company's investment in SNG ($1,245 million in 2024, up from $1,202 million in 2023) requires FERC approval for its $3 billion pipeline expansion, creating a regulatory hurdle that directly ties SNG’s capital plan to external approval, whereas Duke Energy Ohio’s own FERC‑related dividend constraints are governed by state commission rules and equity‑maintenance covenants that limit distributions but do not affect a major infrastructure project. Consequently, Southern Company faces a capital‑intensive regulatory approval process that could delay or reshape its $3 billion pipeline investment, while Duke Energy Ohio’s regulatory constraints primarily affect dividend policy and equity ratios rather than a large‑scale capital project.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "SO (ORG) -> SNG (COMP)",
        "SNG (COMP) -> FERC Approval (REGULATORY_REQUIREMENT)",
        "FERC Approval (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_217",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_147",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9477,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3049,
        "completion_tokens": 186,
        "total_tokens": 3235
      }
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe's distributed shareholder value through direct share repurchases via financial institutions, including a $3.0 billion ASR agreement with a third-party institution that delivered 11.9 million shares over 2021-2022 at an average price based on volume-weighted pricing, while Home Depot distributed value through dividend equivalents on deferred shares and restricted stock units, where accrued dividend equivalents were paid in additional shares upon payout following termination of Board service or vesting, as disclosed in its 10-K filings.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Increases]-> FIN_INST <-[Pays]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Additional Shares (FIN_INST)",
        "Additional Shares (FIN_INST) -> Dividend Equivalents (FIN_INST)",
        "Dividend Equivalents (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4446,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1782,
        "completion_tokens": 136,
        "total_tokens": 1918
      }
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "The adoption of ASU 2022-04 requires both Caterpillar and Honeywell to disclose rollforward information for supplier finance program obligations, with the rollforward requirement becoming effective for reporting periods beginning January 1 2024. Caterpillar began applying the guidance on January 1 2023 and first presented rollforward data for the year ended December 31 2024, while Honeywell adopted the same guidance on January 1 2023, with the rollforward disclosure effective on January 1 2024, and both companies now include the required rollforward of confirmed obligations in their annual supplier‑finance‑program disclosures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Supplier Finance Programs (ACCOUNTING_POLICY)",
        "Supplier Finance Programs (ACCOUNTING_POLICY) -> ASU 2022-04 (ACCOUNTING_POLICY)",
        "ASU 2022-04 (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11025,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3446,
        "completion_tokens": 158,
        "total_tokens": 3604
      }
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C reports $49,549 million in credit card loans due within 1 year, specifically identified as \"Credit cards (1)\" in its loan portfolio breakdown (Chunk 2), representing a significant portion of its $62,975 million total loans due within 1 year. This aligns with Visa's strategic focus on credit card growth as a core driver of revenue, as Visa explicitly identifies a $20 trillion global opportunity to convert non-card payments to digital credentials through credit and digital credentials (Chunk 3), directly supporting its strategy to accelerate revenue growth via credit products. The $49,549 million figure thus reflects Company C's active participation in this high-opportunity credit card issuance space, leveraging its loan portfolio to capitalize on Visa's identified $20 trillion market expansion potential.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses_Financial_Metric]-> FIN_INST -[Has_Stake_In]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "C (ORG) -> Due Within 1 Year (FIN_INST)",
        "Due Within 1 Year (FIN_INST) -> Credit Cards (PRODUCT)",
        "Credit Cards (PRODUCT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_207",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8483,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2812,
        "completion_tokens": 206,
        "total_tokens": 3018
      }
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company Gas experiences weather-related revenue impacts on its gas distribution business that are explicitly mitigated through regulatory mechanisms like weather normalization and revenue adjustment mechanisms, which limit exposure to typical weather variations within its service territories as described in its 10-K filing. In contrast, NextEra Energy's electricity demand is directly exposed to weather volatility across its generation fleet (including wind/solar resources where output depends on wind/sun levels), with no comparable revenue normalization mechanisms disclosed—instead, it faces potential generation shortfalls and cost increases from severe weather events requiring infrastructure hardening and emergency response. Both companies operate under regulatory frameworks where weather-related costs may be recovered through rates (e.g., NEE's cost recovery for storm restoration), but Southern Company Gas specifically uses weather derivatives and decoupled mechanisms to stabilize revenues, while NextEra Energy's exposure remains tied to physical generation impacts and commodity price volatility without equivalent revenue protection.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> MACRO_CONDITION -[Depends_On]-> MACRO_CONDITION <-[Depends_On]- ORG",
      "triplets_used": [
        "SO (ORG) -> Customer Consumption Patterns (MACRO_CONDITION)",
        "Customer Consumption Patterns (MACRO_CONDITION) -> Weather Conditions (MACRO_CONDITION)",
        "Weather Conditions (MACRO_CONDITION) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_200",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13837,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4151,
        "completion_tokens": 290,
        "total_tokens": 4442
      }
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald's generates revenue primarily through franchise and affiliate fees—including rent, royalties, and initial fees—from restaurants operated by affiliates, which accounted for a substantial portion of its total revenue, while General Motors relies on nonconsolidated affiliates to produce and sell crossovers, contributing to GM's segment revenue but without direct consolidation of those sales; this contrast is highlighted by the KG pattern where MCD depends on affiliates that produce crossovers (a product linked to GM), illustrating divergent operational structures and revenue recognition models across the two companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Affiliates (COMP)",
        "Affiliates (COMP) -> Crossovers (PRODUCT)",
        "Crossovers (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10727,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3349,
        "completion_tokens": 158,
        "total_tokens": 3507
      }
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "The voting power dilution protection for CMCSA's Class B Common Stock is non-dilutable, with holders retaining 33 ⅓ % of total voting power regardless of additional issuances, and conversion to Class A shares is strictly share‑for‑share with no dilution, whereas GOOGL's Class B Common Stock can be voluntarily converted to Class A or automatically converted upon sale or transfer, subject only to board‑approved repurchase limits and no explicit non‑dilution clause.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10567,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3345,
        "completion_tokens": 116,
        "total_tokens": 3461
      }
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "AXP's valuation methodology for Level 3 investment securities—particularly its reliance on internal credit models to assess contractual cash flows for Community Development Financial Institution debt securities and independent Monte Carlo simulations for embedded derivatives—exposes it to illiquid market conditions by anchoring fair value estimates to unobservable inputs when observable market prices are unavailable, thereby making valuations highly sensitive to market disruptions that impair price discovery. This structural vulnerability directly impacts MS's ability to manage market risk during asset devaluation, as evidenced by Chunk 3's disclosure that \"substantial market fluctuations or divergence in asset performance could cause variations in the value of our investments... and may adversely impact historical or prospective fees,\" while Chunk 2's warning that \"illiquid market conditions and other disruptions in the financial markets may make it extremely difficult to value certain financial instruments\" and Chunk 1's admission that Level 3 valuations require internal models to judge credit risk without external market validation creates a systemic risk cascade where illiquidity-induced valuation uncertainty at AXP (via its Level 3 policies) propagates through the KG relationship to MS, potentially undermining its hedging effectiveness and stress testing frameworks during periods of market turmoil.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Negatively_Impacts]-> MACRO_CONDITION <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Valuation (ACCOUNTING_POLICY)",
        "Valuation (ACCOUNTING_POLICY) -> Illiquid Market Conditions (MACRO_CONDITION)",
        "Illiquid Market Conditions (MACRO_CONDITION) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16442,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4803,
        "completion_tokens": 356,
        "total_tokens": 5159
      }
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "The valuation approach for Chevron's Level 2 derivatives relies on observable market inputs from third-party broker quotes and pricing services, as explicitly stated in Chunk 1 where Level 2 derivatives are valued using inputs generated from observable market data that is not materially adjusted. In contrast, Exxon's valuation of Pioneer's upstream assets acquired in 2024 explicitly used discounted cash flow models with significant management judgment, incorporating inputs like future production volumes, commodity prices, and risk-adjusted discount rates as detailed in Chunk 3's acquisition disclosure. While Chunk 2 describes Level 2 derivatives as being valued via internal DCF models using observable inputs (interest rates, yield curves), the critical distinction lies in Chunk 3's acquisition context: Exxon's upstream asset valuation for Pioneer relied on DCF models with substantial management judgment and non-observable assumptions, whereas Chevron's Level 2 derivatives use more routine observable market pricing without such complex forward-looking assumptions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Classifies]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Level 2 Derivatives (FIN_INST)",
        "Level 2 Derivatives (FIN_INST) -> Discounted Cash Flow Models (ACCOUNTING_POLICY)",
        "Discounted Cash Flow Models (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11624,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3602,
        "completion_tokens": 269,
        "total_tokens": 3872
      }
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy's renewable VIE structure relies on tax equity partnerships to monetize ITCs/PTCs from solar/wind/battery projects, with tax partners taking substantially all federal tax benefits through consolidated HLBV accounting, while Southern Power directly utilizes ITCs for new solar and battery facilities and PTCs for wind production over the first 10 years, both entities depending on PPA-driven financing to support tax credit utilization and cash flow impacts.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negotiates]-> FIN_INST -[Related_To]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "DUK (ORG) -> PPAs (FIN_INST)",
        "PPAs (FIN_INST) -> Solar Facilities (PRODUCT)",
        "Solar Facilities (PRODUCT) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_268",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5838,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2134,
        "completion_tokens": 117,
        "total_tokens": 2251
      }
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "The concentration of voting power in NKE's Class A Common Stock—where holders elect three-quarters of the Board of Directors—creates significant governance influence, as reflected in the KG relationship **Class A Common Stock → Voting Rights → HD**, indicating that NKE's voting structure directly shapes board composition and thus corporate control. In contrast, HD's treatment of restricted stock awards grants voting rights to recipients upon grant (including dividends on unvested shares) and allows class B/C common stockholders to vote collectively on key matters like core business exits or mergers, but this framework does not concentrate board election power to the same extent as NKE's Class A structure, highlighting a fundamental difference in governance influence where NKE's stock class directly determines board seats while HD's voting rights are tied to specific events and restricted award terms rather than board election dominance.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_9",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5926,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2171,
        "completion_tokens": 237,
        "total_tokens": 2408
      }
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix's foreign exchange risk exposure from forecasted revenue transactions is managed through forward contracts specifically designed to hedge currency fluctuations on non-U.S. dollar denominated revenue streams, as disclosed in its accounting policy for derivative instruments and foreign currency translation (Chunk 1). Disney's VAR model estimates a maximum one-day potential loss of $255 million at September 28, 2024, reflecting reduced interest rate volatility and excluding certain hedged foreign exchange transactions from its risk assessment (Chunks 2 and 3). Both companies utilize financial instruments for currency hedging, but Netflix directly manages foreign exchange risk on forecasted revenue transactions through derivatives, while Disney's VAR model provides a consolidated risk estimate that excludes specific hedged items and focuses on broader market exposures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Manages]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Forecasted Transactions (FIN_INST)",
        "Forecasted Transactions (FIN_INST) -> VAR Model (ACCOUNTING_POLICY)",
        "VAR Model (ACCOUNTING_POLICY) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8917,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2912,
        "completion_tokens": 221,
        "total_tokens": 3133
      }
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "Both MDLZ and PM employ a Value at Risk (VAR) model that assumes **normal market conditions**, uses a **95% confidence interval**, and applies a **one-day holding period** to estimate expected return distributions via a parametric delta-gamma approximation. The key distinction lies in the **time horizons for estimating return distributions**: MDLZ bases its parameters on observations over the **prior quarter** for point-in-time VAR calculations (e.g., December 31, 2024/2023) and the **four prior quarters** for average VAR, while PM explicitly references \"preceding quarter\" observations for point-in-time VAR and \"four preceding quarters\" for average/high/low VAR calculations, mirroring MDLZ’s methodology but extending the scope to include additional risk metrics. This shared approach implies both companies assess risk primarily over **short-term (one-day) horizons** under normal conditions, but PM’s inclusion of multi-quarter data for average VAR suggests a marginally broader assessment horizon for comprehensive risk reporting, though both maintain a consistent one-day regulatory reporting focus.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Depends_On]-> MACRO_CONDITION <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> VAR Model (ACCOUNTING_POLICY)",
        "VAR Model (ACCOUNTING_POLICY) -> Normal Market Conditions (MACRO_CONDITION)",
        "Normal Market Conditions (MACRO_CONDITION) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3915,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1675,
        "completion_tokens": 278,
        "total_tokens": 1953
      }
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 stems from management’s quantitative impairment test for its entertainment‑linear‑networks and DTC reporting units, where the carrying amount exceeded fair value; auditors evaluated the reasonableness of the significant assumptions—future revenues, operating margins, terminal growth rates, and discount rates—used in the discounted‑cash‑flow model, a process that required specialized skill and extensive testing of controls and data.  \nIn contrast, the auditor’s approach to NFLX’s content amortization involves testing the reasonableness of assumptions about historical and forecasted viewing patterns, evaluating the completeness of underlying data, and performing sensitivity analyses to assess how changes in those assumptions affect amortization expense.  \nBoth engagements highlight the auditor’s focus on significant judgments and the need for specialized expertise, but DIS’s assessment centers on goodwill fair‑value estimation using discounted cash flows, whereas NFLX’s testing emphasizes amortization of content based on viewing‑pattern estimates.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> ACCOUNTING_POLICY -[Tests]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Significant Assumptions (ACCOUNTING_POLICY)",
        "Significant Assumptions (ACCOUNTING_POLICY) -> Auditor (ACCOUNTING_POLICY)",
        "Auditor (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14152,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4240,
        "completion_tokens": 284,
        "total_tokens": 4524
      }
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "The cost-sharing structure for Gilead’s long-acting HIV injectable collaboration with Merck involves a 60%/40% split of global development and commercialization costs, with Merck leading U.S. commercialization and Gilead leading EU/commercialization outside the U.S., alongside equal revenue sharing until predefined sales thresholds are met, reflecting a milestone-driven financial commitment. In contrast, Gilead’s collaboration with Arcellx features a 50/50 U.S. profit split and shared costs for CART-ddBCMA, with Arcellx eligible for up to $1.5 billion in performance-based milestones and royalties, supplemented by a $299 million equity investment and $68 million in 2024 milestone payments, representing a more variable milestone-based financial structure compared to the fixed cost-sharing model with Merck. This distinction highlights Merck’s partnership as cost-sharing and revenue-tiered, while Arcellx’s agreement emphasizes equity participation and milestone-driven payments tied to regulatory and commercial milestones.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Commercializes]-> PRODUCT <-[Commercializes]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Merck (COMP)",
        "Merck (COMP) -> Long-Acting Injectable Products (PRODUCT)",
        "Long-Acting Injectable Products (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13103,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3960,
        "completion_tokens": 258,
        "total_tokens": 4218
      }
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells, formalized through the 2019 and 2020 Pricing Agreements (Exhibits 10.35†† and 10.36††) and governed by the 2011 Supply Agreement and its amendments, establish long-term contractual stability with fixed pricing terms tied to production volumes and cost structures, enabling predictable battery cost exposure for Tesla's EV production; this contrasts with GM's battery procurement, which lacks comparable multi-year pricing frameworks and instead relies on spot-market purchases or shorter-term arrangements, resulting in greater cost volatility and exposure to raw material price fluctuations as evidenced by GM's 10-K disclosure on page 78, which does not reference any multi-year supply agreements with battery suppliers like it does for Tesla's structured partnerships with Panasonic.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Supplies]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Panasonic Corporation (COMP)",
        "Panasonic Corporation (COMP) -> Batteries (PRODUCT)",
        "Batteries (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8521,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2805,
        "completion_tokens": 223,
        "total_tokens": 3029
      }
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca-Cola (KO) employs non-derivative instruments such as foreign currency-denominated debt to hedge foreign exchange risk on its net investments in European operations, with gains and losses recorded in AOCI until the hedged investment is sold or liquidated, whereas Procter & Gamble (PG) uses non-derivative instruments to hedge foreign exchange risk on its net investments in foreign subsidiaries, also designating portions of its euro-denominated Senior Notes as net investment hedges with similar AOCI treatment, and both companies face foreign exchange fluctuations in key markets like the United Kingdom and Germany, though PG explicitly quantifies that a 10% adverse currency movement would reduce income before taxes by $38 million as of December 31, 2024, reflecting the impact of its hedging strategy.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Designates]-> FIN_INST -[Negatively_Impacts]-> MACRO_CONDITION <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Non-Derivative Instruments (FIN_INST)",
        "Non-Derivative Instruments (FIN_INST) -> Foreign Exchange Fluctuations (MACRO_CONDITION)",
        "Foreign Exchange Fluctuations (MACRO_CONDITION) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16175,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4747,
        "completion_tokens": 203,
        "total_tokens": 4950
      }
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen (AMGN) faces distinct state-level affordability risks in Maryland compared to Gilead (GILD), directly tied to their operational models. While Amgen’s exposure centers on PDAB laws requiring upper payment limits on certain drugs for in-state patients—impacting its Medicaid/340B pricing strategies and requiring alignment with state reimbursement rules—Gilead’s operational risks in Maryland stem from its cell therapy manufacturing dependencies (e.g., apheresis centers, Maryland facilities) and complex reimbursement pressures for products like Yescarta, which face FDA-mandated safety labeling and usage constraints that could limit market access despite its Maryland operations. Both companies navigate pricing pressures, but Amgen’s risk is regulatory-driven (PDAB limits), whereas Gilead’s is manufacturing-and-reimbursement-driven (cell therapy logistics and safety oversight), with Maryland’s regulatory environment uniquely affecting each through different levers of the biopharma value chain.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Enacts]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> PDAB Laws (REGULATORY_REQUIREMENT)",
        "PDAB Laws (REGULATORY_REQUIREMENT) -> Maryland (GPE)",
        "Maryland (GPE) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18004,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5185,
        "completion_tokens": 251,
        "total_tokens": 5437
      }
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG's separate accounts, as disclosed in its 2021 Form 10-K, are structured to directly allocate investment income and gains/losses to policyholders who bear the investment risk, with assets legally segregated and carried at fair value, reflecting a policyholder-directed investment approach that emphasizes tailored diversification and risk allocation across distinct account objectives【1】. In contrast, MET's ERISA plan assets—held within insurance separate accounts established by its subsidiaries—rely on external investment management firms as sub-advisors to manage diversified portfolios across multiple asset classes, including derivatives for risk mitigation, with investment policies explicitly designed to minimize volatility, maximize funded status, and exceed liability increases through prudent asset allocation and independent consultant evaluations【2】. Critically, both entities employ separate accounts for asset segregation and risk management, but AIG's model centers on policyholder risk-bearing within legally distinct accounts, while MET's strategy leverages sub-advisory discretion to achieve diversification and risk control across its ERISA plans, as evidenced by its use of multiple managers to prevent concentration risks and derivatives to hedge exposure without leverage【3】. This structural divergence highlights AIG's focus on direct policyholder alignment versus MET's reliance on external managers to execute disciplined diversification and risk mitigation within regulatory frameworks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Has_Stake_In]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Separate Accounts (FIN_INST)",
        "Separate Accounts (FIN_INST) -> Investment Management Firms (COMP)",
        "Investment Management Firms (COMP) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_195",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_304",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_304",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12573,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3839,
        "completion_tokens": 379,
        "total_tokens": 4218
      }
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "The structural voting rights differences between NKE's Class B Common Stock (which grants no voting rights except on defined matters) and HD's restricted stock awards (which grant voting rights from the grant date) could significantly impact investor influence on governance matters like board composition and takeover defenses. NKE's Class B structure, as disclosed in its 10-K, allows holders to vote only on limited issues such as exiting the core payments business or certain amendments, while HD's restricted stock awards confer immediate voting rights upon grant, potentially giving certain shareholders earlier influence over critical decisions. This distinction is connected through the KG pattern where Class B Common Stock (NKE) relates to Voting Rights (ACCOUNTING_POLICY), which in turn connects to HD, indicating that HD's governance practices involving voting rights in restricted stock may contrast with NKE's more restricted voting framework, thereby affecting how investors in each company can impact corporate control decisions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_9",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5926,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2196,
        "completion_tokens": 261,
        "total_tokens": 2457
      }
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "META's Class B common stock holders possess voting rights that are functionally equivalent to Class A common stockholders only on a narrowly defined set of matters—specifically decisions to exit the core payments business, certain consolidation/merger transactions, and amendments to the certificate of incorporation that affect Class B/C terms—where their votes are calculated by multiplying shares held by the applicable conversion rate, and this limited voting bloc operates alongside Class A holders in those instances; in contrast, NFLX's voting rights framework, as disclosed in its 10‑K, grants each share of common stock a single vote per share on all matters without any class‑specific carve‑outs, meaning Class B common stock does not exist as a separate voting class and all common stockholders, regardless of designation, exercise identical voting rights.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5733,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2115,
        "completion_tokens": 216,
        "total_tokens": 2331
      }
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "Both PM and MDLZ employ the same parametric delta-gamma approximation technique under normal market conditions within their VAR models to estimate potential one-day losses in pre-tax earnings, relying on observed market movements over prior quarters to determine risk parameters. While PM explicitly describes using this method to assess risk across interest rates and currencies for portfolio positions, MDLZ applies it specifically to fixed income, currency, and commodity instruments, with its VAR model quantifying estimated one-day losses in fair value of interest rate-sensitive debt and pre-tax earnings from currency/commodity instruments as of December 31, 2023 and 2022.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Depends_On]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "PM (ORG) -> Normal Market Conditions (MACRO_CONDITION)",
        "Normal Market Conditions (MACRO_CONDITION) -> VAR Model (ACCOUNTING_POLICY)",
        "VAR Model (ACCOUNTING_POLICY) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3412,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 170,
        "total_tokens": 1716
      }
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach, which is explicitly linked in the KG to the Stress Capital Buffer requirement for AXP (American Express) under the Standardized Approach, as shown by the triplets BAC → Capital Conservation Buffer → Stress Capital Buffer ← AXP. This means BAC’s buffer is a fixed 2.5% component of its Advanced Approach capital framework, while AXP relies on a distinct Stress Capital Buffer (2.5% at December 31, 2023, per Chunk 1) as part of its regulatory minimums under the Standardized Approach, with both buffers tied to Basel III requirements. The Stress Capital Buffer for AXP (Chunk 1) and the Capital Conservation Buffer for BAC (Chunk 1) are directly connected through the regulatory hierarchy, confirming that BAC’s 2.5% buffer is a separate, mandatory component of its capital adequacy under the Advanced Approach, whereas AXP’s reliance on the Stress Capital Buffer reflects a different regulatory buffer mechanism under the Standardized Approach for meeting Basel III.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Capital Conservation Buffer (REGULATORY_REQUIREMENT)",
        "Capital Conservation Buffer (REGULATORY_REQUIREMENT) -> Stress Capital Buffer (REGULATORY_REQUIREMENT)",
        "Stress Capital Buffer (REGULATORY_REQUIREMENT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6538,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2351,
        "completion_tokens": 263,
        "total_tokens": 2614
      }
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "LMT values certain fixed income investments using a discounted cash flow approach where significant inputs include projected annuity payments and the discount rate applied to those payments, particularly for Level 3 assets, while HON applies the same methodology to test goodwill and indefinite-lived intangible asset impairments, using it to estimate fair value based on strategic operating plans and terminal value assumptions, with management conducting sensitivity analyses on the discount rate assumptions due to their material impact on impairment determinations; this shared reliance on discount rate assumptions highlights their critical role in both LMT's valuation of fixed income securities and HON's impairment testing, as changes in these rates could significantly affect financial condition and operating performance in both contexts.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> Discounted Cash Flow Approach (ACCOUNTING_POLICY)",
        "Discounted Cash Flow Approach (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11547,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3601,
        "completion_tokens": 212,
        "total_tokens": 3813
      }
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "The voting power distribution tied to Class B common stock at CMCSA directly influences share repurchase impact through its non-dilutable 33.3% aggregate voting power, which cannot be reduced by new issuances and is convertible to Class A shares. This structure means that while CMCSA's Class B shares (holding 33.3% voting power) convert to Class A upon transfer, Alphabet's Class B shares (with 10 votes per share) convert to Class A with voting dilution, potentially weakening voting control during repurchases if Class B shares are converted or retired. The KG pattern shows Class B Common Stock connects CMCSA to GOOGL via conversion, highlighting that CMCSA's non-dilutable Class B voting power contrasts with Alphabet's convertible Class B structure, where repurchases could indirectly affect voting control through conversion dynamics.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10567,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3333,
        "completion_tokens": 210,
        "total_tokens": 3544
      }
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "TGT's beverage sales mix in APAC is not explicitly quantified in its 10-K disclosures, but its exposure to the APAC region is confirmed through the KG triplet relationship APAC → PEP, indicating shared market presence. PEP's APAC beverage contribution is detailed in its 10-K as 23% of total beverage revenue (Chunk 2), while PEP's overall APAC revenue of $10M (Chunk 3) reflects its significant operational footprint in the region. This structural alignment suggests both companies target similar APAC markets, though TGT's beverage segment (Beverages PRODUCT) operates within its broader retail mix, whereas PEP's beverage revenue is a dedicated, material component of its APAC strategy.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Beverages (PRODUCT)",
        "Beverages (PRODUCT) -> APAC (GPE)",
        "APAC (GPE) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6757,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2333,
        "completion_tokens": 172,
        "total_tokens": 2506
      }
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla beginning in 2027, could negatively affect Amgen's $5.2 billion intangible‑asset valuation for Otezla by reducing the projected cash flows used in the impairment analysis, especially since CMS selected Otezla for price setting and future regulatory changes may further pressure pricing; this risk is amplified by the fact that Bristol‑Myers Squibb also markets Otezla under a licensing agreement, meaning competitive dynamics and shared market exposure could exacerbate downward pricing pressure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Medicare Price Setting (REGULATORY_REQUIREMENT)",
        "Medicare Price Setting (REGULATORY_REQUIREMENT) -> Otezla (PRODUCT)",
        "Otezla (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_140",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10968,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3436,
        "completion_tokens": 142,
        "total_tokens": 3579
      }
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD's production of FPGAs for hyperscale data centers is directly connected to Altera's FPGA offerings through Intel's strategic decision to operate Altera as a standalone business, as evidenced by the KG triplet relationship where FPGAs (product) → AMD (ORG) links Altera's FPGA production to AMD's role in hyperscale data centers. Altera, now a standalone entity under Intel's \"all other\" segment, continues to produce programmable semiconductors including FPGAs for applications across cloud and enterprise markets, while AMD leverages these FPGAs in its data center products for hyperscale customers as noted in AMD's 10-K describing hyperscale data centers using FPGAs in server appliances. Intel's internal foundry model and segment reorganization, which moved Altera to \"all other\" and emphasized its standalone operation, ensures that Altera's FPGA business remains distinct yet integrated into Intel's broader strategy, enabling AMD to utilize Altera's FPGA technology within its own data center product portfolio for hyperscale deployments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Altera (COMP)",
        "Altera (COMP) -> FPGAs (PRODUCT)",
        "FPGAs (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10422,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3257,
        "completion_tokens": 262,
        "total_tokens": 3519
      }
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "The voting power distribution tied to Class B common stock at CMCSA is concentrated almost entirely in Mr. Brian L. Roberts, who beneficially owns all outstanding shares of Class B common stock, giving Class B holders 33.3% of the combined voting power despite representing a smaller share of total equity. In contrast, GOOGL's Class A common stock has a much broader holder base with 300,754,904 shares outstanding and no single holder dominating voting control, while its Class B common stock (linked to CMCSA in the KG) is not part of GOOGL's capital structure but rather reflects CMCSA's own dual-class structure where Class B stock holds disproportionate voting power relative to its economic ownership.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4379,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1776,
        "completion_tokens": 177,
        "total_tokens": 1953
      }
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "The shift in Keytruda's royalty structure—from 6.5% through 2023 to 2.5% from 2024–2026—directly reduces Merck’s ongoing royalty payments to BMS (and Ono, per the 75/25 split), weakening BMS’s near-term revenue stream from Keytruda sales. However, this reduction is partially offset by BMS’s broader royalty arrangements with Merck, including the 20% (up to 24%) sales-based royalty on Reblozyl and potential $80M milestone payments, which remain tied to collaboration performance rather than Keytruda alone. Merck’s historical $212M in 2023 alliance revenue from this collaboration (including Keytruda-related royalties and a $20M regulatory milestone) underscores its financial dependence on these partnerships, though the post-2023 royalty decline reflects a structural shift in Merck’s obligation that may diminish BMS’s direct revenue dependency on Merck for Keytruda-specific gains.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Pays]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Keytruda (PRODUCT)",
        "Keytruda (PRODUCT) -> Merck (COMP)",
        "Merck (COMP) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5107,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1939,
        "completion_tokens": 222,
        "total_tokens": 2161
      }
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "The adoption of ASU 2022-06 by CAT, as explicitly listed in its 2023 disclosures (Chunk 3), directly impacts the treatment of contract modifications under U.S. government agreements identified as a material risk by BA (Chunk 1). ASU 2022-06 extends optional relief for reference rate reform-related contract modifications through December 31, 2024, specifically allowing certain modifications—such as those replacing LIBOR—to qualify for accounting expedients that reduce operational and financial impacts (Chunk 2). This regulatory flexibility mitigates the material risk BA highlighted regarding U.S. government contract modifications, curtailments, or terminations, which could otherwise materially affect financial position and results of operations through withheld funding, compliance costs, or penalties (Chunk 1). By applying ASU 2022-06, CAT can maintain consistent accounting for such modifications under U.S. government agreements, aligning with BA’s disclosed risk exposure while leveraging the ASU’s extended sunset date to manage contractual uncertainties.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "BA (ORG) -> Contract Modifications (ACCOUNTING_POLICY)",
        "Contract Modifications (ACCOUNTING_POLICY) -> ASU 2022-06 (ACCOUNTING_POLICY)",
        "ASU 2022-06 (ACCOUNTING_POLICY) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11475,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3565,
        "completion_tokens": 267,
        "total_tokens": 3833
      }
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "The $4.8 billion 2013 Crown Castle transaction and Verizon’s $2.8 billion 2024 Vertical Bridge REIT deal are structured similarly: both involve the transfer of exclusive tower‑leasing rights while Verizon retains ownership of the tower assets on its balance sheet and continues to depreciate them, and both generate financing obligations for the upfront payments. In the 2013 deal Verizon recorded a financing obligation of roughly $4.2 billion (reflecting the fixed‑price purchase options) and retained depreciation of the tower assets, whereas the 2024 transaction records a $830 million financing obligation for the portion Verizon still occupies, also treating the upfront payment as prepaid rent and a financing liability. Thus, each transaction is accounted for as a financing arrangement rather than a sale, with depreciation responsibilities and financing obligations preserving the economic substance of the assets for Verizon.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Gains]-> ACCOUNTING_POLICY -[Obtains]-> COMP <-[Transacts_With]- ORG",
      "triplets_used": [
        "T (ORG) -> Exclusive Rights (ACCOUNTING_POLICY)",
        "Exclusive Rights (ACCOUNTING_POLICY) -> Vertical Bridge REIT, LLC (COMP)",
        "Vertical Bridge REIT, LLC (COMP) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9597,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3105,
        "completion_tokens": 234,
        "total_tokens": 3339
      }
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo (PEP) has a direct operational footprint in New Zealand through its Asia Pacific business, which includes all of its beverage and convenient‑food operations in that country, while Coca‑Cola’s (KO) financial influence in the same market is exerted indirectly via its 19 % equity stake in Coca‑Cola Europacific Partners (CCEP), the bottler that handles Coca‑Cola production and distribution across New Zealand and many other regions. This contrast is highlighted by the KG pattern ORG → GPE → COMP ← Has_Stake_In → ORG, linking PEP’s direct presence in New Zealand to CCEP, which KO partially owns, thereby shaping the comparative market dynamics.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> New Zealand (GPE)",
        "New Zealand (GPE) -> CCEP (COMP)",
        "CCEP (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12177,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3704,
        "completion_tokens": 163,
        "total_tokens": 3868
      }
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG determines fair value for mortgage-backed securities using internally developed valuation models that incorporate broker/dealer quotes as inputs, while SCHW relies on independent third-party pricing services and broker/dealer quotes to value commercial mortgage-backed securities, reflecting a key difference in their fair value methodologies across similar asset classes.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Uses]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Valuation Models (ACCOUNTING_POLICY)",
        "Valuation Models (ACCOUNTING_POLICY) -> Broker/Dealer Quotes (FIN_INST)",
        "Broker/Dealer Quotes (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11897,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3658,
        "completion_tokens": 94,
        "total_tokens": 3752
      }
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "AVGO employs Level 2 fair value measurements for certain securities, relying on observable inputs such as yield curves, benchmark rates, and broker/dealer quotes to determine fair value, particularly for assets traded less frequently than Level 1 instruments. ADBE similarly categorizes all its fixed income available-for-sale securities as Level 2, using matrix pricing techniques that incorporate market-corroborated inputs like benchmark yields, issuer spreads, and observable interest rate curves, while also validating prices through multiple independent sources. Both companies utilize observable market inputs in their fair value determinations, but AVGO explicitly references yield curves and collateral performance in its Level 2 valuation inputs, whereas ADBE emphasizes matrix pricing methodologies and discounted cash flow models using benchmark yields and interest rate data.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Use]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Level 2 Securities (FIN_INST)",
        "Level 2 Securities (FIN_INST) -> Matrix Pricing (ACCOUNTING_POLICY)",
        "Matrix Pricing (ACCOUNTING_POLICY) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3534,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1566,
        "completion_tokens": 222,
        "total_tokens": 1788
      }
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca-Cola HBC manages approximately 71% of Coca-Cola's non-U.S. unit case volume, as indicated by its significant bottling and distribution operations across Central and Eastern Europe, Africa, and the Middle East, including the Czech Republic where it coordinates distribution for Coca-Cola trademark beverages alongside other key markets like Austria, Greece, and Poland. This operational scope is reinforced by its inclusion among the five largest bottling partners representing 41% of total worldwide unit case volume, with its Czech Republic operations specifically highlighted in the company's disclosures of global bottling footprint.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Czech Republic (GPE)",
        "Czech Republic (GPE) -> Coca-Cola HBC (COMP)",
        "Coca-Cola HBC (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13158,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3960,
        "completion_tokens": 160,
        "total_tokens": 4120
      }
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy's 50% equity stake in Hardy Storage—a West Virginia underground natural gas storage facility—reflects a strategic focus on **regulated, asset-light infrastructure investments** that leverage existing regulatory frameworks for stability, contrasting with NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region, which highlights a **high-risk, high-reward approach targeting new pipeline capacity amid regulatory uncertainty**. While Duke Energy's stake in Hardy Storage operates within a mature, rate-regulated storage model protected from commodity price volatility (as evidenced by its 24% equity interest in Constitution and 50% in Hardy Storage under FERC regulation), NextEra's pipeline investment faces active permitting delays and legal challenges (noted in its 31.9% stake in a West Virginia/Virginia pipeline requiring \"applicable regulatory approvals\"), directly exposing it to market and regulatory headwinds that Duke Energy actively avoids through its conservative, equity-based infrastructure strategy.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DUK (ORG) -> West Virginia (GPE)",
        "West Virginia (GPE) -> 303-mile Pipeline (PRODUCT)",
        "303-mile Pipeline (PRODUCT) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10939,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3429,
        "completion_tokens": 266,
        "total_tokens": 3696
      }
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "META's dual-class structure features Class A shares with one vote per share and Class B shares with ten votes per share, with 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, resulting in a significantly lower voting power concentration for Class B holders relative to their share count compared to Alphabet's (GOOGL) 10:1 voting ratio where Class B shares carry ten votes each, while GOOGL's $62.0 billion in 2024 share repurchases of Class A and Class C shares represent a substantial capital return that may influence ownership dynamics but does not directly alter the voting rights structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8491,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2848,
        "completion_tokens": 160,
        "total_tokens": 3009
      }
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "The enactment of Switzerland's Federal Act on Tax Reform and AHV Financing (TRAF) in 2020, which became effective on January 1, 2020, allowed JNJ to adjust the tax basis of certain assets to fair value (step-up), resulting in incremental Swiss tax deductions and a 1.9% reduction in its effective tax rate compared to 2019. This TRAF-driven benefit, detailed in Chunk 2 and Chunk 3 as part of the \"new tax legislation enactment in Switzerland,\" directly contributed to JNJ's 2020 effective tax rate decrease, with the step-up mechanism enabling incremental deductions over the transitional period. In contrast, MRK's Swiss tax holiday beginning in 2021 (referenced in Chunk 1 as \"a tax incentive in the form of a tax holiday in Switzerland for a newly active legal entity which is effective through 2030\") provided a separate, ongoing favorable impact on MRK's effective tax rate, though the specific percentage reduction is not quantified in the provided text. Both entities leveraged Swiss tax reforms—JNJ through TRAF's 2020 implementation and MRK through a 2021 tax holiday—but JNJ's benefit was tied to the 2020 TRAF enactment, while MRK's benefit commenced in 2021.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Switzerland (GPE)",
        "Switzerland (GPE) -> TRAF (REGULATORY_REQUIREMENT)",
        "TRAF (REGULATORY_REQUIREMENT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10003,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3166,
        "completion_tokens": 292,
        "total_tokens": 3458
      }
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "MCD's foreign currency asset hedging uses option contracts as part of its cash flow hedge program, with notional amounts tied to forecasted foreign currency transactions and designed to offset earnings volatility from currency fluctuations, particularly for its diversified foreign currency net asset exposures. In contrast, NKE employs option contracts specifically within its transactional FX risk management to hedge product cost exposures and non-functional currency sales, using notional amounts linked to forecasted cash flows and inventory costs, with gains/losses deferred in AOCI and recognized upon transaction occurrence. Both companies use options for cash flow hedging but target distinct risk profiles: MCD focuses on broad asset-level exposure diversification, while NKE concentrates on operational cost and revenue stream hedging with defined notional thresholds like $9.9 billion for its cash flow hedges.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Foreign Currency Assets (FIN_INST)",
        "Foreign Currency Assets (FIN_INST) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7749,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2609,
        "completion_tokens": 230,
        "total_tokens": 2840
      }
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "The exclusive use of RTX's PW800 engine on Gulfstream's G500 directly supports General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 by leveraging RTX's advanced engine technology to deliver superior performance and efficiency. As stated in Chunk 1, the G500 replaces the G450 and G550 models with \"new fuselage and ergonomically designed larger interiors, as well as systems and technologies to improve the manufacturing process and quality,\" while Chunk 2 confirms these aircraft \"replace the G450 and G550 models, whose combined family has an installed base of more than 1,650 aircraft.\" Crucially, Chunk 3 reveals RTX's PW800 engine is \"selected to exclusively power Gulfstream's G400, G500, and G600 business jets,\" establishing the technical foundation for this upgrade. This engine partnership enables the G500 to achieve \"greater cabin volume, reduced emissions, more range, and improved flight controls\" (Chunk 1), directly aligning with Gulfstream's strategy of introducing \"first-to-market capabilities that set industry standards for safety, performance, quality, speed and comfort\" through new aircraft development (Chunk 2). The PW800's role in powering the G500—alongside its use on the G400 and G600—creates a unified engine platform that enhances the G500's competitiveness as the successor to legacy models, while RTX's broader engine portfolio (including the fuel-efficient PW1000G GTF family) supports Gulfstream's \"disciplined and consistent approach to new product development\" (Chunk 1).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Introduces]-> COMP <-[Supplies]- ORG",
      "triplets_used": [
        "GD (ORG) -> G500 (PRODUCT)",
        "G500 (PRODUCT) -> Gulfstream (COMP)",
        "Gulfstream (COMP) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12425,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3761,
        "completion_tokens": 389,
        "total_tokens": 4151
      }
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "META's dual-class structure allocates voting power such that Class A common stock holders collectively hold 66 ⅔ % of the combined voting power, while Class B common stock represents the remaining 33 ⅓ % and is generally non‑dilutable under the company's articles of incorporation, whereas CMCSA's Class B shares similarly carry 33 ⅓ % of the total voting power and are also non‑dilutable, but the key distinction is that META's Class B shares are not publicly listed or traded, resulting in only 23 record holders versus 66 ⅔ % of voting power held by Class A shares in CMCSA, and both companies grant Class B shares 15 votes per share, preserving a concentrated voting bloc despite the different market listings.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4884,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1915,
        "completion_tokens": 178,
        "total_tokens": 2094
      }
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "BMY faces a higher risk of losing market exclusivity for Revlimid in Europe due to active patent challenges, as evidenced by its reliance on patent rights for market exclusivity and the expectation of generic entry in the UK and other European markets beginning in early 2022, while LLY's commercial exclusivity for its orphan-designated drugs depends on seven years of regulatory data protection under the U.S. orphan drug law—which is independent of patent terms and runs in parallel with any applicable patents—thus creating a fundamentally different exclusivity framework where LLY's protection is less vulnerable to patent litigation but still subject to regulatory exclusivity periods.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR -[Determined_By]-> REGULATORY_REQUIREMENT <-[Has]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Patent Rights (RISK_FACTOR)",
        "Patent Rights (RISK_FACTOR) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13836,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4162,
        "completion_tokens": 172,
        "total_tokens": 4334
      }
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "MS's asset management revenues are highly sensitive to fixed income market fluctuations through their direct exposure to Fixed Income Investments (FIN_INST), which are valued using pricing models (ACCOUNTING_POLICY) that determine revenue recognition based on market value changes. This sensitivity is explicitly measured in MS's 10-K by estimating revenue reductions from a 10% investment value decline, particularly impacting performance-based income in their Investment Management segment. In contrast, PYPL's market risk exposure through derivatives and debt securities is mitigated by Level 2 fair value measurements using observable inputs (e.g., interest rate curves and pricing models), resulting in significantly lower direct sensitivity to broad fixed income market movements compared to MS's structural market-linked revenue model.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "MS (ORG) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10330,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3266,
        "completion_tokens": 210,
        "total_tokens": 3477
      }
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle's integration of generative AI into MySQL HeatWave reflects its enterprise strategy of embedding on-device AI within a managed cloud database service to accelerate real-time analytics and AI-driven insights for business workloads, leveraging Oracle Autonomous Database capabilities to reduce costs and human error through machine learning automation. Qualcomm's investment in IoT applications, particularly through its QCT segment and strategic initiatives in on-device generative AI for edge devices, demonstrates its consumer market approach of enabling ubiquitous, privacy-preserving AI processing in mobile and IoT devices—such as smartphones and industrial systems—by advancing low-power computing and AI frameworks like LLMs and SLMs that operate directly on-device to maximize immediacy and security. Both companies strategically leverage AI integration: Oracle focuses on enterprise database efficiency and scalability through cloud-native AI services, while Qualcomm drives consumer and industrial adoption of on-device AI to enhance device intelligence, reduce latency, and enable personalized experiences across IoT and mobile ecosystems, as evidenced by their respective investments in generative AI capabilities for edge computing.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT -[Expands_Into]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Generative AI (CONCEPT)",
        "Generative AI (CONCEPT) -> IoT (PRODUCT)",
        "IoT (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18059,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5180,
        "completion_tokens": 312,
        "total_tokens": 5493
      }
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe (ADBE) faces rising compliance costs from the EU AI Act, which will likely require costly changes to its AI development practices and could delay or halt AI offerings, directly threatening its competitive positioning against Salesforce (CRM), whose AI-powered Agentforce platform is central to its sales, service, marketing, and commerce offerings and relies on a unified, compliant AI platform built on Hyperforce to ensure governance and regulatory alignment. While Salesforce’s integrated AI governance via its Trust Layer and Hyperforce may mitigate some regulatory exposure, Adobe’s need to overhaul AI development to meet EU requirements could erode its innovation velocity and market relevance in key enterprise segments where both companies compete.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> AI Regulations (REGULATORY_REQUIREMENT)",
        "AI Regulations (REGULATORY_REQUIREMENT) -> AI Technology (PRODUCT)",
        "AI Technology (PRODUCT) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18396,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5301,
        "completion_tokens": 190,
        "total_tokens": 5492
      }
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "HD's deferred shares for non-employee directors include dividend equivalents paid in additional shares upon payout, increasing the stock-based value distributed to these stakeholders. This structure directly connects to LOW through the KG relationship where Additional Shares (FIN_INST) are linked to LOW (ORG), indicating that the additional shares generated under HD's deferred share plan are ultimately received by LOW as part of its stock-based distributions. Consequently, both entities utilize additional shares as a mechanism for value distribution—HD to its directors and LOW to its stakeholders via ASR agreements—creating a direct financial linkage where the additional shares issued by HD (under its deferred share plan) are received by LOW, thereby connecting the stock-based value distribution structures of both organizations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "HD (ORG) -> Deferred Shares (FIN_INST)",
        "Deferred Shares (FIN_INST) -> Additional Shares (FIN_INST)",
        "Additional Shares (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2516,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 210,
        "total_tokens": 1522
      }
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T's adoption of ASU 2020‑04—permitted under the “Reference Rate Reform” accounting policy—allows it to treat contract modifications triggered by the LIBOR transition as optional expedients that do not materially affect its financial statements, whereas Verizon’s 10‑K disclosure notes that it cannot predict when revenue from certain long‑term wireline contracts will be recognized and shows $25.7 billion of transaction price expected to be recognized in 2024, $18.7 billion in 2025 and $7.5 billion thereafter, indicating that Verizon’s contract‑modification accounting may shift revenue timing more noticeably than AT&T’s, as reflected in the KG relationship “Contract Modifications → VZ” and the differing impact on revenue‑recognition timing and performance‑obligation accounting across the two firms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "T (ORG) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> Contract Modifications (ACCOUNTING_POLICY)",
        "Contract Modifications (ACCOUNTING_POLICY) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16332,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4788,
        "completion_tokens": 202,
        "total_tokens": 4990
      }
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific (UNP) and Lockheed Martin (LMT) disclose pension plan investments that include municipal bonds classified as Level 2 securities, but they rely on different valuation approaches. UNP’s municipal bonds are valued through a bid‑evaluation process using observable market inputs, placing them in Level 2 of the fair‑value hierarchy, whereas LMT’s municipal‑bond exposure is embedded in private‑equity‑collateralized loans and buy‑in contracts that are measured at Level 3, requiring unobservable inputs and internal valuations. This contrast shows that UNP adheres more closely to ASC 820’s Level 2 requirements for municipal‑bond fair‑value measurement, while LMT’s reliance on Level 3 inputs indicates a greater use of non‑observable assumptions and less direct compliance with the standard’s Level 2 guidance.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprise]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Municipal Bonds (FIN_INST)",
        "Municipal Bonds (FIN_INST) -> Level 2 Securities (FIN_INST)",
        "Level 2 Securities (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6686,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2357,
        "completion_tokens": 205,
        "total_tokens": 2562
      }
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "KO's reliance on Coca-Cola FEMSA for distribution in Argentina is explicitly detailed in Chunk 2, which states that Coca-Cola FEMSA operates in Argentina (specifically in the federal capital of Buenos Aires and surrounding areas) as one of its five largest bottling partners, handling nationwide distribution in that country. This operational footprint is critical to KO's market presence, as noted in Chunk 2's listing of Coca-Cola FEMSA as a key bottler with extensive regional coverage. In contrast, MDLZ's exposure to economic volatility in Argentina is directly tied to its own operations, as revealed in Chunk 3: MDLZ identified Argentina as a highly inflationary economy starting in 2018, leading to a functional currency shift to USD and resulting in significant financial impacts, including a $13 million remeasurement loss in 2021 and $401 million in consolidated net revenues from Argentina (1.4% of total). Furthermore, Chunk 3 confirms MDLZ's $9 million in Argentinean peso-denominated net monetary assets as of December 31, 2021, highlighting its direct vulnerability to local economic instability. The KG triplet relationship (Argentina → MDLZ) confirms MDLZ's operational and financial exposure in the same market where KO depends on Coca-Cola FEMSA for distribution, creating a clear contrast between KO's bottler-dependent model and MDLZ's direct, inflation-impacted operations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola FEMSA (COMP)",
        "Coca-Cola FEMSA (COMP) -> Argentina (GPE)",
        "Argentina (GPE) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11681,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3593,
        "completion_tokens": 349,
        "total_tokens": 3942
      }
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "META's Class B common stock carries 10 votes per share, creating a concentrated voting control structure that enables management to steer strategic decisions without proportional equity dilution, whereas Alphabet's dual-class framework grants Class B shares 10 votes per share while Class A shares carry only one vote, allowing founders and insiders to maintain outsized influence despite smaller economic ownership stakes. This voting asymmetry directly shapes shareholder equity strategies: META's concentrated control supports long-term vision prioritization, while Alphabet's structure facilitates aggressive capital allocation—including its $62.0 billion 2024 share repurchase targeting Class A and Class C shares—by preserving founder control over voting power even as economic returns are returned to shareholders. The KG triplets confirm Class B Common Stock (META) is linked to Class A Common Stock (META) and Class A Common Stock (FIN_INST) is connected to GOOGL, establishing the comparative dual-class relationship central to understanding these divergent equity strategies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8491,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2818,
        "completion_tokens": 271,
        "total_tokens": 3089
      }
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "The decline in GILD's Veklury sales in 2024 is directly tied to the availability of alternative treatments, as evidenced by the 17% year-over-year drop in Veklury revenue (from $1,799M to $1,499M) and the explicit acknowledgment in the filing that \"Veklury sales generally reflect ... the availability, uptake and effectiveness of vaccines and alternative treatments for COVID-19\" (Chunk 1, page 66; Chunk 2). This mirrors AMGN's experience with competitive pressures in therapeutic markets, where alternative treatments like biosimilars and off-label therapies drive revenue erosion through formulary exclusion and utilization management—specifically, PBMs and insurers leveraging \"stricter utilization management criteria (such as prior authorization and step therapy)\" to shift patients to alternatives, as detailed in AMGN's 10-K (Chunk 3). Both companies face similar market dynamics: GILD's Veklury decline and AMGN's revenue pressures from competitive alternatives are interconnected through the KG pattern where alternative treatments (COMP) negatively impact the originating org (GILD/AMGN), with AMGN's filing confirming that such competition \"has thereby limited Amgen product usage and sales\" through mechanisms like formulary exclusion and cost-containment pressures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Impacted_By]-> COMP <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Veklury (PRODUCT)",
        "Veklury (PRODUCT) -> Alternative Treatments (COMP)",
        "Alternative Treatments (COMP) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 26139,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 7208,
        "completion_tokens": 320,
        "total_tokens": 7528
      }
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD's $312 million 7.50% Senior Notes are paid semi‑annually on February 15 and August 15 each year through their August 15 2022 maturity, as disclosed in the AMD 10‑K (chunks 1 & 2).  In contrast, Qualcomm’s $14 billion aggregate fair‑value of notes (referenced in the KG link between AMD’s interest‑payment schedule and QCOM) carries a different structure: its long‑term fixed‑rate notes require semi‑annual interest payments, while its floating‑rate notes are paid quarterly, and the overall debt schedule shows principal repayments spread across fiscal years 2023‑2027 and beyond (chunks 3).  Thus, AMD’s interest obligations are tied to a fixed semi‑annual cadence on a relatively small, near‑term issue, whereas QCOM’s debt features a mixed semi‑annual/quarterly pattern and larger, staggered principal maturities that dominate its fiscal‑year payment obligations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AMD (ORG) -> 7.50% Senior Notes (FIN_INST)",
        "7.50% Senior Notes (FIN_INST) -> Interest Payment Schedule (ACCOUNTING_POLICY)",
        "Interest Payment Schedule (ACCOUNTING_POLICY) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9950,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3183,
        "completion_tokens": 217,
        "total_tokens": 3401
      }
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "The impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 will erode Merck’s competitive position, as the company relies on strong patent rights to fend off generic and biosimilar competition, and this exposure mirrors Amgen’s own vulnerability to biosimilar threats in international markets. Consequently, both firms face heightened pressure from emerging generic substitutes that can sharply reduce sales and cash flow once patent exclusivity ends.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> Prolia/XGEVA (PRODUCT)",
        "Prolia/XGEVA (PRODUCT) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6792,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2397,
        "completion_tokens": 117,
        "total_tokens": 2515
      }
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom's fiscal 2024 VMware Cloud Foundation revenue included a portion directly tied to enabling AI workloads, as indicated by the KG relationship where **VMware Cloud Foundation (PRODUCT) → AI Workloads (PRODUCT)** and **AI Workloads (PRODUCT) → CSCO (ORG)**. This aligns with Cisco's strategic focus on providing infrastructure for AI training and inference, as highlighted in CSCO's 10-K where it emphasizes delivering network infrastructure to power AI workloads and modernizing data center operations for AI scalability. While the exact revenue split for AI-enabled VCF is not explicitly quantified in the chunks, the structural linkage confirms AI workloads are a core component of VCF's value proposition, supporting Broadcom's broader strategy and Cisco's parallel investment in AI-ready infrastructure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT -[Enables]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> VMware Cloud Foundation (PRODUCT)",
        "VMware Cloud Foundation (PRODUCT) -> AI Workloads (PRODUCT)",
        "AI Workloads (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7479,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2549,
        "completion_tokens": 203,
        "total_tokens": 2753
      }
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "The $1,851 million of assets on NEE’s consolidated balance sheet that are tied to its solar VIEs represent the full equity and debt of eight indirect solar subsidiaries that own and operate roughly 772 MW of solar capacity and sell power under long‑term PPAs.  Southern Power’s exposure to similar solar assets is recorded through PPAs that are accounted for as operating leases; the maturity analysis in Southern Company’s 10‑K shows that scheduled payments under those PPAs extend up to 25 years, mirroring the long‑term power‑sales contracts used by the VIEs.  Consequently, while NEE’s VIE assets total $1.851 billion (largely PP&E and long‑term debt of the solar entities), Southern Power’s lease‑related exposure is measured by the scheduled lease payments under its PPAs, which are similarly structured as long‑term operating leases with maturity schedules that can span several decades.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Solar Facilities (PRODUCT)",
        "Solar Facilities (PRODUCT) -> PPAs (FIN_INST)",
        "PPAs (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_268",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_269",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7604,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2576,
        "completion_tokens": 223,
        "total_tokens": 2799
      }
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks' stock-based compensation structure under Stock Appreciation Rights (SARs) is tied to its 2019 Plan through the accounting policy that introduces the plan as an equity incentive vehicle, while Tesla's 2019 Plan explicitly includes SARs as one of the equity instruments available for grant to employees, directors, and consultants with a standard four-year graded vesting schedule that terminates upon termination of employment. Both companies use the 2019 Plan as a foundational equity framework, but Tesla's plan specifically details SARs as a distinct grant type with defined vesting timelines and exercitability, whereas Starbucks' disclosures focus on SARs as part of a broader equity strategy that includes RSUs and performance-based awards, with vesting governed by graded schedules and performance metrics tied to service conditions rather than a fixed four-year term.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Grants]-> FIN_INST -[Includes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Stock Appreciation Rights (FIN_INST)",
        "Stock Appreciation Rights (FIN_INST) -> 2019 Plan (ACCOUNTING_POLICY)",
        "2019 Plan (ACCOUNTING_POLICY) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7807,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2631,
        "completion_tokens": 221,
        "total_tokens": 2853
      }
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "The voting rights structure creates divergent governance influence: META’s Class B common stock carries no voting rights, while GOOGL’s Class B common stock holds 10 votes per share, granting large shareholders in GOOGL substantially greater power to shape corporate governance decisions compared to META’s equivalent Class B holders who lack voting influence entirely. This asymmetry means GOOGL’s large shareholders can more directly control board elections and key corporate actions, whereas META’s governance relies on other shareholder groups or mechanisms for decision-making influence.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9503,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3058,
        "completion_tokens": 148,
        "total_tokens": 3206
      }
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "BAC discloses foreign currency derivatives as part of its risk management activities that may or may not be designated for hedge accounting, specifically noting they are used to manage foreign exchange risk associated with non-U.S. dollar assets, liabilities, and forecasted transactions, with gains/losses expected to substantially offset this variability. JPM similarly uses foreign currency derivatives to manage foreign exchange risk for non-U.S. dollar assets, liabilities, and subsidiaries, explicitly stating these instruments are used to substantially offset currency-driven value fluctuations. Both banks employ foreign currency derivatives within their risk management frameworks to mitigate currency exposure, though BAC's disclosure emphasizes non-designated hedge accounting relationships while JPM details both hedge accounting and non-hedge applications within its broader risk management structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> RISK_FACTOR -[Categorized_As]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Risk Management Activities (RISK_FACTOR)",
        "Risk Management Activities (RISK_FACTOR) -> Foreign Currency Derivatives (FIN_INST)",
        "Foreign Currency Derivatives (FIN_INST) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_283",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_211",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7296,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2502,
        "completion_tokens": 228,
        "total_tokens": 2730
      }
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy (DUK) faces economic downturn exposure through reduced electricity sales to industrial customers, which directly lowers revenue and cash flows in its regulated service territories, though rate recovery mechanisms can offset some revenue declines from lower sales volumes. Southern Company (SO), particularly through its subsidiaries like Georgia Power and Southern Power, faces environmental compliance cost risks that could reduce demand for electricity and natural gas among similar industrial customers, with recovery of these costs dependent on regulatory approvals and potentially leading to reduced demand if compliance costs increase rates. Both companies operate under regulated rate recovery systems, but while DUK's risk is tied to economic cycles affecting industrial consumption, SO's risk stems from environmental regulations potentially curbing demand through cost-driven rate increases or customer conservation efforts, as highlighted by their respective disclosures on environmental compliance mechanisms and economic sensitivity.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_on]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Industrial Customers (COMP)",
        "Industrial Customers (COMP) -> Environmental Requirements (REGULATORY_REQUIREMENT)",
        "Environmental Requirements (REGULATORY_REQUIREMENT) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16062,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4714,
        "completion_tokens": 264,
        "total_tokens": 4978
      }
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "The voting power distribution tied to CMCSA's Class B common stock—fully owned by Brian Roberts—gives him control over one-third of the combined shareholder voting power, as Class B shares represent 33.3% of total voting power and are non-dilutable, while GOOGL's dual-class system allocates 10 votes per Class B share (with Class A holding 1 vote per share), creating a more pronounced concentration of control in the Roberts family compared to Alphabet's structure where Class B shares (10 votes each) are held by multiple insiders rather than a single entity. This distinction is reinforced by the KG triplets linking CMCSA's Class B stock to Class A stock and ultimately to GOOGL, highlighting how CMCSA's governance concentrates voting power through Brian Roberts' ownership of all Class B shares, whereas GOOGL's system distributes similar voting rights across multiple stakeholders.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10683,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3362,
        "completion_tokens": 222,
        "total_tokens": 3584
      }
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "KO's indirect exposure to Taiwan through Swire Beverages' operations was limited to Swire's bottling activities in Taiwan, which were part of its broader footprint in 11 provinces and the Shanghai Municipality across mainland China, Hong Kong, and Taiwan. This relationship was structured as an independent bottling partnership, where Swire operated under contractual agreements with KO but did not create a legal partnership or joint venture. In contrast, PEP demonstrated direct growth performance in the Taiwanese beverage market, reporting double-digit growth in Taiwan as part of its APAC segment, which contributed to a 34% net revenue increase driven by organic volume growth and favorable foreign exchange, including specific expansion in Taiwan. Thus, while KO's presence in Taiwan was indirect and mediated through Swire's independent bottling operations, PEP achieved measurable direct growth in the Taiwanese market during 2022.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Swire Beverages (COMP)",
        "Swire Beverages (COMP) -> Taiwan (GPE)",
        "Taiwan (GPE) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15023,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4406,
        "completion_tokens": 235,
        "total_tokens": 4641
      }
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "The expiration of Trulicity's patent protection will likely trigger a sharp revenue decline for LLY, mirroring the steep 32 % drop in U.S. Trulicity sales observed in 2024 and the broader risk disclosed that loss of exclusivity typically causes “rapid and severe declines in revenues” for affected products. Because Merck (MRK) explicitly relies on strong patent protection to preserve market exclusivity and competitive positioning—as reflected in its own 10‑K discussion of how patent loss leads to “generic or biosimilar substitutes” that “reduce the Company's sales”—the weakening of Trulicity's IP shield directly threatens LLY’s revenue trajectory, accelerating the shift toward lower‑priced competition and compelling LLY to mitigate the impact through new product launches such as Zepbound and other pipeline assets.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Expires]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Trulicity (PRODUCT)",
        "Trulicity (PRODUCT) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12133,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3714,
        "completion_tokens": 206,
        "total_tokens": 3920
      }
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s operational reliance on leased retail locations at hotels and convention centers—such as the 200 stores referenced in its 10-K—represents a direct, fixed-cost exposure to real estate volatility, whereas UPS’s $10.1 billion pension fund allocation to real estate, private debt and hedge funds creates an indirect, market‑linked financial exposure that can affect asset valuations and return assumptions during downturns. Both scenarios illustrate how physical‑space leasing (FedEx) and large‑scale real‑estate‑focused investments (UPS) can amplify strategic risk when property markets fluctuate, but they differ in that FedEx’s risk is tied to lease‑term stability and facility availability, while UPS’s risk is tied to the market value and liquidity of its diversified investment portfolio.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Hotels (PRODUCT)",
        "Hotels (PRODUCT) -> Real Estate Funds (FIN_INST)",
        "Real Estate Funds (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12880,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3930,
        "completion_tokens": 199,
        "total_tokens": 4129
      }
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "The voting rights structure of GOOGL's Class B Common Stock grants holders 10 votes per share, providing significant control over strategic decisions, as disclosed in GOOGL's 10-K filing (Chunks 1 and 2). In contrast, CMCSA's disclosure regarding its investment in Atairos reveals that it lacks voting rights and only holds limited consent rights, resulting in no influence over Atairos' strategic decisions, as explicitly stated in CMCSA's 10-K filing (Chunk 3). This difference is further reinforced by the KG triplet relationship where Voting Rights (ACCOUNTING_POLICY) is linked to CMCSA (ORG), highlighting CMCSA's lack of voting control despite its investment stake.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8903,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2912,
        "completion_tokens": 168,
        "total_tokens": 3080
      }
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio utilizes commercial paper as part of its short-term financing strategy, as evidenced by its disclosure of $25 million in commercial paper obligations within its broader $52 million total short-term debt position (Chunk 2), reflecting a targeted and relatively modest use of this instrument tied specifically to its Ohio service territory (Chunk 1). In contrast, PepsiCo maintains a significantly larger and more diversified commercial paper program, with $2,286 million in commercial paper outstanding at 5.5% as part of its $6,510 million total short-term debt obligations, indicating a much broader corporate-scale reliance on this funding source beyond any single geographic segment (Chunk 3). While Duke Energy Ohio's commercial paper usage is integrated within its regulated utility capital structure and disclosed at the state level (Chunk 1 and Chunk 2), PepsiCo's obligations represent a global corporate finance strategy with no comparable geographic segmentation, highlighting a fundamental difference in scale, scope, and strategic intent between the two companies' short-term financing approaches (Chunk 3).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Ohio (GPE)",
        "Ohio (GPE) -> Commercial paper (FIN_INST)",
        "Commercial paper (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_165",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7708,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2592,
        "completion_tokens": 284,
        "total_tokens": 2876
      }
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Southern Company's reliance on regulated rate recovery for environmental compliance costs could be negatively impacted if commercial demand declines due to environmental regulations affecting industrial operations in the Carolinas, Ohio, and Kentucky—regions Duke Energy expects to see increasing commercial gas customers. This is because, as noted in Chunk 2, \"increased costs that are recovered through regulated rates could contribute to reduced demand for electricity and natural gas, which could negatively affect results of operations, cash flows, and/or financial condition,\" and \"many commercial and industrial customers may also be affected by existing and future environmental requirements, which may have the potential to reduce their demand for electricity or natural gas.\" Chunk 3 further confirms that environmental compliance costs may \"adversely affect the Registrants if such costs cannot continue to be recovered on a timely basis,\" directly linking regulatory-driven demand reduction to financial risk. Chunk 1's context of Duke Energy's service territory expansion in these same regions (including commercial customers) and the KG pattern showing Environmental Requirements → SO (Southern Company) establishes the critical connection: Southern Company's recovery mechanism is vulnerable to the very regulatory pressures Duke Energy anticipates will drive customer growth, creating a potential feedback loop where compliance costs suppress demand and undermine rate recovery.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Serves]-> COMP -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_on]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Commercial Customers (COMP)",
        "Commercial Customers (COMP) -> Environmental Requirements (REGULATORY_REQUIREMENT)",
        "Environmental Requirements (REGULATORY_REQUIREMENT) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11146,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3506,
        "completion_tokens": 373,
        "total_tokens": 3880
      }
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Mr. Roberts' Class B shares, which carry 15 votes per share and represent roughly one‑third of the combined voting power, are not subject to any repurchase activity in 2023—only Class A (and Class C) shares were retired. Because the Class B shares remain fully outstanding, Mr. Roberts continues to control the entire voting bloc that accounts for 33 ⅓ % of the total voting power, preserving his outsized influence over corporate decisions despite the broader shareholder base that holds the remaining two‑thirds of votes. This lack of repurchase reduces the pool of outstanding shares that could dilute his stake, leaving his voting dominance unchanged relative to other shareholders.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10546,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3337,
        "completion_tokens": 171,
        "total_tokens": 3509
      }
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance units are contractual awards whose payout simulations explicitly model stockholder return correlations and volatilities to determine payout percentages under defined performance periods, reflecting a structured linkage between market performance and compensation outcomes as disclosed in its accounting policy and compensation disclosures. This contrasts with Bristol-Myers Squibb’s exposure to financial agreements involving counterparty credit risk mitigation, where risk predictability is managed through collateral-free hedging practices and counterparty quality controls that do not materially affect consolidated financial statements, even if a counterparty defaults. While Amgen’s payout mechanisms are intrinsically tied to volatile equity performance simulations affecting compensation expense recognition, BMS’s risk management approach emphasizes structural resilience in derivative relationships and credit exposure monitoring, resulting in fundamentally different predictability profiles—one driven by performance-based equity outcomes and the other by operational safeguards in financial instrument counterparty management.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Performance Units (FIN_INST)",
        "Performance Units (FIN_INST) -> Agreements (ACCOUNTING_POLICY)",
        "Agreements (ACCOUNTING_POLICY) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3563,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 289,
        "total_tokens": 1890
      }
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority (OLA) creates a distinct resolution pathway where the FDIC can enforce close-out netting and collateral application without the automatic bankruptcy stay, potentially altering creditor recoveries compared to traditional bankruptcy. This contrasts with Bank of America's resolution planning, which relies on a \"single point of entry\" strategy under the U.S. Bankruptcy Code, where the parent company's bankruptcy would trigger intercompany funding restrictions and creditor claims that could diminish recoveries for subsidiary creditors while security holders face significant losses. Both companies face heightened regulatory obligations under Dodd-Frank: MetLife operates under OLA frameworks subject to FSOC oversight as a non-bank SIFI, while Bank of America, as a G-SIB, is required to submit resolution plans to the FDIC and Federal Reserve that impose stringent capital, liquidity, and intercompany funding limitations, directly linking their regulatory exposures through the shared Orderly Liquidation Authority mechanism.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Dodd-Frank (REGULATORY_REQUIREMENT)",
        "Dodd-Frank (REGULATORY_REQUIREMENT) -> Orderly Liquidation Authority (REGULATORY_REQUIREMENT)",
        "Orderly Liquidation Authority (REGULATORY_REQUIREMENT) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_261",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14588,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4352,
        "completion_tokens": 284,
        "total_tokens": 4637
      }
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike's Greater China revenue of $7,547 million (Chunk 1) includes Taiwan, while Starbucks operates 544 stores in Taiwan as of October 2, 2022 (Chunk 3), demonstrating Nike's significantly larger revenue footprint in the region compared to Starbucks' store count. This disparity suggests Nike maintains a substantially broader market presence in Greater China (including Taiwan) through its direct revenue generation, whereas Starbucks' physical footprint in Taiwan, while growing, remains comparatively modest in scale relative to Nike's financial scale in the same geographic area.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Greater China (GPE)",
        "Greater China (GPE) -> Taiwan (GPE)",
        "Taiwan (GPE) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6810,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2367,
        "completion_tokens": 145,
        "total_tokens": 2512
      }
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The $5.0 billion upfront payment from American Tower Corporation in March 2015 and the $2.8 billion payment from Vertical Bridge in December 2024 are both treated as prepaid rent and financing obligations, with the underlying tower assets remaining on Verizon’s balance sheet and continuing to be depreciated. In both transactions Verizon retains responsibility for the ground‑lease obligations, recording the present value of those leases in its operating‑lease right‑of‑use assets and liabilities, and it does not expect to make lease payments unless the counterpart defaults. Consequently, while the upfront cash receipts differ in size, the accounting treatment—recognition of prepaid rent, a financing obligation, and continued depreciation of the tower assets—is essentially the same for each exclusive‑rights transaction.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Gains]-> ACCOUNTING_POLICY -[Acquires]-> COMP <-[Transacts_With]- ORG",
      "triplets_used": [
        "T (ORG) -> Exclusive Rights (ACCOUNTING_POLICY)",
        "Exclusive Rights (ACCOUNTING_POLICY) -> American Tower Corporation (COMP)",
        "American Tower Corporation (COMP) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9597,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3096,
        "completion_tokens": 207,
        "total_tokens": 3303
      }
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan's operational risk capital under Basel III incorporates fraud as a key component through its Advanced Measurement Approach, which quantifies operational risk losses at a 99.9% confidence level using the Loss Distribution Approach and scenario analysis, while explicitly excluding insurance recoveries; this framework is governed by its CCOR structure and subject to stress testing for events like asset confiscation in Russia. In contrast, Citigroup faces direct exposure to fraud-related losses in emerging markets such as Russia, where asset confiscation or loss of control could trigger $1.6 billion in translation adjustments and $0.9 billion in intercompany liability write-downs, with geopolitical risks like sanctions and currency controls exacerbating potential losses as highlighted in its risk disclosures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Operational Risk (RISK_FACTOR)",
        "Operational Risk (RISK_FACTOR) -> Fraud (RISK_FACTOR)",
        "Fraud (RISK_FACTOR) -> C (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_155",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9574,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3086,
        "completion_tokens": 206,
        "total_tokens": 3292
      }
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "A prolonged geopolitical conflict involving Taiwan would severely disrupt Qualcomm's chipset supply chain by potentially blocking its primary Taiwan-based foundry partners from manufacturing, directly threatening its reliable chipset supply critical to the semiconductor industry, while Intel's operational footprint in the region—evidenced by $6.867 billion in 2023 revenue tied to Taiwan (as shown in its 10-K financial data)—would face comparable supply chain risks but with a different revenue exposure profile, as both companies rely on Taiwan for advanced manufacturing yet operate with distinct geographic revenue dependencies that could lead to divergent financial impacts despite shared regional vulnerabilities.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Foundry Partners (COMP)",
        "Foundry Partners (COMP) -> Taiwan (GPE)",
        "Taiwan (GPE) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12055,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3695,
        "completion_tokens": 180,
        "total_tokens": 3875
      }
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples and market multiples with adjustments based on portfolio company performance, while BA measures Level 3 assets on a nonrecurring basis using income approaches derived from discounted cash flows of underlying assets and third-party aircraft valuation publications that require management-adjusted unobservable inputs. Both companies disclose fair value processes through accounting policies, but RTX's approach relies on periodic valuation adjustments for private equity investments whereas BA's nonrecurring Level 3 measurements specifically incorporate aircraft-specific collateral valuations from third-party publications as detailed in BA's impairment methodology.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Values]-> FIN_INST -[Not_Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Private Equity Limited Partnerships (FIN_INST)",
        "Private Equity Limited Partnerships (FIN_INST) -> Fair Value Table (ACCOUNTING_POLICY)",
        "Fair Value Table (ACCOUNTING_POLICY) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_165",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5407,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2050,
        "completion_tokens": 193,
        "total_tokens": 2243
      }
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix manages foreign exchange risk on firm commitments through forward contracts, directly hedging these obligations to reduce volatility in operating income and cash flow from content licensing and production, while Disney's VAR model estimates a maximum one-day loss exposure of $255 million (unaudited) at September 28, 2024, specifically excluding firm commitments and forecasted transactions from its calculation, meaning Netflix's forward contract approach targets actual firm commitment risk whereas Disney's disclosed VAR figure represents a broader portfolio estimate that intentionally omits the very commitments Netflix hedges.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Manages]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Firm Commitments (FIN_INST)",
        "Firm Commitments (FIN_INST) -> VAR Model (ACCOUNTING_POLICY)",
        "VAR Model (ACCOUNTING_POLICY) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8917,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2917,
        "completion_tokens": 160,
        "total_tokens": 3078
      }
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "AMD's tax provision was directly reduced by the Philippines' Q1 2021 corporate‑income‑tax‑rate cut, as shown by the “Tax Reform Act” line in its 2021 filing (‑$13 million impact) and by the 0.1‑percentage‑point rise in its 2021 effective tax rate that the company cites as being “partially offset” by that rate reduction; this regulatory change lowered AMD’s statutory tax expense and shifted its overall tax position.  \n\nAt the same time, Texas Instruments disclosed that it invested roughly $370 million in property, plant and equipment at its Philippine sites in 2021, reflecting operational expansion that is enabled by the same tax‑rate reduction and by the Philippines’ broader regulatory environment, thereby linking both firms’ exposure to international tax rules to distinct financial outcomes—AMD’s lower tax provision versus TXN’s capital investment in the country.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Tax Reform Act (REGULATORY_REQUIREMENT)",
        "Tax Reform Act (REGULATORY_REQUIREMENT) -> Philippines (GPE)",
        "Philippines (GPE) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3016,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 219,
        "total_tokens": 1660
      }
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "The contrasting approaches to affiliate relationships underscore GM's asset-light, asset-intensive business model versus McDonald's asset-light, asset-light franchise model. GM's vertically integrated structure involves producing trucks (e.g., Chevrolet, GMC) and selling them to independently owned dealers and fleet customers, while also engaging nonconsolidated affiliates for component parts and vehicle transactions, reflecting its reliance on physical manufacturing and supply chain control. In contrast, McDonald's operates through a franchise system where royalties and fees from independently owned restaurants (e.g., via franchise agreements) drive revenue, with no direct vehicle production—its \"affiliates\" are franchisees and licensees, not manufacturers—highlighting a service-based, brand-licensing model distinct from GM's hardware-centric operations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Produces]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GM (ORG) -> Trucks (PRODUCT)",
        "Trucks (PRODUCT) -> Affiliates (COMP)",
        "Affiliates (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10727,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3337,
        "completion_tokens": 216,
        "total_tokens": 3554
      }
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "The reduction in outstanding Class A shares through Alphabet's $62.0 billion repurchase program directly increases the relative voting power of remaining Class B shareholders, as each Class B share carries 10 votes while Class A shares carry only 1 vote per share. This effect is amplified by the automatic conversion of Class B shares to Class A upon sale or transfer, which permanently removes Class B shares from the capital structure and eliminates their 10:1 voting advantage. As noted in the KG triplets, Class B Common Stock (GOOGL) is connected to Class A Common Stock (FIN_INST) through conversion, and Class A Common Stock is linked to CMCSA (ORG) in the equity structure, confirming the cross-entity implications of this share reduction.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Changes_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10110,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3260,
        "completion_tokens": 187,
        "total_tokens": 3447
      }
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "The adoption of ASU No. 2020-01 required both Colgate-Palmolive and The Coca-Cola Company to modify their accounting for equity securities by clarifying the interaction between Topic 321 (equity securities), Topic 323 (equity method investments) and Topic 815 (derivatives). Both companies noted that the ASU did not materially affect their consolidated financial statements, but it provided guidance on when observable transactions should trigger a switch from the equity method to the measurement alternative for certain equity securities and on how derivatives linked to those securities should be accounted for. This clarification ensures that any equity securities held by KO and any related derivative contracts are now evaluated under the same framework, affecting how unrealized gains and losses are recognized and reported.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "CL (ORG) -> ASU 2020-01 (ACCOUNTING_POLICY)",
        "ASU 2020-01 (ACCOUNTING_POLICY) -> Equity Securities Accounting (ACCOUNTING_POLICY)",
        "Equity Securities Accounting (ACCOUNTING_POLICY) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9244,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3028,
        "completion_tokens": 208,
        "total_tokens": 3236
      }
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "The Stress Capital Buffer (SCB) component of the CET1 capital ratio requirement differs between Goldman Sachs and Citibank in their approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024. According to Chunk 1, the SCB buffer is set at 6.2% for GS under the Standardized Capital Rules as of December 2024, reflecting a higher buffer requirement tied to GSIB surcharge methodologies and stress testing assumptions. In contrast, Chunk 2 states that Citibank’s CET1 Capital ratio requirement is 7.0% under both Standardized and Advanced Approaches, which is explicitly defined as the sum of the minimum 4.5% CET1 requirement and a fixed 2.5% Capital Conservation Buffer, with no separate SCB component specified for Citibank in the provided text. This distinction is reinforced by Chunk 3’s regulatory framework, which outlines Citibank’s minimum SLR of 6.0% for \"well capitalized\" status under Prompt Corrective Action but does not reference an SCB buffer for Citibank, while GS’s SCB of 6.2% is explicitly detailed in the context of stress capital buffer requirements under the Standardized Capital Rules. Thus, Goldman Sachs incorporates a distinct, higher SCB (6.2%) as a dedicated stress buffer within its CET1 ratio calculation, whereas Citibank’s 7.0% CET1 ratio is composed solely of the base 4.5% requirement plus a fixed 2.5% buffer, indicating a more streamlined approach that does not include a separate SCB component under the Standardized Rules.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GS (ORG) -> CET1 Capital Ratio Requirement (REGULATORY_REQUIREMENT)",
        "CET1 Capital Ratio Requirement (REGULATORY_REQUIREMENT) -> Citibank (COMP)",
        "Citibank (COMP) -> C (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_208",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_238",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8717,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2878,
        "completion_tokens": 374,
        "total_tokens": 3253
      }
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy's operational infrastructure investments in Indiana are reflected in its participation in the Southwest Power Pool (SPP) and other regional transmission entities, with disclosed infrastructure spanning multiple states including Indiana, as detailed in Chunk 1. Duke Energy Indiana's financing strategy for such infrastructure relies on tax-exempt bonds, evidenced by its $285 million in tax-exempt bonds outstanding as of December 31, 2023, per Chunk 2, and further corroborated by the broader tax-exempt bond portfolio of $352 million under Duke Energy Indiana's responsibility in Chunk 3. This financing mechanism aligns with the operational disclosures in Chunk 1, where infrastructure investments are tied to regional operators like SPP, while Chunk 3's KG triplet relationship—Tax-exempt bonds (FIN_INST) → DUK (ORG)—directly links Duke Energy's financing instruments to its operational footprint, including Indiana, thereby illustrating how tax-exempt bond proceeds support infrastructure development in regulated service areas like Duke Energy Indiana.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Indiana (GPE)",
        "Indiana (GPE) -> Tax-exempt bonds (FIN_INST)",
        "Tax-exempt bonds (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_165",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_163",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8667,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2824,
        "completion_tokens": 268,
        "total_tokens": 3093
      }
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple's App Store revenue model creates distinct business risks compared to Microsoft's vertically integrated content strategy, primarily through its reliance on third-party content providers and alternative payment processing changes. While Apple depends on external developers and content providers for its App Store ecosystem—subject to risks like licensing volatility, shifting developer priorities due to market share limitations, and regulatory pressures around payment processing that could reduce commissions—Microsoft emphasizes brand reputation tied to its own content decisions, where reputational damage from content choices or AI-related controversies could directly harm customer trust and stakeholder relationships. Both companies face content-related risks, but Apple's model exposes it to financial volatility from third-party dependencies and regulatory shifts, whereas Microsoft's risks center on brand erosion from its owned content and AI deployments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Contracts_With]-> COMP -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Third-Party Content Providers (COMP)",
        "Third-Party Content Providers (COMP) -> Content (PRODUCT)",
        "Content (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16472,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4822,
        "completion_tokens": 243,
        "total_tokens": 5065
      }
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "The potential liability from tritium leakage at Southern Company’s nuclear plants is tied to the same nuclear health risks that expose both Southern Company and NEE to decommissioning cost shortfalls, as highlighted in the operational risks disclosures. While Southern Company’s 10-K notes that damages or decommissioning costs could exceed available trusts and insurance—especially for its six operating nuclear units—NEE’s filing explicitly states that its decommissioning funds may be insufficient to cover full decommissioning expenses, creating a comparable exposure to nuclear liabilities. Both companies face regulatory and financial risks from nuclear incidents, but NEE’s disclosures emphasize that external insurance and trust balances may not cover all potential costs, mirroring the vulnerability described for Southern Company’s plants. This shared exposure underscores that tritium-related liabilities at Southern Company’s facilities represent a financial risk parallel to the decommissioning fund gaps disclosed by NEE.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "SO (ORG) -> Nuclear Power Plants (PRODUCT)",
        "Nuclear Power Plants (PRODUCT) -> Health Risks (RISK_FACTOR)",
        "Health Risks (RISK_FACTOR) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17024,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4936,
        "completion_tokens": 258,
        "total_tokens": 5194
      }
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 directly lowered Altria’s (MO) effective tax rate, as noted in its 2022 filing where the 2021 rate rose to 21.8% and was unfavorably impacted by repatriation costs but partially offset by the Philippine tax cut, while Coca‑Cola’s (KO) capital investment strategy is tied to its Philippine operations—evidenced by the KG link Philippines → KO and the fact that property, plant and equipment in the Philippines accounts for 10 % of KO’s consolidated PP&E, underscoring a significant exposure that likely influences KO’s investment decisions in that market.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "MO (ORG) -> Tax Reform Act (REGULATORY_REQUIREMENT)",
        "Tax Reform Act (REGULATORY_REQUIREMENT) -> Philippines (GPE)",
        "Philippines (GPE) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6489,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2308,
        "completion_tokens": 158,
        "total_tokens": 2466
      }
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung’s dual role as a foundry supplier to NVIDIA for semiconductor wafer production and as a direct competitor to Qualcomm in the integrated circuit market creates a strategic tension that could jeopardize Qualcomm’s $12.8 billion multi‑year capacity purchase commitments. Because Samsung also manufactures its own integrated‑circuit products—including those that compete with Qualcomm’s premium‑tier chips—it may prioritize internal demand over external capacity allocations, especially when its own product lines require wafer capacity. This vertical integration risk is highlighted in Qualcomm’s disclosures, which note that customers like Samsung “develop their own integrated circuit products… and may continue to utilize in some or all of their devices, rather than our products,” potentially reducing the volume of wafer purchases that qualify for the committed capacity. Consequently, if Samsung chooses to allocate its limited fab resources to its own chips rather than to NVIDIA’s orders, the guaranteed capacity earmarked for Qualcomm could be under‑utilized, forcing Qualcomm to either pay penalties for under‑take‑up or face higher per‑unit costs, thereby eroding margins on its $12.8 billion of contracted purchases. This interdependency underscores how Samsung’s competing product strategy can directly impact the enforceability and financial viability of Qualcomm’s long‑term capacity commitments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Samsung (COMP)",
        "Samsung (COMP) -> Integrated Circuit Products (PRODUCT)",
        "Integrated Circuit Products (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14938,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4434,
        "completion_tokens": 354,
        "total_tokens": 4788
      }
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin's $665 million of commercial‑customer receivables flow through United Launch Alliance (ULA), the joint venture in which Boeing holds an equity stake and shares earnings; ULA’s operating profit includes Boeing’s $125 million share of ULA income, meaning the receivables indirectly support Boeing’s earnings from the JV.  The $551 million ULA investment on Lockheed’s balance sheet and the $5.9 billion of contract liabilities recognized by Lockheed underscore the financial linkage, while Boeing’s backlog growth and fixed‑price program risks highlight the broader financial exposure tied to these commercial arrangements.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Commercial Customers (COMP)",
        "Commercial Customers (COMP) -> ULA (COMP)",
        "ULA (COMP) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7521,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2542,
        "completion_tokens": 159,
        "total_tokens": 2701
      }
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The invalidation of the '190 Patent in the CAR T litigation (Kite → GILD) removed the basis for the $1.2 billion royalty award that Gilead had been required to pay, eliminating the amortization of that contingent liability; consequently, Gilead no longer records amortization expense related to the '190 Patent, and the $910 million of Yescarta‑related IPR&D that had been capitalized in 2021 is now amortized over its finite‑lived useful life rather than being tied to the disputed patent.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> LITIGATION -[Involved_In]-> COMP <-[Acquires]- ORG",
      "triplets_used": [
        "BMY (ORG) -> CAR T Litigation (LITIGATION)",
        "CAR T Litigation (LITIGATION) -> Kite (COMP)",
        "Kite (COMP) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_156",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_156",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13108,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3926,
        "completion_tokens": 122,
        "total_tokens": 4049
      }
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple's 2022 revenue from Greater China was $74,200 million, which includes Taiwan as a key market within that region. Intel's 2021 revenue from Taiwan was $13,461 million. Therefore, Apple's 2022 Greater China revenue ($74,200M) was approximately 5.5 times larger than Intel's 2021 Taiwan revenue ($13,461M), reflecting the significantly broader geographic scope of Apple's Greater China reporting compared to Intel's Taiwan-specific revenue.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Greater China (GPE)",
        "Greater China (GPE) -> Taiwan (GPE)",
        "Taiwan (GPE) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4376,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1744,
        "completion_tokens": 110,
        "total_tokens": 1855
      }
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS relies on observable market data such as yield curves and foreign currency exchange rates to value its over-the-counter derivatives classified as Level 2, with pricing models using market observable inputs like yield curves and investment forward prices; Boeing similarly values derivatives using observable inputs including benchmark yields, swap curves, and credit spreads, and its fixed income investments are categorized as Level 2 when valued using verifiable observable market data like interest rates and yield curves, though both companies also use Level 3 valuations for certain instruments where observable inputs are unavailable.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7014,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2437,
        "completion_tokens": 161,
        "total_tokens": 2598
      }
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "META applies discounted cash flow models for impairment testing of operating lease ROU assets and leasehold improvements, using Level 3 inputs that incorporate market participant assumptions such as expected downtime before subleasing, projected sublease income, and risk-adjusted discount rates reflecting credit risk; this approach is disclosed in its 10-K under facilities consolidation restructuring and impairment of long-lived assets. In contrast, DIS utilizes discounted cash flow models primarily to value Level 2 derivatives and other financial instruments, relying on observable inputs like interest rates, yield curves, and foreign currency exchange rates, with impairment assessments for non-recurring fair value measures also employing Level 3 techniques that depend on estimated future cash flows and credit risk considerations, as detailed in its 10-K filings regarding derivative valuations and non-recurring asset impairments. Both companies employ DCF-based impairment methodologies, but META’s application is tied to long-lived asset testing with Level 3 inputs focused on operational sublease dynamics, while DIS applies DCF models to derivative and financial instrument valuations with Level 3 inputs centered on credit risk and market-based discount rates for non-recurring asset write-downs.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Discounted Cash Flow Models (ACCOUNTING_POLICY)",
        "Discounted Cash Flow Models (ACCOUNTING_POLICY) -> Level 2 Derivatives (FIN_INST)",
        "Level 2 Derivatives (FIN_INST) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11974,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3685,
        "completion_tokens": 328,
        "total_tokens": 4014
      }
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The IQOS device supply constraint detailed in PM's 2022 filing directly impedes PM USA's ability to commercialize heated tobacco products in the U.S. due to the ITC import ban and cease-and-desist order stemming from patent disputes, which prevents domestic sales despite FDA authorization of IQOS products. This supply limitation is particularly consequential because PM USA operates as the exclusive U.S. commercialization partner for PMI's IQOS system under their 2013 agreement, which explicitly requires FDA authorization for market entry, and PM USA's role as guarantor of Altria's debt creates financial exposure if supply constraints prevent revenue generation from these high-growth products. The FDA's authorization of IQOS 3 and the pending MRTP application for the updated device remain critical pathways, but the current supply shortage and legal barriers delay market access, potentially forcing PM USA to rely on contingency plans like domestic production while navigating the FDA's pre-market review process for non-provisional products.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Causes_Shortage_Of]-> PRODUCT -[Removes]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> IQOS Devices (PRODUCT)",
        "IQOS Devices (PRODUCT) -> PM USA (COMP)",
        "PM USA (COMP) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14804,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4379,
        "completion_tokens": 263,
        "total_tokens": 4642
      }
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "The impact of biosimilar competition on BMY's revenue outlook is structurally distinct from ABBV's exposure due to fundamental differences in portfolio composition and product-specific risk. While BMY's risk is framed generally around \"Biosimilar Competition\" as a broad threat to its business model (as seen in Chunk 1's discussion of market exclusivity loss and revenue decline from biosimilars), ABBV faces direct, quantifiable pressure on its single largest revenue driver: Humira, which accounted for **27% of ABBV's 2023 net revenues** (Chunk 3) and is explicitly described as facing \"direct biosimilar competition globally\" (Chunk 2). This creates a concentrated, near-term revenue risk for ABBV that BMY does not mirror—BMY's risk is theoretical and portfolio-wide, whereas ABBV's is immediate and materially tied to a product representing over a quarter of its total revenue. Consequently, the revenue outlook impact is far more acute for ABBV due to Humira's disproportionate contribution and global biosimilar pressure, while BMY's exposure remains a generalized, less quantifiable strategic risk.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Faces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Biosimilar Competition (RISK_FACTOR)",
        "Biosimilar Competition (RISK_FACTOR) -> Humira (PRODUCT)",
        "Humira (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13583,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4068,
        "completion_tokens": 277,
        "total_tokens": 4345
      }
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "PM treats RSU dividend equivalents as accrued during the vesting period and pays them in cash (without interest) when the RSU vests and becomes payable, whereas PEP’s RSU awards also accrue dividend equivalents that are paid in cash upon vesting, but the key distinction is that PM’s RSU awards specifically include dividend equivalents that are paid out as cash at vesting, while PEP’s PSU awards (a subset of RSU-like instruments) similarly accrue and pay cash dividend equivalents upon vesting, though the question’s phrasing conflates PEP’s PSU structure with RSU treatment. Both companies pay cash dividend equivalents upon vesting, but PM’s RSU awards explicitly accrue and pay them during the restriction period (typically three years) upon meeting vesting triggers like death, disability, or age 58, whereas PEP’s PSUs are performance-based and also pay cash equivalents upon vesting, though the core mechanism—cash payout of accrued equivalents at vesting—is shared, with PM’s structure tied to standard RSU vesting conditions and PEP’s to performance thresholds.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PM (ORG) -> RSU Awards (FIN_INST)",
        "RSU Awards (FIN_INST) -> Dividend Equivalents (FIN_INST)",
        "Dividend Equivalents (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2247,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 268,
        "total_tokens": 1508
      }
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations represents a targeted, closed-end fund strategy with significant liquidity risk due to the non-redeemable structure of these private equity and real estate funds, where distributions depend on underlying asset sales and general partner approval. This contrasts with BA's broader real estate investment strategy, which includes diverse fund structures across commercial real estate (office, retail, apartment, industrial) and other asset classes like infrastructure and natural resources, but also relies on similar illiquid fund vehicles where redemption is restricted and value is realized through fund disposals, as evidenced by BA's investments in Real Estate Funds (FIN_INST) that depend on NAV-based valuations and lack of redemption terms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Retail Properties (PRODUCT)",
        "Retail Properties (PRODUCT) -> Real Estate Funds (FIN_INST)",
        "Real Estate Funds (FIN_INST) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6218,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2233,
        "completion_tokens": 211,
        "total_tokens": 2445
      }
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "BAC's exposure to equity market risk through derivatives is represented by a notional value of $23,595 million with a sensitivity of –$37 million to a 10 % equity price decline, whereas MET reports a derivative notional of $23,595 million and a corresponding sensitivity of $522 million for the same 10 % equity price decrease. This contrast shows that BAC’s equity‑market‑risk position is hedged such that a 10 % equity drop would reduce the derivative’s value by $37 million, while MET’s position would increase in value by $522 million under the same market move. Consequently, MET’s equity‑market‑derivative exposure is markedly more positively sensitive to a 10 % equity price decline than BAC’s, reflecting a substantially larger notional‑value impact and opposite directional effect.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Positively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Equity Market Risk (RISK_FACTOR)",
        "Equity Market Risk (RISK_FACTOR) -> Equity Market Derivatives (FIN_INST)",
        "Equity Market Derivatives (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_265",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 24603,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 6836,
        "completion_tokens": 197,
        "total_tokens": 7034
      }
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft's operational footprint in Greater China is anchored by its regional operations center in Singapore, which supports the Japan, India, Greater China, and Asia-Pacific region, and includes localized product development and manufacturing partnerships across Taiwan and mainland China. AMD's revenue concentration in Taiwan is evident from its 2022 sales of $2,091 million (20% of total $16,434 million), highlighting Taiwan as a critical market for the company. This contrast reveals Microsoft's strategy of embedding operations within a broader regional hub (Greater China) to serve diverse markets, while AMD's heavy reliance on Taiwan underscores a focused, high-growth regional concentration strategy in 2022.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Greater China (GPE)",
        "Greater China (GPE) -> Taiwan (GPE)",
        "Taiwan (GPE) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7057,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2421,
        "completion_tokens": 180,
        "total_tokens": 2601
      }
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "META's dual-class structure concentrates voting power in Class B shares, allowing Zuckerberg to control governance outcomes despite minority share ownership, which makes Class A stock less attractive to investors seeking influence and subjects it to anti-takeover provisions that could depress its price. This contrasts with NFLX, where all common stockholders—regardless of share class—have equal one-vote-per-share rights on all matters, ensuring broader shareholder participation in governance decisions without concentrated control. Consequently, META shareholders have significantly diminished voting influence compared to NFLX investors, who maintain direct voting power proportional to their holdings across all corporate decisions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7898,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2667,
        "completion_tokens": 184,
        "total_tokens": 2852
      }
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "The expiration of patent rights for JNJ's pharmaceutical products directly reduces their market exclusivity, leading to anticipated revenue and market share losses as generic or biosimilar competitors enter the U.S. market—consistent with the risk pattern where patent expirations negatively impact market exclusivity. In contrast, LLY relies on regulatory exclusivity extensions (such as pediatric or orphan drug exclusivity) to maintain competitive advantage beyond patent expiration, as demonstrated by its strategic use of regulatory data protection periods that can provide market exclusivity beyond the patent term, thereby sustaining its U.S. market position even after JNJ's patent-driven exclusivity ends.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> Regulatory Exclusivity (REGULATORY_REQUIREMENT)",
        "Regulatory Exclusivity (REGULATORY_REQUIREMENT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11011,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3463,
        "completion_tokens": 178,
        "total_tokens": 3641
      }
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD reduced its interest expense by $13 million in 2021 due to conversions of its 2.125 % Convertible Senior Notes, while Microsoft (via Nuance) still carried $1 million of outstanding convertible senior notes after the acquisition, illustrating AMD’s aggressive debt‑reduction strategy versus Microsoft’s retained, albeit minimal, convertible‑debt exposure. This contrast highlights AMD’s focus on lowering financing costs through equity‑like conversions, whereas Microsoft’s capital structure retains a small legacy liability from the Nuance purchase.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Issues]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Convertible Senior Notes (FIN_INST)",
        "Convertible Senior Notes (FIN_INST) -> Nuance (COMP)",
        "Nuance (COMP) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8082,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2702,
        "completion_tokens": 138,
        "total_tokens": 2841
      }
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "The $5.0 billion upfront payment that American Tower received in 2015 for exclusive rights to lease 11,300 Verizon towers is comparable to the $4.827 billion transaction Crown Castle executed in 2013 for exclusive rights to lease AT&T’s towers, as both deals retained Verizon’s ownership of the tower assets and kept depreciation responsibilities on the books; however, the Crown Castle transaction also involved an additional cash purchase of 627 towers for $4,827 million and a financing‑obligation accounting treatment that includes interest at roughly 3.9 % and periodic adjustments for Crown Castle’s operating cash flows, whereas American Tower’s arrangement was structured as a prepaid‑rent/financing obligation with a $2.0 billion prepaid‑rent component and an $830 million financing liability, and both companies continue to record the towers in property, plant and equipment and depreciate them accordingly.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transacts_With]-> COMP -[Acquires]-> ACCOUNTING_POLICY <-[Gains]- ORG",
      "triplets_used": [
        "VZ (ORG) -> American Tower Corporation (COMP)",
        "American Tower Corporation (COMP) -> Exclusive Rights (ACCOUNTING_POLICY)",
        "Exclusive Rights (ACCOUNTING_POLICY) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9597,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3107,
        "completion_tokens": 229,
        "total_tokens": 3336
      }
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power monetizes federal tax credits through tax equity partnerships for its wind facilities, which are structured with long-term PPAs of up to 25 years, enabling the tax partner to capture substantially all federal tax benefits including PTCs, while Duke Energy consolidates its renewable VIEs and relies on tax equity arrangements to finance eligible assets, also utilizing long-term PPAs but with greater operational control over siting and PPA negotiations as the primary beneficiary.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Related_To]-> FIN_INST <-[Negotiates]- ORG",
      "triplets_used": [
        "SO (ORG) -> Wind Facilities (PRODUCT)",
        "Wind Facilities (PRODUCT) -> PPAs (FIN_INST)",
        "PPAs (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_268",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5838,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2146,
        "completion_tokens": 124,
        "total_tokens": 2270
      }
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "The voting rights structures of CMCSA and GOOGL create fundamentally different corporate governance models that directly impact shareholder influence on major corporate decisions. CMCSA's Class B common stock holders possess voting rights (as evidenced by their disclosure in the equity section of its 10-K), while GOOGL's Class B common stock holders have 10 votes per share, Class A has 1 vote per share, and Class C has no voting rights except as required by law – a system explicitly detailed in GOOGL's 10-K under \"Class A and Class B Common Stock and Class C Capital Stock.\" This contrast is further reinforced by the KG triplet relationship where CMCSA's Class B Common Stock (FIN_INST) is connected to GOOGL (ORG), highlighting that CMCSA's Class B structure (with voting rights) differs significantly from GOOGL's dual-class system where only Class B carries voting power (10 votes/share), Class A has 1 vote/share, and Class C has none, thereby concentrating control among Class B shareholders while Class A and C shareholders have minimal direct influence on decisions like mergers or charter amendments unless specific conditions are met as outlined in GOOGL's voting provisions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12163,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3731,
        "completion_tokens": 297,
        "total_tokens": 4029
      }
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "The voting rights structure creates a significant control disparity: GOOGL's Class B shares carry 10 votes per share versus NFLX's single vote per share, and GOOGL's $62.2 billion in 2023 share repurchases (focused on Class A and C shares) reduce the voting pool of non-controlling shares, potentially amplifying the influence of remaining Class B shares held by insiders. This dynamic is reinforced by the KG relationship linking GOOGL's voting rights policy to NFLX as an entity, highlighting how Alphabet's concentrated voting control through Class B shares—combined with aggressive repurchases of lower-voting shares—may intensify control dynamics relative to Netflix's uniform single-vote structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Has]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3632,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1604,
        "completion_tokens": 176,
        "total_tokens": 1780
      }
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMY's retained royalty rights from its 2012 divestiture of the diabetes business (including Byetta*) generated approximately $1.9 billion in pretax royalty income in 2021, but those rights were transferred to LLY when it acquired Amylin, making LLY the current owner of the Byetta* trademark; consequently, BMY’s future earnings are exposed to any decline in Byetta* royalty streams and to the risks outlined in its divestiture and acquisition disclosures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Relates_To]-> COMP -[Owns]-> PRODUCT <-[Owns]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Amylin (COMP)",
        "Amylin (COMP) -> Byetta* (PRODUCT)",
        "Byetta* (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_185",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8003,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2651,
        "completion_tokens": 114,
        "total_tokens": 2765
      }
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "The capital buffer structures differ significantly: Schwab must maintain both a 2.5% stress capital buffer and a 2.5% capital conservation buffer, resulting in a combined buffer requirement that contributes to its minimum total risk-based capital ratio thresholds of 7.0% (CET1), 8.5% (Tier 1), and 10.5% (Total Risk-Based Capital), whereas JPMorgan Chase applies only a 2.5% capital conservation buffer without the stress buffer component, aligning with its regulatory framework that excludes GSIB surcharges and countercyclical buffers for its banking subsidiary. This distinction is reflected in the KG pattern where Stress Capital Buffer connects to Capital Conservation Buffer and both relate to JPMorgan Chase through regulatory requirements, while Schwab's requirements explicitly include the stress buffer element absent in JPMorgan's structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Stress Capital Buffer (REGULATORY_REQUIREMENT)",
        "Stress Capital Buffer (REGULATORY_REQUIREMENT) -> Capital Conservation Buffer (REGULATORY_REQUIREMENT)",
        "Capital Conservation Buffer (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_291",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3921,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1718,
        "completion_tokens": 213,
        "total_tokens": 1931
      }
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "The transition from LIBOR to alternative reference rates (e.g., SOFR) is governed by the regulatory requirement **Reference Rate Reform** and the accounting relief provided by **ASU 2020-04**, which permits temporary optional expedents for contract modifications and hedge accounting during the transition; this framework directly connects LMT’s credit facility and GE’s floating‑rate debt and preferred stock to the standard.  \n\n- LMT’s credit facility includes fallback language that triggers alternative rate calculations upon LIBOR’s cessation, and the company has adopted the ISDA 2020 IBOR Fallbacks Protocol, meaning the transition will be accounted for under ASU 2020‑04, limiting any material impact on its operating results, financial position, or cash flows.  \n- GE’s floating‑rate debt and preferred stock are explicitly tied to USD LIBOR; under New York State legislation and the ASU 2020‑04 guidance, these instruments will automatically switch to SOFR + a spread adjustment when LIBOR ceases, and the resulting accounting effects are also covered by the relief in ASU 2020‑04, which similarly limits material impact on GE’s financial statements.  \n\nThus, ASU 2020‑04 provides accounting relief for both LMT and GE, ensuring that modifications to their LIBOR‑linked contracts—whether in credit facilities, floating‑rate debt, or preferred stock—are handled with minimal disruption to reported earnings, financial position, and cash flows.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Reference Rate Reform (REGULATORY_REQUIREMENT)",
        "Reference Rate Reform (REGULATORY_REQUIREMENT) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16860,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4909,
        "completion_tokens": 363,
        "total_tokens": 5272
      }
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023 reflects its adoption of a dual-class structure designed to maintain control with insiders, analogous to GOOGL's system where Class B shares automatically convert to Class A shares upon sale or transfer, ensuring voting power concentration while preserving market liquidity; this structure is reinforced by the KG relationship where Class B Common Stock (CMCSA) converts to Class A Common Stock (FIN_INST), which is linked to GOOGL (ORG) through stakeholder connections, mirroring GOOGL's explicit disclosure that Class B shares convert automatically upon transfer to Class A shares.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10703,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3365,
        "completion_tokens": 163,
        "total_tokens": 3528
      }
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "The vesting-related financial commitments in MDLZ's multiemployer pension plans involve a $360 million discounted withdrawal liability that is amortized over a 19‑year payment schedule, requiring monthly contributions and accreted interest of $11‑$12 million annually, reflecting a long‑term, liability‑driven cost recognition pattern; in contrast, WMT's equity compensation vesting schedules span up to four years for restricted stock units and one‑to‑three years for performance‑based awards, with expense recognized ratably over each award’s vesting period, resulting in a shorter, equity‑based cost‑recognition timeline. Consequently, while MDLZ's vesting obligations are characterized by multi‑decade liability accrual and interest accretion, WMT's vesting arrangements involve a more limited service‑period horizon and expense amortization tied to equity award vesting, leading to markedly different duration and cost‑recognition patterns across the two companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Multiemployer Pension Plans (FIN_INST)",
        "Multiemployer Pension Plans (FIN_INST) -> Vesting Periods (ACCOUNTING_POLICY)",
        "Vesting Periods (ACCOUNTING_POLICY) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5204,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1983,
        "completion_tokens": 242,
        "total_tokens": 2226
      }
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "The combined capital buffer requirement for BAC under the Advanced Approach, which incorporates the mandatory 2.5% Capital Conservation Buffer and a zero Countercyclical Capital Buffer, is compared to MS's identical buffer structure, where the CCyB is also currently set at zero by the Federal Reserve. Both institutions apply the same 2.5% Capital Conservation Buffer and zero CCyB, resulting in equivalent buffer requirements relative to their minimum risk-based capital ratios, as explicitly confirmed by the regulatory framework described in both BAC's and MS's filings where the capital buffer requirement is defined as the sum of the 2.5% Capital Conservation Buffer, G-SIB surcharge, and CCyB (which is zero for both), with the Advanced Approach requirement mirroring this composition for BAC and explicitly stated for MS as including the same 2.5% buffer component alongside zero CCyB.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Capital Conservation Buffer (REGULATORY_REQUIREMENT)",
        "Capital Conservation Buffer (REGULATORY_REQUIREMENT) -> Countercyclical Capital Buffer (REGULATORY_REQUIREMENT)",
        "Countercyclical Capital Buffer (REGULATORY_REQUIREMENT) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6297,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2301,
        "completion_tokens": 223,
        "total_tokens": 2524
      }
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "AVGO's $56.3 billion fixed-rate senior notes exhibit interest rate sensitivity of approximately $1.7 billion for a 50 basis point rate shift (per Chunk 1), while ORCL's effective interest rate management through swaps—demonstrated by CSCO's $0.5 billion swap converting fixed to floating rates (Chunk 2)—and ORCL's own cross-currency swap reducing its effective rate to 8.76% (Chunk 3) shows a more nuanced approach to mitigating rate risk. Unlike AVGO's fixed-rate exposure, ORCL actively uses swaps to convert both fixed and floating debt obligations into targeted rates, as seen in its 3.07% fixed-rate conversion via cash flow hedges (Chunk 3), directly contrasting with AVGO's reliance on fixed-rate instruments without comparable hedging mechanisms described in the provided data.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Fixed Rate Senior Notes (FIN_INST)",
        "Fixed Rate Senior Notes (FIN_INST) -> Interest Rate Swap (FIN_INST)",
        "Interest Rate Swap (FIN_INST) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4185,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1748,
        "completion_tokens": 196,
        "total_tokens": 1945
      }
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "META's Class B common stock carries 15 votes per share, concentrating 33.3% of total voting power in the hands of holders like Mr. Zuckerberg, while Class A shares (1 vote each) represent the remaining 66.7% of voting rights. This structure contrasts with Alphabet's (GOOGL) repurchase strategy, which targets Class A and Class C shares (Class A carries 1 vote, Class C has no voting rights) and authorized a $70 billion repurchase program in 2024, repurchasing $62 billion of such shares in 2024 alone, reflecting a shareholder-friendly capital allocation approach distinct from META's voting power dynamics.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8023,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2686,
        "completion_tokens": 152,
        "total_tokens": 2838
      }
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm's projection that 46% of smartphones sold in 2027 will be generative AI capable (up from 19% in 2024) directly informs its strategic focus on AI and connectivity technologies, positioning on-device generative AI as essential for maximizing utility, privacy, and personalization in edge devices like smartphones and automotive systems (Chunk 2). This aligns with its broader investment in AI and connectivity, as evidenced by its QCT segment's development of AI/ML techniques and its emphasis on \"generative AI becoming ubiquitous\" across industries beyond mobile (Chunk 2). In contrast, Salesforce is making parallel investments in generative and agentic AI across its CRM platform—specifically through Agentforce, which enables AI agents to autonomously act across sales, service, and marketing functions—to deepen customer engagement and drive productivity via integrated AI on its unified platform (Chunk 3). Both companies are betting on AI's transformative potential, but Qualcomm concentrates on hardware-level AI capabilities for device intelligence and connectivity, while Salesforce focuses on AI-enhanced customer relationship workflows within its software ecosystem (Chunk 1's context of Qualcomm's AI-driven product strategy and Chunk 3's details on Salesforce's AI investments).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT -[Positively_Impacts]-> CONCEPT <-[Invests_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Smartphones (PRODUCT)",
        "Smartphones (PRODUCT) -> Generative AI (CONCEPT)",
        "Generative AI (CONCEPT) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19230,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5489,
        "completion_tokens": 325,
        "total_tokens": 5814
      }
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe's strategic focus on enhancing user experience through AI-driven digital media tools directly aligns with Qualcomm's 2027 vision for generative AI-capable edge devices, as evidenced by their interconnected KG relationships where ADBE's User Experience (UX) concept depends on Generative AI and impacts QCOM. Chunk 1 reveals Adobe's competitive imperative to integrate AI capabilities for digital media generation and editing while prioritizing intuitive user interfaces and AI model integration, directly enabling the personalized, context-aware experiences Qualcomm highlights. Chunk 2 and 3 demonstrate Qualcomm's projection that 46% of 2027 smartphones will be generative AI-capable, with edge devices requiring on-device AI processing to maximize immediacy, privacy, and personalization—exactly the user interface improvements Adobe targets through its AI-driven tools, particularly as 5G Advanced and AI convergence enable ubiquitous generative AI across IoT, automotive, and consumer edge devices.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT -[Impacts]-> CONCEPT <-[Enables]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> User Experience (CONCEPT)",
        "User Experience (CONCEPT) -> Generative AI (CONCEPT)",
        "Generative AI (CONCEPT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15506,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4558,
        "completion_tokens": 252,
        "total_tokens": 4810
      }
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin's compensation plan treats dividend equivalents on RSU awards as payable to directors upon termination of service from the first business day of April following the one-year anniversary of the grant, with payment made in stock or cash and including dividend equivalents, while Honeywell's RSU awards earn dividend equivalents but lack specific vesting-related payment timing details in the disclosed terms. Both companies grant RSUs that entitle holders to receive common stock upon vesting and earn dividend equivalents, but Lockheed Martin's plan specifically ties dividend equivalent payments to director termination terms and timing, whereas Honeywell's disclosure focuses on the general structure of RSU awards without detailing equivalent payment mechanics tied to vesting conditions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Dividend Equivalents (FIN_INST)",
        "Dividend Equivalents (FIN_INST) -> RSU Awards (FIN_INST)",
        "RSU Awards (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4765,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1861,
        "completion_tokens": 201,
        "total_tokens": 2063
      }
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments (TXN) relies on subcontractors for approximately 40 % of its assembly and test services, whereas NVIDIA (NVDA) depends on a limited pool of external foundries and contract manufacturers that handle both wafer fabrication and final assembly, a relationship highlighted by AMD’s experience with third‑party suppliers that can lead to capacity constraints, price volatility, and supply‑chain disruptions. Both companies face similar risks—such as loss of critical capacity, quality‑control challenges, and exposure to supplier‑driven price or delivery changes—but TXN’s higher subcontractor share (40 % vs. NVDA’s more variable exposure) makes it comparatively more vulnerable to the same set of third‑party manufacturing uncertainties.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> COMP -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Subcontractors (COMP)",
        "Subcontractors (COMP) -> Third-Party Manufacturers (COMP)",
        "Third-Party Manufacturers (COMP) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13008,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3948,
        "completion_tokens": 187,
        "total_tokens": 4135
      }
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "Duke Energy Florida's 10 new solar facilities represent an estimated $1 billion investment over three years, as stated in Chunk 1, which will be included in base rates offset by subscription fee revenue. This investment is connected to Southern Power's use of PPAs as operating leases through the KG relationship where Solar Facilities (PRODUCT) -> PPAs (FIN_INST) -> SO (ORG), indicating that Southern Power (SO) enters into PPAs for renewable projects with terms up to 25 years, as detailed in Chunks 2 and 3 where PPAs related to solar/wind facilities are explicitly described as operating leases with remaining terms of up to 25 years.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Solar Facilities (PRODUCT)",
        "Solar Facilities (PRODUCT) -> PPAs (FIN_INST)",
        "PPAs (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_268",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_269",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5352,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2011,
        "completion_tokens": 159,
        "total_tokens": 2171
      }
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "The voting rights structure fundamentally shapes Alphabet's $62.0 billion share repurchase strategy by enabling targeted capital allocation between share classes. Netflix's one-vote-per-share common stock model (Chunk 1) contrasts with Alphabet's Class C capital stock having no voting rights (Chunk 2/3), allowing the company to repurchase Class C shares without diluting Class A voting control. This structure directly facilitates the $62.0 billion 2024 repurchase allocation across Class A and Class C shares, as evidenced by the $62.0 billion repurchase total and $44.7 billion remaining availability for both classes (Chunk 2/3), while the absence of voting rights in Class C specifically supports this strategic allocation.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Repurchases]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class C Capital Stock (FIN_INST)",
        "Class C Capital Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4679,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1861,
        "completion_tokens": 182,
        "total_tokens": 2043
      }
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "The activation of voting rights for BAC’s preferred stockholders due to dividend arrears—triggered when dividends on Series B, F or G Preferred Stock remain unpaid for three consecutive semi‑annual periods (or six consecutive quarterly periods)—requires the holders of those series to vote together as a single class for the election of two additional directors, effectively granting them collective control in governance during financial stress; in contrast, V’s Class C common stockholders possess only limited voting rights that are confined to specific matters such as core‑business exits, certain consolidation or merger transactions, or charter amendments affecting their series, and even then their votes are calculated by multiplying the number of shares held by the applicable conversion rate, reflecting a far more restricted influence compared with the broad, trigger‑based voting rights imposed on BAC’s preferred shareholders when dividend defaults occur.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Negatively_Impacts]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class C Common Stock (FIN_INST)",
        "Class C Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_142",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8747,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2879,
        "completion_tokens": 242,
        "total_tokens": 3121
      }
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney's licensing revenue from Star Wars-branded merchandise generates royalties based on a fixed percentage of wholesale or retail sales across key product categories like toys, apparel, and home décor, providing a stable revenue stream that supports content investment. This licensing income directly funds Disney+'s expansion in European markets, where it competes with Comcast's (CMCSA) Sky Glass and XClass TV platforms—both smart TV products leveraging Comcast's global technology infrastructure and launched in 2021 to challenge Disney's streaming dominance. The competitive landscape in Europe, as noted in CMCSA's 10-K, includes Comcast's Sky Glass/XClass TVs as OTT-focused hardware rivals, while Disney's Star Wars licensing revenue helps offset content development costs in this contested market.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT -[Includes]-> PRODUCT <-[Licenses]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Disney (PRODUCT)",
        "Disney (PRODUCT) -> Star Wars (PRODUCT)",
        "Star Wars (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11405,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3518,
        "completion_tokens": 202,
        "total_tokens": 3720
      }
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "AXP's net interest income is highly sensitive to a 200 basis point rate increase, with the firm's repricing risk analysis showing that interest-rate sensitive assets and liabilities generally reprice by the same magnitude as benchmark changes, subject to caps/floors, and certain deposits reprice at lower magnitudes—directly linking to MS's use of interest rate caps in securitization transactions where such caps mitigate repricing risk exposure for both firms. This repricing risk, disclosed as a core vulnerability in AXP's financial strategy, is structurally connected to MS's securitization derivatives (as evidenced by the KG pattern where Interest Rate Caps depend on Repricing Risk and link to AXP), meaning that the caps employed by MS to hedge rate volatility in asset transfers directly influence the magnitude of AXP's net interest income volatility when rates shift. Consequently, the 200bp sensitivity analysis for AXP is not isolated but reflects the operational impact of the very caps MS deploys in its securitization workflows, where unmitigated repricing risk could amplify losses in AXP's interest income under rising rate environments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST -[Depends_On]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "MS (ORG) -> Interest Rate Caps (FIN_INST)",
        "Interest Rate Caps (FIN_INST) -> Repricing Risk (RISK_FACTOR)",
        "Repricing Risk (RISK_FACTOR) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4779,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1881,
        "completion_tokens": 289,
        "total_tokens": 2170
      }
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "The impact of a weaker U.S. dollar on MDLZ's consolidated earnings is directly contrasted with the favorable currency effects in Coca-Cola's Europe, Middle East and Africa segment through their shared exposure to euro and British pound fluctuations. While MDLZ's 10-K explicitly states that a weaker U.S. dollar benefits its consolidated earnings and net assets by reducing currency-related translation adjustments, Coca-Cola's 10-K confirms that a weaker U.S. dollar specifically generated favorable impacts on its Europe, Middle East and Africa operating segment (alongside Global Ventures), offsetting some of the adverse effects from stronger dollar impacts on other regions like Latin America. Both companies isolate currency effects in their analyses, with MDLZ using constant currency metrics to supplement reported results and KO acknowledging that current spot rates and hedging coverage will continue to influence segment-level revenue trends.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> MACRO_CONDITION -[Impacted_By]-> GPE <-[Positively_Impacts]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Weaker U.S. Dollar (MACRO_CONDITION)",
        "Weaker U.S. Dollar (MACRO_CONDITION) -> Europe, Middle East and Africa (GPE)",
        "Europe, Middle East and Africa (GPE) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10087,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3228,
        "completion_tokens": 238,
        "total_tokens": 3466
      }
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "The voting power concentration in MA's dual-class structure is directly comparable to V's through their shared Class B common stock mechanism, where each Class B share carries 15 votes and collectively represents exactly one-third of the total voting power (33⅓%), mirroring Comcast's (CMCSA) structure described in Chunk 2. This is reinforced by the KG relationship Class B Common Stock → V (ORG) in the triplets, confirming V's Class B shares operate under the same 15-vote-per-share weighting as MA's, resulting in identical structural voting power concentration where Class B shareholders (like Mr. Roberts at V) control precisely 33⅓% of total votes despite representing a minority of shares.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MA (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 24301,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 6752,
        "completion_tokens": 174,
        "total_tokens": 6927
      }
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "The financial risks tied to nuclear generation at NEE and Southern Company are fundamentally similar, as both entities face the possibility that decommissioning costs could exceed the reserves set aside for this purpose. NEE explicitly acknowledges that the cost of decommissioning its nuclear facilities \"could exceed the amount available in NEE's and FPL's decommissioning funds,\" highlighting direct exposure to shortfalls in funding. Southern Company’s disclosures reinforce this concern, stating that \"damages, decommissioning, or other costs could exceed the amount of decommissioning trusts or external insurance coverage\" for its nuclear units operated by Alabama Power and Georgia Power, with additional risks stemming from regulatory actions, cyber threats, or accidents potentially amplifying financial exposure. Both companies rely on decommissioning funds and external insurance to mitigate these liabilities, yet the inherent uncertainty in long-term cost estimation creates comparable vulnerabilities in their financial risk profiles regarding nuclear plant closure and cleanup.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR -[Subject_To]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Financial Risks (RISK_FACTOR)",
        "Financial Risks (RISK_FACTOR) -> Nuclear Power Plants (PRODUCT)",
        "Nuclear Power Plants (PRODUCT) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17024,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4933,
        "completion_tokens": 273,
        "total_tokens": 5206
      }
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "The $9.9 billion valuation of UPS’s pension‑plan investments in real‑estate funds is derived from net‑asset‑value (NAV) calculations that rely on periodic appraisals and unobservable inputs, a methodology that mirrors the Level 3 valuation approach used by General Dynamics for its private‑equity and other non‑market‑observable assets. Both companies apply valuation models that incorporate internal assumptions—UPS through NAV adjustments for real‑estate and private‑equity funds, and GD through discounted‑cash‑flow and other unobservable inputs—so the $9.9 billion figure reflects the same type of internally‑derived fair‑value estimates that GD employs for its Level 3 assets.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Valued_Using]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Real Estate Funds (FIN_INST)",
        "Real Estate Funds (FIN_INST) -> Valuation Models (ACCOUNTING_POLICY)",
        "Valuation Models (ACCOUNTING_POLICY) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10256,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3264,
        "completion_tokens": 170,
        "total_tokens": 3434
      }
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "A supply disruption in Africa and Middle East would directly impact PepsiCo's 30% beverage revenue exposure in AMESA, potentially reducing beverage sales to Target. Given Target's vendor arrangement where payment occurs only after guest sale and merchandise received under these arrangements is not included in inventory, such a disruption could delay Target's beverage SKU availability without immediately affecting reported inventory levels. However, this would likely increase Target's inventory turnover through reduced sales velocity and create cash flow timing shifts as payments to PepsiCo would be deferred until beverages are sold to end consumers, potentially improving short-term cash flow but risking stockouts that could further suppress sales.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Africa and Middle East (GPE)",
        "Africa and Middle East (GPE) -> Beverages (PRODUCT)",
        "Beverages (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6982,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2439,
        "completion_tokens": 189,
        "total_tokens": 2629
      }
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "LLY and AMGN have responded differently to payer-driven pricing pressures on their high-cost biologics amid access restrictions affecting Repatha and insulin products. LLY acknowledges that payer actions—including restrictive coverage policies and pricing pressures—have led to supply disruptions and cost challenges for products like insulin, while AMGN details specific payer tactics (e.g., step therapy, formulary exclusions, and copay accumulator policies) that limit patient access to Repatha, prompting the company to reduce net prices and introduce lower list-price NCBs to improve affordability. Both companies face heightened pressure from consolidated payers (e.g., CVS, Express Scripts, UnitedHealth Group) that demand deeper discounts and rebates, but AMGN explicitly links these dynamics to Repatha sales declines and access barriers, whereas LLY emphasizes broader supply chain vulnerabilities and regulatory risks tied to pricing scrutiny.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Access Restrictions (REGULATORY_REQUIREMENT)",
        "Access Restrictions (REGULATORY_REQUIREMENT) -> Payers (COMP)",
        "Payers (COMP) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16904,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4903,
        "completion_tokens": 238,
        "total_tokens": 5141
      }
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "BAC and SCHW both rely on the same regulatory capital framework where the Countercyclical Capital Buffer (CCyB) is currently fixed at zero, but their approaches to meeting buffer requirements differ in scope and application. While BAC's disclosures indicate it maintains capital buffers including a 2.5% capital conservation buffer and references CCyB as part of its regulatory minimums (Chunk 1), SCHW explicitly details its stress capital buffer of 2.5% and capital conservation buffer requirements for its subsidiaries CSC and CSB, which collectively form part of its risk-based capital ratio calculations (Chunk 3). Notably, the KG pattern reveals a direct connection between SCHW and the Capital Conservation Buffer through the regulatory requirement chain (Countercyclical Capital Buffer → Capital Conservation Buffer → SCHW), whereas BAC's relationship to these buffers is framed through its broader regulatory minimums under Basel III (Chunk 1) and its capital distribution sources from subsidiaries like BANA (Chunk 3). Both institutions operate under the same zero CCyB framework, but SCHW's subsidiaries face explicit buffer thresholds tied to specific capital ratio tiers (7.0%-10.5% for CET1, Tier 1, and Total Capital), while BAC's disclosures focus on its consolidated buffer composition and compliance through parent-level capital adequacy under U.S. regulatory rules (Chunk 1).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Countercyclical Capital Buffer (REGULATORY_REQUIREMENT)",
        "Countercyclical Capital Buffer (REGULATORY_REQUIREMENT) -> Capital Conservation Buffer (REGULATORY_REQUIREMENT)",
        "Capital Conservation Buffer (REGULATORY_REQUIREMENT) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5996,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2199,
        "completion_tokens": 348,
        "total_tokens": 2547
      }
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company's renewable energy financing strategy relies on tax equity partnerships to monetize federal ITCs and PTCs from its solar and wind projects, with $1.2 billion and $0.8 billion in unutilized credits expected to be fully utilized by 2024, while Duke Energy utilizes PPAs through VIE structures to finance renewable assets via third-party tax equity investors, consolidating these projects due to its control over critical operational decisions. Both companies leverage PPAs for renewable facility financing, but Southern Company's approach directly channels tax credits through consolidated partnerships (HLBV accounting), whereas Duke Energy's model depends on external tax equity investors to fund projects under restricted VIE structures, creating divergent timelines for credit utilization and cash flow impacts.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Related_To]-> FIN_INST <-[Negotiates]- ORG",
      "triplets_used": [
        "SO (ORG) -> Solar Facilities (PRODUCT)",
        "Solar Facilities (PRODUCT) -> PPAs (FIN_INST)",
        "PPAs (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_268",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5838,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2139,
        "completion_tokens": 207,
        "total_tokens": 2346
      }
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "The automatic conversion of Class B to Class A shares upon transfer at Alphabet (GOOGL), coupled with Comcast’s non-dilutable Class B voting structure (CMCSA), reinforces investor concerns about Meta’s (META) dual-class governance model that grants disproportionate voting control to its founder, potentially making META’s Class A stock less attractive to investors seeking equitable governance and voting rights.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Depends_On]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6753,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2390,
        "completion_tokens": 103,
        "total_tokens": 2493
      }
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "The increased market availability of biosimilars through CVS's Cordavis subsidiary will likely expand utilization of lower-cost biosimilar products, which under UnitedHealth's (UNH) rebate structure would increase the volume of rebate-eligible prescriptions. As noted in UNH's 10-K, rebates are accrued monthly based on contract terms and product utilization, and totaled $12.5 billion receivable as of December 31, 2024 (up from $11.0 billion in 2023), with receipt typically occurring 2-5 months after billing. This suggests that higher biosimilar adoption driven by Cordavis's commercialization efforts could accelerate rebate accruals and potentially shift revenue recognition timing, as rebates are recorded as reductions to medical costs when earned but collected later, creating a timing difference between when utilization occurs and when cash is received.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> COMP -[Works_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Cordavis (COMP)",
        "Cordavis (COMP) -> Pharmaceutical Manufacturers (COMP)",
        "Pharmaceutical Manufacturers (COMP) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12774,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3908,
        "completion_tokens": 216,
        "total_tokens": 4124
      }
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "The SEC’s Regulation Best Interest (Reg BI) obligates broker‑dealers to place retail investors’ interests first, which will raise compliance costs for both Goldman Sachs and Morgan Stanley as they expand retail‑focused offerings. Goldman Sachs (GS) already faces heightened consumer‑protection risk in its consumer‑oriented activities and transaction‑banking compliance, and it must invest further in controls to meet Reg BI’s suitability and privacy requirements. Morgan Stanley (MS) competes directly with GS in the broker‑dealer space and, per its 10‑K, is subject to the same SEC Reg BI rules that “require broker‑dealers to act in the best interest of retail consumers,” meaning both firms will incur similar regulatory expenses while contending with potentially divergent state‑level fiduciary proposals that could increase litigation risk and affect their competitive positioning.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Applies_To]-> COMP <-[Competes_With]- ORG",
      "triplets_used": [
        "GS (ORG) -> Regulation Best Interest (REGULATORY_REQUIREMENT)",
        "Regulation Best Interest (REGULATORY_REQUIREMENT) -> Broker-Dealers (COMP)",
        "Broker-Dealers (COMP) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15295,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4535,
        "completion_tokens": 221,
        "total_tokens": 4757
      }
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "CMCSA's Class B common stock carries 15 votes per share, granting it 33.3% of the combined voting power despite representing a smaller equity stake, resulting in concentrated control as the sole holder of all Class B shares (Brian L. Roberts) maintains decisive influence; in contrast, GOOGL's Class B common stock carries 10 votes per share, providing voting power proportional to its equity structure without the same concentrated control mechanism observed at CMCSA.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10683,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3373,
        "completion_tokens": 117,
        "total_tokens": 3490
      }
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "The analysis of illicit trade in Turkey reveals a dual operational risk for both Philip Morris International (PM) and Procter & Gamble (PG), but with distinct manifestations tied to their business models and exposure profiles. In Turkey, illicit trade prevalence directly suppressed PM’s cigarette volume growth—evidenced by PM’s own commentary noting that in Turkey, \"partly offset by a higher estimated prevalence of illicit trade\" contributing to a market increase of 8.2% while also highlighting that illicit trade \"impacting product availability\" and \"market disruptions\" negatively affected PM’s regional performance, even as it benefited from pandemic-driven tourism and relaxed restrictions. This illicit trade risk is structurally significant for PM because it operates in a highly regulated tobacco market where excise tax policies and regulatory enforcement (e.g., under the WHO FCTC framework) are critical, and where illicit trade directly erodes volume and pricing power in key markets like Turkey, as seen in its Middle East & Africa commentary. Conversely, PG’s exposure to Turkey’s foreign exchange volatility is explicitly detailed in its 10-K, where it identifies Turkey as a country experiencing \"significant exchange rate fluctuations\" that have \"significantly impacted our historical net sales, costs and net earnings,\" with transaction exposure stemming from input costs and working capital denominated in foreign currencies. While PG’s risk is financial (currency-driven margin pressure), PM’s risk is operational (volume suppression via illicit trade), creating a dual exposure where PM faces a *regulatory-volume* risk (illicit trade undermining legal sales) and PG faces a *financial-currency* risk (FX volatility eroding profitability), yet both are simultaneously vulnerable to Turkey’s macroeconomic instability—PM through lost legal market share and PG through currency-driven cost and revenue compression—demonstrating how the same market can impose divergent but equally critical risks on different types of multinational consumer goods companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> GPE -[Negatively_Impacts]-> RISK_FACTOR <-[Faces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Turkey (GPE)",
        "Turkey (GPE) -> Illicit Trade (RISK_FACTOR)",
        "Illicit Trade (RISK_FACTOR) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14857,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4399,
        "completion_tokens": 520,
        "total_tokens": 4919
      }
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan's Firmwide Climate Risk Framework explicitly identifies and manages transition risk as a core component of its climate risk strategy, directly linking it to reputational exposure through the KG pattern where Transition Risk negatively impacts Reputational Risk and connects to BAC. While JPMorgan focuses on its internal climate risk governance and metrics to address transition risk drivers like policy shifts, Bank of America's $1.5 trillion sustainable finance goal—particularly its $1 trillion allocation for low-carbon transition—creates direct reputational vulnerability if it fails to meet these targets, as highlighted by BAC's dedicated governance structures (e.g., Climate Risk Council and ERC oversight) that monitor climate-related commitments. This contrast reveals JPMorgan's proactive, framework-driven approach to transition risk management versus BAC's exposure to reputational damage stemming from its ambitious but externally scrutinized financial commitments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Faces]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Transition Risk (RISK_FACTOR)",
        "Transition Risk (RISK_FACTOR) -> Reputational Risk (RISK_FACTOR)",
        "Reputational Risk (RISK_FACTOR) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16856,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4914,
        "completion_tokens": 247,
        "total_tokens": 5161
      }
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft recognizes revenue from hardware sales combined with software licenses as a single performance obligation at the point of transfer of ownership, typically when hardware is sold through resellers or online marketplaces. Cisco's financing receivables, which fund hardware purchases, have average terms of one to three years, and as of July 29, 2023, Cisco's total credit loss allowance for these financing arrangements—encompassing both loan and lease receivables—is $72 million, reflecting provisions, write-offs, and foreign exchange adjustments disclosed in its 2023 10-K filing.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Hardware (PRODUCT)",
        "Hardware (PRODUCT) -> Loan Receivables (FIN_INST)",
        "Loan Receivables (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_8",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6616,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2354,
        "completion_tokens": 147,
        "total_tokens": 2501
      }
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "Potential delays in FAA certification of Gulfstream's G700 aircraft could force FedEx to continue operating older, less fuel-efficient aircraft beyond ICAO's 2028 production cutoff, directly triggering non-compliance with CORSIA's emissions baseline and increasing mandatory purchase of carbon offsets or sustainable aviation fuel to meet ICAO and EU ETS obligations, thereby significantly raising FedEx's compliance costs under these regulatory frameworks while undermining its ability to leverage fuel-efficient fleet advantages for emissions management.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> FAA Certification (REGULATORY_REQUIREMENT)",
        "FAA Certification (REGULATORY_REQUIREMENT) -> G700 Aircraft (PRODUCT)",
        "G700 Aircraft (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7783,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2638,
        "completion_tokens": 139,
        "total_tokens": 2777
      }
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "CMCSA's Class A common stock carries voting rights that are tied to the aggregate voting power of both Class A and Class B shares, with each Class B share granting 15 votes per share – resulting in roughly a 15:1 per‑share voting ratio in favor of Class B. In contrast, GOOGL's Class A common stock provides one vote per share, while its Class B shares provide 10 votes per share, giving a 10:1 per‑share voting ratio. Thus, while both companies use dual‑class structures, CMCSA's Class B shares confer a higher per‑share voting weight (15 vs 10 votes) than GOOGL's Class B shares.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4097,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1708,
        "completion_tokens": 145,
        "total_tokens": 1853
      }
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "The voting power distribution tied to Class B common stock at CMCSA, where holders of Class B shares have 15 votes per share and represent 33 ⅓ % of the combined voting power, is structurally similar to Alphabet’s dual‑class system but with a markedly higher per‑share voting weight; in Alphabet, Class B shares carry 10 votes per share, and together they account for roughly one‑third of the total voting power, giving Class B shareholders substantial but not dominant influence over corporate decisions. Both companies grant Class B holders disproportionate voting rights that are non‑dilutable under their charter provisions, yet CMCSA’s 15‑vote structure concentrates control more heavily in the hands of the Roberts family (who own all Class B shares) than Alphabet’s 10‑vote structure, which is distributed among multiple insiders. Consequently, while Alphabet’s Class B holders wield significant but comparatively less dominant influence, CMCSA’s Class B shareholders possess a dominant, effectively non‑dilutable voting bloc that can control key corporate actions despite representing only one‑third of total voting power.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4097,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1700,
        "completion_tokens": 282,
        "total_tokens": 1983
      }
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "The FDA approval timeline for BMY's Zeposia in ulcerative colitis (approved in November 2021) came **four months earlier** than Merck’s regulatory milestone for Welireg in von Hippel‑Lindau disease, which received FDA approval in **August 2021** (the milestone referenced in the KG triplets and confirmed by the $50 million milestone payment to former Peloton shareholders upon that approval).  \n\n- **Impact on BMY’s 2021 immunology portfolio:** The Zeposia approval added a new inflammatory‑bowel‑disease product to BMY’s immunology lineup, bolstering its immunology revenue and providing a near‑term growth driver in 2021.  \n- **Impact on MRK’s 2021 oncology portfolio:** Welireg’s approval diversified Merck’s oncology portfolio with a targeted therapy for VHL‑associated tumors, contributing to the strong oncology sales growth reported for 2021.  \n\nThus, while Zeposia’s November 2021 approval gave BMY a timely immunology boost, Welireg’s earlier August 2021 approval helped Merck advance its oncology pipeline and earnings in 2021.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Receives]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> FDA Approval (REGULATORY_REQUIREMENT)",
        "FDA Approval (REGULATORY_REQUIREMENT) -> Welireg (PRODUCT)",
        "Welireg (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15199,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4490,
        "completion_tokens": 259,
        "total_tokens": 4750
      }
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "The vesting period structure for restricted stock at EMR requires cliff vesting over service periods of three to ten years, with compensation expense recognized ratably over each applicable period, as detailed in Chunk 1. In contrast, UPS contributes to multiemployer pension plans with vesting periods defined by collective bargaining agreements that vary by plan and are subject to different funding risks, including potential withdrawal liabilities and multiemployer funding obligations outlined in Chunks 2 and 3. These differences reflect distinct mechanisms: EMR’s vesting is tied to individual performance and service milestones within its equity incentive plans, while UPS’s vesting obligations are embedded in collectively bargained pension plans where funding risk is shared across participating employers and benefit delivery is administered through plan trustees rather than direct employer vesting schedules.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "EMR (ORG) -> Vesting Periods (ACCOUNTING_POLICY)",
        "Vesting Periods (ACCOUNTING_POLICY) -> Multiemployer Pension Plans (FIN_INST)",
        "Multiemployer Pension Plans (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8017,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2695,
        "completion_tokens": 230,
        "total_tokens": 2926
      }
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "NFLX's exposure to data privacy risks under the Communications Act is primarily tied to its handling of member personal information—including billing data—subject to potential regulatory fines, litigation, and reputational harm from breaches, as highlighted in its 10-K disclosures about unauthorized intrusions and mandatory breach notifications. In contrast, CMCSA's regulatory obligations under the same Act extend beyond privacy to encompass spectrum management, copyright compliance, and broader FCC-mandated requirements, imposing operational constraints like costly infrastructure transitions and ongoing royalty payments that directly affect its financial flexibility and incur penalties for noncompliance. Both face financial penalties for data-related failures, but CMCSA's obligations are structurally more expansive due to its status as a telecommunications provider under the Act, while NFLX's risks are concentrated in data privacy and breach-related liabilities.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Restricts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Personal Information (RISK_FACTOR)",
        "Personal Information (RISK_FACTOR) -> Communications Act (REGULATORY_REQUIREMENT)",
        "Communications Act (REGULATORY_REQUIREMENT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17308,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5030,
        "completion_tokens": 244,
        "total_tokens": 5275
      }
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "PM's commercialization of Platform 5 nicotine pouches in Sweden mirrors CCEP's bottling role for Coca-Cola in the same market through their distinct but functionally analogous market entry strategies and dependencies. Both entities operate as specialized distributors within their respective ecosystems: CCEP, as Coca-Cola's bottler in Sweden (and other territories), handles production, packaging, and distribution of Coca-Cola beverages under contractual bottler agreements that grant exclusive territorial rights and require concentrate purchases from the parent company, while PM, through its newly acquired affiliate AG Snus, entered the Swedish nicotine pouch market by launching a reformulated Platform 5 product under the Shiro brand, leveraging its ownership of the brand and control over production despite reliance on external supply chains. Crucially, both models depend on centralized supply and regulatory navigation—CCEP's operations are constrained by bottler agreements that limit its independent product development and require adherence to Coca-Cola's pricing and distribution controls, whereas PM's commercialization faces supply chain vulnerabilities (e.g., semiconductor shortages affecting device production for RRPs) and must navigate complex, evolving nicotine product regulations that could restrict market access, highlighting how both entities' success hinges on managing external dependencies while operating within tightly controlled frameworks dictated by their principal partners.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> CCEP (COMP)",
        "CCEP (COMP) -> Sweden (GPE)",
        "Sweden (GPE) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16052,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4675,
        "completion_tokens": 378,
        "total_tokens": 5053
      }
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "The 8% decline in UnitedHealth Group’s Medicare Part D enrollment (from 3,315 k in 2023 to 3,050 k in 2024, a drop of 265 k or 8%) must be viewed in light of the IRA’s manufacturer discount requirements and the shift of reinsurance costs to Part D plans.  The IRA, which is disclosed as a regulatory requirement that modifies the Medicare Part D framework, introduced a catastrophic‑phase reinsurance reduction that begins in 2025 and requires manufacturers to provide discounts on certain drugs, thereby increasing the financial exposure of pharmacy‑benefit managers such as CVS under its Medicare Advantage contracts.  This regulatory pressure, together with the enrollment decline, heightens CVS’s exposure to cost‑shifting and discount obligations in its Medicare Advantage business.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Modifies]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Medicare Part D (REGULATORY_REQUIREMENT)",
        "Medicare Part D (REGULATORY_REQUIREMENT) -> IRA (REGULATORY_REQUIREMENT)",
        "IRA (REGULATORY_REQUIREMENT) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13891,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4166,
        "completion_tokens": 196,
        "total_tokens": 4363
      }
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company employs cost recovery mechanisms for environmental remediation at its natural gas utilities, as evidenced by its regulatory framework where state commissions approve rates to recover \"all prudently-incurred costs, including... environmental remediation\" (Chunk 2), and its Gas subsidiary manages fuel-hedging programs under state regulatory guidelines that utilize financial derivatives to mitigate price volatility (Chunk 1). This contrasts with Duke Energy's exposure, which faces environmental remediation liabilities requiring reserves for \"probable and estimable costs\" recorded in accounts payable (Chunk 3), where costs are typically expensed unless regulatory recovery is deemed probable, and where liabilities may arise from joint and several liability provisions involving other responsible parties.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Includes]-> RISK_FACTOR <-[Faces]- ORG",
      "triplets_used": [
        "SO (ORG) -> Cost Recovery Mechanisms (ACCOUNTING_POLICY)",
        "Cost Recovery Mechanisms (ACCOUNTING_POLICY) -> Environmental Remediation (RISK_FACTOR)",
        "Environmental Remediation (RISK_FACTOR) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_280",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_163",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11366,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3547,
        "completion_tokens": 206,
        "total_tokens": 3754
      }
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson is **151,915,315** (40,873,176 from Caterpillar + 111,042,139 from Johnson & Johnson), which exceeds 3M's total available securities of **39,563** by a significant margin. This comparison is supported by the KG triplet relationship where \"Securities Remaining Available\" connects all three organizations (CAT, JNJ, and MMM) under their respective equity compensation plans.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Equity Compensation Plans Approved by Security Holders (FIN_INST)",
        "Equity Compensation Plans Approved by Security Holders (FIN_INST) -> Securities Remaining Available (FIN_INST)",
        "Securities Remaining Available (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8370,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2807,
        "completion_tokens": 136,
        "total_tokens": 2943
      }
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck's Januvia and Janumet U.S. market exclusivity expires in May 2026 (with Janumet XR until July 2026) and is immediately followed by IRA‑imposed government price settings—Januvia’s price takes effect on January 1 2026 and Janumet’s on January 1 2027—while Pfizer’s regulatory exclusivity strategy, illustrated by the KG link Regulatory Exclusivity → PFE, shows that its market‑exclusivity periods are tied to patent extensions and FDA‑granted data protection, allowing it to maintain pricing power longer; consequently, Merck relies on a combination of patent‑term restoration, IRA price caps and litigation to protect post‑2025 revenue, whereas Pfizer’s approach hinges on extending exclusivity through patent term adjustments and regulatory data barriers, indicating that Merck’s revenue protection is contingent on navigating IRA pricing constraints and litigation, while Pfizer’s is anchored in broader intellectual‑property and exclusivity mechanisms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> Regulatory Exclusivity (REGULATORY_REQUIREMENT)",
        "Regulatory Exclusivity (REGULATORY_REQUIREMENT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10539,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3351,
        "completion_tokens": 240,
        "total_tokens": 3591
      }
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "MS's investment in CLNs involves selling credit protection to issuers, creating direct counterparty risk where the issuer may fail to repay the principal upon a credit event, as evidenced by the embedded derivatives in CLNs where \"credit protection has been sold to the issuer of the note\" and \"the principal balance of the note may not be repaid in full to the Firm\" upon default. In contrast, BAC manages commercial credit exposure through credit derivatives used to hedge both funded and unfunded loan commitments, explicitly stating they \"purchase credit protection to cover the funded portion as well as the unfunded portion of certain other credit exposures\" and utilize these instruments to \"mitigate the size and risk profile of the commercial credit portfolio\" while acknowledging they are carried at fair value without hedge accounting. Both firms employ credit derivatives for risk mitigation, but MS's CLN exposure creates a structural counterparty risk tied to issuer defaults through sold protection, whereas BAC actively manages counterparty risk by hedging its own loan portfolio exposures through purchased protection within defined credit risk frameworks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Offers]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "MS (ORG) -> CLNs (FIN_INST)",
        "CLNs (FIN_INST) -> Credit Protection (FIN_INST)",
        "Credit Protection (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5632,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2098,
        "completion_tokens": 293,
        "total_tokens": 2391
      }
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "The indemnification structures established by 3M and RTX differ fundamentally in their scope and legal implications following the Solventum spin-off. RTX's indemnification arrangements for financial guarantees involve third-party liabilities subject to indemnification for the company's benefit, while 3M's separation agreement with Solventum explicitly transfers and assigns specific liabilities—such as those related to Bair Hugger and False Claims Act litigation—to Solventum, requiring Solventum to indemnify and defend 3M in these matters. This transfer of liability, as disclosed in 3M's SEC filings, contrasts with RTX's approach of retaining and indemnifying its own financial guarantees, highlighting a key distinction in how each company allocates risk post-spin-off.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Discloses]-> COMP <-[Announces]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Indemnification (ACCOUNTING_POLICY)",
        "Indemnification (ACCOUNTING_POLICY) -> Solventum (COMP)",
        "Solventum (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12014,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3690,
        "completion_tokens": 194,
        "total_tokens": 3884
      }
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD generates $1.841 billion in revenue from Taiwan, representing a significant geographic market for the company, while NVIDIA relies on foundry partners operating in Taiwan that are critical to its chip production and subject to geopolitical tensions involving China and Taiwan. Both companies explicitly identify Taiwan-based supply chain operations as material risk factors, with NVIDIA's risk statement highlighting that \"a significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan,\" directly linking the region's instability to potential disruptions in NVIDIA's manufacturing continuity, whereas AMD's revenue concentration in Taiwan (1,841 million in fiscal 2023) demonstrates its direct economic exposure to the same geopolitical environment.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Foundry Partners (COMP)",
        "Foundry Partners (COMP) -> Taiwan (GPE)",
        "Taiwan (GPE) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13881,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4143,
        "completion_tokens": 215,
        "total_tokens": 4358
      }
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER's 15-year weighted-average contract term for repowered wind facilities creates significant long-term revenue predictability by locking in power sales agreements for substantially all of its capacity and ensuring stable cash flows through the full life of the PTCs, as evidenced by the 28,759 MW of contracted generation assets at December 31, 2023 with \"weighted-average remaining contract term of the power sales agreements, including the remaining life of the PTCs associated with repowered wind facilities, of approximately 15 years\" (Chunk 2). This structural advantage contrasts sharply with Southern Power's reliance on power sales agreements where specific contract terms are not disclosed in its SEC filings, as noted in Chunk 1's reference to \"Southern Power's Power Sales Agreements herein for additional information regarding Southern Power's PPAs\" without revealing term lengths or pricing mechanisms. Consequently, NEER's disclosed 15-year horizon provides greater visibility into future earnings streams compared to Southern Power's opaque agreement structure, directly supporting more reliable revenue forecasting for investors analyzing long-term energy asset performance.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Has_Stake_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "SO (ORG) -> Power Sales Agreements (FIN_INST)",
        "Power Sales Agreements (FIN_INST) -> Wind Facilities (PRODUCT)",
        "Wind Facilities (PRODUCT) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8498,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2818,
        "completion_tokens": 298,
        "total_tokens": 3116
      }
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX recognizes revenue from U.S. government fixed‑price contracts in excess of billings (contract assets) because payments are typically performance‑based or progress payments that retain a portion of the price until contract completion, whereas Honeywell discloses that its U.S. government contracts can be terminated for convenience or for performance failures and are subject to audits that may require downward price adjustments, creating exposure to contract termination risks under the same FAR regulatory framework.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "RTX (ORG) -> FAR (REGULATORY_REQUIREMENT)",
        "FAR (REGULATORY_REQUIREMENT) -> U.S. Government Contracts (REGULATORY_REQUIREMENT)",
        "U.S. Government Contracts (REGULATORY_REQUIREMENT) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15820,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4647,
        "completion_tokens": 130,
        "total_tokens": 4778
      }
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "The absence of voting rights for Alphabet’s Class C Capital Stock—explicitly described in Chunks 1 and 2 as \"no voting rights, except as required by applicable law\"—directly enables governance control to be concentrated in Class A and Class B shares (with Class B holding 10 votes per share), while Comcast’s relinquishment of voting rights in Hulu (Chunk 3) transferred operational control to Disney, demonstrating a stark contrast in power dynamics. Financially, Alphabet’s $62.0 billion repurchase of Class C shares in 2023 (Chunk 1) and $70.0 billion additional authorization (Chunk 2) reflect strategic capital allocation without voting dilution, whereas Comcast’s $8.6 billion put right exercise in Hulu (Chunk 3) generated immediate liquidity ($8.6 billion received) but retained only a non-controlling equity stake, resulting in a $5.1 billion investment balance (Chunk 3) and tax gains from the $9.2 billion minimum equity value, highlighting divergent financial outcomes from governance surrender.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class C Capital Stock (FIN_INST)",
        "Class C Capital Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8903,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2911,
        "completion_tokens": 251,
        "total_tokens": 3162
      }
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "The intertwined vulnerabilities in quality assurance and supply chain execution present significant risks for both LLY and TMO. LLY's reliance on third-party manufacturers for its high-demand incretin products, as documented in Chunk 1 and Chunk 2, directly exposes it to potential quality issues and production delays that could trigger regulatory actions, shortages, or reputational harm. This is critically linked to TMO's $26.92 billion in remaining performance obligations (Chunk 3), where a substantial portion is tied to long-term contract manufacturing agreements spanning 3-5 years. Should quality assurance failures or supply chain disruptions at these third-party facilities (including those serving TMO's contracts) occur, both companies face material adverse impacts: LLY could experience intensified supply constraints for its key products, while TMO risks failing to fulfill its long-term manufacturing commitments, potentially leading to revenue recognition delays, penalties, or loss of customer trust that would materially affect their financial condition and ability to meet strategic objectives. The KG pattern (ORG -[Subject_To]-> PRODUCT -[Negatively_Impacts]-> COMP <-[Depends_On]- ORG) explicitly connects LLY's quality assurance dependencies on third parties to TMO's performance obligations, highlighting that shared vulnerabilities in these areas could simultaneously undermine both companies' capacity to deliver on their long-term commitments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> PRODUCT -[Negatively_Impacts]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Quality Assurance (PRODUCT)",
        "Quality Assurance (PRODUCT) -> Third-Party Manufacturers (COMP)",
        "Third-Party Manufacturers (COMP) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11794,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3669,
        "completion_tokens": 368,
        "total_tokens": 4037
      }
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "Based on the provided information across all chunks, NextEra Energy Resources recognized a total cumulative impairment charge of $0.8 billion ($0.6 billion after tax) on its investment in XPLR as of December 31, 2024. This impairment reduced the carrying value of the investment from approximately $2.6 billion to $1.8 billion, resulting in the $0.8 billion charge recorded in equity in earnings (losses) of equity method investees for 2024. The carrying value before the 2024 impairment was $2.6 billion, as disclosed in Chunk 2, which details the write-down from $2.6 billion to $1.8 billion fair value using the market approach based on XPLR's observable trading price of $17.80 per unit at December 31, 2024. Chunk 3 confirms the aggregate equity method investment balance context but does not alter the specific impairment amount tied to XPLR, which is explicitly detailed in Chunk 2. The KG triplets (DUK → NextEra Energy → XPLR and XPLR → NEE) align with NextEra Energy Resources (a subsidiary of NextEra Energy) holding the investment in XPLR, with the impairment directly tied to the decline in XPLR's unit price triggering other-than-temporary impairment (OTTI) under NEE's equity method accounting policy.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DUK (ORG) -> NextEra Energy (COMP)",
        "NextEra Energy (COMP) -> XPLR (COMP)",
        "XPLR (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_220",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6773,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2361,
        "completion_tokens": 304,
        "total_tokens": 2665
      }
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "The adoption of ASU 2022-04 by both GE and MMM requires similar disclosures for supplier finance programs, but their implementations differ in presentation and scope. Both companies disclose confirmed invoice balances (GE reports $0.3 billion as of December 31, 2024; MMM reports $0.3 billion for 2024 and 2023) and present these obligations within accounts payable on their balance sheets. However, GE's adoption statement (Chunk 1) emphasizes the retrospective approach with prospective roll-forward starting January 1, 2024, while MMM's detailed note (Chunk 3) specifies that program activity includes approximately $1.5 billion of invoices confirmed and paid in 2024, providing more granular roll-forward metrics. Crucially, Chunk 2 confirms ASU 2022-04's core requirement for annual disclosures of program terms, balance sheet presentation, confirmed balances, and roll-forward information—details that both entities implement but with MMM offering explicit quantitative roll-off data (invoices confirmed/paid) absent in GE's more general adoption note. This contrast highlights MMM's more transparent, granular disclosure of program activity under the same standard.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Agrees]- ORG",
      "triplets_used": [
        "GE (ORG) -> ASU 2022-04 (ACCOUNTING_POLICY)",
        "ASU 2022-04 (ACCOUNTING_POLICY) -> Supplier Finance Programs (ACCOUNTING_POLICY)",
        "Supplier Finance Programs (ACCOUNTING_POLICY) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17062,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4963,
        "completion_tokens": 293,
        "total_tokens": 5256
      }
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria's equity-method accounting for its Cronos investment exposes it to financial risks tied to Cronos's compliance with FDA regulations through the indirect regulatory exposure inherent in its 42% ownership stake, where Cronos operates in the cannabis market subject to FDA oversight of cannabis-derived products under the Federal Food, Drug, and Cosmetic Act, creating potential liability for Altria if Cronos fails to comply with evolving FDA guidelines on cannabis products, which could trigger impairment charges on Altria's investment and impact its financial statements as noted in Note 7 of its 10-K. In contrast, Walmart's exposure through its pharmacy operations under the same regulatory framework manifests via direct regulatory enforcement by the DEA and FDA on controlled substance distribution, requiring strict compliance with pharmaceutical regulations that could result in product seizures, criminal penalties, or operational disruptions—exposing Walmart to immediate financial liabilities and reputational damage through its controlled substance licensing and dispensing practices, as detailed in its 10-K's Item 1 discussing DEA enforcement powers and recent regulatory scrutiny over drug pricing and compliance. Both companies face regulatory risks under the ORG-Subject_To-REGULATORY_REQUIREMENT relationship pattern, but Altria's risk is indirect and tied to its equity-method accounting of Cronos's compliance (impacting investment value), while Walmart's risk is direct and operational (impacting its pharmacy business), with both ultimately connected through the shared regulatory nexus of FDA/DEA oversight as reflected in the KG triplet connections across all chunks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MO (ORG) -> Cronos (COMP)",
        "Cronos (COMP) -> FDA Regulations (REGULATORY_REQUIREMENT)",
        "FDA Regulations (REGULATORY_REQUIREMENT) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18496,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5314,
        "completion_tokens": 424,
        "total_tokens": 5738
      }
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "LLY's reliance on Cardinal Health for U.S. distribution amplifies CVS's consolidated financial exposure to Red Oak Sourcing, as Cardinal serves as the exclusive sourcing partner for both entities through their 50/50 joint venture. This arrangement, formalized in Red Oak's VIE structure, requires Cardinal to make quarterly payments to CVS that are recognized as reductions in inventory costs when sold, directly linking Cardinal's operational role to CVS's financial performance. The consolidation of Red Oak in CVS's financial statements—driven by CVS's control over key activities—means Cardinal's dual role as both joint venture partner and distributor creates a concentrated exposure pathway where Cardinal's distribution dominance (accounting for 15-20% of LLY's U.S. revenue) and Red Oak's sourcing mechanics collectively channel financial risk through CVS's consolidated results.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Depends_On]-> COMP <-[Consolidates]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Cardinal Health, Inc. (COMP)",
        "Cardinal Health, Inc. (COMP) -> Red Oak Sourcing,LLC (COMP)",
        "Red Oak Sourcing,LLC (COMP) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_138",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13511,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4043,
        "completion_tokens": 221,
        "total_tokens": 4265
      }
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle's $6.0 billion commercial paper program provides short-term unsecured financing that directly coexists with Cisco's $13.5 billion senior fixed-rate notes, as evidenced by the KG relationship where Senior Fixed-Rate Notes (FIN_INST) are Related_To Commercial Paper Notes (FIN_INST) and both are issued by their respective issuers (ORCL and CSCO). Crucially, Cisco explicitly states its senior notes \"rank at par with the commercial paper notes that have been issued pursuant to our short-term debt financing program,\" confirming a pari passu (equal standing) ranking between Cisco's $13.5 billion senior fixed-rate notes and its commercial paper obligations, mirroring the structural equivalence implied by Oracle's program. This structural parity means both companies utilize these instruments as complementary short-term financing tools within their broader capital structure, with Cisco's senior notes specifically designed to maintain equal priority with its commercial paper issuances.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST -[Related_To]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Commercial Paper Notes (FIN_INST)",
        "Commercial Paper Notes (FIN_INST) -> Senior Fixed-Rate Notes (FIN_INST)",
        "Senior Fixed-Rate Notes (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5481,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2069,
        "completion_tokens": 249,
        "total_tokens": 2318
      }
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy's Commercial Renewables segment relies on wind energy as a key generation source, as explicitly stated in its 10-K filing, which aligns with its broader strategy of developing and acquiring generation assets for wholesale electricity sales. Southern Company's strategic commitment to the Skookumchuck wind project, a 136 MW wind facility with a 20-year Power Purchase Agreement (PPA), directly connects to Duke Energy's reliance on wind through the shared product category, though Southern Company (SO) is the owner/operator of Skookumchuck, not Duke Energy. This contrast highlights Duke Energy's diversified wind portfolio (including projects like Glass Sands at 118 MW with 12-year PPAs) versus Southern Company's focused, long-term 20-year PPA commitment for the 136 MW Skookumchuck project, underscoring differing strategic approaches to wind energy within their respective commercial renewable operations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Wind (PRODUCT)",
        "Wind (PRODUCT) -> Skookumchuck (PRODUCT)",
        "Skookumchuck (PRODUCT) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_330",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_330",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11996,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3676,
        "completion_tokens": 230,
        "total_tokens": 3907
      }
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "The capital buffer requirement structure under the Advanced Approach for MS and SCHW both incorporate the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve, as reflected in the KG relationship where CCyB (REGULATORY_REQUIREMENT) is connected to both MS and SCHW (ORG) through Subject_To links. While MS's capital buffer requirement under the Advanced Approach includes the CCyB as part of its sum with the 2.5% capital conservation buffer and G-SIB surcharge, SCHW explicitly maintains a zero CCyB but still requires additional buffers like the stress capital buffer (2.5%) and capital conservation buffer (2.5%) for its regulatory capital ratios, as detailed in its disclosure of minimum requirements (7.0%, 8.5%, 10.5%) for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MS (ORG) -> Capital Conservation Buffer (REGULATORY_REQUIREMENT)",
        "Capital Conservation Buffer (REGULATORY_REQUIREMENT) -> Countercyclical Capital Buffer (REGULATORY_REQUIREMENT)",
        "Countercyclical Capital Buffer (REGULATORY_REQUIREMENT) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3243,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 207,
        "total_tokens": 1730
      }
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney applies discounted cash flow models to value Level 2 derivatives and to assess impairment on non-recurring assets, as disclosed in its 10‑K (Notes 2, 4, 18), while Meta uses the same DCF methodology to estimate the fair value of impaired operating‑lease ROU assets and leasehold improvements, recording a $383 million impairment charge in fiscal 2024 based on market‑participant assumptions and Level 3 inputs (see Meta 10‑K, page 98, Note 3). Both companies rely on observable market inputs for their DCF models, but Disney’s derivative valuations focus on interest‑rate, yield‑curve and FX inputs, whereas Meta’s impairment DCF incorporates lease‑term assumptions, projected sublease income and credit‑risk‑adjusted discount rates to determine the recoverable amount of lease assets.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Level 2 Derivatives (FIN_INST)",
        "Level 2 Derivatives (FIN_INST) -> Discounted Cash Flow Models (ACCOUNTING_POLICY)",
        "Discounted Cash Flow Models (ACCOUNTING_POLICY) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11974,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3691,
        "completion_tokens": 198,
        "total_tokens": 3889
      }
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "The 8.2% volume growth in Turkey's total tobacco market—driven by eased pandemic restrictions and tourism but partially offset by rising illicit trade—directly strengthens **PM's market share** in that market, as evidenced by its regional market share increase to 23.1% (Chunk 2), while **MO faces heightened illicit trade risks** in its broader operations, particularly in markets like Turkey where illicit prevalence is explicitly cited as a headwind (Chunk 3). This contrast underscores PM's more favorable exposure dynamics in Turkey relative to MO's overall vulnerability to illicit trade across its global tobacco business.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "PM (ORG) -> Turkey (GPE)",
        "Turkey (GPE) -> Illicit Trade (RISK_FACTOR)",
        "Illicit Trade (RISK_FACTOR) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18503,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5314,
        "completion_tokens": 157,
        "total_tokens": 5471
      }
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The Inflation Reduction Act's redesign of Medicare Part D shifts liability toward plans and imposes government‑set pricing caps, which directly increases CVS's exposure to higher claim costs and potential penalties under the new regulations. At the same time, AbbVie's blockbuster drug Imbruvica is slated for Medicare price‑setting under the IRA, meaning its Medicare Part D reimbursement will be capped at a statutory ceiling—significantly reducing AbbVie's pricing flexibility and revenue from that product. Both entities must therefore adjust their financial and pricing strategies to accommodate the IRA's expanded government control and cost‑containment mandates.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Redesigns]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Medicare Part D Program (REGULATORY_REQUIREMENT)",
        "Medicare Part D Program (REGULATORY_REQUIREMENT) -> IRA (REGULATORY_REQUIREMENT)",
        "IRA (REGULATORY_REQUIREMENT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17354,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5038,
        "completion_tokens": 167,
        "total_tokens": 5206
      }
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing (BA) relies on third-party aircraft value publications to determine fair value for impaired customer financing assets, using median collateral values adjusted for aircraft-specific conditions or expected net sales prices, with management reviewing these publications quarterly for market consistency. RTX values its private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, incorporating valuation adjustments based on portfolio company performance, while both entities employ unobservable inputs—Boeing through market-based third-party aircraft valuations and RTX through discounted cash flow models and multiples—to estimate fair value for Level 3 investments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Not_Subject_To]-> FIN_INST <-[Values]- ORG",
      "triplets_used": [
        "BA (ORG) -> Fair Value Table (ACCOUNTING_POLICY)",
        "Fair Value Table (ACCOUNTING_POLICY) -> Private Equity Limited Partnerships (FIN_INST)",
        "Private Equity Limited Partnerships (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_165",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5407,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2054,
        "completion_tokens": 182,
        "total_tokens": 2236
      }
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "META's Class A common stock carries one vote per share while Class B carries ten votes per share, creating a stark voting power disparity that concentrates control in the hands of insiders who hold the high‑voting Class B shares; this structure is reinforced by META's disclosed outstanding share counts of 2,189,898,148 Class A and 343,761,117 Class B shares, meaning that even a modest number of Class B shares can dominate board and shareholder decisions. In contrast, Alphabet (GOOGL) also operates with a dual‑class system where Class B shares hold ten votes per share, but its recent aggressive share‑repurchase program—$62 billion in 2024 alone and an additional $70 billion authorized—has reduced the relative proportion of high‑voting shares outstanding, thereby diluting the concentration of voting power over time. Consequently, while META's fixed share structure leaves voting control heavily weighted toward Class B holders, GOOGL's ongoing buybacks can lessen that concentration by shrinking the pool of high‑voting shares, illustrating how differing capital‑allocation strategies can either amplify or mitigate insider dominance across the two tech giants.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9503,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3063,
        "completion_tokens": 292,
        "total_tokens": 3356
      }
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "Procter & Gamble (PG) operates in Greater China, which explicitly includes Taiwan as a geographic sub-region, positioning PG as a key player across this entire market; meanwhile, PepsiCo (PEP) demonstrates strong performance in APAC's convenient foods segment with 19% unit volume growth—including low-single-digit growth specifically in Taiwan—highlighting overlapping but distinct market dynamics where Taiwan serves as both a shared market and a critical component of PG's Greater China structure and PEP's APAC growth narrative.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> Greater China (GPE)",
        "Greater China (GPE) -> Taiwan (GPE)",
        "Taiwan (GPE) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11885,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3636,
        "completion_tokens": 133,
        "total_tokens": 3769
      }
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The updated PCA Framework thresholds under Basel III raise the CET1 capital ratio requirement for Category III institutions like BAC and COF to 6.5% (from 4.5%), with BAC maintaining a 6.5% CET1 ratio and COF at 4.5% under its Category III classification, while both institutions remain well-capitalized under the revised framework. The Basel III Finalization Proposal would phase in recognition of AOCI in CET1 capital and reduce deduction thresholds for Category III/IV institutions, potentially affecting capital ratios by 2028, though current thresholds under Basel III require BAC to hold 6.5% CET1 and COF 4.5% to be well-capitalized, with both institutions meeting these levels as of 2023.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Updates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> Basel III Capital Rules (REGULATORY_REQUIREMENT)",
        "Basel III Capital Rules (REGULATORY_REQUIREMENT) -> PCA Framework (REGULATORY_REQUIREMENT)",
        "PCA Framework (REGULATORY_REQUIREMENT) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_192",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12204,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3751,
        "completion_tokens": 174,
        "total_tokens": 3925
      }
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "The sensitivity of NFLX's content amortization to viewing pattern assumptions—examined through audit-performed sensitivity analyses that test changes in historical and forecasted viewing hours—differs fundamentally from T's sensitivity analyses around pension discount rates and goodwill impairment assumptions, which focus on actuarial inputs (e.g., corporate bond yields) and valuation methodology adjustments (e.g., terminal growth rates) to assess impacts on pension obligations and impairment losses. While NFLX's approach directly ties amortization changes to viewing pattern shifts, T's analyses evaluate discount rate and impairment assumption variations to gauge effects on pension liabilities and goodwill valuation, reflecting distinct financial risk profiles tied to content consumption versus long-term liability and asset valuation uncertainties.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reviews]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Auditor (ACCOUNTING_POLICY)",
        "Auditor (ACCOUNTING_POLICY) -> Sensitivity Analyses (ACCOUNTING_POLICY)",
        "Sensitivity Analyses (ACCOUNTING_POLICY) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15857,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4643,
        "completion_tokens": 215,
        "total_tokens": 4858
      }
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe maintains a localized field office presence in Taiwan as part of its broader global operations, with specific mention of Taiwan among its international office locations in the marketing and sales section of its 2022 10-K filing (Chunk 1), indicating a direct operational footprint in the region. While Adobe's disclosures highlight its Taiwan office as part of its worldwide field office network supporting sales and customer engagement, Apple's strategy for the Greater China region—which explicitly includes Taiwan—differs in structure and scale, as evidenced by Apple reporting $74.2 billion in net sales attributed to Greater China (Chunk 3), a figure that encompasses Taiwan within its broader geographic segment. This contrast is further illuminated by the knowledge graph relationship where Taiwan (GPE) is connected to both Adobe (ORG) via Operates_In and to Greater China (GPE), while Greater China is linked to Apple (ORG), underscoring how Apple aggregates Taiwan within its larger Greater China segment strategy, whereas Adobe treats Taiwan as a distinct operational location within its global field office model.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8232,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2721,
        "completion_tokens": 282,
        "total_tokens": 3004
      }
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin (LMT) discloses in its 10-K that its credit facilities and certain derivatives reference LIBOR-based rates, with contractual fallback language and adherence to the ISDA 2020 IBOR Fallbacks Protocol to manage the transition to alternative rates like SOFR, while explicitly stating it does not expect a significant impact to results or cash flows from the LIBOR transition. Both LMT and 3M reference ASU 2020-04 (Reference Rate Reform) in their filings as the accounting framework governing this transition, with 3M’s disclosure confirming it reviewed relevant arrangements and determined the ASU’s implications would not materially affect its financial statements. However, 3M’s preparedness is further characterized by its proactive assessment of contractual modifications under ASU 2020-04, concluding no material impact, whereas LMT’s exposure is defined by its LIBOR-linked instruments and fallback mechanisms under the same regulatory framework.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Reference Rate Reform (REGULATORY_REQUIREMENT)",
        "Reference Rate Reform (REGULATORY_REQUIREMENT) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15749,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4631,
        "completion_tokens": 241,
        "total_tokens": 4873
      }
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "CMCSA's voting power structure shows Class A common stock holders control 66 ⅔% of the combined voting power, while Class B common stock holders control 33 ⅓% despite representing only one‑third of the total share count. Each Class B share carries 15 votes, which concentrates control in the hands of Mr. Brian L. Roberts, who beneficially owns all outstanding Class B shares, thereby giving him decisive influence over shareholder decisions even though the Class B shares constitute a minority of total shares. This 15‑vote‑per‑share mechanism ensures that Class B holders maintain a fixed, non‑dilutable majority of voting power (33 ⅓%) that cannot be overridden by the larger number of Class A shares.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13959,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4165,
        "completion_tokens": 176,
        "total_tokens": 4341
      }
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "CMCSA's sensitivity analyses focus on interest rate risk from its debt portfolio, quantifying impacts on consolidated interest expense through market valuation techniques tied to variable-rate debt and swaps, while NFLX's sensitivity analyses evaluate changes to content amortization driven by viewing pattern assumptions, reflecting exposure to operational risk in its streaming business model. Both companies are audited by the same firm, which performed procedures on each company's respective sensitivity analyses—CMCSA's interest rate risk modeling and NFLX's content amortization assumptions—ensuring consistency in audit methodology despite their distinct financial risk profiles. This shared auditor relationship underscores standardized oversight of their divergent sensitivity approaches, where CMCSA manages macroeconomic interest rate volatility and NFLX mitigates estimation risk in content valuation.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Sensitivity Analyses (ACCOUNTING_POLICY)",
        "Sensitivity Analyses (ACCOUNTING_POLICY) -> Auditor (ACCOUNTING_POLICY)",
        "Auditor (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11482,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3547,
        "completion_tokens": 228,
        "total_tokens": 3775
      }
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer's Enbrel U.S. formulation patent expires in 2037, creating a critical competitive window where AbbVie's biologics face no direct biosimilar challenge under the 12-year Hatch-Waxman exclusivity framework, while AbbVie's regulatory exclusivity strategy for its own biologics (like Prolia) extends beyond patent terms through mechanisms such as pediatric extensions and orphan drug designations, thereby positioning AbbVie to maintain market dominance in inflammation/immunology longer than Pfizer's Enbrel, which loses its key U.S. formulation protection only in 2037 after earlier patent expirations for other Enbrel-related claims.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Decreases]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Enbrel (PRODUCT)",
        "Enbrel (PRODUCT) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8637,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2834,
        "completion_tokens": 159,
        "total_tokens": 2993
      }
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "A shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge would materially reduce JPMorgan Chase’s capital requirements under a resolution scenario where the Parent Company enters bankruptcy, as the lower surcharge directly decreases the capital burden on the bank (MS_10k_2023.pdf, page 60). This reduction would occur within the context of the G-SIB surcharge proposal’s impact on capital requirements (KG: Capital Requirements → G-SIB Surcharge Proposal → MS), while the loss-absorbing structure of eligible long-term debt ensures that creditors, not equity holders, first absorb losses in a bankruptcy resolution, preserving value for subsidiaries (Chunk 1). The proposed effective date—two calendar quarters after final Federal Reserve rule adoption—further ties the regulatory change to JPMorgan’s capital planning (MS_10k_2023.pdf, page 60).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Impacts]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Capital Requirements (REGULATORY_REQUIREMENT)",
        "Capital Requirements (REGULATORY_REQUIREMENT) -> G-SIB Surcharge Proposal (REGULATORY_REQUIREMENT)",
        "G-SIB Surcharge Proposal (REGULATORY_REQUIREMENT) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6315,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2302,
        "completion_tokens": 220,
        "total_tokens": 2523
      }
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "LMT applies a discounted cash flow approach to value Level 3 fixed income investments, relying on significant inputs such as projected annuity payments and the discount rate applied to those payments, as disclosed in its Level 3 valuation methodology. HON similarly employs a discounted cash flow approach to test goodwill and indefinite-lived intangible assets for impairment, explicitly using assumptions about expected cash flows and discount rates that are subject to sensitivity analysis, with impairment measured as the excess of carrying amount over fair value derived from these discounted cash flow estimates. Both companies utilize DCF methodologies for Level 3 valuations, but LMT applies it directly to fixed income investments with projected payments, while HON uses it to assess fair value in impairment testing of goodwill and intangible assets, where the discount rate and cash flow projections are key drivers of potential impairment.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> Discounted Cash Flow Approach (ACCOUNTING_POLICY)",
        "Discounted Cash Flow Approach (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10883,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3431,
        "completion_tokens": 237,
        "total_tokens": 3668
      }
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T's pension discount rates are tied to corporate bond credit quality, requiring auditors to evaluate the credit quality of bonds and their correlation with benefit payment timing, whereas Netflix amortizes content using forecasted viewing patterns that are subject to auditor review of historical and projected consumption trends; both scenarios involve auditors testing management's significant assumptions—AT&T's through discount rate validation and Netflix's through viewing pattern modeling—highlighting how auditors assess the reasonableness of critical judgments across different accounting policies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Tests]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "triplets_used": [
        "T (ORG) -> Significant Assumptions (ACCOUNTING_POLICY)",
        "Significant Assumptions (ACCOUNTING_POLICY) -> Auditor (ACCOUNTING_POLICY)",
        "Auditor (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15857,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4660,
        "completion_tokens": 152,
        "total_tokens": 4813
      }
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "The adoption timeline of ASU No. 2023-07 differs between MO and PM: MO will begin interim disclosures in the first quarter of 2025, while PM adopted the standard for its year-end December 31, 2024 financial statements with retrospective application to prior periods. Both companies implemented changes to segment reporting by disaggregating expense information, with PM specifically integrating former Swedish Match results into its four geographical segments and requiring incremental disclosures of disaggregated segment expenses as outlined in Note 22 of its financial statements.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Updates]- ORG",
      "triplets_used": [
        "MO (ORG) -> ASU No. 2023-07 (ACCOUNTING_POLICY)",
        "ASU No. 2023-07 (ACCOUNTING_POLICY) -> Segment Reporting (ACCOUNTING_POLICY)",
        "Segment Reporting (ACCOUNTING_POLICY) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11351,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3513,
        "completion_tokens": 145,
        "total_tokens": 3659
      }
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "The IRA’s Medicare Part D drug‑price negotiation will affect both Bristol‑Myers Squibb and Pfizer, but the scale of exposure differs because of each company’s product mix and regulatory exclusivity timelines.  BMY’s Pomalyst is slated for negotiation beginning in 2027, and its broader portfolio (including Eliquis, Opdivo, Revlimid, etc.) faces price caps and rebates that could erode revenue once exclusivity ends, whereas PFE’s near‑term IRA impact is projected to be roughly $1 billion of unfavorable revenue in 2025 from Part D redesign changes, with additional negotiation‑related price cuts expected for drugs such as Ibrance and Xtandi starting in 2027.  Consequently, BMY’s revenue outlook is more directly tied to the loss of market exclusivity for Pomalyst and other high‑cost Part D products under the IRA’s negotiation schedule, while PFE’s outlook is shaped by a larger near‑term revenue hit from the overall Part D discount and rebate structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Pomalyst (PRODUCT)",
        "Pomalyst (PRODUCT) -> IRA (REGULATORY_REQUIREMENT)",
        "IRA (REGULATORY_REQUIREMENT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13827,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4150,
        "completion_tokens": 240,
        "total_tokens": 4390
      }
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDLZ's Argentine operations generated $401 million in net revenue in 2021, representing 1.4 % of its consolidated sales and involving $9 million of peso‑denominated net monetary assets that were remeasured into dollars, resulting in a $13 million remeasurement loss for the year【MDLZ_10k_2022.pdf, page_89】; KO's reliance on Arca Continental in Argentina is highlighted by Arca Continental's status as one of KO's top bottlers, operating in northern Argentina and forming part of KO's network of five largest bottling partners that together accounted for 41 % of worldwide unit case volume【KO_10k_2022.pdf, page_7】; the KG relationship ORG → Operates_In → GPE → Operates_In → COMP → Has_Stake_In → ORG links MDLZ‑Argentina, Argentina‑Arca Continental, and Arca Continental‑KO, underscoring that both companies have a stake in the same Argentine market but through different operational roles【MDLZ_10k_2022.pdf, page_89】 and 【KO_10k_2022.pdf, page_7】.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Argentina (GPE)",
        "Argentina (GPE) -> Arca Continental (COMP)",
        "Arca Continental (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16222,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4732,
        "completion_tokens": 237,
        "total_tokens": 4970
      }
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "BMY's Fast Track Designation for PR006, as reflected in the KG relationship Fast Track Designation → PR006, validates the gene therapy's regulatory pathway and accelerates its development timeline, directly enhancing LLY's strategic acquisition of Prevail's portfolio. This regulatory advantage, combined with the CVR payment structure tied to PR006's approval by December 31, 2024 (with declining value thereafter), creates a clear milestone-driven financial incentive that aligns with LLY's long-term investment in neurodegenerative disease therapies, while also underscoring the importance of global regulatory approvals across key markets like the U.S., Japan, and Germany as outlined in the acquisition terms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Receives]-> PRODUCT <-[Acquires]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Fast Track Designation (REGULATORY_REQUIREMENT)",
        "Fast Track Designation (REGULATORY_REQUIREMENT) -> PR006 (PRODUCT)",
        "PR006 (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9949,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3174,
        "completion_tokens": 178,
        "total_tokens": 3353
      }
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "V's Class A common stock shares increased from 1,594 (2023) to 1,733 (2024), reflecting organic growth in its own equity structure. This contrasts with MA's Class B-to-A conversion mechanism, where only 7 Class B shares were outstanding in 2024 (as disclosed in MA's 10-K), requiring full conversion to Class A shares upon sale or transfer—eliminating Class B holdings entirely. Consequently, MA's shareholder structure dynamics differ significantly: V's Class A growth stems from internal equity changes, while MA's Class B shares (though minimal in number) are inherently tied to conversion-driven transitions that reduce Class B outstanding shares to zero post-conversion, accelerating Class A share concentration among restricted eligible holders.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Changes_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 23728,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 6641,
        "completion_tokens": 187,
        "total_tokens": 6828
      }
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Saudi Arabia's data localization mandates—highlighted as a risk by Adobe (ADBE) in its 10-K filing—require storage and processing of data within the country, which conflicts with U.S. export controls restricting NVIDIA's (NVDA) H100 and L40S chip shipments to certain Middle Eastern nations under the AI Diffusion IFR. This regulatory tension creates a dual challenge: while Saudi localization laws compel NVIDIA to potentially establish domestic data infrastructure, U.S. export rules may block the deployment of its high-performance chips unless specific licenses are secured, directly limiting its ability to serve the market under current U.S. regulations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Implements]-> GPE <-[Depends_On]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Data Localization Requirements (REGULATORY_REQUIREMENT)",
        "Data Localization Requirements (REGULATORY_REQUIREMENT) -> Saudi Arabia (GPE)",
        "Saudi Arabia (GPE) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19569,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5587,
        "completion_tokens": 165,
        "total_tokens": 5752
      }
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx and GE both applied ASU 2020-04 (and its extension by ASU 2022-06) to ease accounting for LIBOR discontinuation, but their disclosures reflect distinct applications of the relief: FedEx explicitly details ongoing monitoring of contracts for potential application of the ASUs through December 31, 2024, and notes no material effect as of May 31, 2024, while GE states the overall impact on its financial statements is immaterial and does not elaborate on future monitoring or specific contract assessments. This divergence is underscored by their KG connections—FDX links to ASU 2022-06 (which extends ASU 2020-04’s sunset date to December 31, 2024), ASU 2020-04 links to GE, and ASU 2022-06 is tied to FDX—ensuring all chunks are integrated to show FedEx’s proactive, detail-oriented disclosure of continued evaluation versus GE’s concise, immateriality-focused statement.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Defers]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "FDX (ORG) -> ASU 2022-06 (ACCOUNTING_POLICY)",
        "ASU 2022-06 (ACCOUNTING_POLICY) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_168",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11295,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3499,
        "completion_tokens": 219,
        "total_tokens": 3719
      }
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Geopolitical tensions involving Taiwan could materially disrupt both Apple and NVIDIA's supply chains by jeopardizing their reliance on foundry partners and manufacturing locations in the region. As noted in the KG pattern (AAPL → Taiwan → Foundry Partners ← Depends_On → NVDA), Taiwan serves as a critical hub for Apple's contract manufacturers and NVIDIA's key suppliers, with both companies explicitly identifying geopolitical instability in the area as a risk that could impair production, delay shipments, and force costly restructuring of their supply networks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Operates_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Foundry Partners (COMP)",
        "Foundry Partners (COMP) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18332,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5243,
        "completion_tokens": 141,
        "total_tokens": 5385
      }
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Based on the provided data, **100% of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation (VCF)**, as explicitly stated in Chunk 2 (\"$15,239 million related to customer contracts... of which a significant portion related to certain customer contracts; $4,730 million related to in-process research and development... of which $4,705 million related to VCF\") and Chunk 3 (\"Developed technology relates to products used for VMware cloud foundation...\"). This $24,156 million represents the total developed technology intangible asset acquired, with VCF being the sole specified application area for a significant portion of it, and the KG triplet relationship (VCF → Produces → AVGO) confirms its direct connection to Broadcom's acquisition.  \n\nOracle's net developed technology intangible asset is $1,893 million (from Chunk 1's \"Developed technology\" row under \"Intangible Assets, Net\"), which constitutes **38.6%** of its total intangible assets net ($9,837 million), calculated as ($1,893 / $9,837) × 100. This contrasts with Broadcom's VCF-specific allocation, where the entire $24,156 million developed technology asset is explicitly linked to VCF through the acquisition details and KG relationships.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Developed Technology (PRODUCT)",
        "Developed Technology (PRODUCT) -> VMware Cloud Foundation (PRODUCT)",
        "VMware Cloud Foundation (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7434,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2554,
        "completion_tokens": 323,
        "total_tokens": 2878
      }
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "The voting power distribution tied to Class B common stock at CMCSA is concentrated in Mr. Brian L. Roberts, who beneficially owns all outstanding Class B shares representing 33.3% of the combined voting power, while Class A holders collectively possess 66.7% voting power. In contrast, GOOGL's structure shows Class A Common Stock (with 1 vote per share) is linked to Class B Common Stock through the KG pattern, but its specific voting distribution and non-affiliate market value ($1.451 trillion as of June 30, 2021) are not detailed in the provided chunks, whereas CMCSA's non-affiliate market value context and class-based control mechanisms (e.g., non-dilutable Class B voting power) are explicitly documented.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4379,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1779,
        "completion_tokens": 179,
        "total_tokens": 1958
      }
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "The equity structure concentration of CMCSA and META reflects markedly different share class dynamics as disclosed in their 2024 filings. CMCSA’s equity features only Class A common stock with a modest 9.4 million issued Class B shares (par value $0.01), indicating a relatively concentrated ownership base, whereas META discloses both Class A (1 vote per share) and Class B (10 votes per share) common stock, with 2.19 billion Class A and 343.8 million Class B shares outstanding, highlighting a more fragmented voting concentration. This contrast is reinforced by the KG relationship where Class B Common Stock (CMCSA) is linked to META, underscoring that META’s dual‑class structure disperses equity ownership across broader investor segments compared with CMCSA’s single‑class profile.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14427,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4281,
        "completion_tokens": 197,
        "total_tokens": 4478
      }
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS's Oak Street Health faces direct Medicare reimbursement risks through its dependence on Medicare revenue streams and participation in Medicare programs, with exposure to potential payment reductions or rule changes affecting its primary care operations. The IRA's price-setting provisions specifically target AbbVie's Medicare Part D and Part B drug reimbursements, creating distinct regulatory exposure where government price-setting could significantly reduce revenues from its high-revenue pharmaceutical products starting in 2026 and 2028. Both entities operate under heightened regulatory risk from government programs, but CVS's exposure centers on provider reimbursement and Medicare Advantage rules, while AbbVie's stems from statutory drug pricing mechanisms under the IRA.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> REGULATORY_REQUIREMENT -[Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Medicare Program (REGULATORY_REQUIREMENT)",
        "Medicare Program (REGULATORY_REQUIREMENT) -> IRA (REGULATORY_REQUIREMENT)",
        "IRA (REGULATORY_REQUIREMENT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16743,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4874,
        "completion_tokens": 196,
        "total_tokens": 5070
      }
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft's inclusion of operating systems in its product revenue creates a critical dependency for AMD, as explicitly stated in both Chunk 2 and Chunk 3: AMD's ability to innovate beyond Intel's x86 instruction set and successfully market its x86-based microprocessors and graphics products directly relies on Microsoft continuing to design and develop operating systems that run on or support AMD's hardware, including certification of drivers and software development for AMD's platforms. This dependency is underscored by AMD's explicit warning that loss of Microsoft's support or failure to develop compatible operating systems would materially adversely affect AMD's ability to sell products, as Microsoft's operating system support is foundational for AMD's x86-based microprocessor and graphics product ecosystems.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Includes]-> PRODUCT -[Develops]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Operating Systems (PRODUCT)",
        "Operating Systems (PRODUCT) -> Microsoft Corporation (COMP)",
        "Microsoft Corporation (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15219,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4474,
        "completion_tokens": 205,
        "total_tokens": 4680
      }
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI workload infrastructure relies on its high‑density routers, switches, and observability stack to deliver unified, policy‑consistent multicloud architectures that simplify data‑center operations and provide end‑to‑end visibility for AI training and inference across on‑prem and cloud environments. Broadcom, through its ownership of VMware Cloud Foundation, extends this capability by offering a private‑cloud software stack with native Kubernetes that enables enterprise‑scale AI/ML workloads, workload portability across on‑prem and cloud endpoints, and integrated data‑services—thereby supporting multicloud and Kubernetes integration at scale. The KG pattern CSCO → AI Workloads → VMware Cloud Foundation → AVGO illustrates how Cisco’s networking foundation feeds into VMware’s platform, which Broadcom then leverages to enable enterprise‑wide, Kubernetes‑ready, multicloud AI deployments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Enables]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> AI Workloads (PRODUCT)",
        "AI Workloads (PRODUCT) -> VMware Cloud Foundation (PRODUCT)",
        "VMware Cloud Foundation (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8140,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2727,
        "completion_tokens": 225,
        "total_tokens": 2952
      }
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal relies on Level 2 fair value measurements for derivatives, using observable inputs like currency rates and interest rates without significant unobservable assumptions, whereas Morgan Stanley employs Level 3 techniques for non-tradable investments that depend on significant unobservable inputs and judgment, particularly for private equity and structured products, highlighting a key contrast in valuation approaches where PayPal avoids Level 3 reliance while Morgan Stanley uses it for certain assets.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> Level 3 Valuation (ACCOUNTING_POLICY)",
        "Level 3 Valuation (ACCOUNTING_POLICY) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_212",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9014,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2936,
        "completion_tokens": 127,
        "total_tokens": 3063
      }
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "The ownership structure of META's 343,761,117 outstanding Class B shares, which carry limited voting rights except on specific corporate actions, creates a significantly constrained environment for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares that serve as the primary voting class with full voting rights on all matters. This fundamental difference in voting power—where META's Class B holders cannot influence routine governance decisions without Class A approval, while CMCSA's Class A shares dominate voting control—means that shareholder proposals at META would require substantially higher coordination and consensus across both classes to effect change, whereas CMCSA's Class A dominance enables existing shareholders to more readily drive governance outcomes through their primary voting class.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15439,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4581,
        "completion_tokens": 214,
        "total_tokens": 4795
      }
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "Based on the provided data, 71 % of Coca‑Cola’s non‑U.S. unit case volume is attributable to sparkling soft drinks in the territories where CCEP operates. In Portugal—one of CCEP’s key markets—PM’s presence is demonstrated by its manufacturing footprint that includes a major facility in Portugal, highlighting its operational reach in that territory.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> CCEP (COMP)",
        "CCEP (COMP) -> Portugal (GPE)",
        "Portugal (GPE) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14512,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4288,
        "completion_tokens": 87,
        "total_tokens": 4376
      }
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco's reduction in credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023 indicates a significant improvement in its expected credit risk, freeing up capital that can be redeployed to support its financing activities. Because technical support services are explicitly included in the loan receivables portfolio (Loan Receivables → Technical Support → ADBE) and Cisco discloses these receivables as financing arrangements for hardware, software and related services (including technical support), the lower allowance suggests stronger confidence in collecting payments from customers who purchase such support. Consequently, Cisco may be better positioned to extend or expand financing for technical support contracts, using the reduced loss provision to maintain or increase funding for these service‑related receivables.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Provides]-> PRODUCT -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Technical Support (PRODUCT)",
        "Technical Support (PRODUCT) -> Loan Receivables (FIN_INST)",
        "Loan Receivables (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_8",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6983,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2433,
        "completion_tokens": 215,
        "total_tokens": 2648
      }
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T's Series B Preferred Stock grants limited voting rights exclusively on specific merger-related matters (e.g., approvals requiring affirmative votes of each series' outstanding voting power), whereas Netflix's common stockholders possess universal voting rights on all matters, including amendments to the certificate of incorporation affecting preferred stock. This structural distinction creates a critical governance difference: AT&T's preferred shareholders wield voting influence only in narrowly defined corporate restructuring scenarios, while Netflix's common shareholders exercise broad, unrestricted voting authority across all shareholder matters. The KG triplet relationship confirms this contrast through the chain: Series B Preferred Stock (AT&T) → Voting Rights (ACCOUNTING_POLICY) → NFLX (ORG), highlighting how AT&T's preferred stock governance differs fundamentally from Netflix's universal common stock voting rights.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "T (ORG) -> Series B Preferred Stock (FIN_INST)",
        "Series B Preferred Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5129,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1974,
        "completion_tokens": 235,
        "total_tokens": 2209
      }
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal faces a heightened risk of technological disruption from emerging payment methods like BNPL and cryptocurrency, as it must continuously innovate to avoid obsolescence and relies on third parties—including competitors—for access to evolving technologies, with failure to adapt potentially harming its business; in contrast, Visa strategically positions itself as both partner and competitor to these alternative payment providers, leveraging its global network, security, and broad acceptance to maintain a competitive edge while navigating complex regulatory landscapes that impact its operations across multiple jurisdictions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> COMP -[Partners_With]-> COMP <-[Competes_With]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Visa (COMP)",
        "Visa (COMP) -> Alternative Payments Providers (COMP)",
        "Alternative Payments Providers (COMP) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16169,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4718,
        "completion_tokens": 158,
        "total_tokens": 4876
      }
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Both Netflix and Alphabet disclose voting rights tied to their common stock structures. Netflix's common stock carries one vote per share, as stated in its 2023 10-K filing (Chunk 1). Alphabet's Class A Common Stock also carries one vote per share, consistent with its disclosed equity structure in the 2023 10-K (Chunks 2 and 3). Therefore, the voting power per share for Netflix's common stock is equivalent to that of Alphabet's Class A Common Stock, each being one vote per share.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Has]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3632,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 121,
        "total_tokens": 1705
      }
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "Both PM and MDLZ apply the parametric delta-gamma approximation under normal market conditions with a 95% confidence interval and one-day holding period to estimate VAR, using observed interest rate, currency, and commodity movements over prior quarters to determine risk parameters. While PM's disclosure emphasizes calculating risk of underlying portfolio positions through these interrelationships for value-at-risk at period ends, MDLZ explicitly states its VAR model estimates the maximum potential one-day loss in fair value for interest rate-sensitive debt and pre-tax earnings from currency/commodity instruments, with its estimated potential loss decreasing to $255 million at September 28, 2024 from $284 million the prior year due to reduced interest rate volatility—demonstrating that despite shared methodology, MDLZ quantifies and reports a specific, audited VAR figure reflecting actual portfolio composition and market condition impacts, whereas PM's description focuses on the computational technique's application without disclosing a comparable audited VAR amount.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "PM (ORG) -> Normal Market Conditions (MACRO_CONDITION)",
        "Normal Market Conditions (MACRO_CONDITION) -> VAR Model (ACCOUNTING_POLICY)",
        "VAR Model (ACCOUNTING_POLICY) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3822,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1651,
        "completion_tokens": 270,
        "total_tokens": 1922
      }
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One's exposure to the Market Risk Rule is triggered by its trading assets meeting the $1 billion threshold (or 10 % of total assets), which subjects it to Basel III‑based capital adjustments; JPMorgan Chase also operates under the same Basel III framework but applies a regulatory VaR methodology that uses a ten‑day holding period and a 99 % confidence level, whereas Capital One’s Market Risk Rule relies on a standardized approach that adjusts risk‑based capital ratios directly based on trading‑book exposures. Consequently, while both firms must satisfy Basel III capital requirements, Capital One’s capital ratios are modified by the Market Risk Rule’s market‑risk adjustments, whereas JPMorgan’s capital adequacy is tied to its Regulatory VaR‑derived capital buffers under the Basel III standardized approach.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> Market Risk Rule (REGULATORY_REQUIREMENT)",
        "Market Risk Rule (REGULATORY_REQUIREMENT) -> Basel III Capital Rules (REGULATORY_REQUIREMENT)",
        "Basel III Capital Rules (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10825,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3424,
        "completion_tokens": 206,
        "total_tokens": 3630
      }
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco's credit loss allowance for loan receivables tied to technical support services is $53 million as of July 29, 2023, reflecting specific risk exposure to service delivery through its financing arrangements with customers. This allowance is directly linked to Loan Receivables that finance technical support and advanced services, which Cisco discloses as part of its financing receivables portfolio. In contrast, Salesforce relies on third-party technical support providers for service delivery, creating indirect exposure to execution risks that Cisco manages internally through its own support infrastructure and credit loss reserves. Both companies face service delivery risks, but Cisco's allowance explicitly accounts for credit losses on financing tied to its proprietary technical support services, while Salesforce's model depends on external provider performance without equivalent disclosed credit loss provisions for such dependencies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Relates_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Technical Support Services (PRODUCT)",
        "Technical Support Services (PRODUCT) -> Loan Receivables (FIN_INST)",
        "Loan Receivables (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_8",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8005,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2685,
        "completion_tokens": 237,
        "total_tokens": 2922
      }
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "The governance risk stemming from META's dual-class structure—where Class B shares retain voting power that can override Class A shareholders' interests—directly undermines investor confidence in Class A stock, as reflected in the “controlled company” disclosures and anti‑takeover provisions that can depress its price. In contrast, CMCSA’s equity includes Class B common stock but does not impose conversion restrictions tied to governance limitations, allowing holders to convert to Class A shares without the same voting‑power constraints, thereby preserving a more conventional governance profile for investors.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Converts_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12877,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3919,
        "completion_tokens": 154,
        "total_tokens": 4073
      }
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG values its RMBS using discounted cash flow models that rely on unobservable inputs such as constant prepayment rates and loss severity, as shown in Chunk 2 where the RMBS fair‑value estimate ($1,321 million) incorporates a range of prepayment rates (4.10%–9.26% weighted avg 6.68%) and loss‑severity rates (40.81%–76.72% weighted avg 58.76%). This valuation approach is explicitly linked to MS’s fair‑value methodology in Chunk 3, which describes Level 3 inputs and the use of discounted cash flow techniques that “incorporate significant unobservable inputs and, therefore, require the greatest use of judgment.” Both firms thus depend on unobservable inputs for DCF‑based fair‑value estimation, but AIG’s RMBS valuation directly applies these inputs to its securities, whereas MS’s discussion frames DCF as part of a broader fair‑value hierarchy and impairment testing process. Consequently, while AIG’s RMBS valuation is a specific instance of DCF relying on those unobservable inputs, MS’s use of DCF in fair‑value estimation is more general and also emphasizes the role of Level 3 inputs across its entire asset portfolio.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_Using]-> ACCOUNTING_POLICY <-[Estimates]- ORG",
      "triplets_used": [
        "AIG (ORG) -> RMBS (FIN_INST)",
        "RMBS (FIN_INST) -> Discounted Cash Flow (ACCOUNTING_POLICY)",
        "Discounted Cash Flow (ACCOUNTING_POLICY) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9903,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3149,
        "completion_tokens": 282,
        "total_tokens": 3431
      }
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "The allowance for credit losses on Cisco's loan receivables tied to hardware financing decreased from $103 million (July 30 2022) to $53 million (July 29 2023), reflecting a $50 million reduction in the provision for loan losses. This contrasts with Microsoft’s revenue‑recognition model, which treats tightly integrated hardware‑software bundles as a single performance obligation and recognizes the associated revenue upfront when control transfers, rather than spreading it over time. Consequently, Cisco’s financial exposure to integrated hardware‑software financing is manifested through a measurable credit‑loss reserve on its receivables, whereas Microsoft’s exposure is reflected in its timing of revenue recognition and reliance on judgments about distinct performance obligations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Loan Receivables (FIN_INST)",
        "Loan Receivables (FIN_INST) -> Hardware (PRODUCT)",
        "Hardware (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6616,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2353,
        "completion_tokens": 197,
        "total_tokens": 2551
      }
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, a figure that reflects its exposure to hybrid structured‑credit products that contain embedded derivatives. This loss is directly tied to the same type of embedded‑derivative instruments that are embedded within the CDOs referenced in Morgan Stanley’s disclosures, where such instruments generate credit‑risk exposure for the issuer. Consequently, while AIG’s standalone embedded‑derivative loss is $75 million, Morgan Stanley’s broader credit‑risk exposure through its CDO holdings—driven by those same embedded derivatives—is not quantified in the provided data but is structurally linked to the same risk drivers.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MS (ORG) -> CDOs (FIN_INST)",
        "CDOs (FIN_INST) -> Embedded Derivatives (FIN_INST)",
        "Embedded Derivatives (FIN_INST) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8442,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2788,
        "completion_tokens": 170,
        "total_tokens": 2959
      }
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney's foreign exchange cash flow hedges for forecasted transactions are designed to cover periods generally not exceeding four years, with the company hedging forecasted foreign currency transactions within an established annual exposure range. The notional amounts of these hedges totaled $9.9 billion as of September 28, 2024, and gains/losses on the contracts offset changes in the U.S. dollar equivalent value of related forecasted transactions, with net deferred gains of $99 million recorded in AOCI for contracts maturing within the next twelve months.  \n\nGoogle's foreign exchange cash flow hedges, as disclosed in its 10-K, specifically target forecasted revenue transactions with maturities of 24 months or less, and the net accumulated gain on these hedges before tax effects was $731 million as of December 31, 2024, expected to be reclassified from AOCI into revenue within the next 12 months.  \n\nThe knowledge graph relationship **Option Contracts → GOOGL** confirms that Google's use of option contracts (as part of its cash flow hedging strategy) is directly linked to its hedging of forecasted transactions, while Disney's hedges (also involving option contracts) are structured for longer durations up to four years, contrasting with Google's 24-month maximum maturity for forecasted revenue hedges. This structural difference—Disney's broader 4-year horizon versus Google's 2-year limit—represents the key comparison of hedge duration between the two companies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Hedges]-> FIN_INST -[Impacts]-> FIN_INST <-[Designates]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Forecasted Transactions (FIN_INST)",
        "Forecasted Transactions (FIN_INST) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9362,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3020,
        "completion_tokens": 370,
        "total_tokens": 3391
      }
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "The Global Minimum Tax is expected to impact QCOM's fiscal year 2025 tax liabilities, but QCOM does not currently expect this to materially affect its consolidated financial statements, as noted in Chunk 1. In contrast, INTC's exposure under the Pillar Two Model Rules is assessed as not expected to materially increase its global tax costs due to the absence of operations in jurisdictions with tax rates below the 15% minimum, though uncertainty remains regarding final rule implementation, as detailed in Chunk 2. Both companies operate in non-US jurisdictions where tax reforms are advancing, but INTC's analysis specifically references the OECD's Pillar Two framework and its phased adoption by jurisdictions like the EU Member States beginning in 2024, while QCOM's exposure is framed around monitoring country-level implementations starting in fiscal 2025.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> Pillar Two Model Rules (REGULATORY_REQUIREMENT)",
        "Pillar Two Model Rules (REGULATORY_REQUIREMENT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7486,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2577,
        "completion_tokens": 215,
        "total_tokens": 2792
      }
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "The voting power disparity between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B rights directly shapes founder control: Alphabet's Class B shares carry 10 votes per share and can convert to Class A (1 vote per share) at the holder's option, while Comcast's Class B shares hold 15 votes per share with non-dilutable voting power protected by its charter. This structure, as revealed in the KG pattern linking ORG (GOOGL) → Class B Common Stock → Class A Common Stock → META (ORG) and reflected in Chunk 1's conversion mechanics and Chunk 2's non-dilutable voting percentages, ensures founders like Zuckerberg (via META's dual-class structure described in Chunk 3) maintain outsized influence—particularly when Class B shares represent less than 50% of combined voting power, triggering special governance thresholds that prioritize controlling stockholder interests over others.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Converts_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6753,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2374,
        "completion_tokens": 229,
        "total_tokens": 2604
      }
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The indemnification agreement between PM USA and PMI allocates tobacco‑product liability based on the manufacturer, with PMI indemnifying Altria and PM USA for claims arising from PMI‑manufactured or contract‑manufactured‑for‑PMI products, and PM USA indemnifying PMI for claims arising from its own manufacturing. Because the fair value of this indemnification is considered insignificant, Altria does not record a related liability on its balance sheet, meaning its direct financial exposure to tobacco‑related litigation is limited to the contingent guarantees it provides for PM USA’s debt and commercial paper. Consequently, while PM USA’s indemnity shields Altria from most tobacco‑product judgments, PM’s retained obligations through the RBH deconsolidation remain minimal and are not reflected in Altria’s recorded liabilities.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> COMP -[Indemnifies]-> COMP <-[Indemnifies]- ORG",
      "triplets_used": [
        "PM (ORG) -> PM USA (COMP)",
        "PM USA (COMP) -> PMI (COMP)",
        "PMI (COMP) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8380,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2751,
        "completion_tokens": 208,
        "total_tokens": 2959
      }
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "The decline in Cisco’s allowance for credit losses on loan receivables—from $103 million in 2022 to $53 million in 2023—reflects a reduced reserve for financing the technical‑support services it bundles with hardware and software sales, indicating tighter credit risk management that may lower the amount of financing available to customers for those support offerings. In contrast, Adobe funds its technical‑support services primarily through subscription and maintenance fees rather than direct loan receivables, so its support financing is not tied to a credit‑loss allowance and remains insulated from the kind of reserve reductions seen at Cisco. Both companies link their financing structures to the products they provide, but Cisco’s financing is explicitly tied to loan receivables for technical support, whereas Adobe’s support is embedded in its subscription model and does not rely on a comparable allowance for credit losses.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Loan Receivables (FIN_INST)",
        "Loan Receivables (FIN_INST) -> Technical Support (PRODUCT)",
        "Technical Support (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6983,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2435,
        "completion_tokens": 234,
        "total_tokens": 2669
      }
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Citibank, N.A. serves as administrative agent in both Caterpillar's 2022 Five-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement, but with distinct operational timelines and syndication structures. While Caterpillar's facility was initially established on September 1, 2022 (with Amendment No. 1 dated August 31, 2023), Boeing's agreement was executed on October 30, 2019 (amended August 25, 2022), reflecting an earlier implementation timeline for Boeing. Both agreements involve Citibank as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger, though Boeing's structure explicitly includes JPMorgan as a named agent in its syndication arrangement, whereas Caterpillar's documentation emphasizes Citibank Europe plc and MUFG Bank as local currency agents without naming a separate syndication agent.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Regulates]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Citibank, N.A. (COMP)",
        "Citibank, N.A. (COMP) -> Five Year Credit Agreement (FIN_INST)",
        "Five Year Credit Agreement (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 25289,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 7014,
        "completion_tokens": 216,
        "total_tokens": 7230
      }
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "A prolonged geopolitical conflict involving Taiwan would severely disrupt the supply chain reliability for both NVIDIA and Qualcomm, as their operations depend on foundry partners located in Taiwan for critical chip manufacturing. This vulnerability is explicitly highlighted in both companies' disclosures: NVIDIA warns that geopolitical tensions in Taiwan could impair its ability to receive consistent chip supply from foundry partners, potentially damaging customer relationships and revenue, while Qualcomm explicitly states that such conflicts could \"severely limit or prevent us from receiving chipset supply from Taiwan,\" directly threatening its business continuity. Both companies further emphasize that disruptions in Taiwan would ripple across their global operations, affecting everything from product manufacturing and shipping to broader economic conditions, ultimately jeopardizing their ability to meet demand and maintain stable supply chains.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> GPE -[Operates_In]-> COMP <-[Supplies]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Foundry Partners (COMP)",
        "Foundry Partners (COMP) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18331,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5239,
        "completion_tokens": 240,
        "total_tokens": 5479
      }
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing's indemnification risk exposure from U.S. government contracts stems from its contractual obligations to assume liability for certain product-related claims (e.g., aircraft systems, cybersecurity, and space technologies) where insurance coverage may be inadequate, particularly outside SAFETY Act protections, while also allocating pension and postretirement costs to U.S. government contracts under Cost Accounting Standards that directly impact contract profitability and equity—exposures amplified by potential liabilities from government contracts that could materially affect financial position. In contrast, 3M's indemnification liabilities transferred to Solventum following the spin-off were formally assumed under the separation agreement, which explicitly transferred and assigned to Solventum all liabilities tied to matters like the Bair Hugger and False Claims Act litigations, with Solventum now obligated to indemnify and defend 3M in these proceedings, thereby shifting the legal and financial risk exposure entirely to the newly independent entity.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Discloses]-> COMP <-[Announces]- ORG",
      "triplets_used": [
        "BA (ORG) -> Indemnification (ACCOUNTING_POLICY)",
        "Indemnification (ACCOUNTING_POLICY) -> Solventum (COMP)",
        "Solventum (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15794,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4635,
        "completion_tokens": 268,
        "total_tokens": 4903
      }
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "The voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, creates a concentrated control mechanism that directly influences META's governance risks through the Class A common stock ownership chain. Specifically, CMCSA's Class B stock represents 33.3% of combined voting power with 15 votes per share, while Class A stock holds 66.7% of voting power, establishing a dual-class structure where Roberts' ownership of all Class B shares grants him decisive control over META's board elections and major corporate decisions despite owning less than a majority of shares. This controlled company status, as described in META's 10-K, exacerbates governance risks for Class A shareholders by limiting board independence, eliminating mandatory independent compensation and nominating committees, and enabling Roberts to override minority stockholder interests through his Class B voting dominance, ultimately making META's Class A stock less attractive to investors seeking standard governance protections.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13498,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4071,
        "completion_tokens": 261,
        "total_tokens": 4332
      }
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina creates a direct operational link to the country that exposes Procter & Gamble to foreign exchange risk through its Argentina operations, as evidenced by PG's explicit disclosure of Argentina as a market experiencing significant exchange rate fluctuations that impact its net sales, costs, and earnings. The KG relationship Argentina (GPE) -> PG (ORG) confirms this exposure, while Arca Continental's operations in northern Argentina (from Chunk 1) establish the distribution dependency that anchors Coca-Cola's presence in the same market where P&G faces currency volatility.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Impacted_By]- ORG",
      "triplets_used": [
        "KO (ORG) -> Arca Continental (COMP)",
        "Arca Continental (COMP) -> Argentina (GPE)",
        "Argentina (GPE) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18094,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5181,
        "completion_tokens": 166,
        "total_tokens": 5347
      }
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "The expiration of Alimta's patent protection will trigger rapid and severe revenue decline for Eli Lilly, as explicitly stated in Chunk 2 where it is noted that \"the entry of generic competition for Alimta in the U.S. following the loss of patent exclusivity will cause a rapid and severe decline in revenue for the product and have a material adverse effect on our consolidated results of operations and cash flows.\" In contrast, Amgen's exposure to patent-related risks for its biologics is governed by a different regulatory framework where data exclusivity periods (e.g., 12 years under BPCIA) and biosimilar-specific pathways like umbrella exclusivity debates (Chunk 3) create uncertainty around the timing of biosimilar entry, but this risk is structurally distinct from the automatic, near-term revenue collapse seen with small-molecule patent expirations like Alimta. Crucially, the KG triplet relationship (Patent Protection → AMGN) confirms Amgen's direct exposure to similar patent challenges, yet the regulatory mechanisms for biologics—such as the BPCIA pathway and potential changes to data exclusivity—mean that loss of protection does not guarantee immediate generic competition, unlike small-molecule drugs where patent expiry typically triggers generic entry under Hatch-Waxman (Chunk 2 and 3). This distinction is underscored by Chunk 2's emphasis that for biologics like Erbitux or Cyramza, \"loss of exclusivity may or may not result in the near-term entry of competitor versions (i.e., biosimilars) due to many factors, including development timelines, manufacturing challenges, and/or uncertainties regarding the regulatory pathways,\" whereas Alimta's small-molecule status ensures generic competition follows patent expiry with minimal regulatory delay. Consequently, while both companies face patent expiration risks, Eli Lilly's oncology revenue stream (particularly Alimta) is far more vulnerable to abrupt, severe declines from patent expiration under standard Hatch-Waxman rules, whereas Amgen's biologic portfolio experiences a more protracted and uncertain competitive threat shaped by evolving biosimilar regulations and data exclusivity frameworks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Alimta (PRODUCT)",
        "Alimta (PRODUCT) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16069,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4711,
        "completion_tokens": 545,
        "total_tokens": 5256
      }
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "The impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits is directly tied to its higher proportion of income taxed in non-US jurisdictions, which generated a $1.2 billion increase in tax benefits in 2023 (Chunk 1), yet this advantage is being offset by the $20.4 billion of 2024 capital commitments and ongoing exposure to tax reform (Chunk 1). In contrast, Microsoft faces a different exposure: while it does not have material operations in low‑tax jurisdictions, the Pillar Two rules are expected to apply globally and could affect its worldwide effective tax rate, though the company currently anticipates no material increase in global tax costs (Chunk 2). Both firms are monitoring legislative developments, but Intel’s tax benefit is more closely linked to its international income mix and recent legislative changes, whereas Microsoft’s risk stems from potential future adjustments to its global tax framework under the same OECD rules (Chunk 3).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Pillar Two Model Rules (REGULATORY_REQUIREMENT)",
        "Pillar Two Model Rules (REGULATORY_REQUIREMENT) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12690,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3874,
        "completion_tokens": 243,
        "total_tokens": 4118
      }
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO's 2024 transfer of $523 million of surplus international pension assets to general assets reduces the size of its pension fund, which lowers the expected return on those assets and raises net periodic pension cost to about $81 million in 2025. PEP continues to invest pension assets in limited partnerships (as disclosed in its 2024 10‑K), whereas KO’s move eliminates that exposure, meaning KO’s pension portfolio is now less tied to limited‑partnership investments than PEP’s ongoing strategy. This shift makes KO’s pension fund more directly exposed to market‑wide asset performance and less dependent on the risk‑adjusted returns typically sought through limited‑partner structures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Includes]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Pension Plan (FIN_INST)",
        "Pension Plan (FIN_INST) -> Limited Partnerships (FIN_INST)",
        "Limited Partnerships (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9528,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3063,
        "completion_tokens": 172,
        "total_tokens": 3235
      }
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "The $17.3 billion increase in PFE’s income from continuing operations in 2021 versus 2020 was driven largely by higher revenues and favorable financial items, but this upside is tied to the market‑exclusivity protection afforded by its patent portfolio – a protection that, per the KG pattern, ultimately safeguards LLY’s revenue streams by extending exclusivity periods.  Patent rights (the risk factor) generate market‑exclusivity rights (the regulatory requirement) that shield LLY’s products from generic or biosimilar competition, and under U.S. law LLY can rely on the 12‑year data‑protection period for biologics to preserve revenue even after the underlying compound patents expire.  Consequently, the financial boost PFE reports is fundamentally linked to the strength of patent‑derived exclusivity, which, through the regulatory framework, underpins LLY’s strategy of using 12‑year biologic data protection to maintain its post‑patent revenue base.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Determined_By]-> REGULATORY_REQUIREMENT <-[Has]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Patent Rights (RISK_FACTOR)",
        "Patent Rights (RISK_FACTOR) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15062,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4475,
        "completion_tokens": 239,
        "total_tokens": 4715
      }
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "The revenue-sharing arrangement between ESPN and Hulu, reflected in Disney's 2024 financials through fees paid by Hulu to ESPN for carrying its networks on Hulu Live, is directly tied to Comcast's $8.6 billion payment in late 2023 following its exit from Hulu. This payment, stemming from Comcast's 33% stake in Hulu and the exercise of its put option in November 2023, was structured as an advance on the sale of its interest, with Disney agreeing to share 50% of future tax benefits from the transaction. The $8.6 billion payment (net of $557 million for prior capital calls) was received by Comcast after Disney acquired full operational control of Hulu in 2019, and it underscores the financial interdependence between the entities, where Comcast's stake sale and Disney's subsequent control of Hulu enabled the revenue-sharing dynamics observed in Disney's segment reporting.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT -[Pays_Fees_To]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> ESPN (PRODUCT)",
        "ESPN (PRODUCT) -> Hulu (COMP)",
        "Hulu (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9506,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3038,
        "completion_tokens": 220,
        "total_tokens": 3258
      }
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "KO applies its Black-Scholes-Merton option-pricing model to expense stock option awards on a straight-line basis over the generally four-year vesting period, using weighted-average assumptions for valuation. MDLZ, in contrast, applies weighted-average assumptions from its postretirement benefit accounting to determine net periodic postretirement health care costs, recognizing those costs over the timing of the plans' liability cash flows as measured by specific spot rates on the yield curve. Thus, while KO's financial assumptions are tied to stock option award expensing over a fixed four-year period, MDLZ's assumptions are applied to postretirement benefit costs over variable liability cash flow timing.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "KO (ORG) -> Black-Scholes-Merton Model (ACCOUNTING_POLICY)",
        "Black-Scholes-Merton Model (ACCOUNTING_POLICY) -> Weighted-Average Assumptions (ACCOUNTING_POLICY)",
        "Weighted-Average Assumptions (ACCOUNTING_POLICY) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2192,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 178,
        "total_tokens": 1418
      }
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "The expiration timeline of Enbrel's patent protections directly impacts Pfizer's international revenue from the drug, as evidenced by the provided data. Chunk 2 reveals Enbrel's U.S. patent expirations extend to 2028 (11/22/2028) and 2029 (4/24/2029), with additional formulation protection until 2037, while Chunk 3 confirms Pfizer markets Enbrel internationally under \"Inflammation & immunology\" (noting it is \"outside the U.S. and Canada\"). Crucially, Chunk 1 explains AbbVie's strategy of seeking patent term restoration under the Hatch-Waxman Act, which can extend exclusivity beyond standard expiration dates—potentially delaying generic/biosimilar entry in international markets where AbbVie holds patents. This aligns with the KG pattern where \"Patent Protection\" (regulated by regulatory frameworks) decreases revenue potential for \"Enbrel\" (produced by Pfizer), directly linking AbbVie's patent strategy to Pfizer's international revenue streams through regulatory exclusivity mechanisms described in Chunk 1.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> Enbrel (PRODUCT)",
        "Enbrel (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8637,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2841,
        "completion_tokens": 254,
        "total_tokens": 3095
      }
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MET's stress testing explicitly incorporates early policyholder withdrawal scenarios into its liquidity planning, which directly increases its reliance on global funding sources like commercial paper to offset potential cash outflows from contracts, as evidenced by its disclosure of \"cash flows from operations, sales of liquid assets, global funding sources including commercial paper and various credit and committed facilities\" as critical alternatives when facing \"significant cash requirements beyond anticipated liquidity needs\" (Chunk 1). In contrast, COF's liquidity framework emphasizes a diversified funding structure and maintains explicit liquidity reserves—such as \"cash and cash equivalents, high-quality, unencumbered securities and committed collateralized credit lines\"—to withstand funding degradation under stress, reflecting its focus on \"fortified balance sheet resilience\" and \"stockpile of liquidity reserves\" rather than dependence on short-term market instruments (Chunk 3). While both companies conduct stress testing (Chunk 2), MET's approach ties funding source selection to withdrawal risk scenarios, making it more vulnerable to market conditions affecting commercial paper access, whereas COF's framework uses diversified sources and reserves to reduce such dependencies, aligning with its stated objective to \"maintain an adequate level of liquidity... through systemic, idiosyncratic, and combined liquidity stress scenarios\" via \"stable and diversified funding sources\" (Chunk 3).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Impacts]-> FIN_INST <-[Reports]- ORG",
      "triplets_used": [
        "MET (ORG) -> Stress Testing (ACCOUNTING_POLICY)",
        "Stress Testing (ACCOUNTING_POLICY) -> Funding Sources (FIN_INST)",
        "Funding Sources (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_163",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12349,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3781,
        "completion_tokens": 378,
        "total_tokens": 4160
      }
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "The adoption of ASU 2022‑04 requires a retrospective disclosure of supplier‑finance‑program obligations, with the annual roll‑forward disclosed prospectively beginning in 2024. GE began applying the roll‑forward requirement in 2024, while Caterpillar (CAT) disclosed its roll‑forward information for the first time in 2024 as well, presenting the same quantitative detail (e.g., $830 million of confirmed obligations and the rollforward schedule) that the standard mandates. Thus, ASU 2022‑04 makes the supplier‑finance‑program disclosures of GE and CAT comparable, because both now present the roll‑forward data on an identical prospective basis starting in 2024.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "GE (ORG) -> ASU 2022-04 (ACCOUNTING_POLICY)",
        "ASU 2022-04 (ACCOUNTING_POLICY) -> Supplier Finance Programs (ACCOUNTING_POLICY)",
        "Supplier Finance Programs (ACCOUNTING_POLICY) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12538,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3823,
        "completion_tokens": 166,
        "total_tokens": 3989
      }
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "MDLZ determines the fair value of its exchange-traded commodity futures using quoted market prices on commodity exchanges and applies daily settlement practices, while PEP excludes these futures from its Level 2/3 fair value hierarchy disclosures and instead classifies them as cash-settled instruments not requiring offsetting under master netting agreements; PEP's Level 2 investments are valued using observable market transactions of spot and forward rates, and its derivative assets/liabilities are presented gross without collateral posting, contrasting with MDLZ's daily settlement approach that directly impacts the timing and presentation of gains/losses in its financial statements.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Level 1 Financial Assets and Liabilities (FIN_INST)",
        "Level 1 Financial Assets and Liabilities (FIN_INST) -> Exchange-Traded Commodity Futures (FIN_INST)",
        "Exchange-Traded Commodity Futures (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7323,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2539,
        "completion_tokens": 173,
        "total_tokens": 2712
      }
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "The voting rights structure at CMCSA features Class A common stock holders with 66 ⅔% of the combined voting power, while Class B common stock holders (representing 33 ⅓% of voting power and non‑dilutable) each carry 15 votes per share, with Mr. Brian L. Roberts owning all Class B shares; this dual‑class arrangement is linked to META through the KG relationship where Class B Common Stock is related to META, indicating that META’s own dual‑class share structure mirrors this pattern, with its Class A and Class B common stock providing comparable voting concentration and non‑dilutable control.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13959,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4149,
        "completion_tokens": 149,
        "total_tokens": 4299
      }
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "Both AIG and MetLife evaluate credit losses on structured products using present-value cash flow models that incorporate delinquency rates, default timing, loss severity, and prepayment speeds, but AIG explicitly ties its recoverable value estimate to management’s present value of expected cash flows and reverses allowances if conditions improve, whereas MetLife’s methodology is embedded in its broader “expected credit loss” framework disclosed in Note 24 without detailing the allowance reversal mechanics. Both companies recognize unrealized losses on structured product holdings within AOCI, yet AIG reports a $439 million unrealized gain on Corebridge ownership and notes that non‑credit price declines are presented separately in AOCI, while MetLife’s disclosures focus on the maximum loss exposure equal to the carrying amount of fixed‑maturity AFS and variable interests in Structured Products, emphasizing passive investor status and fee‑based variable interests rather than explicit unrealized gain/loss accounting. Consequently, AIG’s exposure is characterized by a credit‑loss allowance that can be reversed and tied to specific recoverable cash‑flow estimates, whereas MetLife’s exposure is framed by a passive investment stance with limited loss exposure tied to management fees and a broader “maximum exposure” concept, leading to distinct approaches in both methodology and unrealized loss recognition.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "AIG (ORG) -> CLO (FIN_INST)",
        "CLO (FIN_INST) -> Structured Products (FIN_INST)",
        "Structured Products (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_223",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7321,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2501,
        "completion_tokens": 355,
        "total_tokens": 2857
      }
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The Inflation Reduction Act's redesign of Medicare Part D directly impacts both CVS's forecasting capabilities and BMY's rebate obligations through regulatory dependencies. CVS's 10-K explicitly warns that Medicare Part D redesign elements—including inflation penalties and beneficiary cost caps—create significant uncertainty in forecasting health care cost trends, as inaccurate projections cannot be recovered through premiums and are vulnerable to external factors like pandemic-related utilization changes and regulatory shifts (Chunk 1). Meanwhile, BMY's 10-K confirms that the IRA's Medicare Part D redesign triggers mandatory manufacturer rebates, inflation-based pricing penalties, and potential future price caps that directly affect its revenue recognition and rebate accruals, particularly for drugs like ENBREL subject to Medicare price setting starting in 2026 (Chunk 2). Critically, the KG triplet relationship shows Medicare Part D (as a REGULATORY_REQUIREMENT) is both redesigned by the IRA and depends on BMY as an ORG, meaning BMY's rebate accruals are intrinsically tied to the same regulatory framework that CVS must forecast under—creating a shared but distinct exposure where CVS manages cost volatility across its insurance portfolio while BMY faces direct financial penalties and pricing constraints from manufacturer-level rebate obligations under the redesigned Part D program (Chunk 3).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Redesigns]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "CVS (ORG) -> IRA (REGULATORY_REQUIREMENT)",
        "IRA (REGULATORY_REQUIREMENT) -> Medicare Part D (REGULATORY_REQUIREMENT)",
        "Medicare Part D (REGULATORY_REQUIREMENT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_125",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18053,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5191,
        "completion_tokens": 353,
        "total_tokens": 5544
      }
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase's capital distribution is constrained by its Stress Capital Buffer (SCB), which can increase due to stress losses and directly raises the capital required to meet regulatory thresholds, limiting shareholder distributions if not maintained; this is distinct from Charles Schwab's obligations under the Capital Conservation Buffer (CCyB), which is currently set at 2.5% and forms part of its regulatory capital requirements alongside its own stress buffer, but Schwab's specific buffer composition and distribution constraints are defined by its risk-based capital ratios and buffer requirements as disclosed in its 10-K, where it maintains a 2.5% stress buffer and a 2.5% capital conservation buffer above minimum ratios, with distribution restrictions triggered if buffers fall below thresholds.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Stress Capital Buffer (REGULATORY_REQUIREMENT)",
        "Stress Capital Buffer (REGULATORY_REQUIREMENT) -> Capital Conservation Buffer (REGULATORY_REQUIREMENT)",
        "Capital Conservation Buffer (REGULATORY_REQUIREMENT) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7398,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2569,
        "completion_tokens": 202,
        "total_tokens": 2772
      }
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "General Dynamics (GD) excludes state and local income taxes allocable to U.S. government contracts from its tax provision, as explicitly stated in its 2022 10-K (Chunk 1), where such taxes are treated as operating costs rather than part of the tax expense. This exclusion reflects GD’s specific accounting treatment under its regulatory framework for government contracts. In contrast, Raytheon Technologies (RTX) operates under FAR-governed cost allowability and pricing mechanisms, as detailed in its 10-K (Chunk 3), where U.S. government contracts are subject to FAR rules that mandate uniform procurement policies and cost allowability, directly tying RTX’s pricing and cost treatment to FAR compliance. Both companies are subject to FAR regulations governing U.S. government contracts (Chunk 2 and Chunk 3), but GD’s exclusion of these taxes from its tax provision distinguishes its financial exposure from RTX’s structured cost allowability and pricing mechanisms under the FAR.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "GD (ORG) -> U.S. Government Contracts (REGULATORY_REQUIREMENT)",
        "U.S. Government Contracts (REGULATORY_REQUIREMENT) -> FAR (REGULATORY_REQUIREMENT)",
        "FAR (REGULATORY_REQUIREMENT) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10610,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3370,
        "completion_tokens": 246,
        "total_tokens": 3616
      }
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "META's dual-class structure grants Class B shares 15 votes per share, concentrating voting power in that class despite no public market for Class B shares, while Class A shares receive equal dividend treatment ($0.50/share quarterly, equivalent to $2.00 annually) as part of its newly initiated dividend program. In contrast, GOOGL's Class B shares automatically convert to Class A upon transfer or sale, eliminating permanent voting concentration, and its Class A shares carry one vote per share with no automatic conversion mechanism for Class B holdings. The KG pattern reveals META's Class B stock converts to Class A (linking to GOOGL as a related entity), whereas GOOGL's Class B conversion is triggered by transfer/sale rather than structural equivalence, creating fundamentally different governance dynamics where META's Class B holders retain disproportionate voting power indefinitely while GOOGL's Class B converts to equivalent voting rights upon movement.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Converts_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4588,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1830,
        "completion_tokens": 242,
        "total_tokens": 2072
      }
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "The 95% confidence interval under normal market conditions directly shapes the one-day loss estimation methodology for both Philip Morris and Mondelez by anchoring their VaR calculations to a statistically defined risk threshold, with PM’s disclosure confirming that this interval is applied to interest-rate-sensitive and foreign currency-sensitive derivatives using a parametric delta-gamma approximation to model interrelationships from recent quarterly market movements. Mondelez’s filings corroborate this approach, specifying that the same confidence level and holding period are used to estimate potential one-day losses in fair value for interest rate-sensitive instruments and pre-tax earnings from currency and commodity exposures, while also noting that currency and commodity options are valued non-linearly within the parametric framework. Both companies rely on the delta-gamma technique to capture non-linear price sensitivities across their derivative portfolios, ensuring consistency in how market volatility is translated into risk metrics, and the shared use of quarterly historical observations to calibrate return distributions further aligns their methodologies under the same accounting policy framework.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Depends_On]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "PM (ORG) -> Normal Market Conditions (MACRO_CONDITION)",
        "Normal Market Conditions (MACRO_CONDITION) -> VAR Model (ACCOUNTING_POLICY)",
        "VAR Model (ACCOUNTING_POLICY) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3915,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1693,
        "completion_tokens": 306,
        "total_tokens": 2000
      }
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley's embedded derivatives within CDOs and Bank of America's structured liabilities with embedded derivatives are both exposed to credit event risks that can impair principal repayment on the underlying notes, particularly affecting their market-making activities. Both institutions disclose that such instruments—classified as variable interests in VIEs and structured liabilities with embedded derivatives—subject them to potential losses if reference entities experience credit events, necessitating careful risk management and valuation under fair value frameworks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Relates_To]- ORG",
      "triplets_used": [
        "MS (ORG) -> CDOs (FIN_INST)",
        "CDOs (FIN_INST) -> Embedded Derivatives (FIN_INST)",
        "Embedded Derivatives (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_164",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6324,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2265,
        "completion_tokens": 145,
        "total_tokens": 2410
      }
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Based on the provided information, the global minimum tax under the OECD's Pillar Two model rules will impact Salesforce's effective tax rate compared to Microsoft's projected tax liability by potentially increasing Salesforce's tax burden as it expands globally, while Microsoft currently projects no material impact due to its lack of operations in low-tax jurisdictions below the 15% minimum. However, both companies face significant uncertainty regarding implementation timelines and jurisdictional adoption, with Salesforce explicitly identifying global tax developments—including Pillar Two—as a material risk that could affect its cash flows and financial results, and Microsoft noting that while it does not currently estimate a material impact, it continues to monitor legislative changes as countries implement the rules starting in fiscal year 2025.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> Pillar Two Model Rules (REGULATORY_REQUIREMENT)",
        "Pillar Two Model Rules (REGULATORY_REQUIREMENT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11862,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3675,
        "completion_tokens": 215,
        "total_tokens": 3890
      }
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing's Five-Year Credit Agreement (Exhibit 10.4 in BA_10k_2023.pdf) involves JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank N.A. and JPMorgan Chase Bank, N.A. as joint lead arrangers, with Citibank N.A. serving as administrative agent, reflecting a syndication structure that includes multiple arrangers and agents. Honeywell's comparable credit agreement (Exhibit 10.68 in HON_10k_2023.pdf) features JPMorgan Chase Bank, N.A. as one of two syndication agents within an Amended and Restated Five-Year Credit Agreement, explicitly listing it alongside Wells Fargo Bank, National Association as co-syndication agents. Both agreements demonstrate JPMorgan Chase Bank, N.A.'s central role as a key banking partner in structuring these credit facilities, though Boeing's arrangement specifies JPMorgan solely as syndication agent while Honeywell's agreement designates it as co-syndication agent within a broader syndication led by Bank of America as administrative agent.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Regulates]-> COMP <-[Enters_Agreement]- ORG",
      "triplets_used": [
        "BA (ORG) -> Five Year Credit Agreement (FIN_INST)",
        "Five Year Credit Agreement (FIN_INST) -> JPMorgan Chase Bank, N.A. (COMP)",
        "JPMorgan Chase Bank, N.A. (COMP) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_125",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 27936,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 7673,
        "completion_tokens": 247,
        "total_tokens": 7920
      }
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "The absence of the Countercyclical Capital Buffer (CCyB) requirement—currently set at 0% for both institutions—reduces their total capital buffer requirements under the Advanced Approaches framework. For Bank of America, this means its total buffer consists of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, while Morgan Stanley’s buffer similarly relies on its 2.5% Capital Conservation Buffer and 2.5% G-SIB surcharge, as the CCyB contributes nothing to either institution’s regulatory capital calculations. This omission directly lowers the aggregate buffer thresholds applicable to both banks, though their G-SIB surcharges and Capital Conservation Buffer obligations remain fully operational.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Countercyclical Capital Buffer (REGULATORY_REQUIREMENT)",
        "Countercyclical Capital Buffer (REGULATORY_REQUIREMENT) -> Capital Conservation Buffer (REGULATORY_REQUIREMENT)",
        "Capital Conservation Buffer (REGULATORY_REQUIREMENT) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6096,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2255,
        "completion_tokens": 179,
        "total_tokens": 2434
      }
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA's effective tax rate for fiscal year 2022 was 1.9%, as explicitly stated in Chunk 1's \"Income Taxes\" section, which attributes this rate to tax benefits from the foreign-derived intangible income deduction, income earned in low-tax jurisdictions, and excess tax benefits from stock-based compensation. Apple's operating income margin in Greater China for the same period was 42% ($31,153 million operating income divided by $74,200 million net sales in Greater China, as shown in Chunk 3's table), and this region is connected to NVIDIA through the KG triplet relationship where Greater China (GPE) includes Hong Kong (GPE) and operates in relation to AAPL (ORG), confirming Apple's operational presence in the same geographic scope referenced in NVIDIA's tax disclosures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Hong Kong (GPE)",
        "Hong Kong (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7109,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2429,
        "completion_tokens": 194,
        "total_tokens": 2624
      }
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Based on the 2024 filings and KG relationships, BA and UPS apply distinct pricing model approaches for Level 2 asset valuation with divergent observable input emphases. BA prioritizes market-based inputs like benchmark yields, swap curves, and quoted exchange rates for derivatives and commingled funds (as detailed in Chunk 1's valuation methodologies), while UPS explicitly classifies its foreign currency and interest rate derivatives as Level 2 specifically due to reliance on observable inputs such as yield curves and exchange rates (per Chunk 3). This distinction is reinforced by the KG pattern where both firms disclose pricing models (ACCOUNTING_POLICY) but UPS's derivatives are directly linked to observable inputs through its Level 2 classification, whereas BA's broader asset valuations incorporate both market and income approaches with inputs spanning credit data and appraised values across multiple asset classes.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "BA (ORG) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7014,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2421,
        "completion_tokens": 232,
        "total_tokens": 2654
      }
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "GOOGL's Class B common stock carries 10 votes per share, creating a significant voting power disparity compared to NFLX's uniform one-vote-per-share structure for all common stockholders, a distinction highlighted by GOOGL's $62.2 billion share repurchase program in 2023 that specifically targeted Class A and Class C shares. This repurchase program, authorized by the Board in April 2023 and leaving $36.3 billion available as of December 31, 2023, underscores the company's capital allocation strategy while maintaining the dual-class structure where Class B shares retain disproportionate voting rights despite the absence of voting rights for Class C shares except under specific circumstances.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4946,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1922,
        "completion_tokens": 174,
        "total_tokens": 2097
      }
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "ACN classifies U.S. government debt securities as Level 2 assets in its portfolio, where they are valued using observable inputs like yield curves but not quoted prices in active markets, resulting in a carrying amount of $9,765 (in thousands) as shown in its 2023 10-K (Chunk 1). This contrasts with AVGO's disclosures, which categorize similar securities as Level 1 due to active market pricing, creating a material difference in classification that impacts comparability between the two firms' investment valuations (Chunks 2 and 3). The KG triplet relationship confirms U.S. Government Debt Securities are linked to Level 1 classification for AVGO while ACN's Level 2 placement reflects a distinct methodology that excludes these securities from the Level 1 category used by AVGO.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Comprise]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "ACN (ORG) -> U.S. Government Debt Securities (FIN_INST)",
        "U.S. Government Debt Securities (FIN_INST) -> Level 1 Securities (FIN_INST)",
        "Level 1 Securities (FIN_INST) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3247,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 196,
        "total_tokens": 1696
      }
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate-Palmolive adopted ASU 2022-04 effective January 1, 2023 for supplier finance disclosures, requiring annual reporting of confirmed amounts outstanding and roll-forward details beginning January 1, 2024, as noted in its 2023 adoption timeline within Note 15 of its financial statements. Target similarly utilizes supplier finance programs requiring annual disclosures of confirmed obligations outstanding, with its arrangements structured to allow vendors to elect early payment at discounted rates without altering Target's payment obligations or requiring security, as detailed in its 2024 10-K filing. Both companies implemented the ASU 2022-04 disclosure requirements, though Target's specific structure—where confirmed obligations represent amounts payable to vendors but not actual sold receivables—highlights a key operational distinction in how the confirmed amount outstanding is tracked and reported under the same accounting policy framework.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> ASU 2022-04 (ACCOUNTING_POLICY)",
        "ASU 2022-04 (ACCOUNTING_POLICY) -> Supplier Finance Programs (ACCOUNTING_POLICY)",
        "Supplier Finance Programs (ACCOUNTING_POLICY) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7374,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2545,
        "completion_tokens": 239,
        "total_tokens": 2785
      }
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock's exposure to operational risks through Microsoft and other third-party technology partners creates reputational vulnerability via the Operational Risk → Reputational Impact pathway, where failures in cloud infrastructure or data providers could trigger client attrition and asset management declines, as explicitly detailed in BLK_10k_2024.pdf's disclosures about Microsoft Azure dependencies and migration risks.  \nMastercard's approach to managing similar reputational risks through its operational resilience strategy is defined by its explicit categorization of \"Reputation\" as a distinct risk factor under \"Stakeholder Relationships\" in MA_10k_2024.pdf, directly linking brand reputation to stakeholder perceptions and requiring proactive management of external reputational threats.  \nWhile BlackRock's risk disclosure emphasizes third-party provider concentration (including Microsoft) as a source of operational and regulatory risk that could materially impact AUM and earnings, Mastercard's framework treats reputation as an inherent business risk requiring dedicated strategic oversight, highlighting a fundamental difference in how each firm conceptualizes and mitigates reputational exposure stemming from operational dependencies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Operational Risk (RISK_FACTOR)",
        "Operational Risk (RISK_FACTOR) -> Reputational Impact (RISK_FACTOR)",
        "Reputational Impact (RISK_FACTOR) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13151,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3975,
        "completion_tokens": 313,
        "total_tokens": 4288
      }
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "Cardinal Health was BMY's third-largest customer in 2021, accounting for 20% of its revenue - a significant but not dominant relationship given that BMY's top customer (McKesson) represented 32% and the next largest (AmerisourceBergen) 25%. This customer significance is contextualized by Cardinal's structural role in CVS's generic pharmaceutical strategy: CVS and Cardinal each own 50% of Red Oak Sourcing, LLC, which they jointly operate to source and negotiate generic pharmaceutical supply contracts, with Cardinal Health serving as CVS's key partner in this arrangement that bypasses direct inventory ownership.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Red Oak Sourcing,LLC (COMP)",
        "Red Oak Sourcing,LLC (COMP) -> Cardinal Health, Inc. (COMP)",
        "Cardinal Health, Inc. (COMP) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10620,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3320,
        "completion_tokens": 154,
        "total_tokens": 3475
      }
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "The voting power of META Class B common stockholders is restricted to specific scenarios (e.g., core payments business exit, certain consolidations, or charter amendments) and each share carries a multiplier based on the conversion rate, resulting in voting power equal to the number of shares held multiplied by that rate; however, this voting structure is distinct from Netflix (NFLX), where common stockholders possess one vote per share on all matters with no such restrictions or multipliers, as evidenced by the KG triplet connection showing Voting Rights (ACCOUNTING_POLICY) is subject to NFLX through the ORG relationship.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5733,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2125,
        "completion_tokens": 157,
        "total_tokens": 2283
      }
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "The automatic conversion of GOOGL's Class B shares upon transfer—triggered by any sale or change of control—differs sharply from META's structural safeguard, which requires a majority of Class B voting power to approve any transaction that would effect a change of control, thereby preserving the controlling shareholder's veto. Mastercard’s mandatory post‑conversion rule that forces Class B holders to divest any Class A shares they receive reinforces a dual‑class framework where control is tightly coupled to shareholder approval, highlighting how such governance mechanisms can limit or channel ownership changes across the three firms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Converts_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6438,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2321,
        "completion_tokens": 160,
        "total_tokens": 2481
      }
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "MRK's pediatric market exclusivity opportunities are protected by up to five and a half years of pediatric market exclusivity under U.S. law, which can extend patent protection and provide longer lasting marketing exclusivity for biologics, as noted in the discussion of regulatory exclusivity tied to clinical data protection and patent term restoration (Chunk 1). In contrast, AMGN faces regulatory exclusivity risks because recent policy shifts—such as the removal of a mandatory 10‑year data‑exclusivity requirement for biologics from the USMCA and FDA considerations about “umbrella exclusivity” for subsequent changes to licensed biologics—could shorten the effective exclusivity period and expose it to earlier biosimilar competition (Chunk 3). Both companies rely on a combination of patent rights and regulatory data‑protection incentives, but while MRK can seek extensions through pediatric study awards and patent term adjustments, AMGN’s exclusivity is increasingly vulnerable to regulatory changes and legislative efforts that aim to lower barriers for generic and biosimilar approvals (Chunk 2 and Chunk 3).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Determined_By]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> Regulatory Exclusivity (REGULATORY_REQUIREMENT)",
        "Regulatory Exclusivity (REGULATORY_REQUIREMENT) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12283,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3760,
        "completion_tokens": 280,
        "total_tokens": 4041
      }
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "The dual-class structures of MA and V differ fundamentally in voting power distribution and control concentration: MA's Class B shares (held exclusively by Mr. Roberts) carry 15 votes per share, concentrating ~33.3% of total voting power in a single insider despite representing only ~1.7% of outstanding shares (7.2M Class B vs. 925.7M Class A), whereas V's Class B-1 shares (now reclassified post-amendment) also carry 15 votes per share but are subject to exchange restrictions and conversion mechanisms tied to litigation resolution, with Class B-1 representing a non-dilutable portion of combined voting power that can be converted to Class A shares upon transfer to non-members, while V's Class C shares have no voting rights and preferred stock participates on an as-converted basis. Crucially, MA's Class B shares are non-dilutable and held entirely by Roberts, creating a fixed control mechanism where Class B's 33.3% voting stake is structurally insulated from dilution, whereas V's Class B-1 shares are convertible to Class A upon specific events (e.g., litigation resolution or transfer to non-members), and its Class B-2 shares (issued via exchange offer) carry similar conversion dynamics but with double the impact on conversion rates, demonstrating how both companies use Class B structures to concentrate control but with V's system incorporating more complex conversion triggers and exchange mechanisms compared to MA's simpler, insider-dominated voting concentration.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9365,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3016,
        "completion_tokens": 371,
        "total_tokens": 3388
      }
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts involves revenue recognized in excess of billings due to performance-based or progress payments that retain a portion of the contract price until completion, creating contract assets on its balance sheet, while potential liabilities from government audits may arise from cost allowability challenges under FAR and CAS regulations, as evidenced by its exposure to post-award audits and investigations that could result in repayments or penalties; in contrast, LMT similarly faces risks under FAR-regulated contracts where revenue recognition over long-term aftermarket agreements can generate contract assets or liabilities based on progress, and its subject to U.S. government audits under the same FAR and CAS framework that could trigger liability for overbilling—however, while RTX specifically acknowledges that its U.S. government fixed-price contracts often result in revenue recognized in excess of billings requiring allowance for advance payments as liabilities, LMT's disclosures highlight that its U.S. government contracts are subject to audits covering cost, performance, and accounting practices under FAR and CAS, with potential for administrative, civil, or criminal liabilities including repayments or debarment if noncompliance is found, though neither company currently reports material losses from such exposures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "RTX (ORG) -> FAR (REGULATORY_REQUIREMENT)",
        "FAR (REGULATORY_REQUIREMENT) -> U.S. Government Contracts (REGULATORY_REQUIREMENT)",
        "U.S. Government Contracts (REGULATORY_REQUIREMENT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16277,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4775,
        "completion_tokens": 353,
        "total_tokens": 5128
      }
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "META’s Class B common stock carries 15 votes per share, while its Class A shares have one vote per share, giving the Class B holders (who represent roughly 33 % of the combined voting power) a disproportionately large influence over corporate decisions. In contrast, Alphabet’s (GOOGL) structure grants each Class B share 10 votes per share, with Class A shares limited to one vote per share and Class C shares having no voting rights; the Class B shares therefore account for about 10 % of the total voting power, a markedly lower concentration than META’s. Consequently, while both companies use dual‑class structures to keep insiders in control, META’s voting power is more heavily weighted toward its Class B shares (15 × per share) and represents a larger share of total voting power than the equivalent Class B shares in GOOGL.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4894,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1894,
        "completion_tokens": 208,
        "total_tokens": 2103
      }
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "The expiration of regulatory data protection for BMY’s Opdivo creates a clear precedent that once such protections lapse, generic manufacturers can file Paragraph IV ANDA certifications earlier—often after the fourth year of exclusivity—triggering patent‑litigation challenges that directly increase JNJ’s exposure to similar patent‑cliff risks for drugs like Stelara, as illustrated by the ORG‑[Subject_To]->REGULATORY_REQUIREMENT‑[Negatively_Impacts]->LITIGATION‑[Faces]->ORG pattern linking market exclusivity to litigation and ultimately to JNJ. This chain shows that as BMY’s data‑protection shield ends, the ensuing Paragraph IV filings can erode patent protection for JNJ’s upcoming biologics, amplifying JNJ’s litigation risk in the coming years.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> LITIGATION <-[Faces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> Patent Litigation (LITIGATION)",
        "Patent Litigation (LITIGATION) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15819,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4669,
        "completion_tokens": 188,
        "total_tokens": 4857
      }
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "META's dual-class structure imposes a critical anti-takeover barrier requiring Class B approval for any change-of-control transaction until Class B voting power falls below 35%, whereas GOOGL's framework automatically converts Class B shares to Class A upon transfer without such a threshold-based approval trigger. This distinction is reinforced by META's explicit control mechanisms (e.g., board classification and supermajority voting requirements when Class B voting power drops below majority) and GOOGL's automatic conversion feature that eliminates dual-class voting complexity upon share transfer, as evidenced by both companies' stock structures and governance provisions detailed across all three provided chunks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6753,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2394,
        "completion_tokens": 180,
        "total_tokens": 2575
      }
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS explicitly chose not to apply the practical expedients under ASU 2020-04 for its SOFR transition in 2023, meaning it did not elect optional relief for reference rate reform accounting despite the relief being available through December 31, 2024, as confirmed by its disclosure in Chunk 1 stating it \"did not elect to apply the practical expedients provided under Topic 848.\" In contrast, MMM's hedging relationships were likely managed under the same ASU 2020-04 framework with relief applied, as evidenced by Chunk 2's description of the ASU providing \"optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions affected by reference rate reform\" and its adoption of the guidance with \"no material impact on consolidated financial statements,\" while Chunk 3 details MMM's active use of hedge accounting for interest rate contracts (including reclassification of gains/losses from accumulated other comprehensive income into income) and its explicit reference to ASU 2020-04 as the basis for managing reference rate reform impacts. This contrast highlights UPS's deliberate rejection of the optional accounting relief—potentially increasing transition complexity or disclosure burden—whereas MMM leveraged the expedients to streamline hedge accounting under the same regulatory framework, as directly tied through the KG relationship \"Hedging Relationships → MMM\" and the shared ASU 2020-04 context across all chunks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> Hedging Relationships (ACCOUNTING_POLICY)",
        "Hedging Relationships (ACCOUNTING_POLICY) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16394,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4805,
        "completion_tokens": 368,
        "total_tokens": 5174
      }
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "MDLZ classifies exchange-traded commodity futures as Level 1 financial assets measured at quoted market prices, and these futures cash-settle daily—directly aligning with the KG pattern where Commodity Futures (FIN_INST) are linked to PEP (ORG) and impact valuation methodology. PEP’s similar exposure to these instruments, as evidenced by its use of index fund pricing and cash-settled futures (noted in Chunk 3), confirms that daily cash-settlement is a key input in MDLZ’s Level 1 valuation approach for such assets.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Valued_Using]-> FIN_INST -[Includes]-> FIN_INST <-[Cash-Settles]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Level 1 Financial Assets (FIN_INST)",
        "Level 1 Financial Assets (FIN_INST) -> Commodity Futures (FIN_INST)",
        "Commodity Futures (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7442,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2535,
        "completion_tokens": 129,
        "total_tokens": 2664
      }
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "The voting power structure of Comcast (CMCSA) allocates 33 ⅓ % of the combined vote to Class B common stock—held entirely by Mr. Brian L. Roberts—while Class A shares collectively carry the remaining 66 ⅔ % of voting power, with each Class B share granting 15 votes and each Class A share one vote. In contrast, Alphabet (GOOGL) also uses a multi‑tier system but assigns 10 votes per Class B share, whereas its Class A shares carry only one vote each; Class C shares have no voting rights, and Class B shares may convert to Class A and are subject to automatic conversion on transfer, reflecting a different dilution‑protected voting hierarchy than CMCSA’s non‑dilutable Class B structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10683,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3353,
        "completion_tokens": 172,
        "total_tokens": 3525
      }
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "BAC generates market-making gains from embedded derivatives in structured liabilities that are typically offset by gains/losses on the underlying credit spread changes, as disclosed in Note 14 of its 10‑K, while MS’s involvement in credit‑linked notes (CLNs) structured as hybrid instruments with embedded derivatives exposes it to credit‑event risk that can affect the note’s principal repayment, as described in the MS 10‑K notes on Investment Securities and VIE activities. Both banks therefore face related but distinct credit‑risk exposures: BAC’s gains are tied to hedging embedded derivatives within its own structured liabilities, whereas MS’s losses can arise from full or partial principal non‑repayment when a credit event occurs in the CLNs it underwrites.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Relates_To]-> FIN_INST -[Related_To]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Embedded Derivatives (FIN_INST)",
        "Embedded Derivatives (FIN_INST) -> CLNs (FIN_INST)",
        "CLNs (FIN_INST) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_164",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6324,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2256,
        "completion_tokens": 192,
        "total_tokens": 2448
      }
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Intel's (INTC) effective tax rate could be materially affected by the OECD's Pillar Two Model Rules, as indicated by the KG relationship where Pillar Two Model Rules (REGULATORY_REQUIREMENT) are Subject_To by Intel (ORG) and negatively impact tax obligations. While Intel's 2023 effective tax rate decreased due to higher non-US income taxation and R&D credits, the company acknowledges ongoing evaluation of Pillar Two impacts, particularly as non-US jurisdictions enact related legislation beginning in 2024, which could influence its global tax position despite currently not expecting material cost increases from lower-tax jurisdictions.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> Pillar Two Model Rules (REGULATORY_REQUIREMENT)",
        "Pillar Two Model Rules (REGULATORY_REQUIREMENT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13231,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4025,
        "completion_tokens": 160,
        "total_tokens": 4186
      }
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "RTX's revenue recognition under FAR-regulated U.S. government fixed-price contracts results in revenue recognized in excess of billings (recorded as contract assets) due to performance-based or progress payments that retain a portion of the contract price until completion, while Boeing's U.S. government contracts expose it to termination risk where termination for default could require repayment of previously received payments and limit recovery to work already accepted, creating less predictable cash flows compared to RTX's more predictable revenue timing under FAR's progress payment structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "RTX (ORG) -> FAR (REGULATORY_REQUIREMENT)",
        "FAR (REGULATORY_REQUIREMENT) -> U.S. Government Contracts (REGULATORY_REQUIREMENT)",
        "U.S. Government Contracts (REGULATORY_REQUIREMENT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14084,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4223,
        "completion_tokens": 150,
        "total_tokens": 4374
      }
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "Both MMM and GE disclose near-term debt instruments containing 2025 put options, but the scale and structure of their obligations differ significantly. MMM reports $119 million in floating rate notes with put provisions maturing in 2025, specifically classified as the current portion of long-term debt due to these redemption features, while GE discloses $315 million in aggregate fixed and floating rate notes with similar 2025 put options that contractually mature after 2025. This comparison reveals MMM's $119 million represents a smaller, more immediate near-term obligation compared to GE's substantially larger $315 million exposure, though both companies utilize puttable debt instruments to manage refinancing risk within their broader credit facility frameworks.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Put Options (FIN_INST)",
        "Put Options (FIN_INST) -> Fixed and Floating Rate Notes (FIN_INST)",
        "Fixed and Floating Rate Notes (FIN_INST) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4456,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1808,
        "completion_tokens": 193,
        "total_tokens": 2001
      }
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "Both PEP and MDLZ determine fair value for exchange-traded commodity futures using quoted market prices on commodity exchanges, relying on daily market pricing for valuation. However, PEP excludes these futures from its Level 2 fair value hierarchy disclosure (as they are cash-settled daily and not included in its table), while MDLZ explicitly classifies them as Level 1 financial assets and liabilities, directly incorporating them into its Level 1 category with no mention of exclusion. Both companies' valuation approaches are grounded in observable market pricing, but PEP's treatment diverges in classification and disclosure scope, whereas MDLZ consistently includes them within its Level 1 framework.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Commodity Futures (FIN_INST)",
        "Commodity Futures (FIN_INST) -> Level 1 Financial Assets (FIN_INST)",
        "Level 1 Financial Assets (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5063,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1949,
        "completion_tokens": 177,
        "total_tokens": 2126
      }
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple's revenue from the Greater China region, which includes Taiwan, was $74.2 billion in 2022, as reported in its 10-K filing (Chunk 1 and Chunk 2), where Greater China is explicitly defined as encompassing China mainland, Hong Kong, and Taiwan. Intel's revenue specifically from Taiwan operations was $13.461 billion in 2022, as shown in its 10-K filing (Chunk 3), with Taiwan listed as a distinct geographic segment under Intel's revenue breakdown. The knowledge graph relationship confirms that Taiwan (GPE) is part of Greater China (GPE) and is associated with Intel (INTC), while Apple's Greater China segment includes Taiwan, making Apple's regional revenue significantly larger than Intel's Taiwan-specific revenue in 2022.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Greater China (GPE)",
        "Greater China (GPE) -> Taiwan (GPE)",
        "Taiwan (GPE) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3026,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 183,
        "total_tokens": 1585
      }
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "The combined net property, plant, and equipment investment in the Americas by MMM is $5,864 million (as reported in MMM’s 2021 financials), while GD’s revenue contribution from South America—part of the Americas geographic segment—was $234 million in 2021 (per GD’s 2021 10‑K). This shows that MMM’s capital investment in the Americas is roughly 25 times larger than GD’s South‑American revenue within the same geographic footprint.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "GD (ORG) -> South America (GPE)",
        "South America (GPE) -> Americas (GPE)",
        "Americas (GPE) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_140",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2793,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 108,
        "total_tokens": 1484
      }
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "NFLX's auditor employs sensitivity analyses to evaluate how changes in estimated viewing patterns impact content amortization judgments, specifically testing the effect of assumption variations on amortization timing as part of audit procedures to assess control effectiveness over this complex accounting estimate. In contrast, CMCSA applies sensitivity analyses within its interest rate risk management framework to quantify the potential effect of interest rate fluctuations on debt-related expenses, using market valuation and sensitivity techniques to assess exposure from its interest rate derivative instruments, which directly influence consolidated interest expense. Both entities utilize sensitivity analyses as a core component of their respective risk assessment processes—NFLX for content amortization accounting estimates and CMCSA for interest rate risk exposure—though applied within distinct financial and operational contexts as reflected in their SEC filings.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reviews]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Auditor (ACCOUNTING_POLICY)",
        "Auditor (ACCOUNTING_POLICY) -> Sensitivity Analyses (ACCOUNTING_POLICY)",
        "Sensitivity Analyses (ACCOUNTING_POLICY) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11482,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3553,
        "completion_tokens": 244,
        "total_tokens": 3798
      }
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PEP utilizes exchange-traded commodity futures for cash-settled hedging of market risk, as explicitly noted in its disclosure that such futures are excluded from fair value tables due to daily cash settlement, while simultaneously disclosing a contingent tax liability linked to COST through the KG pattern where Level 1 financial liabilities connect to COST; however, COST's 2022 10-K explicitly states it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, confirming the absence of Level 1 financial liabilities as required by its fair value hierarchy disclosure under the same framework.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Cash-Settles]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Commodity Futures (FIN_INST)",
        "Commodity Futures (FIN_INST) -> Level 1 Financial Liabilities (FIN_INST)",
        "Level 1 Financial Liabilities (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7741,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2623,
        "completion_tokens": 160,
        "total_tokens": 2784
      }
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "The expiration timeline of U.S. patent protections for Enbrel, as outlined in Amgen's 2024 10-K (Chunk 2), shows key U.S. patent expirations extending to 2028 (11/22/2028) and 2037 (10/19/2037), with no immediate generic biosimilar competition anticipated before 2028. This prolonged protection directly supports Merck's competitive positioning by delaying biosimilar entry into the U.S. market, aligning with Merck's stated exposure to biosimilar competition risks in its 10-K (Chunk 1), which highlights that loss of patent protection typically triggers generic/biosimilar substitution and adverse financial impacts. However, Pfizer's international production strategy for Enbrel (KG triplet: Enbrel → PFE) is indirectly shaped by this U.S. patent timeline, as Pfizer's global operations (Chunk 1) face heightened risks in markets with weaker patent enforcement, potentially incentivizing accelerated international manufacturing to capitalize on U.S. market exclusivity before expiration, while Merck's pricing pressures from U.S. cost-containment policies (Chunk 1) may further drive Pfizer to prioritize international production to offset U.S. revenue declines from future biosimilar entry.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> Enbrel (PRODUCT)",
        "Enbrel (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7309,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2529,
        "completion_tokens": 298,
        "total_tokens": 2827
      }
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "The $90 of unfunded commitments disclosed by EMR for private equity funds and the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS both involve investments measured at NAV, but they differ in scale and context: EMR reports a relatively small $90 of unfunded commitments tied to its private‑equity fund holdings, whereas UPS discloses a much larger $2.7 billion of unfunded commitments across its private‑equity, private‑debt and real‑estate partnership interests, reflecting the broader scope of UPS’s alternative‑investment portfolio. Both companies apply the same NAV‑based accounting policy, yet the magnitude of UPS’s commitment underscores a significantly larger exposure to illiquid alternative investments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "EMR (ORG) -> Private Equity Funds (FIN_INST)",
        "Private Equity Funds (FIN_INST) -> NAV (ACCOUNTING_POLICY)",
        "NAV (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6180,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2232,
        "completion_tokens": 191,
        "total_tokens": 2423
      }
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo's APAC segment revenue in 2024 was $10 million, with beverages accounting for 23% of that segment ($2.3 million), as shown in Chunk 2's APAC row indicating 23% Beverages (a) and 77% Convenient Foods (a). Mondelēz's total beverage revenue in 2024 was $1,096 million (in millions), as reported in Chunk 3's \"Beverages\" line under \"Total net revenues\" for 2024. Thus, PepsiCo's APAC beverage revenue ($2.3 million) represented approximately 0.21% of Mondelēz's total beverage revenue ($1,096 million), highlighting a significantly smaller contribution relative to Mondelēz's overall beverage business.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> GPE -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> APAC (GPE)",
        "APAC (GPE) -> Beverages (PRODUCT)",
        "Beverages (PRODUCT) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6102,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2171,
        "completion_tokens": 151,
        "total_tokens": 2322
      }
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "The volume of Capital One's (COF) delinquent loans as of December 31, 2023 ($623 million total), which includes reperforming loan balances within the > 90‑day delinquent category, directly determines the supply of reperforming assets available for MetLife (MET) to purchase, as indicated by the KG relationship **Delinquent Loans → Reperforming Loans → MET** (COF discloses delinquent loans; those loans transition to reperforming status; MET buys reperforming loans). Consequently, a higher delinquent‑loan volume provides a larger pool of reperforming loans that MET can acquire for its residential mortgage portfolio, influencing both the availability and pricing of such assets. Additionally, MET's structured‑product and RMBS portfolios rely on reperforming and non‑performing loan pools, and its risk‑based pricing and loss‑rate assumptions incorporate the characteristics of these reperforming loans, underscoring how COF's delinquency metrics feed into MET's investment strategy and portfolio management.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Causes_Shortage_Of]-> FIN_INST <-[Buys]- ORG",
      "triplets_used": [
        "COF (ORG) -> Delinquent Loans (FIN_INST)",
        "Delinquent Loans (FIN_INST) -> Reperforming Loans (FIN_INST)",
        "Reperforming Loans (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_161",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_240",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9792,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3124,
        "completion_tokens": 253,
        "total_tokens": 3377
      }
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP's pension plan exposure to real estate funds is valued using each partnership's NAV, reflecting illiquid private real estate investments. UPS has $3.3 billion of unfunded commitments to similar limited partnership real estate structures, also measured at NAV, highlighting comparable reliance on NAV‑based valuations for these non‑traded assets. Both companies treat such holdings as Level 2/non‑Level investments, with valuations dependent on partnership‑reported NAV and subject to estimation risk.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Limited Partnerships (FIN_INST)",
        "Limited Partnerships (FIN_INST) -> Real Estate Funds (FIN_INST)",
        "Real Estate Funds (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12239,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3743,
        "completion_tokens": 126,
        "total_tokens": 3869
      }
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD's reliance on third-party manufacturers for 7 nm and smaller node production creates significant exposure to quality control risks through limited supplier control and dependence on external process technologies, as evidenced by its dependence on TSMC for advanced nodes where yield failures or supply disruptions could materially increase per-unit costs and harm customer relationships. In contrast, Cisco maintains quality control through automated testing and ISO 9001-certified processes, reflecting a fundamentally different risk profile where regulatory compliance and standardized manufacturing oversight are embedded in its operational model rather than outsourced to specialized foundries. This structural divergence means AMD faces compounded supply chain vulnerabilities tied to semiconductor-specific constraints like equipment scarcity and yield variability, while Cisco's approach mitigates such exposure through direct process control and certified quality frameworks across its manufacturing partners.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Negatively_Impacts]-> CONCEPT <-[Maintains]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Third-Party Manufacturers (COMP)",
        "Third-Party Manufacturers (COMP) -> Quality Control (CONCEPT)",
        "Quality Control (CONCEPT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17634,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5096,
        "completion_tokens": 255,
        "total_tokens": 5351
      }
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast's investment in Atairos lacks voting rights, limiting its governance influence to consent-based protections while exposing it to financial risk only through its $1.4 billion unfunded capital commitment and $5.1 billion investment balance, whereas Alphabet's Class C Capital Stock similarly carries no voting rights but enables governance control through Class A/B shares with 10x voting power, allowing Alphabet to maintain decision-making authority despite repurchasing $62 billion of Class C shares in 2024 and maintaining $44.7 billion in repurchase capacity, creating a structural contrast where Comcast's passive financial exposure contrasts with Alphabet's active governance and capital management.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Repurchases]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class C Capital Stock (FIN_INST)",
        "Class C Capital Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8903,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2917,
        "completion_tokens": 178,
        "total_tokens": 3095
      }
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca-Cola HBC's operational footprint in Austria is explicitly documented in Chunk 1 as part of its bottling and distribution operations spanning 19 countries, including Austria (listed alongside 18 other nations such as Armenia, Belarus, and Switzerland). This confirms Coca-Cola HBC's direct presence and operational territory within Austria as a key European market for the Coca-Cola Company's bottling partner. In contrast, Chunk 3 reveals Philip Morris International's (PMI) market presence in Austria through its competitive position, stating PMI holds \"at least 15% market share in approximately 100 markets, including Austria\" for its combustible cigarette and heated tobacco products, specifically referencing Marlboro and IQOS brands. While Chunk 1 details Coca-Cola HBC's bottling operations in Austria (as part of its European territory), Chunk 3 establishes PMI's market share dominance in Austria's tobacco sector, confirming both companies maintain significant but distinct operational footprints within the same country—Coca-Cola HBC through beverage bottling/distribution and PMI through tobacco product sales and market share.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola HBC (COMP)",
        "Coca-Cola HBC (COMP) -> Austria (GPE)",
        "Austria (GPE) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16103,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4679,
        "completion_tokens": 286,
        "total_tokens": 4965
      }
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "The deterioration in BAC's commercial real estate credit quality—specifically the noted weakness in office properties—directly influences MET's use of the Bornhuetter-Ferguson Method for estimating unpaid claims in both Protection Life and Protection Health products. This macroeconomic trend is reflected in the accounting policy for unpaid claims assumptions, which are updated annually to incorporate emerging trends in claim experience, thereby linking BAC's credit quality indicators to MET's reserving methodology.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> MACRO_CONDITION -[Reflects]-> ACCOUNTING_POLICY <-[Updates]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Emerging_Trends (MACRO_CONDITION)",
        "Emerging_Trends (MACRO_CONDITION) -> Unpaid Claims Assumptions (ACCOUNTING_POLICY)",
        "Unpaid Claims Assumptions (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_196",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_196",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7064,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2466,
        "completion_tokens": 130,
        "total_tokens": 2596
      }
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "The voting rights structures of Netflix and Meta both center on Class A common stock, which carries one vote per share and therefore serves as the primary vehicle for shareholder influence in each company’s governance framework. In Netflix’s case, the disclosed accounting policy states that each share of common stock—including Class A shares—grants its holder one vote per share on all matters submitted to a vote of stockholders, while Meta’s filing explicitly identifies Class A common stock as the class that provides one vote per share, with Class B shares holding 10 votes per share and Class C shares having no voting rights. Consequently, although both firms use Class A shares to anchor voting power, Meta’s governance includes a dual‑class system where Class B shares concentrate substantially more voting influence, whereas Netflix’s single‑class structure gives all shares equal voting weight. This distinction means that, despite the shared reliance on Class A common stock for baseline voting rights, Meta’s overall voting power dynamics are more complex due to the presence of high‑vote Class B shares, whereas Netflix’s voting rights are uniformly distributed across all shares.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7955,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2661,
        "completion_tokens": 298,
        "total_tokens": 2960
      }
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "Both PEP and MDLZ classify exchange-traded commodity futures as Level 1 financial liabilities measured at fair value through quoted market prices on commodity exchanges, with cash settlement resulting in daily mark-to-market adjustments that are not offset on the balance sheet. While PEP’s cash-settled futures are excluded from fair value tables per its disclosure (Chunk 1, g), MDLZ explicitly includes them in Level 1 and reports their valuation methodology as relying on observable market prices (Chunk 2, 3), reflecting a consistent but separately disclosed treatment across both companies’ liability portfolios.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Cash-Settles]-> FIN_INST -[Includes]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Commodity Futures (FIN_INST)",
        "Commodity Futures (FIN_INST) -> Level 1 Financial Liabilities (FIN_INST)",
        "Level 1 Financial Liabilities (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7442,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2553,
        "completion_tokens": 154,
        "total_tokens": 2707
      }
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "The cost-sharing model for Merck and Gilead’s HIV combination therapy—splitting global development and commercialization costs 60%/40% (Gilead 60%, Merck 40%) with equal revenue sharing until $2 billion (oral) or $3.5 billion (injectable) in net sales, after which Gilead’s share rises to 65%—contrasts with Pfizer’s broader enterprise‑wide cost‑reduction initiatives, which focus on productivity programs, manufacturing optimization, and restructuring to lower overall expenses rather than sharing R&D costs on a per‑product basis. This partnership limits each company’s financial exposure to the upfront and milestone payments tied to the HIV program while spreading development risk, whereas Pfizer’s cost‑reduction efforts could affect its overall margin and cash flow across all business units. Consequently, Merck and Gilead’s exposure is confined to the specific HIV assets and shared cost structure, while Pfizer’s exposure is tied to the success of its company‑wide efficiency programs and the realization of projected savings.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Merck (COMP)",
        "Merck (COMP) -> Islatravir (PRODUCT)",
        "Islatravir (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 20375,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5777,
        "completion_tokens": 259,
        "total_tokens": 6036
      }
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 is explicitly tied to its contracts and hedging relationships that reference LIBOR, with the standard extending the optional expedient sunset date to December 31, 2024 (per Chunk 1 and Chunk 2), and this accounting policy is designated as applicable to FDX (via the KG pattern ORG → ASU 2022-06 → Hedging Relationships ← Designates ORG). UPS's use of hedging relationships, as described in Chunk 3, involves designating derivatives as cash flow, fair value, or net investment hedges where gains/losses are reported in other comprehensive income or earnings based on the hedged exposure, but the question specifically compares FDX's LIBOR-focused ASU 2022-06 exposure to UPS's broader hedging framework—highlighting that while FDX's ASU 2022-06 application is limited to LIBOR-referencing contracts and hedges with a 2024 sunset, UPS's hedging relationships (including cash flow and fair value designations) operate under general principles without the same LIBOR-specific sunset provision, though both are subject to ASU 2022-06's extended timeline for affected contracts.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Designates]- ORG",
      "triplets_used": [
        "FDX (ORG) -> ASU 2022-06 (ACCOUNTING_POLICY)",
        "ASU 2022-06 (ACCOUNTING_POLICY) -> Hedging Relationships (ACCOUNTING_POLICY)",
        "Hedging Relationships (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15463,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4551,
        "completion_tokens": 285,
        "total_tokens": 4836
      }
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "META's dual-class structure, as detailed in Chunk 1, creates significant investor protection concerns through its anti-takeover provisions and controlled company status, which can make its Class A common stock less attractive to investors and allows the controlling stockholder to override minority interests without standard governance safeguards. In contrast, GOOGL's Class B common stock (which automatically converts to Class A upon sale or transfer, as stated in Chunk 2 and Chunk 3) grants holders 10 votes per share compared to Class A's single vote, but this concentrated voting power is mitigated by the automatic conversion feature that ensures eventual alignment with public shareholders. Crucially, the KG triplet relationship **Class B Common Stock → GOOGL (ORG)** confirms that GOOGL's Class B shares are directly tied to its parent entity, while META's lack of such automatic conversion mechanisms for its controlling shares (implied by Chunk 1's focus on Class B's voting dominance without conversion triggers) creates a fundamentally different investor protection dynamic where GOOGL's structure inherently reduces dual-class risk through forced conversion, unlike META's more rigid control mechanisms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7216,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2496,
        "completion_tokens": 304,
        "total_tokens": 2801
      }
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "KO employs option contracts as a hedging tool specifically for forecasted transactions, using them to manage exposure to market risks such as foreign currency exchange rates. These option contracts are designated as cash flow hedges, with gains and losses deferred in AOCI and recognized in earnings when the hedged transactions occur, directly offsetting the financial impact of forecasted exposures. In contrast, MDLZ discloses gains and losses on similar forecasted transactions through commodity and currency exchange contracts, where the net financial impact is materially larger ($1,949 million in 2024) and recognized across multiple income statement lines (cost of sales, interest expense, and SG&A), reflecting a broader hedging strategy that includes both cash flow and fair value hedges for diverse exposures like commodity prices and equity method investments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> Forecasted Transactions (FIN_INST)",
        "Forecasted Transactions (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11450,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3535,
        "completion_tokens": 218,
        "total_tokens": 3753
      }
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "TMO's fixed income funds are explicitly classified as \"not subject to leveling\" in its pension disclosures, meaning they are valued using inputs that cannot be directly observed in active markets and are excluded from the fair value hierarchy's leveling structure, whereas BMY classifies its fixed income funds under Level 2 of the fair value hierarchy, relying on observable inputs such as quoted prices for similar instruments and corroborated market data to determine fair value. This contrast indicates that TMO's fixed income fund valuations depend less on observable market data and more on internally derived or less transparent inputs, while BMY's classification reflects a structured reliance on verifiable market-based inputs for pension asset valuation.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TMO (ORG) -> Significant Other Observable Inputs (Level 2) (FIN_INST)",
        "Significant Other Observable Inputs (Level 2) (FIN_INST) -> Fixed Income Funds (FIN_INST)",
        "Fixed Income Funds (FIN_INST) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13035,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3977,
        "completion_tokens": 191,
        "total_tokens": 4168
      }
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "The application of the Federal Acquisition Regulation (FAR) in cost‑plus‑fixed‑fee contracts creates a distinct revenue‑recognition pattern for LMT and BA. Both companies treat U.S. government contracts as a single performance obligation and allocate the transaction price—typically cost plus a negotiated fee—using the contract‑stated selling price, which under FAR is effectively the same as the standalone price. Because the FAR requires that revenue be recognized over time as control of work‑in‑process transfers to the government, LMT and BA defer revenue until the contract is performed, even though the fee is fixed at inception. This timing difference—driven by the regulatory requirement to recognize revenue only as performance obligations are satisfied—means that each company’s revenue is recorded progressively throughout the contract rather than up front, leading to a slower, contract‑duration revenue stream for both LMT and BA relative to the fixed‑fee structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "LMT (ORG) -> FAR (REGULATORY_REQUIREMENT)",
        "FAR (REGULATORY_REQUIREMENT) -> U.S. Government Contracts (REGULATORY_REQUIREMENT)",
        "U.S. Government Contracts (REGULATORY_REQUIREMENT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13585,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4090,
        "completion_tokens": 245,
        "total_tokens": 4335
      }
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie's debt agreements with U.S. Bank National Association consistently designate the bank as trustee across multiple indentures (Supplemental Indentures Nos. 6-9 in Chunk 1), while Abbott Laboratories uses the identical trustee relationship through its subsidiary Abbott Ireland Financing DAC as issuer (Chunk 2/3, Items 4.24-4.25), establishing a direct structural parallel in trustee roles. Both entities employ U.S. Bank National Association as trustee in their respective indentures, but AbbVie's agreements specifically reference additional agent roles like paying agent (Elavon Financial Services DAC) and registrar, whereas Abbott Ireland Financing DAC's indentures explicitly include Elavon as both paying agent and transfer agent/registrar, demonstrating a more comprehensive agency structure for the latter (Chunk 1 vs. Chunk 2/3). Regarding note issuance timelines, AbbVie's supplemental indentures were filed between 2016-2020 (Chunk 1: 2016, 2019, 2020 dates), while Abbott Ireland Financing DAC issued its initial 2018 indenture and subsequent 2019/2020 supplemental indentures with specific note forms (e.g., 1.500% due 2026, 0.100% due 2024, 0.375% due 2027; Chunk 2/3: Items 4.27-4.29), reflecting AbbVie's more recent and varied issuance pattern compared to Abbott's earlier, multi-tranche structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Regulates]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> U.S. Bank National Association (COMP)",
        "U.S. Bank National Association (COMP) -> Abbott Ireland Financing DAC (COMP)",
        "Abbott Ireland Financing DAC (COMP) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 25486,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 7061,
        "completion_tokens": 330,
        "total_tokens": 7391
      }
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVDA's reliance on foundries for advanced 7nm and smaller process nodes is explicitly highlighted in Chunk 1 as a critical risk, where failure to implement high-quality process technologies—including transitions to smaller nodes—could \"adversely affect our business operations, gross margin, revenue and/or financial results,\" directly linking its advanced manufacturing dependency to foundry capabilities like TSMC's. In contrast, AMD's exposure to larger wafers for competitive IC production is underscored in Chunks 2 and 3 through its explicit reliance on TSMC (and UMC) for 7nm and smaller nodes, with both chunks emphasizing that \"TSMC is not able to manufacture wafers for our products at 7nm or smaller nodes in sufficient quantities to meet customer demand\" would have a \"material adverse effect\" on AMD's business, while also noting that foundries must \"transition to advanced manufacturing process technologies and increased wafer sizes\" to remain competitive. Crucially, the KG pattern reveals that \"Foundries (COMP) -> Larger Wafers (PRODUCT) -> AMD (ORG)\" connects AMD's production to larger wafers (a product of foundries), while NVDA's dependency operates through the same foundry layer without specifying wafer size as a direct product link, making NVDA's advanced node reliance more precarious due to its direct exposure to the most cutting-edge process technologies that AMD also depends on via TSMC.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Foundries (COMP)",
        "Foundries (COMP) -> Larger Wafers (PRODUCT)",
        "Larger Wafers (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16675,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4841,
        "completion_tokens": 354,
        "total_tokens": 5196
      }
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "The unresolved WTO customs dispute involving Philip Morris in Thailand creates ongoing regulatory uncertainty that could affect supply chain operations for any foreign manufacturer operating in the country, including Colgate-Palmolive's Thai manufacturing facilities. While Colgate-Palmolive's 2024 10-K filing (Chunk 3) confirms its manufacturing presence in Thailand through owned/leased properties in the Oral Care segment, the WTO panel decision specifically targeted Philip Morris' customs valuation practices and required Thailand to revise its import regulations - obligations that remain unimplemented due to stalled Appellate Body processes (Chunk 1). This regulatory environment increases compliance risk and potential customs cost exposure for all foreign manufacturers in Thailand, directly impacting Colgate-Palmolive's operational costs through heightened customs clearance expenses, potential retroactive tax assessments, and increased legal compliance costs associated with the unresolved dispute. The WTO conflict's persistence also creates indirect supply chain volatility that could affect raw material sourcing and distribution costs for Colgate-Palmolive's Thai operations, as Thailand must maintain revised customs procedures that may introduce additional administrative burdens and cost structures for imported inputs or finished goods.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Faces]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> WTO Panel Decision (REGULATORY_REQUIREMENT)",
        "WTO Panel Decision (REGULATORY_REQUIREMENT) -> Thailand (GPE)",
        "Thailand (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12843,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3926,
        "completion_tokens": 339,
        "total_tokens": 4266
      }
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "The $265,000 decline in UnitedHealthcare’s Medicare Part D enrollment (from 3,315 k in 2023 to 3,050 k in 2024) reflects the coverage loss caused by the IRA‑mandated redesign of the Part D benefit, which shifts higher out‑of‑pocket costs and manufacturer discounts onto plans and sponsors.  This redesign triggers Pfizer’s projected $1 billion revenue hit in 2025, as the same IRA provisions—including the new manufacturer discount schedule and the Medicare price‑setting program—reduce drug pricing and usage across the Medicare market.  Consequently, the enrollment drop for UnitedHealthcare and Pfizer’s revenue loss are two direct outcomes of the IRA’s Part D reforms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Modifies]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Medicare Part D (REGULATORY_REQUIREMENT)",
        "Medicare Part D (REGULATORY_REQUIREMENT) -> IRA (REGULATORY_REQUIREMENT)",
        "IRA (REGULATORY_REQUIREMENT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10929,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3420,
        "completion_tokens": 168,
        "total_tokens": 3588
      }
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin (LMT) reports $4,863 million of private‑equity fund investments recorded under the NAV practical expedient, while FedEx (FDX) also applies the same NAV‑based measurement to its equity securities without readily determinable fair values, as disclosed in LMT’s 2024 10‑K (pages 88‑89) and FDX’s 2024 10‑K (page 117). Both companies value these investments at NAV, but LMT quantifies the private‑equity exposure at $4,863 million, whereas FDX only notes that it uses the NAV alternative for such securities without providing a comparable dollar amount.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Private Equity Funds (FIN_INST)",
        "Private Equity Funds (FIN_INST) -> NAV Practical Expedient (ACCOUNTING_POLICY)",
        "NAV Practical Expedient (ACCOUNTING_POLICY) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10267,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3265,
        "completion_tokens": 141,
        "total_tokens": 3406
      }
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "The voting power dilution mechanisms differ significantly between CMCSA and GOOGL: CMCSA's Class B shares carry 15 votes per share and maintain a fixed 33.3% non-dilutable voting aggregate that cannot be diluted by new issuances, while GOOGL's Class B shares carry 10 votes per share and convert to Class A shares (1 vote each) upon sale or transfer, with no fixed non-dilutable percentage. GOOGL's $62.0 billion 2024 share repurchase specifically targets Class A and Class C shares (not Class B), whereas CMCSA's Class B shares are convertible to Class A but maintain distinct voting rights that are protected from dilution under their Articles of Incorporation.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10567,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3333,
        "completion_tokens": 165,
        "total_tokens": 3498
      }
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s 50% owned Red Oak Sourcing, LLC negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., creating a direct revenue exposure through its sourcing arrangement with Cardinal Health. In contrast, LLY relies on Cardinal Health as one of its top-three U.S. wholesale distributors, each accounting for 15–20% of LLY’s consolidated revenue, highlighting a significantly higher revenue concentration risk for LLY compared to CVS’s indirect exposure via Red Oak.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Red Oak Sourcing,LLC (COMP)",
        "Red Oak Sourcing,LLC (COMP) -> Cardinal Health, Inc. (COMP)",
        "Cardinal Health, Inc. (COMP) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13883,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4165,
        "completion_tokens": 120,
        "total_tokens": 4285
      }
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "The voting rights per share differ significantly between UPS and Honeywell as of 2024: UPS discloses Class B common stock with voting rights of **7 votes per share** (as indicated by the $7 par value allocation to Class Bcommonstock in its equity section), while Honeywell's common stock (which lacks a separate Class B designation in its disclosures) provides **1 vote per share** for all common shareowners, as explicitly stated in Honeywell's accounting policy for common stock. This contrast is reinforced by the KG relationship where UPS's Class B Common Stock (FIN_INST) discloses Voting Rights (ACCOUNTING_POLICY) linked to HON (ORG), confirming Honeywell's standard 1-vote structure versus UPS's 7-vote Class B rights.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8092,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2690,
        "completion_tokens": 181,
        "total_tokens": 2872
      }
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "The maturity of AMGN's 3.625% 2024 Notes—triggering the termination of $1.4 billion in interest rate swap contracts—aligns with the repayment of that specific debt issuance, as noted in AMGN's 10-K where the swaps matured concurrently with the notes' repayment and were linked to ABBV through shared hedging activity. In contrast, ABBV employs interest rate swap contracts as cash flow hedges for its long-term debt, with no indication in its disclosures of swaps maturing due to note redemptions; instead, ABBV's swaps are designed to hedge future floating-rate cash flows, as evidenced by its 2024 disclosures of pre-tax gains/losses from cash flow hedge accounting for interest rate swaps (though specific notional amounts are not detailed in the provided excerpt). This contrast highlights AMGN's use of swaps as direct, time-bound hedges tied to debt maturity, while ABBV treats swaps as ongoing cash flow hedges without such direct termination triggers.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.625% 2024 Notes (FIN_INST)",
        "3.625% 2024 Notes (FIN_INST) -> Interest Rate Swap Contracts (FIN_INST)",
        "Interest Rate Swap Contracts (FIN_INST) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6990,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2432,
        "completion_tokens": 239,
        "total_tokens": 2672
      }
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "The adoption of ASU 2022-02 required Capital One to replace its prior TDR accounting guidance with a new framework for financial difficulty modifications (FDMs), eliminating the concession requirement and mandating rolling 12-month performance reporting for modified loans, while JPMorgan had previously classified similar residential real estate modifications as TDRs under the old concession-based definition; as disclosed in Chunk 1, Capital One explicitly stated that \"FDM disclosures are not directly comparable to the prior period TDR disclosures due to differences in the respective accounting guidance and disclosure requirements,\" and Chunk 2 confirms that Capital One's modification types (e.g., interest rate reductions, term extensions, principal reductions) remained unchanged post-ASU adoption, whereas Chunk 3 reveals JPMorgan's pre-ASU TDR disclosures included $362 million in new TDRs for 2022 with no additional lending commitments, highlighting the structural shift in reporting that renders direct comparison between Capital One's FDMs and JPMorgan's prior TDR disclosures unreliable.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Replaces]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "COF (ORG) -> ASU 2022-02 (ACCOUNTING_POLICY)",
        "ASU 2022-02 (ACCOUNTING_POLICY) -> TDR Guidance (ACCOUNTING_POLICY)",
        "TDR Guidance (ACCOUNTING_POLICY) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_159",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_245",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9549,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3073,
        "completion_tokens": 276,
        "total_tokens": 3349
      }
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD aligns interest rate swap maturities with debt exposure through a dollar-weighted two-year average maturity approach that directly matches swap durations to the risk horizon of underlying operations, reflecting a precise, operationally integrated hedging strategy focused on minimizing specific financial risks. UPS employs economic hedges for interest rate swaps that are intentionally not designated as formal hedge accounting instruments, prioritizing balance sheet risk mitigation for debt obligations and cash flow stability over formal accounting alignment, revealing a risk management priority centered on operational flexibility and balance sheet resilience rather than strict accounting policy adherence. This contrast highlights GD's focus on accounting-compliant risk matching against UPS's emphasis on practical economic exposure management through non-designated hedges.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Enables]-> ACCOUNTING_POLICY <-[Aims]- ORG",
      "triplets_used": [
        "GD (ORG) -> Interest Rate Swap Contracts (FIN_INST)",
        "Interest Rate Swap Contracts (FIN_INST) -> Economic Hedge (ACCOUNTING_POLICY)",
        "Economic Hedge (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_159",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_159",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7093,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2461,
        "completion_tokens": 221,
        "total_tokens": 2682
      }
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet's 2023 share repurchases of $62.2 billion in Class A and Class C shares reduce the pool of those shares, leaving the non‑dilutable Class B shares to represent a larger proportion of the total voting power; because each Class B share carries 10 votes, the relative voting power of the undiluted Class B shares rises as the total vote‑eligible shares shrink. This dynamic contrasts with Comcast, where the Class B shares already hold a fixed 33 ⅓ % of the combined voting power that is generally non‑dilutable, so share buybacks of other classes have a more limited impact on the Class B voting share percentage. Consequently, while Alphabet’s repurchases can increase the relative voting weight of its Class B shares over time, Comcast’s Class B structure maintains a stable, pre‑specified 33 ⅓ % voting stake regardless of other share‑repurchase activity.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4894,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1919,
        "completion_tokens": 216,
        "total_tokens": 2135
      }
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger's Rule 10b5-1 trading plan at DIS involves up to 372,412 shares of DIS common stock from vested options expiring December 18, 2024, with a termination date of December 17, 2024, governed by Rule 10b5-1(c) under the same regulatory framework as META's plans; Peggy Alford's META plan authorizes up to $1.2 million in Class A share sales with a termination date of November 15, 2025, both complying with the identical Rule 10b5-1(c) requirements under the shared regulatory structure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Trading Plan (ACCOUNTING_POLICY)",
        "Trading Plan (ACCOUNTING_POLICY) -> Rule 10b5-1(c) (REGULATORY_REQUIREMENT)",
        "Rule 10b5-1(c) (REGULATORY_REQUIREMENT) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6437,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2301,
        "completion_tokens": 123,
        "total_tokens": 2425
      }
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "CL's equity awards follow a vesting schedule that is tied to the contractual term of the options (generally three years of ratable vesting) and are disclosed as part of its accounting policy for stock‑option grants, whereas PM's RSU awards specifically vest on the third anniversary of the grant date and the related compensation expense is amortized over that three‑year restriction period (with $160 million of unrecognized costs expected to be recognized over roughly 17 months). Consequently, CL recognizes compensation expense over the three‑year vesting period of its stock options, while PM spreads RSU expense over the three‑year restriction period (accelerating recognition if certain events occur), leading to a more immediate expense impact for PM's RSU awards.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Vest]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> Vesting Schedule (ACCOUNTING_POLICY)",
        "Vesting Schedule (ACCOUNTING_POLICY) -> RSU Awards (FIN_INST)",
        "RSU Awards (FIN_INST) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2243,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 193,
        "total_tokens": 1424
      }
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Regulatory restrictions that limit product differentiation—such as menthol bans, standardized packaging, bans on display of tobacco products, and constraints on advertising and product design—directly undermine PM and MO’s ability to maintain brand equity and pricing power in key international and U.S. markets. By curtailing the use of flavors, restricting packaging and branding, and imposing product‑design standards, these regulations diminish the distinctiveness of each company’s offerings, forcing reliance on price competition and limiting the capacity to raise prices, especially in premium segments and high‑margin geographies. Consequently, both firms face heightened risk of down‑trading, reduced margins, and weaker brand positioning, as highlighted in PM’s 10‑K (Chunk 1) and MO’s discussion of flavor bans and settlement‑agreement marketing limits (Chunk 3), while their strategic growth and profitability—dependent on product innovation, market expansion, and margin improvement—are further constrained by the same regulatory environment described in PM’s 10‑K (Chunk 2).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Faces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Product Differentiation (RISK_FACTOR)",
        "Product Differentiation (RISK_FACTOR) -> Regulation (REGULATORY_REQUIREMENT)",
        "Regulation (REGULATORY_REQUIREMENT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16296,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4768,
        "completion_tokens": 272,
        "total_tokens": 5040
      }
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG's exposure to structured securities containing RMBS is measured through accounting for credit losses and yield adjustments under amortized cost accounting, where effective yields are recalculated based on actual cash flows and updated prepayment expectations, with changes in expected cash flows reflected as yield adjustments rather than credit loss allowances (Chunk 1). This accounting treatment directly impacts BAC's valuation risks, as BAC holds RMBS-backed securities whose fair value is highly sensitive to fluctuations in prepayment speeds and default rates, with significant increases in market yields or default rates leading to lower fair values for long positions and opposite impacts for short positions (Chunk 3). Both entities' exposures are interconnected through the structured securities (FIN_INST) and RMBS (FIN_INST) relationship, where AIG's yield adjustments for RMBS and BAC's fair value sensitivity to prepayment/default dynamics represent complementary risk dimensions within the same underlying structured finance assets (Chunks 1-3).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Structured Securities (FIN_INST)",
        "Structured Securities (FIN_INST) -> RMBS (FIN_INST)",
        "RMBS (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_169",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_161",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5771,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2127,
        "completion_tokens": 266,
        "total_tokens": 2393
      }
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom (AVGO) uses the multiperiod excess earnings method under the income approach to value its developed cybersecurity technology—including cloud security solutions—by estimating the present value of projected cash flows generated by that technology, adjusted for the contribution of other assets and based on the technology’s economic useful life tied to its cycle and cash‑flow forecast. In contrast, Cisco (CSCO) recognizes revenue for its Cloud Security product category ratably over the contract term as a single distinct performance obligation, with hardware and perpetual software recognized upfront and SaaS arrangements also recognized ratably over time. Both companies ultimately recognize SaaS‑related revenue ratably, but Broadcom’s valuation relies on discounted cash‑flow analysis of the underlying technology, whereas Cisco’s revenue‑recognition policy spreads the Cloud Security revenue evenly across the contract period.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Developed Technology (PRODUCT)",
        "Developed Technology (PRODUCT) -> Cloud Security (PRODUCT)",
        "Cloud Security (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4635,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1834,
        "completion_tokens": 235,
        "total_tokens": 2070
      }
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "META's dual-class structure features Class A common stock with one vote per share and Class B common stock with ten votes per share, with the 10-K explicitly stating 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, creating a significant voting power disparity where Class B shares (representing only ~13.6% of total shares) control approximately 86.4% of voting rights, a dynamic mirrored in Alphabet's (GOOGL) structure where Class B shares carry 10 votes per share while Class A shares carry one vote per share, though GOOGL's Class C shares have no voting rights, and both companies' governance mechanisms—META's voting rights concentrated in Class B shares for specific corporate actions and GOOGL's Class B shares enabling 10-vote control for certain decisions—demonstrate how high-vote shares can disproportionately influence corporate governance despite minority share ownership.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "META (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9503,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3070,
        "completion_tokens": 233,
        "total_tokens": 3303
      }
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca-Cola FEMSA's Argentina operations directly support KO's contractual pricing model by enabling independent bottling of Coca-Cola products in Argentina, which contributes to KO's net sales to equity method investees through purchases of beverage products (as reflected in the $496 million purchases from equity method investees in 2021, driven by international expansion) and reinforces CL's organic sales growth in Latin America, where Argentina is a key market driving 8.0% organic growth in 2021 alongside Brazil, Mexico, and Colombia.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola FEMSA (COMP)",
        "Coca-Cola FEMSA (COMP) -> Argentina (GPE)",
        "Argentina (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8633,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2825,
        "completion_tokens": 135,
        "total_tokens": 2960
      }
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott's private equity investments are valued using NAV as a practical expedient, with redemption restrictions ranging from quarterly to multi-year lockups including specific gates (e.g., 33% gate on $280M of absolute-return funds) and potential illiquidity until final liquidation between 2024-2033, while Merck similarly measures alternative investments at NAV per FASB principles but discloses typical redemption restrictions of 10-15 year partnership terms with no active secondary market guarantees and $3.3B unfunded commitments across its private equity, private debt, and real estate funds. Both companies apply NAV-based valuation to private funds subject to redemption limitations, though Abbott specifically notes private fund illiquidity requiring liquidation for redemption while Merck emphasizes partnership term restrictions and secondary market uncertainties.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Private Equity Funds (FIN_INST)",
        "Private Equity Funds (FIN_INST) -> NAV (ACCOUNTING_POLICY)",
        "NAV (ACCOUNTING_POLICY) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12694,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3864,
        "completion_tokens": 219,
        "total_tokens": 4083
      }
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock's management of Separate Account Assets—legally segregated and not subject to general creditor claims—directly enables AIG to report equal and offsetting Separate Account Liabilities tied to contract holder balances, as explicitly required by the accounting relationship between Separate Account Assets and Liabilities (AIG_10-K p.232). This structure ensures that Separate Account Liabilities, representing contract holder account balances, are precisely matched to the underlying assets and recorded as equal and offsetting figures on AIG's consolidated statements (AIG_10-K p.233), with the segregation legally protecting these assets from general creditor claims while maintaining the offsetting liability position.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Separate Account Assets (FIN_INST)",
        "Separate Account Assets (FIN_INST) -> Separate Account Liabilities (FIN_INST)",
        "Separate Account Liabilities (FIN_INST) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_233",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_232",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12675,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3864,
        "completion_tokens": 182,
        "total_tokens": 4046
      }
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie recognizes revenue from Imbruvica sales in the U.S. as the principal end-customer seller, with Janssen's profit share recorded as cost of products sold under their equal pre-tax profit/loss sharing arrangement, while outside the U.S. Janssen bears exclusive commercialization rights and AbbVie's profit share is also included in net revenue. This cost-sharing model—where Janssen covers ~60% of development costs and both parties split profits equally in the U.S.—directly reflects their co-exclusive commercialization structure, contrasting with Johnson & Johnson's global strategy of retaining exclusive rights outside the U.S. and leveraging its broader MedTech portfolio to drive Imbruvica sales through Janssen's international commercial infrastructure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Janssen Biotech (COMP)",
        "Janssen Biotech (COMP) -> Imbruvica (PRODUCT)",
        "Imbruvica (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10367,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3264,
        "completion_tokens": 191,
        "total_tokens": 3455
      }
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged geopolitical conflict involving Taiwan would severely disrupt NVIDIA's supply chain execution by jeopardizing its critical foundry partners in Taiwan, which are essential for chip production and directly tied to its revenue streams and inventory stability, as highlighted by NVIDIA's explicit risk acknowledgment of Taiwan-related tensions impacting supply continuity and potential revenue loss. This disruption would simultaneously impair Apple's manufacturing operations, given its reliance on Taiwan-based foundries for critical components and its extensive supply chain concentration in the region, potentially causing production delays, inventory shortages, and broader operational instability across Apple's global device ecosystem.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Depends_On]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Foundry Partners (COMP)",
        "Foundry Partners (COMP) -> Taiwan (GPE)",
        "Taiwan (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18332,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5258,
        "completion_tokens": 187,
        "total_tokens": 5446
      }
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "LMT applies pricing models for its Level 2 fixed‑income investments that rely on verifiable observable market inputs such as interest‑rate curves, yield‑curve levels and credit spreads, supplemented by indicative quotes or bid evaluations from vendors and brokers, and may also use discounted cash‑flow techniques with significant inputs like projected annuity payments and discount rates. HON’s pricing models for corporate bonds and government securities similarly employ observable market data (e.g., quoted yields, credit spreads) and incorporate risk adjustments for credit and liquidity, but the models are embedded within its broader valuation framework for futures, collective‑trust funds and private‑equity/debt holdings that also uses discounted cash‑flow and market‑price approaches. Both companies therefore use observable market inputs for Level 2 valuations, yet HON’s approach explicitly integrates additional risk adjustments and extends the same modeling methodology to a wider set of instruments—including futures and private‑equity exposures—whereas LMT’s Level 2 fixed‑income valuation is confined to fixed‑income securities and uses pricing models that emphasize verifiable market data and discounted cash‑flow inputs.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9567,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3078,
        "completion_tokens": 309,
        "total_tokens": 3388
      }
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "The unfavorable foreign currency exchange rate impact from a stronger U.S. dollar negatively affected Coca-Cola’s (KO) Europe, Middle East and Africa segment in 2024, contributing to an 11% adverse impact on consolidated operating income and net operating revenues, as explicitly detailed in Chunk 1 and Chunk 2. This exposure mirrors Mondelez (MDLZ)’s similar macroeconomic risk, as indicated by the KG triplet linking Stronger U.S. Dollar (MACRO_CONDITION) to MDLZ (ORG), reflecting shared vulnerability to currency volatility under comparable conditions. Both companies faced adverse currency-driven pressures in their international segments, though KO’s 2024 disclosures specifically quantify the 11% headwind in EMEA, while MDLZ’s 10-K highlights ongoing hedging efforts and the broader structural risk without a precise percentage for 2024.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Impacted_By]-> MACRO_CONDITION <-[Impacted_By]- ORG",
      "triplets_used": [
        "KO (ORG) -> Europe, Middle East and Africa (GPE)",
        "Europe, Middle East and Africa (GPE) -> Stronger U.S. Dollar (MACRO_CONDITION)",
        "Stronger U.S. Dollar (MACRO_CONDITION) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9976,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3196,
        "completion_tokens": 211,
        "total_tokens": 3408
      }
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, reflecting its significant operational footprint in the region. This aligns with QCOM's explicit risk disclosure that its business depends on consistent chipset supply from foundry partners in Taiwan, where geopolitical tensions involving China and Taiwan could severely disrupt supply chains, potentially causing material adverse impacts on both companies' operations and financial results.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Foundry Partners (COMP)",
        "Foundry Partners (COMP) -> Taiwan (GPE)",
        "Taiwan (GPE) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11952,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3669,
        "completion_tokens": 116,
        "total_tokens": 3786
      }
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple's heavy reliance on manufacturing operations in Taiwan creates significant exposure to regional geopolitical risks, particularly given Taiwan's inclusion within the Greater China geopolitical entity that is directly linked to Microsoft (MSFT) through the KG dependency relationship (AAPL → Taiwan → Greater China → MSFT). This structural connection means that geopolitical tensions affecting Taiwan—such as those stemming from its status within Greater China—would not only disrupt Apple's supply chain but also indirectly impact Microsoft's operational footprint, as Microsoft's regional center in Singapore supports Greater China operations, thereby tying both tech giants' regional vulnerabilities to the same geopolitical hotspot. Consequently, while Apple faces direct supply chain disruption risks from Taiwan-related instability, Microsoft's exposure is amplified through its Greater China operations managed via Singapore, making both companies interdependent in their regional risk profiles despite differing operational models.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13292,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3995,
        "completion_tokens": 260,
        "total_tokens": 4256
      }
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million decrease in Union Pacific's deferred tax expense, as disclosed in its 10-K filing (Chunk 2), while Boeing's exposure to federal appropriations delays—highlighted in its 10-K as a risk due to potential government shutdowns and funding uncertainties (Chunk 3)—underscores how regulatory and legislative shifts (e.g., Nebraska's tax policy and federal budget processes) directly impact corporate financial outcomes across industries.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Introduces]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Nebraska (GPE)",
        "Nebraska (GPE) -> Legislation (REGULATORY_REQUIREMENT)",
        "Legislation (REGULATORY_REQUIREMENT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6956,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2414,
        "completion_tokens": 126,
        "total_tokens": 2540
      }
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "The expiration timelines of Enbrel-related patents in the U.S. (extending to 2037) directly support MRK's strategic focus on maintaining patent protection for its own products, as evidenced by the KG pattern where **Patent Protection** (a regulatory requirement) is linked to **Enbrel** and **AMGN** (the patent holder). This protection is critical in the face of competitive dynamics, as highlighted in Chunk 1, where the Company explicitly states that loss of patent protection for a product leads to generic/biosimilar substitution, reducing sales and cash flows, and that maintaining patent rights is a core policy to avoid such adverse effects. Chunks 2 and 3 provide the specific patent expiration dates for Enbrel in the U.S., confirming that these protections are actively leveraged to sustain market exclusivity and mitigate competitive pressures from generics or biosimilars.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> Enbrel (PRODUCT)",
        "Enbrel (PRODUCT) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6792,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2383,
        "completion_tokens": 221,
        "total_tokens": 2604
      }
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD's revenue from operations in Taiwan was $2,091 million in 2022 (Chunk 1), while Apple's revenue contribution from Taiwan (as part of Greater China) was $74,200 million in 2022 (Chunk 3), reflecting Apple's significantly larger market presence in the region through its Greater China reporting segment (Chunk 2). This disparity, with Apple's Taiwan-inclusive Greater China revenue being over 35 times greater than AMD's standalone Taiwan revenue, indicates Apple's dominant and integrated market position in the region compared to AMD's more limited operational footprint.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4855,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1876,
        "completion_tokens": 143,
        "total_tokens": 2019
      }
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet's repurchase of Class C shares—carrying no voting rights—provides capital allocation flexibility by allowing the company to reduce its equity base without altering voting control, as Class C shares can be retired independently of voting structures; this contrasts with Netflix's uniform voting rights structure, where share repurchases would proportionally reduce voting power across all shareholders, limiting strategic flexibility in capital deployment. The KG triplet connection (Voting Rights → NFLX) confirms Netflix's lack of dual-class share differentiation, reinforcing that its repurchase strategy operates under a single-vote-per-share framework, unlike Alphabet's Class C repurchases which preserve voting concentration while returning capital.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Lacks]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class C Capital Stock (FIN_INST)",
        "Class C Capital Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3632,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 191,
        "total_tokens": 1783
      }
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET's exposure to non-agency pass-through mortgage-backed securities containing $1,699 million in NQM and Alt‑A loans represents 5 % of its total RMBS portfolio and generated $37 million of unrealized losses, while AIG's liquidity risk stems from its heavy reliance on illiquid mortgage‑related assets that are difficult to value and may require forced sales at depressed prices. This contrast is highlighted by MET's $1,294 million unrealized loss on pass‑through securities versus AIG's concerns about valuing and liquidating similar mortgage‑backed investments, underscoring MET's relatively smaller but still material exposure compared with AIG's broader illiquidity challenges.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Secured By]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Pass-Through Mortgage-Backed Securities (FIN_INST)",
        "Pass-Through Mortgage-Backed Securities (FIN_INST) -> Mortgage & Loans (FIN_INST)",
        "Mortgage & Loans (FIN_INST) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14213,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4272,
        "completion_tokens": 170,
        "total_tokens": 4443
      }
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "Based on the provided data, Coca-Cola's Asia Pacific beverage revenue contribution was derived from its consolidated net operating revenues of $5,291 million (Chunk 1), while PepsiCo's Asia Pacific beverage share represented 20% of its total beverage revenue (Chunk 2 and 3). This indicates that Coca-Cola reported a specific beverage revenue figure for the Asia Pacific region ($5,291M), whereas PepsiCo's reporting shows beverages accounted for 20% of its regional revenue mix, highlighting a structural difference in how each company discloses segment performance. The KG triplet relationship (Beverage → Produces → PEP) confirms PepsiCo's beverage operations are segmented under its broader portfolio, contrasting with Coca-Cola's more granular regional reporting.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "KO (ORG) -> APAC (GPE)",
        "APAC (GPE) -> Beverage (PRODUCT)",
        "Beverage (PRODUCT) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11008,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3408,
        "completion_tokens": 192,
        "total_tokens": 3600
      }
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead and Merck's revenue-sharing structure for long-acting HIV products involves a tiered model where Gilead's share increases to 65% of revenues above $2.0 billion for oral combinations and $3.5 billion for injectable combinations, while Merck's royalty obligations to BMS and Ono for Keytruda are fixed at 6.5% through 2023 and 2.5% through 2026, with a 75/25 split of payments between BMS and Ono. This contrast highlights Merck's higher short-term profitability from Keytruda royalties (6.5% fixed rate) versus Gilead's performance-dependent HIV revenue share (65% only above thresholds), though Merck's overall profitability from both partnerships is amplified by its 20% royalty on Reblozyl sales (up to 24%) and equal profit-sharing in collaborations like V940 with Moderna, as evidenced by $212 million in alliance revenue from BMS partnerships in 2023.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Pays]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Merck (COMP)",
        "Merck (COMP) -> Keytruda (PRODUCT)",
        "Keytruda (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9874,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3137,
        "completion_tokens": 215,
        "total_tokens": 3353
      }
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "BAC's investment in CDOs with embedded credit default swaps transfers risk through tranche structures, where credit events can trigger losses across multiple tranches in the capital stack, similar to how AIG's $75 million loss from embedded derivatives in 2024 was driven by credit contracts that required payouts upon credit events. Both institutions face exposure through structured finance vehicles where embedded derivatives create contingent liabilities tied to credit events, though BAC's losses would flow through its VIE investments and tranche losses while AIG's loss is explicitly reported in its embedded derivatives line item. The KG pattern shows CDOs (FIN_INST) are connected to both BAC and AIG through embedded derivatives, with AIG's $75 million loss specifically attributed to embedded derivatives in its 2024 financials.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> CDOs (FIN_INST)",
        "CDOs (FIN_INST) -> Embedded Derivatives (FIN_INST)",
        "Embedded Derivatives (FIN_INST) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7097,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2461,
        "completion_tokens": 209,
        "total_tokens": 2671
      }
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "Citibank, N.A. serves as administrative agent in both 3M's May 2023 Five‑Year Credit Agreement and Caterpillar’s September 2022 credit facilities, where it also acts as agent for the lenders and, in Caterpillar’s case, as local‑currency and Japan‑currency agent, handling loan administration, facility oversight and related agency duties; however, in 3M’s agreement Citibank’s role is limited to being a named participant/lender under the agreement, whereas in Caterpillar’s facilities it holds the broader administrative‑agent function that includes managing the facility, coordinating with other agents and handling currency‑specific addenda.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Amends]-> FIN_INST -[Regulates]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Five Year Credit Agreement (FIN_INST)",
        "Five Year Credit Agreement (FIN_INST) -> Citibank, N.A. (COMP)",
        "Citibank, N.A. (COMP) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 24000,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 6684,
        "completion_tokens": 161,
        "total_tokens": 6845
      }
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "KO employs option contracts as a specific derivative instrument to hedge foreign currency exposure, directly impacting its foreign currency liabilities through cash flow hedge accounting that records gains/losses in AOCI until reclassified into earnings when the hedged transactions occur. This approach aligns with PEP's foreign exchange risk management strategy, which also uses option and forward contracts designated as cash flow hedges for forecasted transactions, with notional amounts of $9.9 billion (2024) and $8.3 billion (2023), and similarly records deferred gains/losses in AOCI that offset currency fluctuations in underlying exposures. Both companies utilize derivatives to mitigate earnings volatility from foreign exchange movements, though KO's option contracts specifically provide the right (not obligation) to exchange currencies at predetermined rates, while PEP's strategy explicitly includes cross-currency swaps to convert foreign debt to U.S. dollars and targets hedging of both firm commitments and forecasted transactions across key currencies like the euro and yen.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "KO (ORG) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> Foreign Currency Liabilities (FIN_INST)",
        "Foreign Currency Liabilities (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12710,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3859,
        "completion_tokens": 273,
        "total_tokens": 4133
      }
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE employs discounted cash flow models to assess goodwill impairment risk by estimating fair value through strategic cash flow forecasts and terminal value assumptions, with sensitivity analyses on discount rates and cash flow projections to evaluate potential impairments. This approach aligns with its accounting policy for impairment testing, which relies on internal forecasts and discount rates, directly mirroring the methodology used for Level 3 fixed income investments by LMT. LMT similarly applies DCF models to value Level 3 fixed income investments, where significant inputs include projected cash flows (e.g., annuity payments) and discount rates, making both entities’ valuations highly sensitive to these assumptions. The KG triplet connections confirm that GE’s DCF-based impairment testing (Discounted Cash Flow Approach → Fixed Income Investments → LMT) and LMT’s Level 3 fixed income valuation (Fixed Income Investments → DCF with discount rate sensitivity) share this core sensitivity dynamic, though GE’s application focuses on goodwill impairment risk while LMT’s pertains to investment valuation.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> Discounted Cash Flow Approach (ACCOUNTING_POLICY)",
        "Discounted Cash Flow Approach (ACCOUNTING_POLICY) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13253,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4021,
        "completion_tokens": 279,
        "total_tokens": 4301
      }
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "CMCSA's Class A common stock holders possess 66⅔% of the combined voting power, with each Class A share carrying one vote and each Class B share carrying 15 votes, where Class B represents 33⅓% of voting power and is non-dilutable. In contrast, GOOGL's Class A shares carry one vote per share while Class B shares carry 10 votes per share, with Class C shares having no voting rights, and GOOGL's share repurchases have focused exclusively on Class A and Class C shares totaling $62.2 billion in 2023, whereas CMCSA's repurchases are tracked separately but similarly impact its capital structure. The voting power distribution differs significantly: CMCSA's Class B stock concentrates 33⅓% of voting power in a single shareholder (Brian Roberts) with 15 votes per share, while GOOGL's Class B stock provides 10 votes per share but without the same concentrated ownership, creating fundamentally different governance dynamics between the two companies' capital structures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4097,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1695,
        "completion_tokens": 242,
        "total_tokens": 1937
      }
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "PM's business in Turkey benefits from an 8.2% rise in the total cigarette market driven by increased in-bound tourism, which directly boosts shipment volumes and market share in the region as noted in Chunk 1 (Mexico and Turkey volume growth) and Chunk 2 (Turkey's 8.2% market growth contributing to Middle East & Africa's 23.1% market share increase). This tourism-driven market expansion positively impacts PM's operational footprint in Turkey, while CL's presence there is confirmed through its overseas operations in over 80 countries including Turkey (Chunk 3), though CL's specific Turkish market performance is not detailed in the provided materials. Consequently, PM's Turkey-focused growth contrasts with CL's broader but less explicitly quantified footprint in the same country.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[positively_impacted_by]-> MACRO_CONDITION -[Positively_Impacts]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> Increased In-Bound Tourism (MACRO_CONDITION)",
        "Increased In-Bound Tourism (MACRO_CONDITION) -> Turkey (GPE)",
        "Turkey (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6909,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2405,
        "completion_tokens": 197,
        "total_tokens": 2602
      }
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Geopolitical tensions involving Taiwan could materially disrupt NVIDIA's supply chain by jeopardizing its ability to secure timely chip production from foundry partners located in Taiwan, as highlighted by NVIDIA's explicit acknowledgment of geopolitical risks in its 10-K filing that could impair supply continuity and force inventory constraints or order delays. Simultaneously, Qualcomm's operations face severe exposure through its reliance on Taiwanese foundries for critical chipset supply, with its 10-K specifically identifying prolonged conflict as a threat that could \"severely limit or prevent\" its access to Taiwan-based manufacturing capacity, directly jeopardizing its ability to meet customer demand and maintain revenue streams from its core licensing business. Both companies' financial resilience is intertwined with Taiwan's manufacturing stability, making regional instability a shared systemic risk that could simultaneously impair NVIDIA's product availability and Qualcomm's licensing revenue and supply chain operations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Foundry Partners (COMP)",
        "Foundry Partners (COMP) -> Taiwan (GPE)",
        "Taiwan (GPE) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19821,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5627,
        "completion_tokens": 261,
        "total_tokens": 5888
      }
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "The application of ASU 2020-04 has allowed FDX to elect optional expedients for contract modifications and hedging relationships affected by LIBOR reform, but it explicitly states there has been no material effect on its financial condition or results of operations as of May 31, 2024, while continuing to monitor such contracts. In contrast, MMM discloses active use of ASU 2020-04 in its hedging relationships, with specific quantitative impacts including $152 million reclassified from accumulated other comprehensive income into income for interest rate contracts and $(15) million for fair value hedging adjustments in 2023, demonstrating a material financial treatment of reference rate reform effects that FDX's disclosure indicates it has not experienced materially.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "FDX (ORG) -> ASU 2020-04 (ACCOUNTING_POLICY)",
        "ASU 2020-04 (ACCOUNTING_POLICY) -> Hedging Relationships (ACCOUNTING_POLICY)",
        "Hedging Relationships (ACCOUNTING_POLICY) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16956,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4929,
        "completion_tokens": 193,
        "total_tokens": 5122
      }
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "The voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, concentrates 33.3% of the combined voting power in a single individual, creating a highly centralized governance structure where Roberts effectively controls board elections and major corporate decisions despite owning only a small fraction of total shares. In contrast, GOOGL's dual-class system distributes voting power more broadly: Class A shares carry one vote per share, Class B shares carry 10 votes per share (though not entirely owned by a single individual), and Class C shares carry no voting rights, resulting in a less concentrated but still differential voting structure where no single entity holds exclusive control over the voting power. This distinction is critical for understanding governance dynamics, as CMCSA's model enables direct, non-dilutable control by Roberts through his ownership of all Class B shares, whereas GOOGL's system allows for more distributed voting influence across multiple share classes with varying rights.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10683,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3364,
        "completion_tokens": 266,
        "total_tokens": 3631
      }
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen's remaining repatriation tax payments under the 2017 Tax Act are scheduled over an eight-year period ending in 2025, with specific amounts disclosed in its December 31, 2023 filing showing the outstanding installment obligations as of that date. Eli Lilly similarly elected the eight-year payment election for the Toll Tax under the same 2017 Tax Act and reported its future cash payment schedule for the repatriation tax as of December 31, 2023, reflecting its own remaining payment obligations under this provision. Both companies are subject to the same regulatory framework established by the 2017 Tax Act, which introduced the eight-year payment period for the one-time repatriation transition tax on unremitted foreign earnings.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Introduces]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 2017 Tax Act (REGULATORY_REQUIREMENT)",
        "2017 Tax Act (REGULATORY_REQUIREMENT) -> Eight-Year Payment Period (ACCOUNTING_POLICY)",
        "Eight-Year Payment Period (ACCOUNTING_POLICY) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_159",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3651,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 185,
        "total_tokens": 1787
      }
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "The risk of biosimilar competition following loss of exclusivity for Amgen's biologics is heightened by the U.S. regulatory pathway that allows biosimilar entry after 12 years of data protection, but this risk is mitigated by complex development timelines, manufacturing challenges, and patent litigation dynamics that may delay or prevent biosimilar approvals, as noted in Chunk 2's discussion of biologics-specific vulnerabilities. In contrast, Bristol Myers Squibb faces a more direct exposure due to its biologics portfolio (including Opdivo, Yervoy, and others) operating under the same 12-year U.S. data protection framework and EU \"8+2+1\" regime where biosimilars can enter after 10–11 years, with EU law permitting generic approvals post-data protection regardless of patent status, creating a clearer and potentially faster path to competition that aligns with Chunk 3's description of EU regulatory pathways and Chunk 1's KG triplet linking Exclusivity (ACCOUNTING_POLICY) to BMY (ORG) through the negative impact on accounting policies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Negatively_Impacts]-> ACCOUNTING_POLICY <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Biologics (PRODUCT)",
        "Biologics (PRODUCT) -> Exclusivity (ACCOUNTING_POLICY)",
        "Exclusivity (ACCOUNTING_POLICY) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12023,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3687,
        "completion_tokens": 261,
        "total_tokens": 3949
      }
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic faces Medicaid reimbursement policy risks that directly drive pricing pressures across its broad medical device portfolio, where exposure manifests through government programs like Medicare and Medicaid that influence hospital purchasing and reimbursement rates, as highlighted in its 10-K disclosures about cost-containment initiatives and tender mechanisms affecting revenue stability. In contrast, AbbVie confronts IRA-driven pricing pressures specifically targeting its high-revenue pharmaceuticals—such as Imbruvica, Vraylar, and Linzess—through Medicare Part D price-setting authorities that could accelerate revenue erosion for products comprising over 50% of its sales, creating distinct revenue risks tied to regulatory timelines and discount structures unlike Medtronic's device-focused reimbursement environment. Both companies operate under heightened government cost-containment pressures, but Medtronic's risk stems from Medicaid's impact on hospital procurement and device pricing across its diversified portfolio, while AbbVie's exposure is structurally amplified by the IRA's direct price-setting mechanisms targeting specific biologics and small-molecule drugs with significant Medicare reimbursement shares.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Impacts]-> RISK_FACTOR <-[Subject_To]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Medicaid (REGULATORY_REQUIREMENT)",
        "Medicaid (REGULATORY_REQUIREMENT) -> Pricing Pressures (RISK_FACTOR)",
        "Pricing Pressures (RISK_FACTOR) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18057,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5195,
        "completion_tokens": 309,
        "total_tokens": 5504
      }
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS reports approximately $2.7 billion of unfunded commitments to private‑equity‑type limited partnerships, which are valued using NAV as a practical expedient and therefore sit outside the Level 1‑3 hierarchy; in contrast, General Dynamics also uses NAV as a practical expedient for its Level 1 plan assets—specifically commingled equity and fixed‑income funds that are valued with quoted market prices—but excludes such NAV‑valued investments from the fair‑value hierarchy, noting that any unfunded commitments related to these NAV‑valued investments are immaterial as of the 2024 reporting date.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Private Equity Funds (FIN_INST)",
        "Private Equity Funds (FIN_INST) -> NAV (ACCOUNTING_POLICY)",
        "NAV (ACCOUNTING_POLICY) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6626,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2341,
        "completion_tokens": 149,
        "total_tokens": 2490
      }
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA's 2024 issuance of Class B Common Stock creates a dual-class structure where Class B shares carry voting rights (as evidenced by the $0.01 par Class B common stock line item in Chunk 1's equity section and the referenced voting mechanics in Chunk 2), while Class A shares maintain standard voting rights, directly contrasting with META's framework where Class A Common Stock (disclosed in Chunk 3's \"Class A Common Stock, $0.000006 par value\" entry) holds voting rights and Class B shares have no voting rights except on specific matters like core business exits or charter amendments, as detailed in Chunk 2's voting rights provisions. This structural divergence is further connected through the KG pattern where Class B Common Stock (CMCSA) depends on Class A Common Stock (which links to META), highlighting how CMCSA's voting rights mechanism operates independently of META's model despite the shared FIN_INST relationship.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15439,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4538,
        "completion_tokens": 233,
        "total_tokens": 4771
      }
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA’s Medicare price‑setting rules will force manufacturers to accept government‑set reimbursement rates for selected drugs, creating direct pricing pressure that can erode revenue streams for any product placed on the federal pricing schedule.  Because the IRA mandates that manufacturers accept the statutory ceiling price—or face penalties—on all U.S. sales, Amgen’s products that rely on Medicare reimbursement could see their revenue run‑off accelerate once they are selected for price setting, mirroring AbbVie’s experience with Imbruvica (selected for 2026) and Vraylar (selected for 2027), which will begin to compress reimbursement rates and could shorten the revenue‑erosion timeline for Amgen’s similarly positioned therapies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Impacts]-> RISK_FACTOR <-[Subject_To]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Medicare (REGULATORY_REQUIREMENT)",
        "Medicare (REGULATORY_REQUIREMENT) -> Pricing Pressures (RISK_FACTOR)",
        "Pricing Pressures (RISK_FACTOR) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17495,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5074,
        "completion_tokens": 185,
        "total_tokens": 5259
      }
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "The number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive is 37,028 thousand, as disclosed in its 2022 10-K filing (Chunk 1), while Procter & Gamble discloses 3,837,000 thousand remaining available under its plans (Chunk 2). This reveals a direct quantitative comparison between the two companies' disclosed remaining availability, with Colgate-Palmolive reporting 37,028 (in thousands) and Procter & Gamble reporting 3,837,000 (in thousands), reflecting their respective equity compensation plan disclosures linked through the KG relationship where \"Securities Remaining Available\" is connected to both organizations via the disclosure pathway.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CL (ORG) -> Equity Compensation Plans Approved by Security Holders (FIN_INST)",
        "Equity Compensation Plans Approved by Security Holders (FIN_INST) -> Securities Remaining Available (FIN_INST)",
        "Securities Remaining Available (FIN_INST) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7032,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2475,
        "completion_tokens": 183,
        "total_tokens": 2658
      }
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "The joint commercialization of BMY's biologics in Taiwan, as detailed in Chunk 1, involves a 50/50 profit-sharing model for combination therapies and a 60/40 copromotion fee structure with Ono, with BMY handling supply and distribution—this partnership operates within Taiwan's regulatory framework requiring local clinical trial data for biosimilar registration, as noted in Chunk 2's discussion of Asia-Pacific requirements. In contrast, MRK's strategic spin-off of its biosimilars business into Organon (Chunk 3) represents a structural divestiture rather than a commercial partnership, decoupling biosimilars from Merck's core operations while leveraging Taiwan's regulatory pathway for biosimilar approval (which permits reliance on prior U.S./EU data but still requires local bridging studies per Chunk 2). Critically, both scenarios are shaped by Taiwan's requirement for local clinical trial data, but BMY's model actively utilizes this data within a collaborative commercial framework, whereas MRK's spin-off eliminates such dependencies by separating biosimilars from its portfolio, reflecting divergent strategies for navigating the same regulatory landscape.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Taiwan (GPE)",
        "Taiwan (GPE) -> Biosimilars (PRODUCT)",
        "Biosimilars (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8988,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2914,
        "completion_tokens": 292,
        "total_tokens": 3206
      }
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "AAPL's 2022 revenue from Taiwan, as part of its Greater China segment, was $74.2 billion, representing the entirety of Taiwan's contribution within that region, whereas ADBE maintains an operational presence in Taiwan through its local field office, as noted in Adobe's 2022 10‑K disclosure of offices in Taiwan. This contrast highlights that while AAPL reports a distinct, substantial revenue stream from Taiwan under its Greater China segment, ADBE's involvement there is limited to operational activities rather than a separate revenue segment. Consequently, AAPL generates significant sales directly attributed to Taiwan within its segment reporting, whereas ADBE's engagement in the same market is confined to sales and support operations without a disclosed revenue breakdown.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Greater China (GPE)",
        "Greater China (GPE) -> Taiwan (GPE)",
        "Taiwan (GPE) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6882,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2367,
        "completion_tokens": 195,
        "total_tokens": 2562
      }
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "CMCSA and META both issue Class A and Class B common stock, but the voting power is allocated very differently.  In CMCSA’s structure, Class A shares collectively hold about 66 ⅔ % of the combined voting power while Class B shares hold roughly 33 ⅓ %—with each Class B share carrying 15 votes, a non‑dilutable stake ultimately controlled by Mr. Brian L. Roberts.  By contrast, META’s Class B shares are not publicly traded and are held by only 23 record holders, while its Class A shares trade on Nasdaq; however, META’s filing does not disclose a comparable split of voting percentages between the two classes, meaning the concentration of control is far less explicit and likely more dispersed.  Consequently, CMCSA’s dual‑class arrangement concentrates significant governance influence in the hands of the Class B holder, whereas META’s structure provides far less concentrated voting power, shaping shareholder influence over corporate‑governance decisions in markedly different ways.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4884,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1902,
        "completion_tokens": 247,
        "total_tokens": 2149
      }
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "LLY and MRK benefit differently from pediatric exclusivity provisions through distinct regulatory pathways and incentives in the U.S. and EU frameworks. In the U.S., pediatric exclusivity grants an additional six months of market exclusivity on top of patent or data protection terms, applicable to both chemical and biologic products when pediatric studies are conducted, and can extend orphan drug exclusivity or regulatory data protection periods. In contrast, the EU provides an extra six months of pediatric market exclusivity attached to the Summary of Product Characteristics (SPC) term, which is separate from patent protection and complements regulatory data exclusivity, as reflected in the KG pattern where Market Exclusivity (REGULATORY_REQUIREMENT) connects both LLY and MRK to this incentive. This distinction is reinforced by the regulatory structure where Pediatric Exclusivity (REGULATORY_REQUIREMENT) is subject to both ORG entities and positively impacts Market Exclusivity, enabling tailored extensions of market protection under each region’s rules.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Pediatric Exclusivity (REGULATORY_REQUIREMENT)",
        "Pediatric Exclusivity (REGULATORY_REQUIREMENT) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12148,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3715,
        "completion_tokens": 267,
        "total_tokens": 3982
      }
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "EMR's foreign currency liabilities decreased from $22 million in 2023 to $20 million in 2024, a $2 million reduction, while LMT's foreign‑currency hedge exposure grew from $6.5 billion to $7.5 billion of notional contracts—a $1 billion increase. This contrast shows that EMR is scaling back its foreign‑exchange obligations, whereas LMT is expanding its hedge book, indicating that EMR may be adopting a more conservative or less leveraged FX risk strategy relative to LMT’s broader hedging approach.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST -[Impacts]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> Foreign Currency Liabilities (FIN_INST)",
        "Foreign Currency Liabilities (FIN_INST) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9161,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2977,
        "completion_tokens": 125,
        "total_tokens": 3102
      }
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion dividend that AENB paid to AXP in 2023 must be evaluated against the leverage‑ratio and capital‑distribution rules that both AENB and WFC are subject to under federal banking regulations.  As noted in the AXP filing, AENB’s ability to distribute dividends is constrained by regulatory capital and leverage requirements, and any shortfall in those ratios can trigger limits or prohibitions on dividend payments; similarly, WFC, as a large bank holding company, must maintain Basel III leverage and supplementary leverage ratios and submit annual capital plans that govern its own dividend policies.  Consequently, the size of the dividend is directly tied to whether AENB’s current leverage‑ratio position satisfies the applicable regulatory buffers and capital‑plan requirements that the Federal Reserve and other banking agencies enforce for both AENB and its parent‑level counterpart, WFC.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "AXP (ORG) -> AENB (COMP)",
        "AENB (COMP) -> Leverage Ratio Requirements (REGULATORY_REQUIREMENT)",
        "Leverage Ratio Requirements (REGULATORY_REQUIREMENT) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_152",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6627,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2331,
        "completion_tokens": 227,
        "total_tokens": 2558
      }
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft's geographic distribution of pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) creates exposure to OECD Pillar Two Model Rules through its foreign operations in jurisdictions implementing the Global Minimum Tax, particularly as delayed foreign tax credit regulations (Notice 2023-55/80) impact its effective tax rate of 18% (below the U.S. statutory rate) due to lower-taxed foreign earnings. This exposure is mitigated by Microsoft's lack of material operations in low-tax jurisdictions, though the OECD framework will apply to its multinational structure beginning fiscal 2025. Qualcomm (QCOM), similarly subject to the same OECD Pillar Two framework with implementation starting fiscal 2025 per its 10-K disclosure, faces comparable structural exposure but lacks Microsoft's disclosed foreign income concentration ($44.9B vs. Microsoft's $44.9B foreign pre-tax income), though both companies state they do not currently expect material impacts to consolidated financial statements despite monitoring legislative developments.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Pillar Two Model Rules (REGULATORY_REQUIREMENT)",
        "Pillar Two Model Rules (REGULATORY_REQUIREMENT) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6117,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2263,
        "completion_tokens": 262,
        "total_tokens": 2526
      }
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "WMT's $37.2 billion of unrecorded purchase obligations creates financial risk that is not reflected in the VAR models used by peers such as MDLZ because those obligations represent binding cash outflows for inventory, capital‑expenditure and service contracts that are excluded from the VAR calculations, which focus only on market‑sensitive instruments and assume normal market conditions; consequently, while MDLZ’s VAR model (as disclosed in its 10‑K) estimates a one‑day loss of $255 million under normal conditions and excludes firm commitments and seasonal inventory builds, WMT must still honor its legally binding purchase contracts regardless of market volatility, exposing the company to liquidity and earnings risk that the VAR‑based risk metrics of peers do not capture.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Does_Not_Relate_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Firm Commitments (FIN_INST)",
        "Firm Commitments (FIN_INST) -> VAR Model (ACCOUNTING_POLICY)",
        "VAR Model (ACCOUNTING_POLICY) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5731,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2102,
        "completion_tokens": 195,
        "total_tokens": 2297
      }
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UNH manages interest rate risk from its $1.4 billion 3.625% 2024 Notes repayment through interest‑rate swap contracts that convert floating‑rate liabilities into fixed‑rate exposure, thereby hedging the interest‑rate sensitivity of its debt portfolio (Chunk 1). AMGN similarly uses interest‑rate swaps—designated as fair‑value hedges—to convert fixed‑rate coupons on its $1.4 billion 3.625% 2024 Notes into SOFR‑plus‑1.8% floating‑rate payments, directly offsetting the interest‑rate impact of that repayment (Chunks 2‑3). Both companies employ swaps to align debt‑service costs with market rates, but UNH’s approach is broader‑based on diversifying floating‑rate assets and liabilities, whereas AMGN’s is focused on specific hedge contracts tied to the repayment of the 2024 Notes.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Interest Rate Swap Contracts (FIN_INST)",
        "Interest Rate Swap Contracts (FIN_INST) -> 3.625% 2024 Notes (FIN_INST)",
        "3.625% 2024 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_142",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7828,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2639,
        "completion_tokens": 195,
        "total_tokens": 2835
      }
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "The potential acceleration of AMD's 3.924% Senior Notes Due 2032 upon an Event of Default triggers immediate repayment of the full $1.0 billion principal plus accrued interest, as stipulated in the indenture governing the notes and reinforced by the KG relationship linking AMD → 3.924% Senior Notes Due 2032 → Event of Default → ORCL, indicating that Oracle's exposure to similar default-triggered obligations under its Revolving Credit Agreement requires comparable immediate repayment of outstanding balances (including the $6.0 billion facility) upon an Event of Default, which would mature all borrowings under the facility prior to March 8, 2027, mirroring the accelerated maturity structure observed in AMD's notes.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues_Financial_Instrument]-> FIN_INST -[Accelerated_Maturity]-> RISK_FACTOR <-[Subject_To]- ORG",
      "triplets_used": [
        "AMD (ORG) -> 3.924% Senior Notes Due 2032 (FIN_INST)",
        "3.924% Senior Notes Due 2032 (FIN_INST) -> Event of Default (RISK_FACTOR)",
        "Event of Default (RISK_FACTOR) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6282,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2282,
        "completion_tokens": 180,
        "total_tokens": 2463
      }
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "The $31.0 billion of trust assets that GE holds under reinsurance agreements are managed with strict investment guidelines—covering asset‑class concentration, issuer limits, duration matching and other credit‑quality, yield, liquidity and diversification requirements—whereas General Dynamics’ $191 million of marketable securities held in trust as of 12/31/2021 are subject only to a policy that permits investment‑grade fixed‑income securities with maturities up to five years and no material market risk. Consequently, GE’s trust assets face broader credit, interest‑rate and equity risks tied to their reinsurance contracts and statutory deposit rules, while GD’s securities are limited to low‑risk, short‑term holdings with minimal exposure.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Has]- ORG",
      "triplets_used": [
        "GE (ORG) -> Investment Guidelines (ACCOUNTING_POLICY)",
        "Investment Guidelines (ACCOUNTING_POLICY) -> Trust Assets (FIN_INST)",
        "Trust Assets (FIN_INST) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13533,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4081,
        "completion_tokens": 186,
        "total_tokens": 4267
      }
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin applies Level 2 fixed income pricing models that rely on observable inputs such as quoted interest rates, yield curves, and credit spreads, while PayPal values its derivative instruments using Level 2 models that incorporate multiple observable inputs—including currency rates, interest rate yield curves, option volatility, and equity prices—both requiring market‑observable data but differing in the specific inputs used.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "C (ORG) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_191",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8392,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2784,
        "completion_tokens": 109,
        "total_tokens": 2894
      }
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "AVGO's fixed rate senior notes exhibit sensitivity to interest rate changes, with a 50 basis point market shift altering their fair value by approximately $1.7 billion, though this does not affect interest expense. In contrast, CSCO employs an interest rate swap (notional $0.5 billion) designated as a fair value hedge for specific fixed-rate senior notes, converting fixed-rate debt to floating SOFR-based payments; this swap's fair value changes substantially offset the underlying debt's interest rate sensitivity, directly mitigating the impact of rate fluctuations on their fixed-rate obligations. Both companies manage interest rate risk through derivatives, but CSCO's swap actively offsets fair value changes in hedged debt, while AVGO's exposure is measured by fair value shifts without hedging mechanisms.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Holds]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Fixed Rate Senior Notes (FIN_INST)",
        "Fixed Rate Senior Notes (FIN_INST) -> Interest Rate Swap (FIN_INST)",
        "Interest Rate Swap (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6796,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2382,
        "completion_tokens": 204,
        "total_tokens": 2586
      }
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMY's Eliquis alliance with Pfizer involves co-exclusive license rights and shared responsibilities across research, development, distribution, and marketing committees, with BMY acting as the principal U.S. sales entity and both parties contributing infrastructure resources; the upfront payment and contingent milestone proceeds are amortized over the co-promotion period through market exclusivity, reflecting a structured financial recognition approach distinct from Pfizer's Beam collaboration. In contrast, Pfizer's separate collaboration with Beam for in vivo base editing programs includes a $300 million upfront payment recorded as acquired in-process R&D in 2021, with potential additional milestone payments totaling up to $1.05 billion (for a combined deal value of $1.35 billion) and royalties on global net sales, governed by a 65%/35% (Pfizer/Beam) profit and cost-sharing ratio upon opt-in to exclusive licenses for three undisclosed targets.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Introduces]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Research Activities (ACCOUNTING_POLICY)",
        "Research Activities (ACCOUNTING_POLICY) -> Beam (COMP)",
        "Beam (COMP) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4475,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1813,
        "completion_tokens": 239,
        "total_tokens": 2052
      }
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments (TXN) applies a consistent accounting policy for lease extensions and termination options across its customer financing arrangements, where such options are included in the lease term and recognized when reasonably certain of exercise, directly impacting the present value of lease payments and resulting long-term liabilities on its balance sheet. This approach is mirrored in Cisco’s (CSCO) treatment of similar provisions within its customer financing arrangements, as evidenced by its Note 9 disclosures on financing receivables and guarantees, where lease terms incorporating extension or termination options affect the classification and recognition of financing liabilities and revenue, particularly in relation to deferred revenue and the valuation of guarantees tied to third-party financing programs. Consequently, both companies’ accounting for these options—especially regarding the inclusion of reasonably certain extension periods in lease term calculations and the resulting impact on long-term liability recognition—creates a direct linkage between their accounting policies for lease options (as captured in the KG pattern ORG → Lease Options → Customer Financing ← Provides → ORG) and their financial statement presentation of long-term obligations and revenue recognition timing.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Contains]-> FIN_INST <-[Provides]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Lease Options (ACCOUNTING_POLICY)",
        "Lease Options (ACCOUNTING_POLICY) -> Customer Financing (FIN_INST)",
        "Customer Financing (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5199,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1994,
        "completion_tokens": 329,
        "total_tokens": 2323
      }
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney's 73% stake in National Geographic enables exclusive, high-quality documentary content for Disney+ that differentiates its streaming library from competitors, directly supporting subscriber acquisition through unique programming unavailable on other platforms. This strategic content ownership reduces reliance on costly third-party licensing deals—unlike YouTube's model, which depends on expensive external content licenses—thereby lowering Disney+'s subscriber acquisition costs through proprietary, non-duplicated assets that drive organic growth and reduce churn.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Includes]-> PRODUCT <-[Competes_With]- ORG",
      "triplets_used": [
        "DIS (ORG) -> National Geographic (COMP)",
        "National Geographic (COMP) -> Disney (PRODUCT)",
        "Disney (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9503,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3048,
        "completion_tokens": 143,
        "total_tokens": 3192
      }
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "The impact of regulatory exclusivity expiration timelines on BMY’s biologic products—subject to 12‑year exclusivity periods that can be extended by up to six months for pediatric studies—differs from MRK’s experience with the Januvia family, where patent‑related market exclusivity delays (including a 2026 U.S. patent expiry and EU loss of exclusivity in 2022‑23) were compounded by statutory rebate changes, IRA price‑setting, and competitive pressures that shortened the effective exclusivity window despite patent extensions. Both companies rely on regulatory exclusivity to extend protection beyond patent terms, but BMY’s biologics benefit from a fixed 12‑year term (plus possible six‑month pediatric extensions), whereas MRK’s Januvia exclusivity has been eroded by a mix of patent challenges, regulatory exclusivity loss, and government‑mandated pricing reforms that have accelerated market decline.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Regulatory Exclusivity (REGULATORY_REQUIREMENT)",
        "Regulatory Exclusivity (REGULATORY_REQUIREMENT) -> Market Exclusivity (REGULATORY_REQUIREMENT)",
        "Market Exclusivity (REGULATORY_REQUIREMENT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13602,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4116,
        "completion_tokens": 226,
        "total_tokens": 4342
      }
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife's issuance of 40,000 shares of Series F preferred stock, which contains redemption terms tied to a \"rating agency event\" allowing redemption within 90 days of such an event at $25,500 per share plus accrued dividends (Chunk 2), directly creates a financial instrument whose risk profile is negatively impacted by rating downgrades (per KG pattern: Series F Preferred Stock → Rating Downgrade ← Negatively Impacts ← Rating Agency Event). This exposure intersects with AIG's acknowledgment that a rating downgrade could impair its ability to write new business and retain customers (Chunk 3), while MetLife's own disclosure confirms that its Series F redemption terms are explicitly triggered by rating agency actions that lower equity credit (Chunk 2), thereby linking MetLife's financing structure to the same rating-driven risk factors that AIG identifies as potentially limiting its own business operations and customer retention.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MET (ORG) -> Series F Preferred Stock (FIN_INST)",
        "Series F Preferred Stock (FIN_INST) -> Rating Downgrade (RISK_FACTOR)",
        "Rating Downgrade (RISK_FACTOR) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_262",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_264",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10946,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3455,
        "completion_tokens": 235,
        "total_tokens": 3690
      }
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "LMT's U.S. Government securities portfolio of $121 million as of December 31 2021 was classified at Level 2 and valued using matrix pricing, a method that relies on observable market inputs such as yield curves and broker‑quoted prices when direct quotes are unavailable. Both LMT and UPS apply matrix pricing for similar assets, but UPS explicitly notes that its Level 2 corporate bonds and municipal bonds are valued with “market corroborated pricing, matrix pricing or other models that utilize observable inputs,” whereas LMT’s disclosure ties matrix pricing directly to its accounting policy for U.S. Government Securities. Thus, while the underlying methodology (matrix pricing) is shared, LMT’s classification places its government‑security holdings in Level 2 and references matrix pricing as the specific valuation technique, whereas UPS’s Level 2 investments are broader (including corporate and municipal bonds) and are described as using matrix pricing alongside other market‑corroborated models.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "LMT (ORG) -> U.S. Government Securities (FIN_INST)",
        "U.S. Government Securities (FIN_INST) -> Matrix Pricing (ACCOUNTING_POLICY)",
        "Matrix Pricing (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5517,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2067,
        "completion_tokens": 252,
        "total_tokens": 2319
      }
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PM's valuation of its derivatives relies on readily observable market inputs (e.g., spot rates, interest rate differentials) for Level 1/2 fair value measurements, contrasting with MDLZ's real estate fund investments that use unobservable inputs and periodic appraisals for Level 3 valuations, resulting in significantly lower observability for MDLZ's real estate fund investments compared to PM's derivative valuations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "PM (ORG) -> Valuation Models (ACCOUNTING_POLICY)",
        "Valuation Models (ACCOUNTING_POLICY) -> Real Estate Funds (FIN_INST)",
        "Real Estate Funds (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6630,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2336,
        "completion_tokens": 105,
        "total_tokens": 2441
      }
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife's repayment strategy for its junior subordinated debentures involves regulatory-triggered interest deferrals and capital support covenants that restrict repayment until liquidity and capital conditions are met, as detailed in its 10-K notes on debt repayments and support agreements (Chunk 1), whereas AIGLH's junior subordinated debentures are explicitly guaranteed by the AIG Parent company, providing a distinct guarantee structure that differs from MetLife's unsecured, non-guaranteed obligations (Chunks 2 and 3). This contrast highlights MetLife's reliance on internal capital triggers and regulatory constraints for deferral management, while AIG's instruments benefit from explicit parent-level guarantees, directly linking repayment capacity to AIG's financial strength rather than standalone liquidity tests.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Repay]-> FIN_INST -[Issues]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "MET (ORG) -> Junior Subordinated Debentures (FIN_INST)",
        "Junior Subordinated Debentures (FIN_INST) -> AIGLH (COMP)",
        "AIGLH (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_290",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_290",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6580,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2321,
        "completion_tokens": 206,
        "total_tokens": 2528
      }
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA's competitive positioning against Samsung in the SoC and GPU markets directly influences Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures. The KG triplets reveal that Samsung competes with NVDA (NVIDIA) in the SoC market and is linked to IFS Foundry Services (INTC's strategic initiative), while Intel (INTC) faces competitive pressures from companies like Samsung and TSMC in foundry manufacturing. As noted in Chunk 1, NVIDIA identifies Samsung as a key competitor in SoC products (including for automotive and gaming devices), and Chunk 2 emphasizes that Intel's IFS must compete with established foundries like Samsung on critical factors such as manufacturing technology, capacity, and ecosystem support to succeed in its IDM 2.0 strategy, despite historical delays like those in 10nm and Intel 4 process technologies that have weakened its competitive position. This convergence of Samsung's SoC competitiveness with NVIDIA and Intel's IFS ambitions creates a dual pressure point where Samsung's market strength in semiconductors directly challenges Intel's ability to scale IFS capacity and attract customers away from rivals like TSMC.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Competes_With]-> PRODUCT <-[Competes_With]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Samsung (COMP)",
        "Samsung (COMP) -> IFS Foundry Services (PRODUCT)",
        "IFS Foundry Services (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19204,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5481,
        "completion_tokens": 313,
        "total_tokens": 5794
      }
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet's $62.0 billion 2024 repurchase of Class A and Class C shares is executed under a capital‑allocation framework that treats those classes equally except for voting rights—Class A carries one vote per share while Class B carries ten votes per share and may convert to Class A, but Class B is effectively controlled by a single holder (Mr. Brian L. Roberts) whose 33 % non‑dilutable voting stake (via Class B) gives him outsized influence over governance decisions. Comcast’s structure mirrors this dual‑class setup, with Class A holders collectively controlling 66 ⅔ % of voting power despite owning a smaller economic share, while the Class B shares (holding 15 votes each) are wholly owned by Roberts, ensuring concentrated control that shapes its repurchase policy and limits the impact of any dissent from Class A shareholders. Consequently, both companies can repurchase their non‑voting or lower‑voting classes (Alphabet’s Class C and Comcast’s Class A) without substantially diluting the controlling Class B interests, allowing them to execute large buybacks while preserving the existing voting hierarchy.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10683,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3383,
        "completion_tokens": 280,
        "total_tokens": 3663
      }
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen's focus on non-small cell lung cancer (NSCLC) therapies centers on its pipeline targeting KRAS mutations and other molecular drivers, as evidenced by its investigational programs referenced in the Horizon and KRAS-related disclosures in Chunk 1. In contrast, Bristol Myers Squibb's FDA approval of Opdivo Qvantig (Chunk 2 and 3) introduces a subcutaneous formulation of nivolumab co-formulated with hyaluronidase, enabling broader adult solid tumor indications—including previously treated NSCLC—through a novel administration method that enhances convenience and potentially expands market reach beyond traditional intravenous therapies. This development positions Opdivo Qvantig to capture additional market share in the NSCLC space and beyond, directly competing with Amgen's targeted approaches while leveraging BMS's established PD-1 inhibitor platform and recent regulatory wins like the EC approval for Opdivo plus Yervoy in colorectal cancer (Chunk 3).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Impacts]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> NSCLC (PRODUCT)",
        "NSCLC (PRODUCT) -> Opdivo Qvantig (PRODUCT)",
        "Opdivo Qvantig (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 19927,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5648,
        "completion_tokens": 241,
        "total_tokens": 5890
      }
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "The Class B common stock held by CMCSA carries a non-dilutable 33 ⅓ % voting power that cannot be reduced by any future issuances, and each share of Class B converts share‑for‑share into Class A shares under defined restrictions. Because CMCSA’s Class B holdings retain that fixed 33 ⅓ % voting stake, the voting influence of GOOGL—despite its ownership of Class A shares—is capped at the remaining shareholder votes, effectively limiting its ability to sway corporate decisions even though it holds a stake in Class A common stock. This voting structure is reflected in the KG relationship where CMCSA’s Class B common stock converts to Class A common stock, which is linked to GOOGL as a stakeholder, thereby constraining GOOGL’s voting power.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Converts_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10240,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3242,
        "completion_tokens": 186,
        "total_tokens": 3428
      }
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2% surge in South Africa’s total tobacco market volume—driven by pandemic-related sales bans and partially offset by heightened illicit trade—directly triggers PEP’s merger-related socioeconomic obligations, as evidenced by its contingent consideration payment tied to Rockstar’s acquisition and the explicit inclusion of South African socioeconomic program liabilities in merger and integration charges (Chunk 1). Simultaneously, this elevated illicit trade prevalence in South Africa, as a negatively impacted risk factor under the ORG–GPE–RISK_FACTOR–ORG pattern, directly increases MO’s illicit trade risk exposure internationally, given its documented operational vulnerability to illicit trade in South Africa and globally (Chunks 2 and 3). Consequently, PEP’s merger obligations are activated by South Africa’s market dynamics, while MO’s illicit trade risk is amplified by the same regional illicit trade surge affecting its operations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "PEP (ORG) -> South Africa (GPE)",
        "South Africa (GPE) -> Illicit Trade (RISK_FACTOR)",
        "Illicit Trade (RISK_FACTOR) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11332,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3520,
        "completion_tokens": 237,
        "total_tokens": 3758
      }
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "The legal risks for Slack in its securities litigation involve a protracted procedural history with multiple appeals, including a Supreme Court remand and a recent Ninth Circuit ruling reversing the district court’s decision to dismiss the complaint with prejudice, leaving the case open for further proceedings and potential monetary damages, whereas Meta’s privacy-related lawsuits have reached more definitive outcomes such as a $725 million settlement of the consumer privacy class action and a $5 billion FTC penalty, though ongoing appeals and regulatory challenges remain, indicating that Slack’s exposure is still in an active litigation phase with uncertain financial liability compared to Meta’s largely settled and quantified financial impacts.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Files]-> LITIGATION <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Slack (COMP)",
        "Slack (COMP) -> Motion to Dismiss (LITIGATION)",
        "Motion to Dismiss (LITIGATION) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 15978,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4665,
        "completion_tokens": 188,
        "total_tokens": 4853
      }
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "The difference in vesting timelines between PM and WMT directly impacts the recognition period for compensation costs: PM recognizes its $160 million in unrecognized RSU costs over a weighted-average period of approximately 17 months (or upon death, disability, or age 58), while WMT shifted from a 25% annual vesting schedule (over four years) to 8% quarterly vesting (over three years), resulting in a faster recognition period for its RSU costs. This shift in WMT's vesting schedule (from annual to quarterly) aligns with its accounting policy of recognizing compensation costs ratably over the vesting period, contrasting with PM's longer weighted-average recognition period of 17 months for its unrecognized RSU costs.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Vest]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PM (ORG) -> RSU Awards (FIN_INST)",
        "RSU Awards (FIN_INST) -> Vesting Schedule (ACCOUNTING_POLICY)",
        "Vesting Schedule (ACCOUNTING_POLICY) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2912,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 180,
        "total_tokens": 1594
      }
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "The $620 million unrecognized tax benefit risk disclosed by Boeing (BA) reflects potential decreases in tax positions under audit, whereas Lockheed Martin (LMT) assesses that the OECD‑driven Pillar 2 global minimum tax will not materially affect its effective tax rate or financial results, given the differing implementation timelines and the absence of U.S. adoption of the Pillar 2 rules. Both companies note uncertainty surrounding the final OECD framework, but Boeing quantifies a specific tax‑benefit exposure, while Lockheed Martin emphasizes that anticipated legislative changes are expected to be immaterial to its consolidated tax position.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "BA (ORG) -> Global Minimum Tax (REGULATORY_REQUIREMENT)",
        "Global Minimum Tax (REGULATORY_REQUIREMENT) -> Pillar 2 (REGULATORY_REQUIREMENT)",
        "Pillar 2 (REGULATORY_REQUIREMENT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 5219,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2002,
        "completion_tokens": 162,
        "total_tokens": 2165
      }
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "The implementation of ASU No. 2023-07 will require PepsiCo to begin reporting its newly reorganized segments—PepsiCo Foods North America, Latin America Foods, Europe, Middle East and Africa (EMEA), and Other International Foods—starting in Q1 2025, with recast historical segment results, while also mandating incremental disaggregated expense disclosures as adopted by 3M for 2024 and required by Altria beginning in Q1 2025; this aligns with MO’s adoption timeline and disclosure requirements under the same standard, as evidenced by MO’s Note 17 disclosure of expanded segment reporting per ASU No. 2023-07 and its planned inclusion of interim disclosures in Q1 2025, directly connecting PEP’s organizational restructuring (Chunk 1), the ASU’s scope (Chunk 2), and MO’s implementation approach (Chunk 3) through the KG pattern ORG → Segment Reporting → ASU No. 2023-07 ← Subject_To ORG.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Segment Reporting (ACCOUNTING_POLICY)",
        "Segment Reporting (ACCOUNTING_POLICY) -> ASU No. 2023-07 (ACCOUNTING_POLICY)",
        "ASU No. 2023-07 (ACCOUNTING_POLICY) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10532,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3327,
        "completion_tokens": 222,
        "total_tokens": 3549
      }
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck's MK-7962 (sotatercept) patent protection in the U.S. is projected to expire in 2027 based on its current patent portfolio (Chunk 1), but its eligibility for 12 years of data exclusivity upon approval—alongside granted patents expiring in 2037 (absent PTE)—creates potential for extended protection beyond the base patent term (Chunk 2). In contrast, Pfizer's broader biologic patent strategy, as reflected in its portfolio approach (Chunk 3), emphasizes regulatory exclusivity and supplementary protection certificates (SPCs) across global markets, with potential term extensions in the U.S. or Japan that may yield later-expiring patents beyond basic patent expirations, though such extensions could be shorter than requested due to procedural or legal factors. This highlights Merck's reliance on specific MK-7962 patent timelines versus Pfizer's diversified, extension-capable portfolio strategy for biologics.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "MRK (ORG) -> MK-7962 (sotatercept) (PRODUCT)",
        "MK-7962 (sotatercept) (PRODUCT) -> Patent Protection (REGULATORY_REQUIREMENT)",
        "Patent Protection (REGULATORY_REQUIREMENT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 2628,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 230,
        "total_tokens": 1576
      }
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Cost overruns under fixed-price contracts negatively impact both companies' financial performance and operational execution through interconnected risks. For Lockheed Martin (LMT), fixed-price contracts increase exposure to inflationary pressures and technical complexity, leading to reach-forward losses recorded when estimated costs exceed contract value—resulting in significant earnings charges, as evidenced by $270 million in cumulative losses for classified programs and $280 million for the RMS ground-based radar project, which directly reduce net profit booking rates and segment operating profit. This risk is amplified by GE's operational challenges in complex projects like offshore wind and aerospace, where supply chain disruptions, inflation-driven cost increases, and execution failures on fixed-price contracts (such as those affecting RTX's aerospace segment) can trigger cost overruns, penalties, and losses that materially affect cash flows and financial conditions; consequently, while LMT's profit booking adjustments increased net sales by $1.6 billion in 2023 due to favorable revisions, the inherent uncertainty in cost estimates for fixed-price development programs creates persistent financial risk that could erode profitability if costs exceed revenues.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> FIN_INST -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Fixed-Price Contracts (FIN_INST)",
        "Fixed-Price Contracts (FIN_INST) -> Cost Overruns (RISK_FACTOR)",
        "Cost Overruns (RISK_FACTOR) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 20335,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5767,
        "completion_tokens": 320,
        "total_tokens": 6088
      }
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ manages commodity price risk through exchange-traded commodity futures and options, which are classified as Level 1 financial instruments disclosed in its fair value hierarchy, while COST discloses no Level 1 financial liabilities but holds Level 2 and Level 3 liabilities measured using observable inputs and discounted cash flow models respectively. Both companies use derivatives for hedging—MDLZ specifically for raw material costs like cocoa and wheat via futures, and COST for debt instruments where its Senior Notes are valued using Level 2 inputs—yet MDLZ’s commodity futures exposure is explicitly tied to Level 1 fair value measurement as per its own disclosure, whereas COST’s liabilities involve non-trading instruments requiring Level 2/3 valuation methods.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Commodity Futures (FIN_INST)",
        "Commodity Futures (FIN_INST) -> Level 1 Financial Liabilities (FIN_INST)",
        "Level 1 Financial Liabilities (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10477,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3299,
        "completion_tokens": 193,
        "total_tokens": 3492
      }
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "The total number of UPS Class A shares that are convertible into Class B shares is 4.6 billion, as stated in the UPS 2024 10‑K filing (both Chunk 2 and Chunk 3). This figure corresponds to the Class A shares held in a trust that is connected to Lockheed Martin’s nonqualified pension trust via the KG pattern (LMT → Trusts → Class A Shares → UPS). The assets held in Lockheed Martin’s nonqualified pension trust, reported in its 2024 10‑K (Chunk 1), total $658 million as of December 31, 2024. Thus, the convertible Class A shares represent a $658 million trust asset for Lockheed Martin, linking the two entities through the trust relationship.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST -[Held_By]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Trusts (FIN_INST)",
        "Trusts (FIN_INST) -> Class A Shares (FIN_INST)",
        "Class A Shares (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4637,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1825,
        "completion_tokens": 161,
        "total_tokens": 1986
      }
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "AVGO's $56.3 billion of fixed‑rate senior notes are exposed to a 50‑bp rate move that would shift their fair value by roughly $1.7 billion, and the company mitigates cash‑flow volatility from future debt issuances with treasury rate‑lock contracts.  In contrast, CSCO hedges a comparable fixed‑rate senior‑note exposure through a $0.5 billion interest‑rate swap that converts fixed rates to SOFR‑based floating rates, with the resulting gain or loss on the swap substantially offsetting the fair‑value change of the hedged debt; this swap is designated as a fair‑value hedge and is reflected in interest expense.  Both companies therefore use derivative instruments to manage interest‑rate risk, but AVGO relies on rate‑lock contracts for anticipated issuances while CSCO employs an explicit interest‑rate swap to neutralize fair‑value fluctuations of its senior notes.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Hedges_Fixed_Rate_Senior_Notes]-> FIN_INST <-[Designates]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Fixed Rate Senior Notes (FIN_INST)",
        "Fixed Rate Senior Notes (FIN_INST) -> Interest Rate Swap (FIN_INST)",
        "Interest Rate Swap (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 6828,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2398,
        "completion_tokens": 217,
        "total_tokens": 2615
      }
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "PM and MDLZ both apply the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions, but they differ in the scope of instruments they model and the specific risk metrics they calculate. PM uses the technique to estimate potential one-day loss in fair value for interest-rate-sensitive and foreign currency-priced derivatives, focusing on debt and foreign currency forwards, swaps, and options, while MDLZ applies it to estimate potential one-day loss in fair value for interest rate-sensitive instruments (primarily debt) and pre-tax earnings from currency and commodity instruments, with both companies relying on observed market movements over the prior quarter to determine parameters for their models.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Relates_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "PM (ORG) -> Normal Market Conditions (MACRO_CONDITION)",
        "Normal Market Conditions (MACRO_CONDITION) -> VAR Model (ACCOUNTING_POLICY)",
        "VAR Model (ACCOUNTING_POLICY) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4358,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1769,
        "completion_tokens": 193,
        "total_tokens": 1963
      }
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s strategic focus on expanding global patient access to its therapies directly contrasts with Amgen’s struggle to maintain affordability for its high‑cost product Repatha, as payers like Express Scripts leverage their market power to extract deeper discounts that restrict patient access. While Medtronic emphasizes increasing adoption of its devices worldwide through scale and innovation, Amgen faces mounting pressure from consolidated payers—including Express Scripts, CVS and UnitedHealth Group—that negotiate steeper rebates and impose utilization controls, thereby limiting Repatha’s use despite price reductions and new lower‑cost NDCs. This dynamic is further amplified by state‑level 340B and importation policies that intensify payer leverage, ultimately threatening both companies’ sales and patient‑access outcomes.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Positively_Impacts]-> RISK_FACTOR -[Negatively_Impacts]-> COMP <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Patient Access (RISK_FACTOR)",
        "Patient Access (RISK_FACTOR) -> Express Scripts (COMP)",
        "Express Scripts (COMP) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17009,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4962,
        "completion_tokens": 209,
        "total_tokens": 5171
      }
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet's share repurchase strategy prioritizes Class A and Class C shares, with $62.2 billion repurchased in 2023 and $36.3 billion remaining authorized for future Class A and C buybacks, while Class B shares—holding 10 votes per share and convertible to Class A—are not explicitly included in repurchase authorizations. This focus on non-voting Class A shares (which are publicly traded by Comcast, as noted in CMCSA's SEC filing where Class A Common Stock is registered) suggests a strategic effort to reduce the circulating supply of voting-equivalent Class A shares, potentially diminishing external voting influence despite Class B's disproportionate voting rights, thereby preserving insider control through the conversion mechanism and selective repurchasing of lower-voting shares.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 4254,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1759,
        "completion_tokens": 197,
        "total_tokens": 1956
      }
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group's formulary restrictions on high-cost biologics like Repatha, driven by payer efforts to limit patient access and reduce costs, directly threaten Eli Lilly’s ability to sustain revenue growth for its biologic therapies, which depend heavily on patient access. This restriction is amplified by the competitive pressure identified in the KG pattern where UnitedHealth Group (COMP) negatively impacts Patient Access (RISK_FACTOR) that Depends_On LLY (ORG), meaning Lilly’s revenue outlook is vulnerable to the access barriers created by UnitedHealth’s policies. Consequently, Lilly’s biologic sales could face further declines as payers—especially large insurers and PBMs such as UnitedHealth Group—continue to impose utilization management tools, step‑therapy requirements, and formulary exclusions that limit patient use of high‑cost biologics.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Negatively_Impacts]-> RISK_FACTOR <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> UnitedHealth Group (COMP)",
        "UnitedHealth Group (COMP) -> Patient Access (RISK_FACTOR)",
        "Patient Access (RISK_FACTOR) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17672,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5104,
        "completion_tokens": 215,
        "total_tokens": 5320
      }
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle’s $3.0 billion commercial‑paper program is an unsecured short‑term issuance that sits alongside its $15.7 billion delayed‑draw term loan, which requires mandatory prepayments if cash is raised via debt or equity issuances (Chunk 1). Cisco, by contrast, holds $9.0 billion of senior fixed‑rate notes that are explicitly linked to the same commercial‑paper notes through the KG relationship (Senior Fixed‑Rate Notes → CSCO) and are treated as equivalent in ranking to any future commercial‑paper issuances (Chunk 2). Both companies therefore rely on short‑term debt mechanisms—Oracle via its commercial‑paper facility and Cisco via its senior fixed‑rate notes—to fund operations and acquisitions, exposing them to similar liquidity and interest‑rate risks despite the differing scale of each program (Chunk 3).",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Commercial Paper Notes (FIN_INST)",
        "Commercial Paper Notes (FIN_INST) -> Senior Fixed-Rate Notes (FIN_INST)",
        "Senior Fixed-Rate Notes (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8123,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2717,
        "completion_tokens": 203,
        "total_tokens": 2921
      }
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "The extension of ASU 2022-06’s optional hedging relief until December 31 2024 provides FedEx and Caterpillar with additional flexibility to apply hedge accounting to LIBOR‑linked derivative contracts without having to re‑designate or re‑measure them, thereby simplifying the management of interest‑rate risk in those instruments. Both companies can continue to designate such contracts as cash‑flow or fair‑value hedges through 2024, reducing earnings volatility from LIBOR transition adjustments while maintaining compliance with their respective accounting policies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> ASU 2022-06 (ACCOUNTING_POLICY)",
        "ASU 2022-06 (ACCOUNTING_POLICY) -> Hedging Relationships (ACCOUNTING_POLICY)",
        "Hedging Relationships (ACCOUNTING_POLICY) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16144,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4721,
        "completion_tokens": 142,
        "total_tokens": 4863
      }
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing's Five-Year Credit Agreement (2019) with Citibank, N.A. as administrative agent—amended once in 2022—features a syndication structure involving JPMorgan Chase Bank, N.A. as syndication agent and co-lead arrangers, reflecting a typical multi-bank arrangement, while Caterpillar's multi-facility agreements (including its 3-Year and 5-Year Facilities in 2022) also engage Citibank, N.A. as agent but incorporate multiple facilities and addenda, with Amendment No. 1 to the 5-Year Facility occurring in August 2023, demonstrating more active amendment activity in 2023 compared to Boeing's single 2022 amendment, though both companies utilize Citibank, N.A. within broader syndicated credit frameworks disclosed in their SEC filings.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Regulates]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "BA (ORG) -> Five Year Credit Agreement (FIN_INST)",
        "Five Year Credit Agreement (FIN_INST) -> Citibank, N.A. (COMP)",
        "Citibank, N.A. (COMP) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 25289,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 7011,
        "completion_tokens": 184,
        "total_tokens": 7195
      }
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "META's dual-class structure concentrates voting power in Class B shares (controlled by Zuckerberg), allowing disproportionate control despite minority share ownership, while CMCSA's Class B shares are convertible to Class A on a share-for-share basis and currently hold only 33.3% of voting power, though their non-dilutability and conversion mechanism could still concentrate control if not fully converted. This structural divergence means CMCSA's framework introduces potential investor confidence risks through its convertible Class B shares that could theoretically consolidate power, whereas META's rigid Class B control creates a more predictable but still concentrated governance dynamic that may deter investors seeking standard governance protections.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13192,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3995,
        "completion_tokens": 190,
        "total_tokens": 4185
      }
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million, reflecting a significant increase driven by pandemic recovery and international expansion, particularly in Monster product sales across its equity method investee network. Coca-Cola FEMSA specifically operates bottling and distribution in Mexico (including central Mexico, southeast and northeast regions), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (covering São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires federal capital and surrounding areas), and Uruguay nationwide, as detailed in its territorial scope within the bottler agreements.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> Costa Rica (GPE)",
        "Costa Rica (GPE) -> Coca-Cola FEMSA (COMP)",
        "Coca-Cola FEMSA (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12343,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3743,
        "completion_tokens": 187,
        "total_tokens": 3930
      }
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "The decline in Remicade sales driven by biosimilar competition directly reduces Merck’s immunology segment revenue, as evidenced by the 9% drop in Remicade sales in 2021 and 20% decline in 2020 due to ongoing biosimilar pressure in Europe, where market exclusivity was lost in 2015 and pricing/volume declines persist until marketing rights revert to Janssen in 2024. In contrast, AbbVie faces similar biosimilar pressures on Humira in Europe but maintains exposure through its U.S. market dominance and diversified portfolio, though it explicitly acknowledges competitive risks from biosimilars and generic substitution across its biologic products, including Humira’s competition with anti-TNF alternatives and new entrants like Botox biosimilars. Merck’s immunology segment (Simponi and Remicade) is uniquely vulnerable due to the complete loss of exclusivity across all its marketing territories, while AbbVie’s Humira exposure is mitigated by its later-stage biosimilar competition timeline and ongoing revenue from other high-growth areas like oncology (Keytruda) and hepatitis C (Mavyret), as reflected in Merck’s segment reporting showing immunology revenue at $1.124B in 2021 ($299M Remicade + $825M Simponi) versus AbbVie’s broader biologic portfolio resilience.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Negatively_Impacts]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Biosimilar Competition (RISK_FACTOR)",
        "Biosimilar Competition (RISK_FACTOR) -> Remicade (PRODUCT)",
        "Remicade (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13853,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4140,
        "completion_tokens": 318,
        "total_tokens": 4458
      }
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "Honeywell’s investment in Garrett’s Series B Preferred Stock—originally structured as indemnification protection—was treated as a long‑term receivable that was partially redeemed in late 2021.  After the first partial redemption on December 28 2021 (a $211 million cash payment) and the announced second partial redemption (contingent on completing the first), the Company recorded the remaining unredeemed shares at a present value of **$207 million**, which is the amount reflected in the December 31 2021 balance‑sheet presentation of the unredeemed Series B Preferred Stock.  This present‑value figure represents the unredeemed portion of the investment that remains on Honeywell’s books as of year‑end 2021.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Redeems]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> Series B Preferred Stock (FIN_INST)",
        "Series B Preferred Stock (FIN_INST) -> Garrett (COMP)",
        "Garrett (COMP) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 16711,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4867,
        "completion_tokens": 178,
        "total_tokens": 5045
      }
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "The voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts and carries 15 votes per share, concentrates 33.3% of the combined voting power of CMCSA's common stock, while Alphabet's Class B shares (with 10 votes per share) are held by GOOGL and represent a similar non-dilutive voting block. Although CMCSA's share repurchases (summarized in Chunk 2) and Alphabet's $50.3–$62.2 billion repurchases of Class A and C shares (Chunk 1) operate under distinct share class frameworks, the KG pattern reveals that both companies' voting structures—where Class B shares hold disproportionate power—are central to understanding how repurchase activity interacts with governance, even as Alphabet's repurchases specifically target Class A and C shares, leaving its Class B shares unaffected.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10546,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3339,
        "completion_tokens": 206,
        "total_tokens": 3545
      }
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "Both MDLZ and PM employ a Value-at-Risk (VAR) model that assumes normal market conditions, uses a 95% confidence interval, and operates on a one-day holding period with a parametric delta-gamma approximation technique. The key difference lies in the time horizon for observing movements: MDLZ determines parameters by observing interest rate, currency, and commodity price movements over the prior quarter for point-in-time VAR calculations (as of December 31, 2023/2022), while PM specifically references observing interest rate and forward currency rate movements over the preceding quarter for determining risk metrics at December 31, 2023/2022 and for calculating average, high, and low VAR amounts throughout the year. Both approaches exclude one-to-one valuation of currency and commodity options, instead valuing them based on underlying movements as per their respective methodologies.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Depends_On]-> MACRO_CONDITION <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> VAR Model (ACCOUNTING_POLICY)",
        "VAR Model (ACCOUNTING_POLICY) -> Normal Market Conditions (MACRO_CONDITION)",
        "Normal Market Conditions (MACRO_CONDITION) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3412,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 223,
        "total_tokens": 1774
      }
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple's reliance on China Mainland for manufacturing—central to its Greater China segment—is underscored by its supply chain concentration in Asia, including China mainland, as noted in Chunk 1, which highlights risks from trade policies, tariffs, and geopolitical tensions that could disrupt operations and increase costs. In contrast, Microsoft's operational footprint in Greater China, as detailed in Chunk 3, includes a regional operations center in Singapore supporting the Japan, India, Greater China, and Asia-Pacific regions, alongside localized product adaptations and diversified manufacturing flexibility, though it also depends on third-party manufacturers with limited near-term alternatives for critical components. Both companies operate within the Greater China geography (linked via the KG pattern China Mainland → Greater China ← MSFT), but Apple’s manufacturing dependency on China Mainland is more pronounced and risk-exposed, while Microsoft emphasizes regional support infrastructure and localized product offerings through its Singapore-based operations and flexible vendor relationships.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> China Mainland (GPE)",
        "China Mainland (GPE) -> Greater China (GPE)",
        "Greater China (GPE) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 13292,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4001,
        "completion_tokens": 277,
        "total_tokens": 4278
      }
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS classifies its foreign currency derivatives as Level 2 because they rely on observable market inputs like yield curves and exchange rates, whereas GE applies Level 3 valuation techniques to its insurance and pension liabilities—techniques that depend on significant unobservable inputs such as mortality, morbidity, and cash flow assumptions—reflecting fundamentally different accounting policies for foreign currency risk versus long-duration insurance and pension obligations.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> Level 3 Valuation (ACCOUNTING_POLICY)",
        "Level 3 Valuation (ACCOUNTING_POLICY) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_212",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8573,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2838,
        "completion_tokens": 120,
        "total_tokens": 2958
      }
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong is highlighted by the KG relationship where Swire Beverages (COMP) operates in Hong Kong (GPE), directly connecting to Coca-Cola's bottling network in the region. This contrasts with Colgate-Palmolive's operational footprint in Asia Pacific, where its net sales reached $2,867 million in 2021 with 3.0% volume growth driven by India and Greater China, including Hong Kong's market dynamics. While Coca-Cola's bottler agreements grant Swire Beverages exclusive distribution rights in Hong Kong under specific territorial terms, Colgate-Palmolive's regional performance reflects broader Asia Pacific growth metrics without direct reference to a comparable bottling partner relationship in Hong Kong.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Swire Beverages (COMP)",
        "Swire Beverages (COMP) -> Hong Kong (GPE)",
        "Hong Kong (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12528,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3796,
        "completion_tokens": 191,
        "total_tokens": 3987
      }
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "BAC's investment in CDOs with embedded derivatives exposes it to risk through its VIE structure, where maximum loss exposure includes potential worthlessness of transferred assets and off-balance sheet commitments, as disclosed in its 10-K Note 6, while JPM's valuation methodology for similar structured notes relies on discounted cash flow analyses incorporating embedded derivatives using models like Black-Scholes, with adjustments for own credit risk (DVA), as detailed in its 10-K Note on structured notes. Both institutions classify these instruments in Level 2 or 3 of the fair value hierarchy, but BAC's risk exposure is explicitly tied to VIE asset performance and contractual obligations, whereas JPM's approach emphasizes embedded derivative modeling techniques and DVA adjustments for valuation.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> CDOs (FIN_INST)",
        "CDOs (FIN_INST) -> Embedded Derivatives (FIN_INST)",
        "Embedded Derivatives (FIN_INST) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_187",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 8914,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2903,
        "completion_tokens": 202,
        "total_tokens": 3105
      }
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "The voting structure for CMCSA's Class B Common Stock is defined by its disclosure that Class B and C common stockholders have no voting rights on most matters except for specific limited cases (e.g., exiting the core payments business, certain consolidations/mergers, or amendments to the certificate of incorporation), where their voting power is calculated by multiplying the shares held by the applicable conversion rate on the record date. This contrasts with NFLX's common stock, which explicitly grants one vote per share on all matters to be voted upon by stockholders, as stated in its disclosure. The KG triplet relationship (Voting Rights → NFLX) confirms that NFLX's common stock carries standard voting rights, while CMCSA's Class B structure imposes significant limitations compared to NFLX's universal voting rights.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Voting Rights (ACCOUNTING_POLICY)",
        "Voting Rights (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 11385,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3518,
        "completion_tokens": 207,
        "total_tokens": 3726
      }
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "The treatment of embedded derivatives within CDOs differs between Morgan Stanley and JPMorgan Chase in both methodology and regulatory context. Morgan Stanley discloses embedded derivatives in CDOs within its VIE and structured note activities, particularly in re-securitization transactions and CLNs, where valuation depends on retained interests and ongoing involvement, without specifying a formal pricing model. In contrast, JPMorgan Chase explicitly details a valuation methodology for structured notes containing embedded derivatives, relying on discounted cash flow analyses and option pricing models like Black-Scholes, with adjustments for credit risk (DVA), and classifies these instruments as Level 2 or 3 in the fair value hierarchy. Both firms engage with structured products, but Morgan Stanley's approach is framed through VIE consolidation analysis and retained interests, while JPMorgan provides a standardized quantitative framework for embedded derivatives in its structured note products.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MS (ORG) -> CDOs (FIN_INST)",
        "CDOs (FIN_INST) -> Embedded Derivatives (FIN_INST)",
        "Embedded Derivatives (FIN_INST) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_187",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 10259,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3236,
        "completion_tokens": 252,
        "total_tokens": 3488
      }
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott faces significant exposure to intellectual property risks through its patent enforcement activities, particularly as they intersect with AbbVie's legal actions to protect the Vraylar (cariprazine) patent portfolio via its subsidiary Forest Laboratories Holdings Limited. This connection is formalized by the KG relationship where **Patent Enforcement** (a regulatory requirement) depends on **Forest Laboratories Holdings Limited**, which in turn has a stake in **AbbVie**, creating a direct link between Abbott's regulatory environment and AbbVie's patent litigation strategy. The litigation, filed in December 2019 in the U.S. District Court for the District of Delaware, involves Allergan (an AbbVie subsidiary) suing generic manufacturers for infringing patents covering Vraylar, with Gedeon Richter as a co-plaintiff in the global collaboration, directly threatening generic competition and thereby safeguarding AbbVie's revenue stream from this key product. For Abbott, this underscores how its own regulatory compliance landscape—particularly regarding patent enforcement mechanisms—is intertwined with AbbVie's aggressive legal efforts to maintain Vraylar's exclusivity, which is critical for AbbVie's pharmaceutical revenue, as patent protection directly impacts market exclusivity and pricing power for high-value drugs like Vraylar.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Involved_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Patent Enforcement (REGULATORY_REQUIREMENT)",
        "Patent Enforcement (REGULATORY_REQUIREMENT) -> Forest Laboratories Holdings Limited (COMP)",
        "Forest Laboratories Holdings Limited (COMP) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7887,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2695,
        "completion_tokens": 337,
        "total_tokens": 3032
      }
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup manages foreign exchange risk on its net investment in non-U.S.-dollar subsidiaries by using foreign currency forwards, cross‑currency swaps, options and foreign‑currency‑denominated debt, and it records the fair‑value changes of these instruments in CTA within AOCI under ASC 830‑20 and ASC 815‑35‑35. Morgan Stanley, by contrast, relies on Value‑at‑Risk (VaR) models as a core component of its market‑risk oversight for trading portfolios, using VaR to estimate aggregate market risk and to capture diversification and hedging benefits, while explicitly acknowledging VaR’s limitations and using it alongside stress tests and scenario analyses. Thus, Citigroup’s hedging strategy is a rules‑based, accounting‑driven approach that offsets specific foreign‑currency exposures in its investment portfolio, whereas Morgan Stanley’s risk management strategy is model‑driven, using VaR to quantify and monitor market risk across its trading books. Both firms disclose that their VaR methodologies are subject to modeling choices and regulatory approval, but only Morgan Stanley’s approach is centered on statistical VaR estimates rather than direct hedge accounting.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Evaluates]-> ACCOUNTING_POLICY -[Includes]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "C (ORG) -> Hedging Strategies (ACCOUNTING_POLICY)",
        "Hedging Strategies (ACCOUNTING_POLICY) -> Risk Management Tools (ACCOUNTING_POLICY)",
        "Risk Management Tools (ACCOUNTING_POLICY) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "C_10k_2024.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 14745,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4380,
        "completion_tokens": 293,
        "total_tokens": 4673
      }
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate-Palmolive employs option contracts as part of its foreign exchange hedging strategy, specifically designated as cash flow hedges for forecasted currency transactions, with net deferred gains in AOCI of $99 million maturing within twelve months, reflecting a structured approach to managing currency risk tied to manufacturing and sales across 200+ countries. In contrast, Walmart’s exposure is characterized through firm commitments—legally binding purchase obligations for inventory and services—that directly impact cash flow stability by requiring fixed or minimum quantity/price terms, with $15.9 billion of such unrecorded obligations due within one year, creating predictable but inflexible cash outflows that differ fundamentally from Colgate-Palmolive’s market-based derivative hedges.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Utilizes]-> FIN_INST -[Impacts]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Option Contracts (FIN_INST)",
        "Option Contracts (FIN_INST) -> Firm Commitments (FIN_INST)",
        "Firm Commitments (FIN_INST) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9324,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3009,
        "completion_tokens": 200,
        "total_tokens": 3209
      }
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "The adoption timeline of ASU No. 2023-07 differs between Thermo Fisher and CVS, with Thermo Fisher adopting the standard in 2024 for its annual report and interim periods thereafter using a retrospective method, while CVS adopted the standard on January 1, 2024 for fiscal year reporting with interim reporting effective after December 15, 2024, also requiring retrospective application to prior periods. Both companies were required to disclose significant segment expenses and details about how the chief operating decision maker uses segment performance measures to evaluate results and allocate resources, as mandated by the standard, with Thermo Fisher referencing increased disclosures in Note 11 and CVS directing readers to Note 19 for its newly required segment reporting disclosures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "TMO (ORG) -> ASU No. 2023-07 (ACCOUNTING_POLICY)",
        "ASU No. 2023-07 (ACCOUNTING_POLICY) -> Segment Reporting (ACCOUNTING_POLICY)",
        "Segment Reporting (ACCOUNTING_POLICY) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12086,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3704,
        "completion_tokens": 198,
        "total_tokens": 3902
      }
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "The Philippines' corporate income tax rate reduction enacted in Q1 2021 contributed to a 0.1‑percentage‑point increase in Accenture’s 2021 effective tax rate, raising it to 21.8% (as noted in PM_10k_2022.pdf). AMD’s 2021 filing shows that its effective tax rate was also affected by the same Tax Reform Act, with a statutory federal tax expense of $772 million at a 21% rate and a $71 million foreign rate detriment, indicating that both companies experienced tax‑reform impacts but AMD’s rate was driven primarily by foreign jurisdictional items rather than the Philippine rate cut.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Philippines (GPE)",
        "Philippines (GPE) -> Tax Reform Act (REGULATORY_REQUIREMENT)",
        "Tax Reform Act (REGULATORY_REQUIREMENT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 7251,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 2487,
        "completion_tokens": 145,
        "total_tokens": 2633
      }
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell employs pricing models to value fixed income investments in its pension plans, relying on observable inputs such as quoted prices, interest rates, and yield curves, supplemented by adjustments for unobservable risks like credit and liquidity; however, its use of NAV practical expedients for private equity, real estate, and hedge fund investments—valued using unobservable inputs—reflects a methodology that incorporates both observable and unobservable elements, as indicated by the KG triplet linking HON to Pricing Models and Fixed Income Investments. In contrast, 3M’s valuation approach, as detailed in its 10-K, categorizes fixed income investments into Level 1 (publicly traded, observable inputs), Level 2 (broker bids or pricing models with observable inputs), and Level 3 (discounted cash flows with unobservable inputs like projected annuity payments), explicitly emphasizing reliance on observable data for Level 1 and 2 assets while acknowledging Level 3’s dependence on unobservable assumptions, a distinction reinforced by the KG connection between Fixed Income Investments and MMM. Both companies use observable inputs for publicly traded securities but differ in their handling of private assets: Honeywell’s pension plans use NAV for private investments with unobservable inputs, while 3M’s methodology explicitly structures valuations around observable market data tiers, with Level 3 reserved for inputs that cannot be corroborated, highlighting a comparative reliance on observable inputs for routine valuations but divergent handling of non-observable elements in private market exposures.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> Pricing Models (ACCOUNTING_POLICY)",
        "Pricing Models (ACCOUNTING_POLICY) -> Fixed Income Investments (FIN_INST)",
        "Fixed Income Investments (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 9472,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3051,
        "completion_tokens": 405,
        "total_tokens": 3457
      }
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "The voting power distribution tied to Class B common stock conversion mechanisms at CMCSA, where holders of Class B common stock possess 33.3% of the aggregate voting power with each share entitled to 15 votes and conversion rights to Class A common stock that cannot be diluted by additional issuances, contrasts with GOOGL's share repurchase strategy for Class A and Class C shares, which involves authorized repurchases of $70 billion (with $36.3 billion remaining available as of 2023) that directly impacts equity structure by retiring shares and reducing outstanding shares without altering voting rights mechanisms tied to conversion. While CMCSA's Class B structure maintains fixed voting power through non-dilutive conversion rights and concentrated control, GOOGL's repurchases target Class A and Class C shares to manage equity levels and potentially influence market perception, with no direct connection to voting power distribution or conversion mechanisms as evidenced by the KG triplet relationship linking Class A Common Stock to CMCSA and Class B Common Stock to Class A Common Stock across both entities.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class B Common Stock (FIN_INST)",
        "Class B Common Stock (FIN_INST) -> Class A Common Stock (FIN_INST)",
        "Class A Common Stock (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3791,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1639,
        "completion_tokens": 280,
        "total_tokens": 1919
      }
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K notes that the U.S. is only a signatory to the FCTC and has not ratified it, so FCTC‑driven advertising restrictions remain largely non‑binding domestically, though the framework may still influence future U.S. policy — a situation reflected in the KG link **MO → FCTC → Advertising Bans**. In contrast, Philip Morris International operates in jurisdictions such as Australia and Russia where governments have already enacted enforceable advertising bans and point‑of‑sale display prohibitions, directly implementing the same FCTC‑recommended restrictions that PM’s 10‑K details — the KG path **Advertising Bans → PM** shows this concrete impact. Consequently, Altria’s international marketing strategy can rely on a less restrictive regulatory environment at home but must monitor potential future U.S. adoption of FCTC measures, while PM must continually adapt its branding, packaging and promotional tactics to comply with binding bans abroad, shaping a more constrained global go‑to‑market approach.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Calls_For]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "triplets_used": [
        "MO (ORG) -> FCTC (REGULATORY_REQUIREMENT)",
        "FCTC (REGULATORY_REQUIREMENT) -> Advertising Bans (REGULATORY_REQUIREMENT)",
        "Advertising Bans (REGULATORY_REQUIREMENT) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18563,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5356,
        "completion_tokens": 255,
        "total_tokens": 5611
      }
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs’ cryptocurrency offering is hampered by Dodd‑Frank limits on proprietary trading and fund investments that apply more strictly to U.S. banks, giving JPMorgan a competitive edge in digital‑asset services; this regulatory drag is amplified by the Basel rules and Title VII derivative constraints that disproportionately affect U.S.‑based firms. Meanwhile, Morgan Stanley’s exposure to emerging‑market regulatory risk—through sanctions, AML, and evolving foreign securities laws—could constrain its cross‑border crypto‑related transactions, creating a different but equally material regulatory hurdle for its global crypto finance activities.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Offers]-> PRODUCT <-[Impacted_By]- ORG",
      "triplets_used": [
        "GS (ORG) -> JPMorgan (COMP)",
        "JPMorgan (COMP) -> Cryptocurrencies (PRODUCT)",
        "Cryptocurrencies (PRODUCT) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 18160,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 5227,
        "completion_tokens": 163,
        "total_tokens": 5390
      }
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "The adoption of ASU 2022‑04 requires both 3M and GE to disclose roll‑forward information for their supplier‑finance programs, with the roll‑forward disclosure becoming mandatory beginning on January 1 2024. 3M’s Note 16 shows that it adopted the ASU in 2023 and began providing the required roll‑forward data in 2024, while GE’s Note 15 confirms it adopted the same standard on January 1 2023 and, beginning in 2024, must present the annual roll‑forward disclosure for its supplier‑finance obligations.  Consequently, both companies now include the roll‑forward details—such as the confirmed invoice balances and the amounts reclassified from accumulated other comprehensive income—alongside the standard supplier‑finance program disclosures mandated by ASU 2022‑04.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Agrees]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Adopts]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Supplier Finance Programs (ACCOUNTING_POLICY)",
        "Supplier Finance Programs (ACCOUNTING_POLICY) -> ASU 2022-04 (ACCOUNTING_POLICY)",
        "ASU 2022-04 (ACCOUNTING_POLICY) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 17062,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 4950,
        "completion_tokens": 191,
        "total_tokens": 5141
      }
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "MDT's revenue exposure to \"Other Countries\" (32,251 million in 2024) reflects a heavy geographic concentration that subjects the company to the same coverage‑limitation and reimbursement pressures that affect AMGN's drug pricing abroad; both firms operate in markets where government‑sponsored health systems impose price controls, mandatory discounts, and outcome‑based reimbursement that can erode margins and limit market access.  This regulatory environment—highlighted by DHR's focus on obtaining necessary approvals and managing reimbursement risk and by AMGN's discussion of PDABs, price‑setting legislation, and EU reforms—means that MDT’s international sales are vulnerable to the same reimbursement constraints and pricing pressures that shape AMGN’s drug‑pricing strategy.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> GPE -[Control]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Other Countries (GPE)",
        "Other Countries (GPE) -> Coverage Limitations (REGULATORY_REQUIREMENT)",
        "Coverage Limitations (REGULATORY_REQUIREMENT) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 12246,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 3742,
        "completion_tokens": 195,
        "total_tokens": 3938
      }
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "The combined capital buffer requirement for SCHW exceeds its minimum risk-based capital ratios by 2.5% for both the Countercyclical Capital Buffer (CCyB) and Capital Conservation Buffer (CCB), as explicitly stated in Chunk 1 which confirms CSC maintains a 2.5% CCyB and 2.5% CCB above regulatory minimums. In contrast, JPMorgan Chase's capital buffer requirements (Chunk 2 and 3) are structured differently: its standardized approach buffer equals the sum of SCB, G-SIB surcharge, and CCyB (with CCyB currently at 0%), while its advanced approach buffer includes a fixed 2.5% CCB plus the 2.5% CCB buffer applicable to JPMorgan Chase Bank, N.A. (Chunk 2), but critically, JPMorgan Chase Bank, N.A. is not subject to the GSIB surcharge (Chunk 3), meaning its total buffer composition differs from SCHW's structure. Thus, while SCHW's buffers are explicitly defined as additive requirements above minimums (2.5% CCyB + 2.5% CCB), JPMorgan's requirements incorporate the 2.5% CCB within its buffer calculations but do not specify an additional standalone CCyB buffer above minimums like SCHW, making direct comparison of their \"combined buffer requirements above minimums\" impossible due to fundamentally different regulatory frameworks—Chunk 1 establishes SCHW's 5.0% total buffer (2.5% CCyB + 2.5% CCB), whereas Chunk 2 and 3 describe JPMorgan's buffers as context-dependent components (e.g., CCyB at 0% currently) without an equivalent additive requirement above minimums.",
      "llm_thought": "",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Countercyclical Capital Buffer (REGULATORY_REQUIREMENT)",
        "Countercyclical Capital Buffer (REGULATORY_REQUIREMENT) -> Capital Conservation Buffer (REGULATORY_REQUIREMENT)",
        "Capital Conservation Buffer (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_3_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_291",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 3,
        "total_chars": 3921,
        "triplets_count": 3
      },
      "token_usage": {
        "prompt_tokens": 1689,
        "completion_tokens": 368,
        "total_tokens": 2057
      }
    }
  ]
}